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1 Summary	  
Complex	  multicellular	  organisms	  give	  rise	  to	  a	  wide	  range	  of	  cell	  types	  and	  tissues,	  even	  though	  all	  the	  cells	  share	  the	  same	  DNA	  sequence.	  Key	  to	  this	  diversity	  is	  differential	  gene	  expression	  in	  the	  different	  types	  of	  cells.	  Gene	  expression	  is	  orchestrated	  by	  regulatory	  DNA	  sequences,	  which	  can	  be	  bound	  by	  transcription	  factors	  mediating	  the	  activation	  or	  repression	  of	  a	  target	  gene.	  These	  processes	  interplay	  with	  epigenetic	  mechanisms	  including	  DNA	  methylation	  and	  histone	  modifications	  that	  shape	  the	  chromatin	  structure	  and	  control	  its	  accessibility	  for	  transcription	  factors	  and	  other	  accessory	  proteins.	  Here,	  regulatory	  and	  conventional	  T	  cells	  (Treg	  and	  Tconv,	  respectively)	  were	  utilized	  as	  a	  model	  system	  to	  get	  basic	  insights	  in	  differential	  gene	  expression	  and	  how	  it	  is	  affected	  by	  epigenetic	  mechanisms.	  Treg	  can	  suppress	  the	  activation,	  proliferation	  and	  function	  of	  a	  wide	  range	  of	  immune	  cells	  and	  are	  thus	  indispensable	  for	  immune	  homeostasis	  and	  tolerance	  to	  self-­‐antigens.	  Tconv	  develop	  into	  different	  T	  helper	  (Th)	  cells	  that	  boost	  specialized	  immune	  reactions.	  Both	  Treg	  as	  well	  as	  Tconv	  are	  closely	  related	  CD4+	  T	  cells	  and,	  due	  to	  their	  variable	  abilities	  a	  suitable	  model	  to	  study	  differential	  gene	  expression.	  An	  adaption	  of	  our	  methyl-­‐CpG-­‐immunoprecipitation	  method	  allowed	  us	  to	  systematically	  investigate	  DNA	  methylation	  in	  T	  cells,	  which	  resulted	  in	  the	  identification	  of	  more	  than	  130	  differentially	  methylated	  regions	  (DMRs)	  between	  Treg	  and	  Tconv.	  The	  DMRs	  were	  located	  in	  the	  vicinity	  of	  immunologically	  important	  genes	  including	  FOXP3,	  CTLA4,	  IL2RA	  and	  CD40LG.	  Most	  DMRs	  had	  a	  low	  CpG	  content,	  showed	  no	  conservation	  and	  did	  not	  overlap	  with	  a	  gene	  promoter.	  In	  addition,	  it	  was	  demonstrated	  that	  many	  DMRs	  were	  associated	  with	  “active”	  histone	  modifications	  and	  showed	  enhancer	  activity	  in	  reporter	  assays.	  These	  results	  were	  among	  the	  first	  to	  describe	  widespread	  differences	  in	  DNA	  methylation	  at	  non-­‐promoter	  regions	  and	  to	  connect	  them	  to	  enhancer	  function.	  	  CD4+CD25+	  Treg	  represent	  a	  heterogeneous	  population	  and	  consist	  of	  CD45RA+	  naïve	  Treg	  as	  well	  as	  CD45RA-­‐	  memory	  Treg.	  Upon	  in	  vitro	  expansion	  CD45RA-­‐	  memory	  Treg	  downregulate	  the	  expression	  of	  the	  Treg	  lineage-­‐determining	  transcription	  factor	  FOXP3.	  Hence,	  we	  improved	  technologies	  to	  obtain	  DNA	  and	  RNA	  from	  intracellular	  FOXP3-­‐stained	  and	  sorted	  human	  Treg	  to	  analyze	  stability,	  plasticity	  and	  heterogeneity	  of	  Treg	  subpopulations.	  Gene	  expression	  analyses	  demonstrated	  that	  in	  vitro	  expanded	  CD45RA-­‐FOXP3-­‐	  Treg	  differentiated	  into	  a	  proinflammatory	  Th2-­‐like	  phenotype	  and	  expressed	  the	  Th2-­‐associated	  transcription	  factor	  GATA3	  as	  well	  as	  the	  cytokines	  IL-­‐4,	  IL-­‐5	  and	  IL-­‐13.	  Blockade	  of	  the	  Th2-­‐inducing	  IL-­‐4	  signaling	  pathway	  did	  not	  abrogate	  the	  observed	  Th2	  differentiation,	  arguing	  for	  a	  yet	  unknown,	  alternative	  pathway.	  In	  addition,	  in	  vitro	  expanded	  CD45RA-­‐	  Treg	  expressed	  the	  Th17-­‐determining	  transcription	  factor	  RORC	  and	  IL-­‐17A,	  with	  the	  most	  significant	  increase	  in	  FOXP3+	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cells.	  In	  line	  with	  these	  observations,	  CpGs	  at	  the	  RORC	  locus	  were	  most	  prominently	  demethylated	  in	  in	  vitro	  expanded	  CD45RA-­‐FOXP3+	  cells	  similar	  to	  the	  methylation	  status	  of	  in	  
vitro	  generated	  Th17	  cells.	  In	  contrast,	  CD45RA+	  naïve	  Treg	  showed	  a	  stable	  phenotype	  without	  converting	  into	  proinflammatory	  Th2	  or	  Th17-­‐like	  cells	  even	  after	  prolonged	  in	  vitro	  expansion,	  and	  therefore	  represent	  the	  most	  promising	  population	  for	  clinical	  applications.	  In	  the	  context	  of	  the	  FANTOM5	  project,	  modern	  sequencing	  methods	  identified	  the	  exact	  location	  of	  transcription	  start	  sites	  (TSS)	  in	  primary	  and	  in	  vitro	  expanded	  naïve	  and	  memory	  Treg	  and	  Tconv.	  Several	  thousand	  non-­‐annotated	  TSS	  were	  discovered,	  and	  some	  were	  validated	  as	  alternative	  promoters	  of	  known	  genes	  including	  the	  well-­‐studied	  Treg-­‐specific	  FOXP3	  and	  
CTLA4	  genes.	  In	  addition,	  genome-­‐wide	  histone	  modification	  profiling	  generated	  the	  most	  comprehensive	  atlas	  of	  cell	  type-­‐specific	  enhancers	  in	  Treg	  and	  Tconv	  subpopulations.	  De	  novo	  motif	  analysis	  of	  enhancer	  elements	  identified	  transcription	  factors	  that	  were	  potentially	  involved	  in	  cell	  type-­‐specific	  gene	  regulation.	  Continuative	  experiments	  could	  demonstrate	  a	  participation	  of	  the	  transcription	  factors	  STAT5	  as	  well	  as	  FOXP3	  and	  ETS1	  as	  well	  as	  RUNX1	  in	  Treg-­‐	  or	  Tconv-­‐specific	  enhancer	  architecture,	  respectively.	  	  	  Taken	  together,	  the	  molecular	  characterization	  of	  Treg	  and	  Tconv	  subpopulations	  described	  in	  this	  thesis	  provided	  insights	  into	  basic	  principles	  of	  gene	  regulation	  and	  demonstrates	  the	  impact	  of	  DNA	  methylation,	  histone	  modifications	  and	  transcription	  factor	  binding	  on	  cell	  type-­‐specific	  gene	  expression.	  Moreover,	  technical	  refinements	  of	  standard	  methodologies	  allowed	  the	  concrete	  analysis	  of	  the	  stability,	  heterogeneity	  as	  well	  as	  plasticity	  of	  T	  cell	  subsets.	  The	  integrated	  analysis	  of	  genome-­‐wide	  datasets	  helped	  to	  define	  key	  regulators	  that	  shape	  gene	  expression	  programs	  of	  T	  cell	  subpopulations	  and	  will	  be	  of	  use	  to	  improve	  the	  therapeutic	  potential	  of	  Treg	  for	  clinical	  applications.	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2 Introduction	  
One	  of	  the	  most	  fascinating	  aspects	  of	  complex	  multicellular	  development	  is	  the	  ability	  of	  a	  single	  genome	  to	  give	  rise	  to	  a	  wide	  panel	  of	  different	  cell	  types	  and	  tissues,	  all	  with	  unique	  phenotypes	  and	  abilities.	  How	  can	  these	  differences	  in	  development	  and	  function	  be	  achieved	  when	  all	  these	  cell	  types	  share,	  with	  minor	  exceptions,	  the	  same	  DNA	  sequence?	  The	  answer	  to	  this	  question	  is	  differential	  gene	  expression.	  In	  each	  distinct	  cell	  type	  only	  a	  fraction	  of	  all	  genes	  encoded	  in	  the	  DNA	  sequence	  –that	  is	  to	  say	  the	  genes	  needed	  for	  its	  phenotype	  and	  function–	  are	  transcribed.	  The	  decision	  to	  what	  extent	  a	  gene	  is	  transcribed	  is	  controlled	  by	  so-­‐called	  regulatory	  modules,	  which	  are	  DNA-­‐elements	  that	  can	  integrate	  environmental	  and	  inherited	  cues	  to	  establish	  cell	  type-­‐specific	  gene	  expression	  programs.	  The	  current	  understanding	  classifies	  regulatory	  modules	  into	  promoters,	  enhancers,	  silencers	  and	  boundary	  elements.	  These	  DNA	  sequences	  can	  bind	  transcription	  factors	  (TFs)	  that	  activate	  or	  repress	  the	  binding	  and	  activity	  of	  the	  basal	  transcription	  machinery	  to	  influence	  transcription	  of	  a	  target	  gene	  and	  hence	  ultimately	  shape	  the	  cellular	  phenotype.	  These	  processes	  interplay	  with	  epigenetic	  mechanisms,	  namely	  DNA	  methylation,	  histone	  modifications	  and	  non-­‐coding	  RNAs	  that	  shape	  the	  chromatin	  structure	  and	  control	  its	  accessibility	  for	  TFs	  and	  other	  accessory	  proteins.	  	  The	  main	  focus	  of	  this	  thesis	  lies	  on	  regulatory	  and	  conventional	  T	  cells	  (Treg	  and	  Tconv).	  As	  explained	  below,	  the	  former	  are	  a	  specialized	  immune	  cell	  population	  that	  is	  crucial	  for	  immune	  tolerance	  and	  homeostasis.	  Further,	  the	  administration	  of	  Treg	  is	  explored	  as	  a	  curative	  treatment	  for	  immunological	  and	  transplantation-­‐related	  diseases.	  Treg	  and	  Tconv	  are	  both	  closely	  related	  hematopoietic	  cells	  emerging	  from	  the	  same	  progenitor.	  Nevertheless,	  both	  cell	  types	  have	  different	  development	  potential,	  phenotype	  and	  function	  ascribed	  to	  their	  specialized	  gene	  expression	  programs,	  which	  renders	  comparative	  analysis	  of	  Treg	  and	  Tconv	  cells	  a	  suitable	  model	  to	  study	  genetic	  and	  epigenetic	  mechanisms	  of	  differential	  gene	  expression.	  With	  regards	  to	  their	  crucial	  role	  in	  maintaining	  a	  stable	  immune	  system	  and	  with	  respect	  to	  their	  clinical	  application,	  the	  analysis	  of	  gene	  regulation	  in	  Treg	  compared	  to	  Tconv	  will	  not	  only	  give	  insights	  into	  basic	  mechanisms	  of	  differential	  gene	  expression;	  it	  will	  also	  be	  essential	  to	  understand	  Treg	  development	  and	  function	  and	  thereby	  help	  to	  improve	  their	  effective	  and	  save	  clinical	  application.	  Thus,	  in	  the	  first	  part	  of	  the	  introduction	  basic	  concepts	  of	  gene	  regulation	  are	  described	  while	  the	  specific	  characterization	  on	  gene	  regulation	  of	  regulatory	  t	  cells	  is	  introduced	  in	  the	  second	  part.	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2.1 Epigenetics	  
2.1.1 DNA	  methylation	  Proposed	  in	  1975	  by	  Holliday	  and	  Pugh,	  the	  longest	  known	  epigenetic	  modification	  is	  the	  attachment	  of	  a	  methyl	  group	  (CH3)	  to	  the	  5’	  carbon	  atom	  of	  the	  base	  cytosine	  (C)	  (Holliday	  and	  Pugh	  1975).	  In	  mammals,	  5’-­‐methyl	  cytosine	  (5mC)	  is	  mainly	  associated	  with	  guanine	  (G)	  in	  CG	  dinucleotides	  (CpGs)	  although	  recent	  findings	  confirm	  early	  reports	  describing	  non-­‐CpG	  methylation	  in	  embryonic	  stem	  cells	  (Salomon	  and	  Kaye	  1970;	  Grafstrom	  et	  al.	  1985;	  Ramsahoye	  et	  al.	  2000;	  Lister	  et	  al.	  2009).	  DNA	  methylation	  is	  considered	  to	  mediate	  stable	  gene	  silencing	  at	  promoters	  and	  is	  essential	  for	  embryonic	  development	  (Li	  et	  al.	  1992;	  Okano	  et	  al.	  1999),	  genomic	  imprinting	  (Li	  et	  al.	  1993),	  centromeric	  stability	  (Moarefi	  and	  Chédin	  2011),	  splicing	  (Shukla	  et	  al.	  2011),	  X	  chromosome	  inactivation	  in	  mammals	  (Lee	  2011)	  and	  silencing	  of	  potential	  harmful	  DNA	  elements	  such	  as	  endogenous	  retroviruses	  and	  transposons	  (Bird	  2002).	  Aberrant	  DNA	  methylation	  has	  been	  associated	  with	  abnormal	  developmental	  processes	  including	  cancer	  (Plass	  and	  Soloway	  2002).	  In	  mammals	  three	  known	  enzymes,	  DNA	  methyltransferase	  1,	  3A	  and	  3B	  (DNMT1,	  3A	  and	  3B)	  catalyze	  the	  transfer	  of	  CH3	  from	  S-­‐adenosylmethionine	  (SAM)	  to	  cytosine	  (Wigler	  et	  al.	  1981;	  Okano	  et	  al.	  1999).	  DNMT1	  is	  the	  “maintenance”	  methyltransferase	  that	  adds	  methyl	  groups	  to	  the	  newly	  synthesized	  and	  therefore	  hemimethylated	  DNA-­‐strand	  after	  replication,	  providing	  the	  basis	  for	  inheriting	  methylation	  patterns	  over	  cell	  divisions	  and	  therefore	  rendering	  DNA	  methylation	  the	  only	  “real”	  epigenetic	  mark	  (Wigler	  et	  al.	  1981).	  Dnmt3A	  and	  Dnmt3B	  catalyze	  de	  novo	  methylation	  but	  might	  also	  be	  involved	  in	  maintaining	  methylation	  patterns	  (Okano	  et	  al.	  1999;	  Jones	  and	  Liang	  2009).	  DNA	  methylation	  is	  essential	  for	  normal	  development,	  as	  murine	  knockout	  mice	  for	  all	  three	  DNMTs	  die	  in	  utero	  or	  shortly	  after	  birth,	  and	  mutations	  in	  DNMT3B	  are	  associated	  with	  the	  ICF	  syndrome	  (immunodeficiency,	  centromeric	  instability	  and	  facial	  anomalies)	  in	  humans	  (Xu	  et	  al.	  1999).	  CpG	  dinucleotides	  show	  a	  bimodal	  distribution	  throughout	  the	  genome:	  Most	  CpGs	  in	  mammals	  are	  methylated,	  distributed	  randomly	  and	  appear	  rarer	  than	  statistically	  expected,	  possibly	  caused	  by	  hydrolytic	  deamination	  of	  5mC	  to	  thymine,	  resulting	  in	  a	  C	  to	  T	  transition	  and	  a	  decrease	  of	  CpGs	  over	  time	  in	  evolution	  (Jones	  2012).	  However,	  there	  are	  also	  regions	  with	  higher	  CpG	  density,	  so	  called	  CpG	  islands	  (CGIs)	  that	  are	  often	  associated	  with	  promoter	  regions	  and	  are	  preferentially	  unmethylated	  (Suzuki	  and	  Bird	  2008).	  Basically,	  DNA	  methylation	  can	  influence	  gene	  expression	  by	  (i)	  steric	  hindrance	  of	  protein	  binding	  to	  DNA	  due	  to	  the	  exposure	  of	  the	  methyl	  group	  into	  the	  DNA-­‐helix	  grooves	  (Tate	  1993)	  and	  (ii)	  by	  attracting	  gene-­‐regulatory	  proteins	  recognizing	  5mC	  (methyl-­‐CpG	  binding	  proteins,	  MBPs)	  (Robertson	  2000).	  The	  proteins	  MBD1,	  2	  and	  4	  as	  well	  as	  MeCP2	  can	  bind	  methylated	  DNA	  with	  their	  methyl-­‐CpG	  binding	  domain	  (MBD)	  while	  the	  protein	  Kaiso	  does	  so	  with	  its	  zinc-­‐finger	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domain	  (Prokhortchouk	  et	  al.	  2001;	  Klose	  and	  Bird	  2006).	  The	  MBPs	  come	  in	  complexes	  with	  repressor	  molecules	  that	  alter	  gene	  expression	  by	  the	  modification	  of	  the	  chromatin	  conformation,	  as	  explained	  later	  (Jones	  et	  al.	  1998;	  Nan	  et	  al.	  1998;	  Ng	  et	  al.	  1999;	  Zhang	  et	  al.	  1999).	  Subject	  of	  controversy	  is	  the	  mechanism	  of	  active	  DNA	  demethylation	  (Ooi	  and	  Bestor	  2008).	  Passive	  demethylation	  after	  DNA	  replication	  can	  be	  logically	  explained	  by	  TFs	  occupying	  DNA	  and	  thereupon	  blocking	  DNMT-­‐mediated	  remethylation	  of	  the	  hemimethylated	  DNA	  strand.	  However,	  DNA	  demethylation	  was	  observed	  in	  differentiation	  models	  in	  the	  absence	  of	  cell	  division	  and	  thereby	  DNA	  replication	  (Klug	  et	  al.	  2010),	  arguing	  for	  active	  demethylation	  processes.	  The	  role	  of	  activation-­‐induced	  cytidine	  deaminases	  (AID),	  thymine	  DNA	  glycosidases	  (TDG),	  alpha	  growth	  arrest	  and	  DNA-­‐damage-­‐inducible	  (GADD45a)	  and	  ten-­‐eleven	  translocation	  (TET)	  dioxygenases	  in	  active	  demethylation	  processes	  are	  currently	  under	  investigation	  (Ooi	  and	  Bestor	  2008;	  Jones	  2012).	  TET	  proteins	  can	  process	  5mC	  to	  5-­‐formylcytosine	  and	  5-­‐carboxylcytosine	  that	  are	  readily	  excised	  by	  TDG	  as	  a	  possible	  mechanism	  of	  active	  demethylation	  (Ito	  et	  al.	  2010;	  He	  et	  al.	  2011;	  Ito	  et	  al.	  2011).	  However,	  the	  mechanisms	  of	  active	  demethylation	  need	  further	  investigations,	  preferentially	  in	  non-­‐artificial	  systems	  to	  exclude	  aberrant	  methylation	  phenomena	  described	  for	  cell	  lines	  and	  in	  vitro	  differentiation	  systems	  (Paz	  et	  al.	  2003;	  Meissner	  et	  al.	  2008).	  
2.1.2 Chromatin	  DNA	  is	  packed	  into	  chromatin,	  which	  consists	  of	  DNA,	  histone	  proteins	  and	  non-­‐histone	  proteins	  (Bell	  et	  al.	  2011).	  The	  basic	  subunit	  of	  chromatin	  is	  the	  nucleosome	  core	  particle,	  comprised	  of	  ~145	  base	  pairs	  (bp)	  of	  DNA	  wrapped	  around	  an	  octamer	  consisting	  of	  two	  copies	  each	  of	  histones	  H2A,	  H2B,	  H3	  and	  H4	  in	  a	  1.65	  left-­‐handed,	  superhelical	  turn	  (Kornberg	  and	  Thomas	  1974;	  Kornberg	  1977;	  Luger	  et	  al.	  1997).	  The	  nucleosomes	  are	  arranged	  like	  “beads	  on	  a	  string”,	  and	  metazoan	  chromatin	  contains	  the	  linker	  histone	  H1	  that	  helps	  to	  condense	  the	  “string”	  into	  a	  tighter	  packed,	  higher	  order	  structure	  whose	  organization	  is	  still	  incompletely	  understood	  (Felsenfeld	  and	  Groudine	  2003).	  The	  packing	  of	  DNA	  into	  chromatin	  is	  repressive	  to	  transcription	  per	  se	  as	  it	  potentially	  blocks	  the	  accessibility	  of	  DNA	  elements	  for	  transcription	  factors	  and	  the	  transcription	  machinery	  (Lorch	  et	  al.	  1987).	  Therefore,	  the	  chromatin	  accessibility	  of	  regulatory	  elements	  such	  as	  promoters	  and	  enhancers	  is	  actively	  formed.	  Classically,	  regions	  of	  compacted	  chromatin	  are	  termed	  heterochromatin,	  whereas	  accessible	  chromatin	  is	  called	  euchromatin	  (Bell	  et	  al.	  2011).	  As	  a	  part	  of	  chromatin	  modifying	  processes,	  ATP-­‐dependent	  remodeling	  complexes	  are	  capable	  of	  positioning	  or	  removing	  nucleosomes	  on	  the	  DNA	  (Clapier	  and	  Cairns	  2009)	  to	  expose	  regulatory	  sequences	  to	  their	  target	  proteins.	  In	  addition,	  post-­‐translational	  modifications	  (PTMs)	  of	  histones	  regulate	  chromatin	  accessibility:	  Amino	  acids	  on	  the	  N-­‐terminal	  histone	  tails	  can	  be	  acetylated,	  phosphorylated,	  β-­‐N-­‐
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acetylglucosaminated,	  ADP-­‐ribosylated,	  deaminated,	  ubiquitinated	  and	  sumoylated	  (Bannister	  and	  Kouzarides	  2011).	  	  Methylation	  and	  acetylation	  are	  the	  best-­‐studied	  histone	  PTMs.	  Histone	  acetylation	  is	  mediated	  by	  the	  opposing	  action	  of	  histone	  acetyl	  transferases	  (HAT)	  and	  histone	  deacetylases	  (HDAC).	  Acetylation	  of	  histones	  is	  supposed	  to	  decrease	  the	  interaction	  of	  positively	  charged	  lysine	  residues	  of	  histone	  tails	  with	  the	  negatively	  charged	  DNA	  sugar-­‐phosphate	  backbone	  to	  promote	  an	  accessible	  chromatin	  conformation	  (Sterner	  and	  Berger	  2000).	  More	  important,	  gene-­‐regulatory	  proteins	  with	  a	  bromodomain	  can	  recognize	  and	  bind	  acetylated	  histones.	  To	  name	  just	  a	  few,	  remodeling	  complexes	  such	  as	  SWI/SNF	  (Hassan	  et	  al.	  2002),	  coactivators	  (Dhalluin	  et	  al.	  1999),	  as	  well	  as	  the	  general	  TF	  TFIID	  (Jacobson	  et	  al.	  2000)	  have	  a	  bromodomain	  and	  can	  be	  recruited	  by	  acetylated	  histones	  to	  promote	  transcription.	  Histone	  methylation	  is	  mainly	  observed	  at	  arginine	  and	  lysine	  residues	  of	  histone	  tails	  and	  controlled	  by	  histone	  methyl	  transferases	  (HMT)	  or	  recently	  discovered	  histone	  demethylases	  (Shi	  et	  al.	  2004).	  As	  an	  example,	  Histone	  3	  Lysine	  4	  methylation	  (H3K4me)	  is	  associated	  with	  “active”	  chromatin	  in	  eukaryotes	  (Bernstein	  et	  al.	  2005;	  Barski	  et	  al.	  2007).	  The	  modification	  is	  established	  by	  SET	  domain	  containing	  HMTs	  that	  are	  recruited	  to	  the	  target	  histones	  by	  other	  histone	  modifications	  such	  as	  ubiquitinated	  H2B,	  the	  active	  form	  of	  RNA	  Polymerase	  II	  (PolII)	  or	  specific	  TFs	  (Shilatifard	  2008).	  The	  established	  H3K4me	  can	  be	  “read”	  by	  other	  factors	  with	  a	  chromodomain	  such	  as	  some	  chromatin	  remodeling	  complexes	  (Santos-­‐Rosa	  et	  al.	  2003;	  Wysocka	  et	  al.	  2006),	  HATs	  (Vermeulen	  et	  al.	  2010)	  and	  TFIID	  (Vermeulen	  et	  al.	  2007)	  to	  promote	  transcription.	  Interestingly,	  the	  latter	  binding	  is	  synergistically	  enhanced	  by	  H3K14	  acetylation.	  In	  contrast,	  H3K9	  di-­‐	  and	  trimethylation	  is	  catalyzed	  by	  the	  HMT	  Suv39H1	  and	  is	  recognized	  by	  heterochromatin	  protein	  1	  (HP1)	  that	  helps	  to	  stably	  compact	  chromatin	  (Bannister	  et	  al.	  2001;	  Peters	  et	  al.	  2001;	  Beisel	  and	  Paro	  2011).	  Suv39H1	  interacts	  with	  HP1,	  providing	  a	  possible	  “feed	  forward”	  mechanism	  of	  H3K9	  methylation	  and	  HP1	  binding	  to	  sustain	  chromatin	  compaction	  once	  it	  was	  initiated	  (Schotta	  et	  al.	  2002).	  Classes	  of	  histone	  modifying	  enzymes	  that	  are	  supposed	  to	  set	  and	  interpret	  histone	  modifications	  to	  maintain	  a	  certain	  chromatin	  state	  as	  described	  for	  HP1-­‐Suv39H1	  are	  the	  trithorax	  group	  (TrxG)	  and	  polycomb	  group	  (PcG)	  proteins	  (Ringrose	  2007).	  TrxG	  include	  HMTs	  to	  set	  H3K4	  methylation	  as	  already	  described	  and	  stabilize	  chromatin	  states	  favoring	  transcription.	  Contrary,	  PcG	  proteins	  come	  in	  large	  complexes	  and	  establish	  and	  maintain	  a	  chromatin	  environment	  repressive	  for	  transcription.	  The	  polycomb	  repression	  complex	  2	  (PRC2)	  methylates	  H3K27	  and	  creates	  a	  platform	  for	  polycomb	  repressive	  complex	  1	  (PRC1)	  that	  establishes	  a	  compacted	  chromatin	  environment	  repressing	  transcription	  (Ringrose	  2007).	  	  Interestingly,	  PcG-­‐mediated	  silencing	  is	  interconnected	  to	  DNA	  methylation.	  PRC2	  directly	  controls	  DNA	  methylation	  by	  interacting	  with	  DNMTs	  (Viré	  et	  al.	  2006).	  Further,	  promoters	  with	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H3K27me	  are	  more	  frequently	  de	  novo	  methylated	  than	  other	  promoters	  and	  undergo	  aberrant	  DNA	  methylation	  in	  human	  cancers,	  suggesting	  that	  the	  PcG-­‐repressed	  state	  is	  established	  during	  development	  and	  may	  predispose	  genes	  to	  de	  novo	  methylation	  in	  early	  developmental	  processes	  (Schlesinger	  et	  al.	  2007;	  Mohn	  et	  al.	  2008).	  Moreover,	  the	  interplay	  of	  DNA	  methylation	  and	  chromatin	  structure	  is	  illustrated	  by	  the	  associations	  of	  the	  aforementioned	  MBPs	  with	  chromatin-­‐modifying	  enzymes.	  MeCP2	  for	  example	  is	  associated	  with	  the	  Sin3A/HDAC	  corepressor	  complex	  (Jones	  et	  al.	  1998;	  Nan	  et	  al.	  1998).	  In	  addition,	  the	  MeCP1	  complex	  is	  associated	  with	  HDACs	  and	  can	  bind	  methylated	  DNA	  via	  MBD2	  (Ng	  et	  al.	  1999).	  Moreover,	  MBD1	  can	  also	  bind	  methylated	  DNA	  and	  act	  as	  a	  repressor	  (Fujita	  et	  al.	  2000).	  In	  contrast	  to	  these	  processes	  that	  prohibit	  chromatin	  access	  for	  transcription,	  the	  recently	  identified	  protein	  Cfp1	  is	  recruited	  to	  unmethylated	  CpG	  islands	  and	  interacts	  with	  a	  H3K4	  methyltransferase	  to	  create	  a	  chromatin	  environment	  that	  favors	  transcription	  (Lee	  et	  al.	  2007;	  Thomson	  et	  al.	  2010).	  
2.1.3 Non-­‐coding	  RNAs	  Due	  to	  their	  active	  participation	  in	  shaping	  the	  chromatin	  environment,	  short	  (<200	  nucleotides)	  and	  long	  (>200	  nucleotides)	  non-­‐coding	  RNAs	  are	  classified	  as	  “epigenetic”	  regulators	  as	  well.	  First	  described	  in	  1961	  (Lyon	  1961),	  the	  phenomenon	  of	  X	  chromosome	  inactivation	  in	  mammals	  (XCI)	  is	  a	  prime	  example	  of	  RNA-­‐mediated	  regulation	  of	  gene	  expression.	  In	  females,	  one	  of	  the	  two	  X	  chromosomes	  is	  inactivated	  during	  embryogenesis,	  a	  process	  controlled	  by	  antagonistic	  roles	  of	  two	  non-­‐coding	  RNAs,	  Xist	  and	  Tsix	  (Lee	  2011):	  Sustained	  expression	  of	  Tsix	  prevents	  expression	  of	  Xist	  and	  XCI,	  but	  when	  XCI	  is	  initiated	  Tsix	  expression	  is	  lost	  at	  one	  X	  chromosome.	  This	  allows	  transcription	  of	  the	  lncRNA	  Xist,	  and	  Polycomb	  repressive	  complex	  2	  is	  recruited	  to	  a	  PRC2-­‐binding	  motif	  in	  the	  lncRNA	  and	  effectively	  tethered	  to	  the	  locus	  via	  PolII.	  The	  RNA–PRC2	  complex	  is	  loaded	  onto	  chromatin	  co-­‐transcriptionally	  through	  TFs	  such	  as	  YY1,	  promoting	  H3K27me3	  and	  heterochromatin	  formation	  in	  cis	  (Lee	  2011).	  In	  fission	  yeast,	  transcription	  of	  repeat	  regions	  within	  heterochromatin	  domains	  triggers	  the	  RNA	  interference	  machinery,	  generating	  small	  21	  nucleotide	  long	  RNAs	  (siRNAs).	  The	  siRNAs	  associate	  with	  Argonaute	  protein	  (Ago1)	  and	  guide	  the	  Ago1-­‐containing	  RNA-­‐induced	  initiation	  of	  the	  transcriptional	  gene-­‐silencing	  complex	  (RITS	  complex)	  to	  homologous	  sequences	  of	  nascent	  chromatin-­‐associated	  transcripts	  for	  heterochromatin	  formation	  (Bühler	  et	  al.	  2006).	  Recently	  it	  was	  demonstrated	  that	  small	  RNA	  species	  (piRNAs)	  act	  in	  trans	  to	  silence	  transposable	  elements	  in	  mammals	  by	  mediating	  indirect	  heterochromatin	  formation	  and	  DNA	  methylation	  at	  target	  loci	  (Aravin	  et	  al.	  2008).	  These	  examples	  illustrate	  the	  connection	  between	  histone	  modifications,	  non-­‐coding	  RNAs,	  DNA	  methylation	  and	  chromatin	  accessibility	  to	  prepare	  and	  sustain	  the	  genetic	  environment	  for	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gene	  activation	  or	  repression.	  These	  findings	  are	  summarized	  in	  Figure	  1.	  Still,	  some	  basic	  concepts	  of	  epigenetics	  are	  incompletely	  understood.	  It	  is	  not	  clear,	  if	  and	  how	  chromatin	  modifications	  can	  be	  passed	  on	  over	  cell	  divisions,	  as	  there	  is	  no	  such	  simple	  mechanism	  as	  a	  “maintenance”	  enzyme	  as	  in	  DNA	  methylation.	  Moreover,	  there	  is	  no	  clear	  agreement	  if	  the	  establishment	  of	  DNA	  methylation	  patterns	  is	  a	  cause	  or	  a	  consequence	  of	  gene	  silencing	  or	  activation	  as	  mechanistic	  studies	  are	  scarce	  and	  need	  further	  investigations.	  The	  idea	  of	  heritable	  changes	  in	  gene	  expression	  without	  changes	  in	  the	  DNA	  sequence	  was	  widely	  hoped	  to	  explain	  gene	  expression	  patterns	  in	  developmental	  processes	  and	  diseases.	  The	  efforts	  that	  were	  made	  to	  understand	  epigenetic	  mechanisms	  are	  illustrated	  by	  the	  roughly	  25000	  PubMed	  citations	  for	  the	  term	  “epigenetic”	  (until	  August	  2012).	  	  
	  
	  
2.1.4 Cis-­‐regulatory	  modules	  
2.1.4.1 Transcription	  factors	  Sequence-­‐specific	  transcription	  factors	  comprise	  at	  least	  a	  DNA	  binding	  domain	  for	  recognizing	  and	  binding	  specific	  sites	  in	  the	  genome	  and	  a	  transactivation	  domain	  to	  recruit	  coactivators	  and	  other	  accessory	  proteins	  such	  as	  DNA	  and	  histone	  modifying	  proteins	  that	  ultimately	  help	  to	  facilitate	  transcription	  (MacQuarrie	  et	  al.	  2011).	  Transcription	  factors	  are	  activated	  through	  signaling	  events	  triggered	  by	  environmental	  cues	  and	  can	  establish	  logic	  networks	  to	  drive	  
Figure	  1	  
Epigenetic	  mechanisms	  and	  gene	  regulation.	  General	  properties	  of	  repressive	  and	  active	  chromatin	  environments;	  DNA	  (black	  lines)	  is	  wrapped	  around	  nucleosomes	  (green	  cylinders);	  red	  circles:	  methylated	  CpG	  dinucleotide;	  small	  red	  and	  yellow	  hexagons:	  histone	  methylation	  at	  H3K9,	  H3K27	  or	  H3K4;	  blue	  star:	  histone	  acetylation;	  other	  objects:	  transcription	  factors	  and	  histone-­‐	  as	  well	  as	  DNA-­‐modifying	  enzymes	  as	  described	  in	  the	  introduction.	  (Adapted	  from	  Laird	  2005)	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complex	  programs	  of	  gene	  expression	  as	  seminal	  work	  of	  Nüsslein-­‐Volhard	  and	  colleagues	  demonstrated	  in	  drosophila	  (St	  Johnston	  and	  Nusslein-­‐Volhard	  1992).	  In	  humans,	  a	  manually	  curated	  list	  of	  1391	  DNA-­‐binding	  TFs	  was	  recently	  published	  showing	  that	  many	  TFs	  were	  expressed	  in	  a	  tissue-­‐specific	  manner	  but	  remain	  largely	  uncharacterized	  regarding	  their	  function	  and	  mechanism	  of	  action	  (Vaquerizas	  et	  al.	  2009).	  
2.1.4.2 Promoters	  Promoters	  of	  genes	  are	  genomic	  loci	  that	  overlap	  with	  the	  transcription	  start	  site	  (TSS)	  from	  which	  messenger	  RNA	  (mRNA)	  transcription	  is	  initiated	  at	  a	  rate	  determined	  by	  the	  complete	  integrated	  regulatory	  input	  for	  this	  gene	  (Lenhard	  et	  al.	  2012).	  PolII	  catalyzes	  transcription	  of	  protein-­‐coding	  genes	  and	  some	  small	  RNA	  species	  in	  eukaryotes.	  Therefore,	  components	  of	  the	  basal	  transcription	  machinery	  are	  recruited	  to	  the	  “core	  promoter”,	  the	  region	  in	  close	  vicinity	  to	  the	  TSS,	  with	  the	  help	  of	  general	  and	  cell	  type-­‐specific	  TFs	  recognizing	  DNA	  sequence	  motifs	  (transcription	  factor	  binding	  sites	  TFBS)	  at	  the	  core	  promoter	  or	  distal	  cis-­‐regulatory	  regions	  such	  as	  enhancers	  (Maston	  et	  al.	  2006).	  Due	  to	  their	  difference	  in	  dynamic	  expression	  range	  -­‐from	  constant	  expression	  (“house	  keeping	  genes”)	  to	  cell	  type	  and	  developmental	  state-­‐specific	  expression-­‐	  attempts	  were	  made	  to	  classify	  promoters	  based	  on	  their	  expression	  dynamics	  and	  nucleotide	  composition.	  Recent	  advances	  in	  TSS	  detection	  and	  gene	  expression	  analysis	  such	  as	  RNA-­‐seq	  (Ozsolak	  and	  Milos	  2011)	  and	  cap	  analysis	  of	  gene	  expression	  (CAGE,	  (Kanamori-­‐Katayama	  et	  al.	  2011))	  allow	  fine	  mapping	  of	  TSS	  and	  gene	  expression	  analysis	  throughout	  the	  genome.	  Integrated	  analysis	  suggests	  three	  main	  classes	  of	  promoters:	  “adult”	  (type	  I),	  “ubiquitous”	  (type	  II)	  and	  “developmentally	  regulated”	  (type	  III)	  (Lenhard	  et	  al.	  2012).	  Type	  I	  promoters	  show	  tissue-­‐specific	  expression	  in	  differentiated	  cell	  types	  from	  a	  focused	  TSS,	  have	  mostly	  a	  low	  CG	  and	  CpG	  content	  and	  are	  enriched	  for	  a	  TATA-­‐box,	  a	  sequence	  motif	  recognized	  by	  the	  TATA-­‐box	  binding	  protein	  which	  is	  a	  component	  of	  the	  basal	  transcription	  machinery.	  Type	  II	  promoters	  are	  ubiquitously	  expressed	  (“house-­‐keeping”)	  from	  broadly	  dispersed	  TSS,	  are	  TATA-­‐box	  depleted	  and	  overlap	  with	  CpG	  islands	  at	  their	  TSS	  (Deaton	  and	  Bird	  2011;	  Lenhard	  et	  al.	  2012).	  Type	  III	  promoters	  share	  molecular	  characteristics	  with	  type	  II	  promoters	  but	  are	  developmentally	  regulated	  (Lenhard	  et	  al.	  2012).	  In	  contrast	  to	  prokaryotic	  organisms,	  in	  eukaryotes	  the	  promoter	  alone	  is	  not	  sufficient	  to	  regulate	  gene	  and	  often	  produces	  only	  low	  levels	  of	  mRNA	  on	  its	  own	  (Wittkopp	  and	  Kalay	  2012).	  On	  that	  account,	  enhancers,	  insulators	  and	  boundary	  elements	  control	  the	  “fine	  tuning”	  of	  gene	  expression	  in	  complex	  organisms.	  
2.1.4.3 Enhancers	  and	  silencers	  Enhancers	  were	  described	  as	  non-­‐coding	  regulatory	  DNA	  sequences	  that	  can	  enhance	  the	  expression	  of	  a	  target	  gene	  in	  a	  distance-­‐	  and	  orientation-­‐independent	  manner	  (Banerji	  et	  al.	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1981).	  Distal	  non-­‐coding	  sequences	  are	  often	  necessary	  for	  the	  activation	  and/or	  correct	  lineage-­‐specific	  expression	  of	  a	  gene	  as	  promoters	  alone	  often	  fail	  to	  establish	  accurate	  expression	  patterns.	  For	  example,	  studies	  in	  transgenic	  mice	  showed	  that	  the	  transfer	  of	  small	  fragments	  surrounding	  the	  human	  CD14	  gene	  locus	  (24-­‐33kb)	  only	  establish	  correct	  CD14	  expression	  in	  liver	  whereas	  a	  much	  larger	  region	  of	  80	  kb	  is	  needed	  to	  express	  CD14	  in	  a	  monocyte-­‐specific	  fashion	  (Pan	  et	  al.	  2000).	  Another	  well-­‐studied	  example	  is	  the	  locus	  encoding	  the	  T	  helper	  cell	  type	  1	  (Th1)-­‐specific	  cytokine	  interferon	  gamma	  (Ifng).	  An	  8.6	  kb	  transgene	  of	  the	  human	  IFNG	  locus	  was	  sufficient	  for	  constitutive	  IFN-­‐γ	  production,	  but	  only	  a	  191	  kb	  transgene	  established	  restricted	  IFNG	  expression	  in	  Th1	  cells	  (Soutto	  et	  al.	  2002).	  Enhancers	  are	  thought	  to	  bind	  combinations	  of	  transcription	  factors	  that	  create	  physical	  interactions	  via	  the	  mediator	  complex	  and	  cohesin	  with	  the	  target	  gene	  promoter	  and	  help	  to	  recruit	  the	  general	  transcription	  machinery	  (Kornberg	  2005;	  Kagey	  et	  al.	  2010).	  The	  enhancer	  and	  target	  promoter	  can	  be	  distant	  from	  each	  other	  (up	  to	  a	  million	  base	  pairs	  away)	  or	  even	  on	  another	  chromosome	  (Spilianakis	  and	  Flavell	  2004;	  Lomvardas	  et	  al.	  2006;	  Amano	  et	  al.	  2009).	  These	  observations	  were	  made	  possible	  by	  labeling	  distant	  gene	  loci	  with	  fluorescent	  probes	  (fluorescence	  in	  situ	  hybridization,	  FISH	  (Ong	  and	  Corces	  2011))	  or	  by	  the	  chromosome	  conformation	  capture	  technique	  introduced	  by	  Dekker	  and	  colleagues	  2002	  (Dekker	  et	  al.	  2002),	  a	  technique	  that	  uses	  formaldehyde	  crosslinking	  to	  capture	  physical	  interactions	  between	  chromosome	  arms.	  Silencers	  function	  by	  recruiting	  TFs	  repressing	  transcription,	  block	  DNA	  binding	  of	  activators	  or	  hinder	  the	  assembly	  of	  the	  transcription	  machinery	  (Maston	  et	  al.	  2006),	  but	  are	  less	  well	  characterized	  than	  enhancers.	  	  
2.1.4.4 Boundary	  elements	  Boundary	  elements	  were	  also	  described	  to	  potentially	  act	  as	  repressive	  elements	  by	  blocking	  the	  interaction	  of	  a	  distal	  enhancer	  with	  its	  target	  promoter	  as	  intensively	  studied	  at	  the	  IGF2/H19	  locus	  where	  the	  presence	  of	  the	  CCCTC	  binding	  protein	  (CTCF)	  blocks	  the	  interaction	  of	  an	  enhancer	  with	  the	  IGF2	  gene	  on	  the	  maternal	  allele	  (Bell	  and	  Felsenfeld	  2000).	  CTCF,	  so	  far	  the	  only	  identified	  “boundary”	  element	  in	  humans,	  was	  also	  described	  to	  isolate	  “active”	  and	  “repressive”	  chromatin	  environments	  and	  is	  involved	  in	  many	  developmental	  processes	  such	  as	  stem	  cell	  differentiation,	  neural	  development,	  cytokine	  expression	  and	  immunoglobulin	  chain	  recombination	  by	  mediating	  long-­‐range	  interactions	  of	  chromatin	  elements	  (Herold	  et	  al.	  2012).	  A	  positive	  function	  in	  gene	  regulation	  by	  the	  boundary	  element	  CTCF	  is	  also	  supported	  by	  a	  recent	  study	  highlighting	  the	  role	  of	  CTCF	  in	  mediating	  enhancer-­‐promoter	  interactions	  and	  chromatin	  organization	  (Handoko	  et	  al.	  2011).	  An	  overview	  of	  cis-­‐regulatory	  modules	  is	  shown	  in	  Figure	  2.	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2.1.5 Epigenetics	  at	  cis-­‐regulatory	  modules	  and	  the	  impact	  on	  gene	  regulation	  During	  the	  making	  of	  this	  thesis,	  progress	  in	  high	  throughput	  and	  next	  generation	  sequencing	  technologies	  now	  permits	  the	  examination	  of	  global	  epigenetic	  and	  functional	  properties	  of	  cis-­‐regulatory	  modules.	  In	  terms	  of	  DNA	  methylation	  analysis,	  previous	  studies	  concentrated	  on	  CGIs	  in	  cancer	  as	  aberrant	  DNA	  methylation	  is	  often	  observed	  upon	  malignant	  transformation	  (Plass	  and	  Soloway	  2002).	  CpG	  islands	  at	  promoters	  are	  normally	  unmethylated	  independent	  of	  their	  expression	  status	  (Weber	  et	  al.	  2007;	  Mohn	  et	  al.	  2008).	  However,	  some	  CGIs	  become	  de	  novo	  methylated	  in	  a	  cell	  type-­‐specific	  manner,	  resulting	  in	  long-­‐term	  repression	  of	  the	  associated	  gene	  (Weber	  et	  al.	  2007;	  Farthing	  et	  al.	  2008;	  Meissner	  et	  al.	  2008;	  Mohn	  et	  al.	  2008).	  Long-­‐term	  repression	  of	  CGI-­‐associated	  genes	  is	  described	  for	  imprinted	  genes	  (genes	  that	  show	  parent-­‐of-­‐origin	  expression),	  for	  CGI-­‐associated	  genes	  of	  the	  inactivated	  X-­‐chromosome	  and	  for	  some	  tissue-­‐specific	  genes	  (Jones	  2012).	  Gene	  repression	  by	  CGI	  methylation	  is	  still	  rare	  and	  may	  not	  be	  the	  prevalent	  mechanism	  of	  gene	  silencing	  (Mohn	  et	  al.	  2008;	  Jones	  2012).	  Moreover,	  for	  instance,	  at	  the	  inactive	  X	  chromosome,	  DNA	  methylation	  comes	  late	  during	  the	  inactivation	  and	  silencing	  process	  (Lee	  2011).	  Yet,	  it	  seems	  to	  provide	  an	  additional	  “layer”	  of	  gene	  repression	  to	  ensure	  long-­‐term	  silencing.	  Interestingly,	  regions	  of	  intermediate	  CpG	  content	  are	  more	  commonly	  de	  
novo	  methylated	  and	  repressed,	  whereas	  low	  CpG	  promoters	  tend	  to	  be	  methylated	  regardless	  of	  their	  expression	  state	  (Weber	  et	  al.	  2007;	  Ball	  et	  al.	  2009).	  In	  contrast,	  DNA	  methylation	  of	  gene	  bodies	  was	  positively	  correlated	  to	  gene	  expression	  (Ball	  et	  al.	  2009;	  Lister	  et	  al.	  2009).	  However,	  far	  less	  is	  known	  about	  DNA	  methylation	  at	  non-­‐promoter	  regions.	  Regions	  of	  intermediate	  or	  low	  CpG	  content	  came	  into	  focus	  with	  the	  development	  of	  sensitive	  locus-­‐wide	  or	  genome-­‐wide	  DNA	  methylation	  analysis	  (Schilling	  and	  Rehli	  2007;	  Meissner	  et	  al.	  2008;	  Klug	  et	  al.	  2010;	  Stadler	  et	  al.	  2011).	  Interestingly,	  DNA	  methylation	  is	  more	  dynamic	  at	  CpG	  poor	  
Figure	  2	  
Cis-­‐regulatory	  modules	  in	  the	  genome.	  (Adapted	  from	  Heintzman	  and	  Ren	  2009)	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regions	  (Meissner	  et	  al.	  2008;	  Stadler	  et	  al.	  2011),	  and	  differential	  DNA	  methylation	  was	  observed	  at	  cell	  type-­‐specific	  enhancers	  that	  were	  bound	  by	  lineage	  specific	  TFs	  (Sérandour	  et	  al.	  2011;	  Stadler	  et	  al.	  2011;	  Wiench	  et	  al.	  2011).	  Indeed,	  on	  a	  genome-­‐wide	  scale	  TF-­‐bound	  regions	  are	  associated	  with	  local	  hypomethylation	  (Lister	  et	  al.	  2009).	  Cell	  type-­‐specific	  DNA	  methylation	  patterns	  seem	  to	  be	  established	  by	  both	  cis	  and	  trans	  acting	  factors:	  At	  CGIs	  for	  example,	  combinatorial	  binding	  of	  TFs	  protected	  them	  from	  aberrant	  de	  novo	  methylation	  (Gebhard	  et	  al.	  2010).	  In	  a	  different	  experimental	  setting,	  core	  promoters	  introduced	  into	  a	  new	  locus	  in	  the	  mouse	  genome	  were	  able	  to	  recapitulate	  autonomously	  their	  original	  DNA	  methylation	  state	  (Lienert	  et	  al.	  2011).	  Mutation	  of	  TF	  binding	  sequences	  in	  the	  respective	  promoters	  inhibited	  this	  process,	  which	  suggests	  DNA	  methylation	  control	  in	  cis.	  In	  mice,	  several	  differentially	  methylated	  regions	  were	  identified	  that	  were	  controlled	  in	  cis	  by	  the	  underlying	  DNA	  sequence,	  but	  also	  trans-­‐acting	  elements	  orchestrated	  DNA	  methylation	  patterns	  in	  different	  DMRs	  (Schilling	  et	  al.	  2009).	  Considering	  the	  association	  of	  gene-­‐regulatory	  elements	  with	  the	  disposal	  of	  certain	  histone	  modifications,	  chromatin	  accessibility	  and	  nucleosome	  remodeling,	  genome-­‐wide	  approaches	  were	  used	  to	  systematically	  isolate	  regulatory	  elements	  based	  on	  their	  biochemical	  markers.	  Chromatin	  immunopreciptiation,	  deoxyribonuclease/micrococcal	  nuclease	  digestion	  and	  comparable	  techniques	  coupled	  to	  next	  generation	  sequencing	  (ChIP-­‐seq,	  DNase-­‐seq,	  MNase-­‐seq)	  allow	  the	  genome-­‐wide	  mapping	  of	  TF,	  histone	  modifications	  and	  “open”	  chromatin	  regions	  sensitive	  to	  DNase	  digestion	  (Bell	  et	  al.	  2011;	  Zhou	  et	  al.	  2011).	  Among	  other	  modifications,	  promoters	  of	  active	  genes	  in	  metazoans	  are	  associated	  with	  H3K4me3	  and	  H3K27ac,	  with	  intermediate	  levels	  of	  H3K4me2	  and	  low	  levels/absence	  of	  H3K4me1	  (Barski	  et	  al.	  2007;	  Guenther	  et	  al.	  2007;	  Heintzman	  et	  al.	  2007;	  Mikkelsen	  et	  al.	  2007;	  Wang	  et	  al.	  2008b;	  Bell	  et	  al.	  2011).	  Inactive	  type	  I	  promoters	  (without	  a	  CpG	  island	  spanning	  the	  TSS)	  lack	  these	  active	  histone	  modifications	  whereas	  type	  II	  and	  type	  III	  CpG	  Island	  promoters	  always	  show	  detectable	  H3K4	  trimethylation	  (Barski	  et	  al.	  2007;	  Guenther	  et	  al.	  2007;	  Wang	  et	  al.	  2008b;	  Bell	  et	  al.	  2011;	  Deaton	  and	  Bird	  2011).	  Interestingly,	  genes	  important	  for	  development	  share	  the	  active	  H3K4me3	  and	  the	  repressive	  H3K27me3	  polycomb	  modification,	  probably	  “poising”	  genes	  for	  their	  fast	  activation	  or	  silencing,	  dependent	  on	  the	  fate	  of	  the	  cell	  (Bernstein	  et	  al.	  2006).	  Moreover,	  active	  promoters	  are	  DNase	  hypersensitive	  due	  to	  a	  nucleosome-­‐free	  region	  (NFR)	  directly	  upstream	  of	  the	  TSS,	  show	  binding	  of	  the	  active	  form	  of	  PolII	  and	  are	  frequently	  associated	  with	  histone	  variants	  H3.3	  and	  H2A.Z	  (Jin	  et	  al.	  2009;	  Bell	  et	  al.	  2011).	  	  Most	  of	  these	  findings	  can	  be	  transferred	  to	  enhancer	  regions	  (Ong	  and	  Corces	  2011).	  Compelling	  evidence	  from	  genome	  wide	  studies	  identified	  the	  enrichment	  of	  H3K4me1/me2	  and	  additionally	  H3K27ac	  at	  “poised”	  and	  “active”	  enhancers,	  respectively	  (Heintzman	  et	  al.	  2007;	  Heintzman	  et	  al.	  2009;	  Creyghton	  et	  al.	  2010;	  Rada-­‐Iglesias	  et	  al.	  2011).	  Poised	  enhancers	  were	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shown	  to	  acquire	  an	  active	  state	  during	  development	  when	  the	  linked	  gene	  was	  needed	  to	  be	  expressed	  (Rada-­‐Iglesias	  et	  al.	  2011).	  Enhancers	  are	  further	  characterized	  by	  DNase	  hypersensitivity,	  NFR,	  binding	  of	  a	  coactivator	  such	  as	  p300	  (a	  HAT)	  (Visel	  et	  al.	  2009)	  (Blow	  et	  al.	  2010),	  and	  H3.3	  deposition.	  In	  contrast	  to	  promoters,	  enhancers	  were	  first	  described	  to	  show	  low	  levels	  of	  H3K4me3	  and	  no	  transcriptional	  activity	  (Heintzman	  et	  al.	  2007).	  However,	  some	  enhancers	  produce	  transcripts	  (enhancer	  RNAs	  or	  eRNAs)	  and	  were	  bound	  by	  PolII	  (Kim	  et	  al.	  2010;	  Melgar	  et	  al.	  2011).	  Another	  report	  attributed	  H3K4me3	  at	  some	  enhancers	  as	  well,	  making	  it	  difficult	  to	  definitely	  separate	  enhancers	  and	  promoters	  (Pekowska	  et	  al.	  2011).	  Still,	  enhancer	  and	  promoter	  prediction	  by	  chromatin	  patterns	  and	  TF	  occupancy	  is	  more	  effective	  than	  approaches	  that	  rely	  on	  conservation	  or	  accumulation	  of	  sequence	  motifs	  for	  TFs	  (Hardison	  and	  Taylor	  2012a).	  Interestingly,	  when	  comparing	  the	  diversity	  of	  promoter	  and	  enhancer	  signatures	  between	  cell	  types,	  enhancers	  show	  a	  more	  cell	  type-­‐specific	  distribution	  and	  variety	  than	  promoters,	  highlighting	  their	  role	  in	  tissue-­‐specific	  gene	  expression	  (Heintzman	  et	  al.	  2009;	  Ernst	  et	  al.	  2011).	  Global	  histone	  profiling	  further	  classified	  DNA	  elements	  associated	  with	  different	  function,	  e.g..	  H3K36me3-­‐	  and	  H4K20me1-­‐marked	  regions	  are	  linked	  with	  transcriptional	  elongation	  and	  H3K27me3	  is	  preferentially	  associated	  with	  PCG-­‐repressed	  regions	  (Barski	  et	  al.	  2007;	  Mikkelsen	  et	  al.	  2007).	  The	  question	  arises	  how	  cell	  type	  specificity	  of	  regulatory	  elements	  is	  created	  and	  interpreted	  by	  transcription	  factors.	  Namely,	  the	  sole	  expression	  of	  a	  TF	  does	  not	  result	  in	  its	  binding	  to	  its	  recognition	  sequence	  in	  the	  genome:	  As	  an	  example,	  there	  are	  ~	  2	  million	  binding	  sites	  of	  the	  TF	  PU.1	  located	  in	  the	  human	  genome,	  but	  only	  ~	  80.000	  of	  these	  sites	  are	  effectively	  bound	  in	  PU.1-­‐expressing	  macrophages	  or	  monocytes	  (Pham	  et	  al.	  2012).	  In	  contrast	  to	  shared	  binding	  sites,	  cell	  type-­‐specific	  PU.1	  binding	  in	  each	  cell	  type	  was	  associated	  with	  the	  co-­‐binding	  of	  lineage-­‐specific	  TFs,	  suggesting	  the	  combinatorial	  action	  of	  general	  and	  specific	  transcription	  factors	  to	  establish	  cell	  type-­‐specific	  enhancers	  (Heinz	  et	  al.	  2010;	  Pham	  et	  al.	  2012).	  Moreover,	  these	  regions	  were	  marked	  by	  nucleosome	  repositioning	  and	  accumulation	  of	  H3K4me1	  to	  “prepare”	  chromatin	  for	  signal-­‐dependent	  gene	  activation	  (Ghisletti	  et	  al.	  2010;	  Heinz	  et	  al.	  2010).	  In	  MCF7	  and	  LNCaP	  cells	  FoxA1	  is	  recruited	  to	  different	  sites	  distinguished	  by	  specific	  H3K4	  dimethylation	  (Lupien	  et	  al.	  2008).	  At	  these	  specific	  enhancers,	  FoxA1	  remodels	  chromatin	  to	  mediate	  MCF7	  or	  LNCaP	  specific	  gene	  expression	  programs	  in	  collaboration	  either	  with	  estrogen	  receptor	  alpha	  or	  androgen	  receptor	  TFs.	  These	  observations	  lead	  to	  a	  model	  of	  “pioneer”	  TFs	  that	  can	  easily	  access	  and	  prepare	  chromatin	  for	  the	  binding	  of	  other	  transcription	  factors	  that	  act	  in	  combination	  to	  drive	  cell	  type-­‐specific	  expression	  programs	  (Lupien	  et	  al.	  2008;	  Heinz	  et	  al.	  2010;	  Zaret	  and	  Carroll	  2011).	  Constitutive	  binding	  sites,	  on	  the	  other	  hand,	  do	  not	  seem	  to	  rely	  on	  co-­‐binding	  with	  other	  TFs,	  partially	  explained	  by	  a	  stronger	  TF	  consensus	  site	  as	  demonstrated	  for	  FoxA2	  binding	  in	  liver	  (Tuteja	  et	  al.	  2008).	  However,	  potential	  co-­‐
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binding	  and	  consensus	  site	  quality	  do	  not	  explain	  all	  of	  the	  observed	  binding	  behavior	  of	  TFs	  suggesting	  additional	  determinants.	  Nevertheless,	  it	  was	  demonstrated	  for	  several	  cell	  types	  that	  enhancers	  are	  defined	  by	  combinations	  of	  key	  regulators	  (Lupien	  et	  al.	  2008;	  Heinz	  et	  al.	  2010;	  Lin	  et	  al.	  2010b;	  Mikkelsen	  et	  al.	  2010).	  This	  allows	  the	  computational	  analysis	  of	  regulatory	  elements	  to	  isolate	  overrepresented	  binding	  sites	  and	  hence	  the	  identification	  of	  key	  TFs	  by	  the	  sole	  knowledge	  of	  histone	  modifications	  in	  a	  certain	  cell	  type	  (Pham	  et	  al.	  2012).	  Currently,	  many	  laboratories	  and	  big	  international	  consortia	  such	  as	  the	  ENCODE	  (ENCODE-­‐consortium	  2011)	  gather	  epigenomes	  of	  many	  different	  cells	  with	  the	  hope	  to	  understand	  gene	  regulation	  in	  development,	  disease	  and	  cellular	  states.	  	  
2.2 T	  helper	  cells	  The	  mammalian	  immune	  system	  comprises	  several	  specialized	  cell	  types	  to	  protect	  the	  host	  from	  exogenous	  pathogens	  such	  as	  fungi,	  viruses,	  bacteria	  and	  parasites	  (Delves	  and	  Roitt	  2000).	  Cells	  from	  the	  innate	  immune	  system	  are	  regarded	  as	  a	  “first	  line	  of	  defense”	  against	  pathogens	  as	  they	  can	  recognize	  conserved	  and	  widely	  distributed	  features	  of	  pathogens	  with	  special	  receptors	  (pattern	  recognition	  receptors)	  to	  mount	  initial	  immune	  responses	  (Janeway	  and	  Medzhitov	  2002;	  Underhill	  and	  Ozinsky	  2002).	  Besides	  killing	  microbes	  and	  cytokine	  production	  to	  boost	  inflammation,	  innate	  immune	  responses	  include	  the	  incorporation	  and	  digestion	  of	  pathogens	  by	  professional	  phagocytes	  such	  as	  monocytes,	  macrophages	  as	  well	  as	  dendritic	  cells.	  The	  phagocytes	  then	  present	  parts	  of	  the	  digested	  microbes	  to	  cells	  of	  the	  adaptive	  immune	  system	  that	  can	  recognize	  the	  presented	  molecules	  (“antigens”)	  with	  their	  diverse	  T	  and	  B	  cell	  receptors	  (Delves	  and	  Roitt	  2000;	  Guermonprez	  et	  al.	  2002;	  Jutras	  and	  Desjardins	  2005).	  Somatic	  recombination	  and	  random	  events	  create	  a	  theoretical	  diversity	  of	  up	  to	  1018	  different	  antigen	  receptors	  that	  enable	  cells	  of	  the	  adaptive	  immune	  system	  to	  recognize	  virtually	  every	  antigen	  presented	  (Davis	  and	  Bjorkman	  1988).	  If	  a	  cell	  recognizes	  a	  presented	  antigen	  with	  its	  matching	  receptor,	  it	  proliferates	  to	  increase	  cell	  numbers	  with	  the	  same	  receptor	  (“clonal	  expansion”)	  to	  effectively	  detect	  and	  fight	  the	  corresponding	  pathogen	  (Delves	  and	  Roitt	  2000).	  The	  adaptive	  immune	  system	  comprises	  B	  and	  T	  lymphocytes	  that	  develop	  in	  the	  bone	  marrow	  or	  in	  the	  thymus,	  respectively	  (Delves	  and	  Roitt	  2000).	  T	  lymphocytes	  expressing	  the	  CD4	  coreceptor	  emerge	  as	  naïve	  CD4	  cells	  and	  give	  rise	  to	  different	  T	  helper	  (Th)	  cell	  subsets	  in	  dependence	  of	  signals	  from	  the	  innate	  immune	  system	  and	  other	  environmental	  cues.	  Th1	  cells	  produce	  the	  cytokine	  interferon	  gamma	  (Ifn-­‐γ)	  and	  mediate	  host	  defense	  against	  intracellular	  pathogens	  while	  Th2	  cells	  produce	  Interleukin	  (Il)-­‐4,	  Il-­‐5	  and	  Il-­‐13	  and	  effectively	  resolve	  helminthic	  infections	  (Mosmann	  et	  al.	  1986;	  Heinzel	  et	  al.	  1989;	  Romagnani	  1994).	  Recently,	  Th	  cells	  producing	  Il-­‐17A	  (Th17	  cells)	  were	  described	  to	  contribute	  to	  defense	  against	  extracellular	  pathogens	  and	  fungi	  (Infante-­‐Duarte	  et	  al.	  2000;	  Ye	  et	  al.	  2001;	  Ouyang	  et	  al.	  2008).	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With	  Th	  subsets	  arising	  from	  the	  same	  progenitor	  cell,	  they	  are	  ideal	  to	  study	  TF	  networks	  and	  epigenetic	  mechanisms	  that	  govern	  and	  stabilize	  their	  differential	  gene	  expression	  programs.	  Th1	  development	  is	  favored	  by	  the	  signal	  transducer	  and	  activator	  of	  transcription	  (Stat)1	  and	  Stat4	  that	  are	  activated	  by	  innate	  immune	  cell-­‐derived	  Ifn-­‐γ	  and	  Il-­‐27	  or	  Il-­‐12,	  respectively	  (Schoenborn	  and	  Wilson	  2007).	  Stat1	  activation	  induces	  Tbx21	  (also	  called	  T-­‐bet),	  a	  key	  Th1	  TF	  that	  induces	  among	  others	  Runx3.	  In	  cooperation	  with	  Tbx21	  and	  Stat4,	  Runx3	  binds	  to	  the	  Ifng	  promoter	  to	  sustain	  its	  expression	  in	  a	  positive	  feedback	  loop	  while	  binding	  to	  a	  silencing	  element	  in	  the	  Il-­‐4	  gene	  to	  suppress	  its	  transcription	  and	  hence	  abrogate	  Th2	  differentiation	  (Djuretic	  et	  al.	  2007a).	  In	  addition,	  Tbx21	  interferes	  with	  the	  Th2	  transcription	  factor	  Gata3	  to	  prevent	  it	  from	  binding	  to	  target	  genes	  (Hwang	  et	  al.	  2005).	  Gata3	  is	  sufficient	  and	  necessary	  for	  Th2	  development	  (Zheng	  and	  Flavell	  1997).	  Gata3	  is	  expressed	  upon	  Il-­‐4	  induced	  Stat6	  activation	  and	  T	  cell	  receptor	  (TCR)	  signaling-­‐derived	  TFs	  (Ansel	  et	  al.	  2006)	  or	  by	  Notch	  signaling	  (Amsen	  et	  al.	  2007).	  Gata3	  induces	  Maf,	  and	  in	  cooperation	  with	  Stat6	  these	  three	  TFs	  upregulate	  transcription	  of	  the	  Th2	  cytokines	  Il-­‐4,	  Il-­‐5	  and	  Il-­‐13,	  again	  creating	  a	  positive	  feedback	  loop	  to	  stabilize	  Th2	  differentiation	  (Ansel	  et	  al.	  2006).	  Gata3	  also	  hinders	  Th1	  differentiation	  by	  preventing	  Runx3	  to	  activate	  Th1-­‐essential	  genes	  (Yagi	  et	  al.	  2010).	  In	  mice,	  Th17	  development	  is	  initiated	  by	  transforming	  growth	  factor	  beta	  (Tgf-­‐ß)	  that	  induces	  the	  Th17	  determining	  TF	  retinoic	  acid	  receptor	  related	  orphan	  receptor-­‐gamma	  t	  (Rorc	  or	  Rorγt)	  or	  the	  regulatory	  T	  cell	  (Treg)	  determining	  TF	  Foxp3	  (Chen	  et	  al.	  2003;	  Ivanov	  et	  al.	  2006;	  Manel	  et	  al.	  2008).	  In	  combination	  with	  Il-­‐6,	  Stat3	  abrogates	  Treg	  development	  and	  supports	  Th17	  differentiation	  and	  production	  of	  Il-­‐21	  (Zhou	  et	  al.	  2007;	  Zhou	  et	  al.	  2008a).	  Il-­‐21	  and	  Stat3	  activation	  stabilize	  the	  Th17	  phenotype	  via	  a	  positive	  feedback	  loop	  and	  also	  upregulate	  the	  Il-­‐23	  receptor	  to	  support	  Stat3	  activation	  via	  antigen	  presenting	  cell	  (APC)-­‐	  derived	  Il-­‐23	  (Zhou	  et	  al.	  2007).	  Tgf-­‐ß-­‐independent	  Th17	  generation	  was	  also	  reported	  recently	  (Ghoreschi	  et	  al.	  2010).	  In	  humans,	  requirements	  for	  Th17	  cell	  development	  are	  still	  under	  discussion	  (Annunziato	  et	  al.	  2007;	  Evans	  et	  al.	  2007;	  Manel	  et	  al.	  2008;	  Volpe	  et	  al.	  2008;	  Annunziato	  and	  Romagnani	  2011).	  
2.2.1 Epigenetics	  in	  Th	  development	  As	  illustrated	  in	  the	  previous	  paragraph,	  TF	  networks	  are	  (i)	  able	  to	  sustain	  phenotypes	  in	  feedback	  loops	  and	  (ii)	  can	  prohibit	  differentiation	  to	  other	  phenotypes	  by	  direct	  interference	  with	  other	  TFs	  or	  by	  binding	  to	  regulatory	  regions	  such	  as	  the	  Il-­‐4	  silencer.	  However,	  many	  studies	  suggested	  that	  DNA	  methylation,	  chromatin	  remodeling	  complexes	  and	  chromatin	  modifications	  influence	  Th	  development	  and	  function:	  at	  the	  Th1-­‐signature	  gene	  Ifng,	  many	  cis-­‐regulatory	  elements	  were	  described	  that	  showed	  Th1-­‐specific	  demethylation,	  TF	  binding	  and	  “active”	  chromatin	  modifications	  (Hatton	  et	  al.	  2006;	  Jones	  and	  Chen	  2006;	  Schoenborn	  et	  al.	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2007a).	  Some	  putative	  enhancers	  interacted	  with	  the	  Ifng	  promoter	  in	  a	  cell	  type-­‐specific	  manner	  (Hadjur	  et	  al.	  2009).	  The	  establishment	  of	  cell	  type-­‐specific	  epigenetic	  patterns	  is	  mediated	  by	  lineage-­‐specific	  TFs.	  As	  an	  example,	  Stat4	  was	  reported	  to	  recruit	  the	  remodeling	  complexes	  Swi-­‐SNF	  to	  the	  Ifng	  promoter,	  which	  is	  essential	  for	  nucleosome	  remodeling	  and	  Infg	  expression	  (Zhang	  and	  Boothby	  2006).	  Similarly,	  Tbx21	  was	  described	  to	  be	  associated	  with	  a	  H3K27	  demethylase	  to	  remove	  this	  repressive	  chromatin	  mark	  at	  its	  target	  genes	  to	  promote	  Th1	  development	  (Miller	  et	  al.	  2008).	  With	  respect	  to	  Th2	  development,	  regulatory	  elements	  at	  the	  Il-­‐4	  locus	  acquire	  active	  histone	  marks	  and	  become	  demethylated	  in	  Th2	  cells	  but	  not	  in	  Th1	  cells	  (Avni	  et	  al.	  2002;	  Lee	  et	  al.	  2002).	  Gata3	  is	  in	  parts	  responsible	  for	  chromatin	  remodeling	  and	  DNA	  demethylation	  at	  the	  Th2	  cytokine	  genes	  (Lee	  et	  al.	  2000;	  Yamashita	  et	  al.	  2004)	  to	  create	  an	  open	  chromatin	  environment	  and	  was	  described	  to	  counteract	  DNA	  methylation-­‐mediated	  gene	  silencing	  by	  interference	  with	  Mbd2	  and	  Dnmt1	  binding	  (Hutchins	  et	  al.	  2002;	  Makar	  et	  al.	  2003;	  Makar	  and	  Wilson	  2004).	  In	  line	  with	  these	  observations,	  ablation	  of	  Mbd2,	  Dnmt1	  or	  general	  inhibition	  of	  DNA	  methylation	  with	  5-­‐azacytidine	  lead	  to	  de-­‐repression	  of	  cytokine	  genes	  normally	  silenced	  in	  Th1	  or	  Th2	  cells	  (Ballas	  1984;	  Hutchins	  et	  al.	  2002;	  Makar	  et	  al.	  2003).	  In	  addition,	  acquired	  Th2-­‐state	  seems	  to	  be	  maintained	  by	  Mll,	  a	  TrxG	  protein	  that	  stabilizes	  open	  chromatin	  conformation	  at	  the	  Th2	  cytokine	  locus	  to	  sustain	  the	  expression	  of	  Th2	  related	  genes	  (Onodera	  et	  al.	  2010).	  These	  examples	  illustrate	  the	  participation	  of	  epigenetic	  mechanisms	  in	  T	  helper	  cell	  specification.	  
2.2.2 Regulatory	  T	  cells	  When	  T	  cells	  generate	  T	  cell	  receptors	  to	  recognize	  antigen	  they	  often	  produce	  by	  chance	  TCRs	  that	  are	  reactive	  to	  self-­‐antigens.	  This	  would	  cause	  immune	  responses	  against	  the	  own	  body	  and	  is	  therefore	  restricted	  by	  anergy	  or	  deletion	  of	  self-­‐reactive	  cells	  (negative	  selection)	  during	  T	  cell	  development	  in	  the	  thymus	  (Delves	  and	  Roitt	  2000).	  However,	  some	  self-­‐reactive	  T	  cells	  escape	  negative	  selection	  and	  have	  to	  be	  controlled	  in	  the	  periphery,	  a	  task	  that	  is	  in	  part	  accomplished	  by	  another	  Th	  subset,	  so-­‐called	  regulatory	  T	  cells	  (Sakaguchi	  et	  al.	  2006).	  
2.2.2.1 Phenotypic	  characterization	  The	  notion	  that	  thymus-­‐derived	  T	  cells	  contain	  a	  population	  responsible	  for	  peripheral	  tolerance	  emerged	  from	  experiments	  where	  neonatal	  thymectomy	  in	  mice	  at	  day	  2-­‐4	  after	  birth	  resulted	  in	  autoimmune	  diseases	  that	  were	  prevented	  by	  inoculation	  of	  the	  mice	  with	  thymocytes	  or	  spleen	  cells	  from	  non-­‐thymectomized	  mice	  (Nishizuka	  and	  Sakakura	  1969;	  Sakaguchi	  et	  al.	  1982).	  Further	  work	  identified	  CD25	  (IL-­‐2	  receptor	  alpha	  chain)	  as	  a	  surface	  marker	  for	  these	  so-­‐called	  “regulatory	  T	  cells”	  (Treg)	  (Sakaguchi	  et	  al.	  1995),	  although	  CD25	  was	  also	  expressed	  on	  non-­‐regulatory	  conventional	  CD4+	  T	  cells	  (Tconv)	  upon	  stimulation	  (Wing	  et	  al.	  2005;	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et	  al.	  2007)	  disqualifying	  CD25	  as	  an	  exclusive	  Treg	  marker.	  A	  major	  breakthrough	  in	  Treg	  research	  was	  the	  discovery	  of	  the	  transcription	  factor	  Foxp3	  that	  was	  soon	  recognized	  as	  the	  “master	  regulator”	  of	  the	  Treg	  lineage	  (Fontenot	  et	  al.	  2003;	  Hori	  et	  al.	  2003;	  Zheng	  and	  Rudensky	  2007).	  Foxp3	  is	  crucial	  for	  Treg	  development	  and	  function	  as	  mutations	  in	  Foxp3	  cause	  lethal	  autoimmune	  disease	  in	  humans	  (immune	  dysregulation,	  polyendocrinopathy,	  enteropathy,	  X-­‐linked	  syndrome;	  IPEX)	  and	  mice	  (scurfy	  phenotype)	  (Bennett	  et	  al.	  2001;	  Brunkow	  et	  al.	  2001).	  Since	  Foxp3	  is	  a	  nuclear	  protein	  it	  cannot	  be	  used	  to	  sort	  living	  cells	  for	  functional	  analysis	  by	  fluorescence-­‐activated	  cell	  sorting	  (FACS).	  Therefore	  Treg	  have	  to	  be	  sorted	  by	  surrogate	  markers	  for	  functional	  analysis,	  e.g.	  by	  high	  expression	  of	  the	  surface	  proteins	  CD4	  and	  CD25,	  and	  by	  low	  expression	  of	  the	  Interleukin-­‐7	  receptor	  (CD127)	  (Liu	  et	  al.	  2006).	  	  
2.2.2.2 Development	  CD4+CD25+FOXP3+	  Treg	  differentiate	  in	  the	  thymus	  (and	  are	  thus	  called	  “natural”	  Treg)	  and	  contain	  a	  high	  frequency	  of	  T	  cell	  receptor	  specificities	  reacting	  to	  self-­‐antigen	  (Jordan	  et	  al.	  2001;	  Sakaguchi	  2005).	  During	  thymic	  development,	  an	  intermediate	  avidity	  for	  self-­‐antigens	  seems	  to	  predispose	  for	  the	  development	  of	  Treg,	  while	  a	  low	  reactivity	  of	  TCR	  to	  self-­‐antigens	  (self-­‐reactivity)	  promotes	  the	  development	  of	  conventional	  T	  cells	  (positive	  selection)	  and	  high	  self-­‐reactivity	  causes	  deletion	  of	  potentially	  harmful	  T	  cells	  (negative	  selection)	  (Delves	  and	  Roitt	  2000;	  Maloy	  and	  Powrie	  2001).	  In	  addition	  to	  TCR	  signals,	  the	  co-­‐stimulation	  via	  CD28	  and	  CD40	  by	  antigen-­‐presenting	  cells	  (APCs)	  enhances	  Treg	  development	  (Lohr	  et	  al.	  2004;	  Lio	  et	  al.	  2010).	  The	  self-­‐antigens	  in	  the	  thymus	  are	  presented	  via	  major	  histocompatibility	  (MHC)	  class	  II	  complexes	  by	  APCs	  including	  dendritic	  cells	  (DCs)	  and	  cortical-­‐	  and	  medullary	  thymic	  epithelial	  cells	  (cTEC	  and	  mTEC,	  respectively)	  (Hsieh	  et	  al.	  2012).	  This	  releases	  a	  population	  of	  Treg	  into	  the	  periphery	  with	  TCR	  repertoires	  recognizing	  self-­‐antigens	  presented	  in	  the	  thymus.	  The	  observation	  that	  Treg	  are	  induced	  by	  self-­‐antigens	  normally	  only	  produced	  in	  special	  peripheral	  tissues	  raises	  the	  question	  how	  the	  thymus	  can	  present	  these	  antigens	  (Seddon	  and	  Mason	  1999).	  One	  possibility	  is	  the	  capturing	  of	  peripheral	  antigens	  by	  migrating	  APCs	  or	  the	  ability	  of	  mTEC	  to	  express	  low	  levels	  of	  self-­‐antigens	  regulated	  by	  autoimmune	  regulator	  (AIRE)	  (Mathis	  and	  Benoist	  2009;	  Kyewski	  and	  Peterson	  2010;	  Hsieh	  et	  al.	  2012).	  In	  addition	  to	  TCR	  signaling	  and	  co-­‐stimulatory	  signals,	  cytokines	  are	  required	  for	  Treg	  development	  and	  survival.	  Due	  to	  high	  expression	  of	  the	  Il-­‐2	  receptor	  alpha	  subunit,	  Il-­‐2	  was	  suspected	  to	  be	  essential	  for	  Treg	  generation.	  Indeed,	  genetic	  ablation	  of	  CD25	  resulted	  in	  reduced	  Treg	  numbers,	  and	  deletion	  of	  the	  common	  gamma	  chain	  of	  the	  Il-­‐2	  receptor	  as	  well	  as	  combined	  deletion	  of	  interleukins	  signaling	  through	  it	  (Il-­‐2,	  Il-­‐7	  and	  Il-­‐15)	  led	  to	  a	  complete	  loss	  of	  the	  Treg	  compartment	  (Fontenot	  et	  al.	  2005a;	  Burchill	  et	  al.	  2007;	  Vang	  et	  al.	  2008).	  In	  addition	  to	  thymus	  derived	  Treg,	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induced	  Treg	  (iTreg)	  are	  generated	  in	  the	  periphery	  by	  Tgf-­‐ß	  (Chen	  et	  al.	  2003)	  and	  retinoic	  acid	  (Sun	  et	  al.	  2007;	  Nolting	  et	  al.	  2009).	  Induced	  Treg	  seem	  particular	  important	  for	  homeostasis	  and	  tolerance	  at	  mucosal	  sites	  or	  in	  the	  gut	  (Sun	  et	  al.	  2007;	  Barnes	  and	  Powrie	  2009;	  Josefowicz	  et	  al.	  2012).	  
2.2.2.3 Mechanisms	  of	  suppression	  Treg	  themselves	  lack	  many	  properties	  ascribed	  to	  conventional	  effector	  cells:	  Treg	  do	  not	  proliferate	  upon	  sole	  TCR	  stimulation	  but	  need	  additional	  Il-­‐2	  and	  CD28	  co-­‐stimulation	  to	  overcome	  anergy	  (Thornton	  et	  al.	  2004).	  Moreover,	  they	  do	  not	  produce	  proinflammatory	  cytokines	  and	  survival	  factors	  such	  as	  Il-­‐2	  that	  potentially	  boost	  effector	  T	  cell	  functions:	  On	  the	  molecular	  level	  cytokine	  production	  is	  in	  part	  controlled	  by	  Foxp3	  itself	  as	  it	  was	  shown	  to	  interact	  with	  the	  transcription	  factors	  NFAT	  and	  NFkB	  to	  hinder	  transcriptional	  activation	  of	  Il-­‐2,	  Il-­‐4	  and	  Ifn-­‐γ	  (Bettelli	  et	  al.	  2005;	  Wu	  et	  al.	  2006).	  Most	  importantly,	  they	  can	  suppress	  the	  activation,	  proliferation	  and	  effector	  function	  of	  a	  wide	  range	  of	  immune	  cells	  such	  as	  T	  cells,	  B	  cells,	  mast	  cells,	  natural	  killer	  cells	  and	  APCs	  including	  macrophages	  and	  dendritic	  cells	  (DCs)	  (Vignali	  et	  al.	  2008;	  Shevach	  2009).	  Various	  contact-­‐dependent	  and	  -­‐independent	  mechanisms	  were	  proposed:	  human	  Treg	  express	  granzyme	  A	  while	  mouse	  Treg	  express	  granzyme	  B	  (Grossman	  et	  al.	  2004;	  Gondek	  et	  al.	  2005),	  both	  molecules	  that	  can	  kill	  target	  cells	  by	  cytolysis.	  Moreover,	  Treg	  can	  induce	  apoptosis	  in	  T	  cells	  by	  galectin-­‐1	  (Lgals1)	  (Garín	  et	  al.	  2007).	  Regulatory	  T	  cells	  constitutively	  express	  the	  cytotoxic	  T-­‐lymphocyte-­‐associated	  protein	  4	  (Ctla4),	  a	  molecule	  that	  downregulates	  co-­‐stimulatory	  molecules	  on	  APCs	  and	  hence	  attenuates	  effector	  T	  cell	  activation	  by	  APCs	  (Read	  et	  al.	  2000;	  Wing	  et	  al.	  2008).	  It	  was	  also	  described	  that	  Treg	  can	  upregulate	  lymphocyte-­‐activation	  antigen	  3	  (Lag3)	  that	  ligates	  to	  major	  histocompatibility	  (MHC)	  class	  II	  molecules	  on	  DCs	  to	  inhibit	  their	  maturation	  and	  thereby	  their	  immune-­‐stimulatory	  function	  (Liang	  et	  al.	  2008).	  Recent	  discoveries	  propose	  “metabolic”	  disruption	  as	  another	  possibility	  to	  inhibit	  T	  cell	  function:	  The	  ectoenzymes	  ectonucleoside	  triphosphate	  diphosphohydrolase	  1	  (Entpd1)	  and	  ecto-­‐5'-­‐nucleotidase	  (Nt5e)	  expressed	  in	  Treg	  generate	  immune-­‐suppressive	  extracellular	  adenosine	  (Deaglio	  et	  al.	  2007).	  In	  addition	  there	  is	  a	  discussion	  about	  the	  possibility	  that	  Treg	  deprive	  the	  microenvironment	  of	  the	  essential	  survival	  cytokine	  Il-­‐2	  by	  binding	  it	  with	  their	  highly	  expressed	  Interleukin-­‐2	  receptor	  (Fontenot	  et	  al.	  2005a;	  Pandiyan	  et	  al.	  2007).	  Treg	  also	  secrete	  cytokines	  with	  immunosuppressive	  function,	  namely	  Il-­‐10,	  Tgf-­‐ß	  and	  Il-­‐35,	  but	  the	  importance	  for	  Il-­‐10	  and	  Tgf-­‐ß	  was	  questioned	  by	  differing	  observations	  in	  in	  vitro	  and	  in	  vivo	  studies	  (Vignali	  et	  al.	  2008).	  An	  exciting	  current	  research	  topic	  is	  how	  Treg	  control	  different	  types	  of	  immune	  reactions.	  Apparently	  Treg	  can	  express	  transcription	  factors	  crucial	  for	  Th1,	  Th2,	  Th17	  and	  follicular	  T	  helper	  differentiation	  (T-­‐box	  21,	  interferon	  regulatory	  factor	  4	  [Irf4],	  Stat3	  and	  B	  cell	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leukemia/lymphoma	  [Bcl6],	  respectively)	  to	  activate	  transcriptional	  programs	  in	  Treg	  to	  enable	  their	  correct	  homing	  to	  the	  site	  of	  inflammation	  to	  suppress	  corresponding	  T	  helper	  responses	  (Chaudhry	  et	  al.	  2009;	  Koch	  et	  al.	  2009;	  Zheng	  et	  al.	  2009;	  Linterman	  et	  al.	  2011).	  Further	  research	  is	  needed	  to	  determine	  factors	  driving	  these	  specialized	  Treg	  and	  how	  they	  influence	  the	  corresponding	  Tconv	  at	  different	  sites	  of	  inflammation.	  
2.2.2.4 Gene	  regulation	  at	  the	  FOXP3	  locus	  and	  beyond	  The	  signals	  from	  TCR	  engagement,	  co-­‐stimulation	  and	  cytokines	  in	  Treg	  development	  and	  function	  are	  all	  integrated	  to	  drive	  a	  Treg-­‐specific	  gene	  expression	  program.	  As	  stable	  expression	  of	  FOXP3	  is	  essential	  for	  Treg,	  the	  FOXP3	  locus	  has	  been	  studied	  extensively	  with	  respect	  to	  transcription	  factor	  binding	  and	  epigenetic	  modifications	  (Huehn	  et	  al.	  2009).	  FOXP3	  is	  encoded	  at	  the	  X-­‐chromosome	  and	  consists	  of	  11	  exons.	  Besides	  the	  promoter,	  3	  intragenic	  conserved	  non-­‐coding	  sequences	  (CNS1,	  CNS2	  and	  CNS3)	  were	  described	  to	  be	  important	  for	  correct	  orchestration	  of	  FOXP3	  expression:	  Initial	  TCR	  engagement	  in	  the	  thymus	  results	  in	  the	  binding	  of	  c-­‐Rel,	  a	  NFkB-­‐family	  TF,	  to	  CNS3	  (Long	  et	  al.	  2009;	  Zheng	  et	  al.	  2010)	  and	  the	  promoter	  (Ruan	  et	  al.	  2009),	  which	  is	  regarded	  as	  a	  crucial	  pioneer	  signal	  for	  Foxp3	  expression	  in	  the	  thymus.	  Genetic	  ablation	  of	  CNS3	  resulted	  in	  reduced	  Treg	  numbers	  due	  to	  lower	  probability	  of	  Foxp3	  expression	  (Zheng	  et	  al.	  2010).	  TCR	  engagement	  also	  increased	  nuclear	  factor	  of	  activated	  T	  cells	  (NFAT)	  and	  activator	  protein	  1	  (AP1)-­‐dependent	  activation	  of	  the	  FOXP3	  promoter	  in	  humans	  (Mantel	  et	  al.	  2006).	  In	  mice	  it	  was	  shown	  that	  cyclic-­‐AMP-­‐responsive-­‐element	  (CREB)	  and	  activating	  transcription	  factor	  (ATF)	  bound	  to	  a	  CpG-­‐rich	  intronic	  conserved	  sequence	  (CNS2)	  after	  TCR-­‐ligation	  and	  increased	  Foxp3	  expression	  (Kim	  and	  Leonard	  2007).	  Interestingly,	  this	  binding	  was	  controlled	  by	  DNA	  methylation	  in	  this	  experimental	  setting,	  and	  reduction	  of	  DNA	  methylation	  by	  5-­‐deazacytidine	  or	  by	  knocking	  out	  DNA	  methyltransferase	  1	  (Dnmt1)	  increased	  FoxP3	  expression	  in	  Treg	  (Kim	  and	  Leonard	  2007).	  In	  line	  with	  this,	  reduction	  of	  DNA	  methylation	  by	  5-­‐aza-­‐2’-­‐deoxycytidine	  increased	  FOXP3	  expression	  also	  in	  human	  natural	  killer	  (NK)	  cells	  in	  vitro	  as	  reported	  by	  Zorn	  and	  colleagues	  (Zorn	  et	  al.	  2006).	  CNS2	  was	  termed	  the	  Treg-­‐specific	  demethylated	  region	  (TSDR)	  and	  is	  the	  best-­‐studied	  enhancer	  in	  Treg	  (Huehn	  et	  al.	  2009).	  Notably	  the	  TSDR	  is	  completely	  demethylated	  in	  stable	  Treg	  and	  completely	  methylated	  in	  Tconv	  (Floess	  et	  al.	  2007;	  Polansky	  et	  al.	  2008).	  TGF-­‐ß	  induced	  Foxp3	  expression	  in	  Tconv	  was	  only	  transient	  and	  resulted	  in	  an	  incomplete	  demethylation	  of	  the	  TSDR,	  observations	  also	  published	  in	  the	  human	  system	  (Baron	  et	  al.	  2007).	  Even	  in	  the	  absence	  of	  FOXP3-­‐inducing	  TGF-­‐ß,	  FOXP3	  expression	  was	  increased	  after	  inhibition	  of	  DNA	  methylation	  by	  5-­‐acacytidine	  in	  human	  Treg	  (Zorn	  et	  al.	  2006).	  The	  methylation	  status	  of	  the	  TSDR	  is	  regarded	  as	  such	  a	  sensitive	  molecular	  marker	  that	  it	  is	  used	  to	  quantify	  Treg	  in	  blood	  samples	  (Wieczorek	  et	  al.	  2009;	  de	  Vries	  et	  al.	  2011).	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In	  addition	  to	  TCR	  signaling-­‐dependent	  TFs,	  other	  transcription	  factors	  were	  described	  to	  bind	  the	  TSDR,	  partially	  in	  a	  methylation	  dependent	  manner	  as	  described	  for	  ETS-­‐1	  (Polansky	  et	  al.	  2010).	  Runt-­‐related	  transcription	  factors	  (Runx)	  with	  their	  associated	  TF	  regulatory	  core-­‐binding	  factor	  beta	  (Cbfb)	  were	  shown	  to	  maintain	  Foxp3	  expression	  in	  Treg	  via	  a	  feed	  forward	  loop	  (Bruno	  et	  al.	  2009;	  Rudra	  et	  al.	  2009)	  and	  are	  critical	  for	  the	  regulation	  of	  Foxp3	  downstream	  genes.	  Interestingly,	  Foxp3	  and	  Cbfb	  bind	  to	  the	  TSDR	  in	  a	  DNA	  methylation	  dependent	  manner	  in	  vitro	  (Zheng	  et	  al.	  2010),	  providing	  further	  support	  for	  a	  role	  of	  DNA	  methylation	  in	  Foxp3	  expression.	  These	  data	  suggest	  a	  role	  for	  the	  TSDR,	  once	  demethylated	  and	  accessible	  for	  diverse	  TFs,	  as	  a	  “memory”	  module	  to	  sustain	  Foxp3	  expression	  over	  time,	  which	  is	  supported	  by	  the	  observation	  that	  genetic	  ablation	  of	  the	  TSDR	  led	  to	  progressive	  loss	  of	  Foxp3	  expression	  in	  Treg	  (Zheng	  et	  al.	  2010).	  Recent	  publications	  ad	  the	  Foxo	  proteins	  Foxo1	  and	  Foxo3a	  as	  well	  as	  Gata3	  to	  the	  panel	  of	  TFs	  binding	  to	  the	  TSDR	  and/or	  promoter	  to	  control	  Foxp3	  transcription	  (Harada	  et	  al.	  2010;	  Kerdiles	  et	  al.	  2010;	  Ouyang	  et	  al.	  2010;	  Wang	  et	  al.	  2011).	  However,	  the	  role	  of	  Gata3	  is	  controversial	  as	  Gata3	  can	  inhibit	  Foxp3	  expression	  in	  Th2-­‐polarized	  cells	  by	  binding	  to	  the	  Foxp3	  promoter	  and	  on	  the	  other	  hand	  is	  important	  for	  Treg	  development	  and	  function	  by	  acting	  in	  concert	  with	  Foxp3	  to	  activate	  Foxp3	  expression	  (Mantel	  et	  al.	  2007;	  Wang	  et	  al.	  2011).	  Cytokine	  signaling	  also	  tightly	  controls	  the	  development	  and	  function	  of	  Treg.	  Il-­‐2	  activates	  signal	  transducer	  and	  activator	  of	  transcription	  5	  (Stat5),	  a	  TF	  that	  was	  shown	  to	  bind	  the	  TSDR	  in	  mice	  (Yao	  et	  al.	  2007).	  STAT5	  activation	  increased	  the	  frequency	  of	  Treg	  in	  peripheral	  blood	  in	  cancer	  patients	  in	  vivo	  and	  is	  needed	  for	  the	  in	  vitro	  expansion	  of	  regulatory	  T	  cells	  (Hoffmann	  et	  al.	  2004;	  Hoffmann	  et	  al.	  2006a;	  Zorn	  et	  al.	  2006).	  A	  mediator	  of	  peripheral	  induction	  of	  Foxp3	  expression	  is	  TGF-­‐ß.	  Activation	  of	  downstream	  signaling	  cascades	  recruits	  SMAD	  proteins	  to	  CNS1	  that	  cooperate	  with	  TCR	  stimulation-­‐activated	  NFAT	  to	  induce	  Foxp3	  expression	  (Tone	  et	  al.	  2008).	  In	  line	  with	  these	  observations,	  genetic	  deletion	  of	  CNS1	  limits	  TGF-­‐ß	  induction	  of	  Treg	  in	  the	  periphery	  (Zheng	  et	  al.	  2010).	  Taken	  together,	  these	  data	  confirmed	  a	  role	  for	  many	  TFs	  (derived	  from	  different	  input	  signals)	  for	  stable	  Foxp3	  expression	  as	  summarized	  in	  Figure	  3.	  Knock	  out	  models	  of	  the	  corresponding	  TFs	  or	  regulatory	  CNS	  sequences	  at	  the	  Foxp3	  locus	  resulted	  in	  drastically	  reduced	  Treg	  numbers	  or	  non-­‐functional	  cells	  (Yao	  et	  al.	  2007;	  Kerdiles	  et	  al.	  2010;	  Ouyang	  et	  al.	  2010;	  Zheng	  et	  al.	  2010;	  Wang	  et	  al.	  2011).	  However,	  global	  views	  of	  key	  gene	  loci,	  their	  target	  genes	  and	  underlying	  epigenetic	  mechanisms	  in	  gene	  regulation	  are	  essential	  to	  understand	  basic	  principles	  in	  cell	  stability	  and	  identity.	  This	  is	  of	  great	  interest	  to	  evaluate	  the	  potential	  application	  of	  drugs	  targeting	  transcription	  factor	  signaling	  or	  altering	  the	  epigenetic	  status	  of	  cells.	  First	  attempts	  to	  the	  global	  characterizations	  of	  Treg	  were	  made	  by	  analyzing	  Foxp3	  targets	  in	  mice	  and	  humans	  by	  next	  generation	  sequencing	  or	  ChIP-­‐on-­‐chip	  experiments	  (Zheng	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et	  al.	  2007;	  Sadlon	  et	  al.	  2010;	  Birzele	  et	  al.	  2011),	  revealing	  new	  Foxp3	  target	  genes	  and	  that	  Foxp3	  is	  not	  only	  a	  repressor	  but	  can	  also	  positively	  influence	  gene	  expression.	  Genome	  wide	  maps	  of	  H3K4me3	  and	  H3K27ac	  in	  different	  mouse	  CD4+	  Th	  cell	  populations	  (Th1,	  Th2,	  Treg	  and	  Th17	  cells)	  gave	  insights	  into	  histone	  patterns	  around	  lineage	  defining	  genes	  and	  explained	  some	  observed	  heritable	  gene	  expression	  programs	  in	  fully	  polarized	  cells	  (Wei	  et	  al.	  2009).	  Interestingly,	  these	  experiments	  revealed	  that	  Treg	  have	  no	  repressing	  chromatin	  modification	  at	  the	  Th2	  cytokine	  locus	  encoding	  Il-­‐4,	  while	  they	  have	  both,	  repressive	  and	  active	  histone	  modification	  patterns	  at	  the	  lineage-­‐specific	  TFs	  Rorc,	  Tbx21	  and	  Gata3.	  Thus,	  they	  perhaps	  activate	  Il-­‐4	  and	  Gata3	  expression	  and	  this	  may	  explain	  the	  observed	  Il-­‐4	  driven	  Th2	  differentiation	  of	  Foxp3-­‐losing	  cells	  (Wan	  and	  Flavell	  2007).	  “Poised”	  chromatin	  modifications	  at	  the	  aforementioned	  TFs	  could	  promote	  their	  expression	  in	  specialized	  Treg	  subsets	  to	  drive	  specific	  suppressor	  programs	  as	  discussed	  before.	  In	  humans,	  Tian	  and	  colleagues	  identified	  cell	  type-­‐specific	  enhancers	  by	  comparative	  analysis	  of	  H3K4me1	  ChIP-­‐seq	  in	  Treg	  and	  activated	  Tconv	  (Tian	  et	  al.	  2011).	  They	  demonstrated	  that	  H3K4me3	  signatures	  representing	  promoters	  were	  very	  similar	  in	  Treg	  and	  Tconv,	  while	  broad	  differences	  in	  H3K4me1	  marked	  putative	  enhancer	  regions	  were	  detected.	  Nevertheless,	  comparative	  enhancer	  studies	  of	  Treg	  subpopulations	  and	  the	  identification	  of	  involved	  TFs	  shaping	  epigenetic	  patterns	  are	  still	  elusive,	  but	  would	  be	  important	  to	  understand	  gene	  regulation	  in	  Treg	  populations	  on	  a	  molecular	  level.	  Furthermore,	  several	  groups	  recently	  observed	  mechanisms	  involving	  non-­‐coding	  RNAs	  to	  participate	  in	  Treg	  development	  (Chong	  et	  al.	  2008;	  Zhou	  et	  al.	  2008b)	  and	  function	  (Zhou	  et	  al.	  2008b;	  Lu	  et	  al.	  2010b;	  Beyer	  et	  al.	  2011).	  
Introduction	  	  
	   22	  
	  
	  
2.2.2.5 Stability	  and	  heterogeneity	  It	  has	  long	  been	  accepted	  that	  thymus-­‐derived	  CD4+CD25+FOXP3+	  Treg	  represent	  a	  stable	  lineage	  (Fontenot	  et	  al.	  2003;	  Hori	  et	  al.	  2003;	  Fontenot	  et	  al.	  2005b;	  Sakaguchi	  2005;	  Ziegler	  2006).	  However,	  recent	  advances	  in	  genomic	  fate	  mapping,	  where	  permanent	  expression	  of	  fluorescence	  proteins	  label	  cells	  that	  once	  expressed	  Foxp3,	  identified	  populations	  of	  “exFoxp3”	  cells	  that	  lost	  Foxp3	  expression	  and	  exhibited	  a	  memory	  or	  effector	  phenotype	  (Komatsu	  et	  al.	  2009;	  Zhou	  et	  al.	  2009c).	  Thus,	  these	  findings	  challenge	  the	  view	  of	  Treg	  as	  a	  stable	  lineage.	  Moreover,	  it	  was	  shown	  that	  Foxp3+	  cells	  can	  convert	  into	  pathogenic	  Foxp3-­‐	  Th	  cells	  after	  adoptive	  transfer	  (Duarte	  et	  al.	  2009)	  or	  in	  proinflammatory	  milieus	  (Xu	  et	  al.	  2007;	  Yang	  et	  al.	  2008a).	  In	  contrast,	  a	  recent	  study	  suggests	  that	  the	  observed	  plasticity	  of	  Foxp3+	  cells	  is	  restricted	  to	  a	  small	  population	  of	  conventional	  T	  cells	  promiscuously	  expressing	  Foxp3	  and	  not	  
Figure	  3	  
Gene	  regulation	  at	  the	  Foxp3	  locus.	  Chromatin	  structure,	  DNA	  methylation	  and	  transcription	  factor	  binding	  at	  the	  Foxp3	  cis-­‐regulatory	  elements	  (promoter	  as	  well	  as	  CNS1-­‐3)	  in	  conventional	  T	  cells,	  Tgfß-­‐induced	  Foxp3+	  cells	  as	  well	  as	  stable	  Foxp3+	  Treg	  cells;	  DNA	  (black	  lines)	  is	  wrapped	  around	  nucleosomes	  (green	  cylinders);	  red	  circles:	  methylated	  CpG	  dinucleotide;	  small	  red	  and	  yellow	  hexagons:	  histone	  methylation	  at	  H3K9,	  H3K27	  or	  H3K4;	  blue	  star:	  histone	  acetylation;	  other	  objects:	  transcription	  factors	  as	  described	  in	  the	  introduction.	  (Adapted	  from	  Huehn	  et	  al.	  2009)	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a	  feature	  of	  natural	  regulatory	  T	  cells,	  suggesting	  that	  thymus-­‐derived	  Treg	  represent	  a	  stable	  lineage	  (Miyao	  et	  al.	  2012).	  Seminal	  work	  in	  the	  human	  system	  of	  Hoffmann	  and	  colleagues	  demonstrated	  that	  CD4+CD25+	  Treg	  comprise	  a	  “naïve”	  and	  memory	  population	  discriminated	  by	  the	  expression	  of	  CD45RA	  (Hoffmann	  et	  al.	  2006b).	  Naïve	  Treg	  stably	  expressed	  FOXP3	  even	  after	  in	  vitro	  expansion	  while	  expansion	  of	  memory	  Treg	  resulted	  in	  loss	  of	  FOXP3	  expression	  and	  secretion	  of	  proinflammatory	  cytokines	  (Hoffmann	  et	  al.	  2006b).	  Based	  on	  this	  it	  was	  shown	  that	  human	  memory	  Treg	  contain	  a	  subpopulation	  of	  cytokine-­‐secreting	  FOXP3lo	  cells	  with	  limited	  suppressive	  capabilities	  but	  the	  potential	  to	  differentiate	  into	  Th17	  cells	  (Miyara	  et	  al.	  2009).	  In	  line	  with	  this,	  a	  population	  of	  FOXP3+	  cells	  was	  described	  that	  expressed	  RORC	  and	  produced	  the	  proinflammatory	  cytokine	  IL-­‐17	  (Ayyoub	  et	  al.	  2009;	  Voo	  et	  al.	  2009).	  Gene	  expression	  profiling	  of	  different	  ex	  vivo	  Treg	  subsets	  also	  revealed	  the	  heterogeneity	  of	  Treg	  populations	  in	  different	  organs,	  as	  demonstrated	  for	  adipose	  tissue-­‐derived	  Treg	  (Feuerer	  et	  al.	  2010;	  Cipolletta	  et	  al.	  2012).	  Furthermore,	  heterogeneity	  of	  cells	  solely	  characterized	  by	  expression	  of	  FOXP3	  can	  also	  emerge	  from	  the	  ability	  of	  human	  Tconv	  to	  upregulate	  FOXP3	  upon	  activation	  without	  acquiring	  a	  Treg	  phenotype	  and	  function	  (Gavin	  et	  al.	  2006).	  Molecular	  characterization	  of	  key	  cytokine-­‐	  and	  TF	  loci	  in	  Treg/Foxp3+	  subpopulations	  could	  help	  to	  delineate	  their	  identity	  and	  pathogenic	  potential.	  
2.2.2.6 Treg	  in	  transplantation	  When	  hematopoietic	  cells	  or	  solid	  organs	  are	  transplanted	  between	  genetically	  different	  individuals,	  donor	  T	  cells	  in	  the	  transplant	  recognize	  the	  host	  tissue	  as	  foreign,	  which	  can	  mount	  immune	  reactions	  that	  are	  harmful	  for	  the	  host.	  As	  Treg	  are	  suppressive,	  they	  are	  promising	  agents	  to	  prevent	  such	  unwanted	  immune	  reactions,	  a	  hypothesis	  that	  was	  already	  tested	  successfully	  in	  mouse	  models	  (Hoffmann	  et	  al.	  2002b;	  Edinger	  and	  Hoffmann	  2011b)	  and	  first	  clinical	  studies	  (Edinger	  Matthias,	  unpublished	  observations;	  (Brunstein	  et	  al.	  2011b;	  Di	  Ianni	  et	  al.	  2011a).	  Interestingly,	  co-­‐transplantation	  of	  Treg	  in	  hematopoietic	  stem	  cell	  transplantation	  (e.g.	  to	  cure	  leukemia)	  did	  not	  impair	  the	  beneficial	  graft-­‐versus-­‐leukemia	  effect,	  a	  process	  in	  which	  transplanted	  Tconv	  help	  to	  eradicate	  residual	  host	  leukemic	  cells	  (Edinger	  et	  al.	  2003).	  To	  obtain	  sufficient	  numbers	  for	  the	  repetitive	  application	  of	  regulatory	  T	  cells	  in	  transplantation,	  the	  cells	  can	  be	  expanded	  up	  to	  40000-­‐fold	  by	  repeated	  TCR	  stimulations	  in	  the	  presence	  of	  high-­‐dose	  IL-­‐2	  (Hoffmann	  et	  al.	  2004).	  Furthermore,	  efficient	  enrichment	  methods	  for	  the	  isolation	  of	  CD4+CD25+	  Treg	  under	  good	  manufacturing	  practice	  (GMP)	  conditions	  have	  already	  been	  established	  (Hoffmann	  et	  al.	  2006a).	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2.3 Objectives	  With	  the	  goal	  to	  apply	  Treg	  in	  clinical	  trials,	  the	  lack	  of	  understanding	  in	  Treg	  gene	  regulation,	  mechanisms	  of	  suppression,	  cellular	  development	  as	  well	  as	  the	  observations	  about	  their	  heterogeneity,	  plasticity	  and	  behavior	  in	  expansion	  systems	  demand	  their	  thorough	  molecular	  characterization.	  This	  thesis	  focuses	  on	  basic	  principles	  of	  gene	  regulation	  in	  Treg	  and	  Tconv	  to	  understand	  the	  interaction	  of	  transcription	  factor	  networks	  with	  regulatory	  elements	  and	  their	  impact	  on	  gene	  expression.	  Moreover,	  molecular	  methods	  are	  applied	  to	  analyze	  distribution,	  differences	  and	  dynamics	  of	  epigenetic	  features	  in	  regulatory	  and	  conventional	  T	  cell	  subpopulations	  and	  their	  connected	  gene	  expression	  programs.	  Furthermore,	  the	  question	  of	  stability	  and	  heterogeneity	  of	  Treg	  subpopulations	  is	  addressed	  to	  improve	  potential	  clinical	  application	  of	  Treg.	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Abstract	  
DNA	  methylation	  participates	  in	  establishing	  and	  maintaining	  chromatin	  structures	  and	  regulates	  gene	  transcription	  during	  mammalian	  development	  and	  cellular	  differentiation.	  With	  few	  exceptions,	  research	  thus	  far	  focused	  on	  gene	  promoters,	  and	  little	  is	  known	  about	  the	  extent,	  functional	  relevance	  and	  regulation	  of	  cell	  type-­‐specific	  DNA	  methylation	  at	  promoter-­‐distal	  sites.	  Here,	  we	  present	  a	  comprehensive	  analysis	  of	  differential	  DNA	  methylation	  in	  human	  conventional	  CD4+	  T	  cells	  (Tconv)	  and	  CD4+CD25+	  regulatory	  T	  cells	  (Treg),	  cell	  types	  whose	  differentiation	  and	  function	  are	  known	  to	  be	  controlled	  by	  epigenetic	  mechanisms.	  Using	  a	  novel	  approach	  that	  is	  based	  on	  the	  separation	  of	  a	  genome	  into	  methylated	  and	  unmethylated	  fractions,	  we	  examined	  the	  extent	  of	  lineage-­‐specific	  DNA	  methylation	  across	  whole	  gene	  loci.	  More	  than	  one	  hundred	  differentially	  methylated	  regions	  (DMR)	  were	  identified	  that	  are	  mainly	  present	  in	  cell	  type-­‐specific	  genes	  (e.g.	  FOXP3,	  IL2RA,	  CTLA4,	  CD40LG	  and	  IFNG),	  and	  show	  differential	  patterns	  of	  histone	  H3	  lysine	  4	  methylation.	  Interestingly,	  the	  majority	  of	  DMR	  was	  located	  at	  promoter-­‐distal	  sites	  and	  many	  of	  these	  areas	  harbor	  DNA	  methylation-­‐dependent	  enhancer	  activity	  in	  reporter	  gene	  assays.	  Thus,	  our	  study	  provides	  a	  comprehensive,	  locus-­‐wide	  analysis	  of	  lineage-­‐specific	  methylation	  patterns	  in	  Treg	  and	  Tconv	  cells,	  links	  cell	  type-­‐specific	  DNA	  methylation	  with	  histone	  methylation	  and	  regulatory	  function	  and	  identifies	  a	  number	  of	  cell-­‐type	  specific,	  CpG	  methylation-­‐sensitive	  enhancers	  in	  immunologically	  relevant	  genes.	  	  
	  All	  microarray	  data	  have	  been	  submitted	  and	  are	  available	  from	  the	  NCBI/GEO	  repository	  (accession	  number	  GSE14281).	  The	  manuscript	  is	  accompanied	  by	  six	  supplemental	  tables	  and	  seven	  figures	  as	  well	  as	  twelve	  UCSC	  Genome	  Browser	  track	  files.	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  A	  cell’s	  identity	  and	  its	  developmental	  potential	  are	  governed	  by	  epigenetic	  mechanisms	  which	  control	  chromatin	  structure	  and	  accessibility	  of	  regulatory	  DNA	  sequences.	  Methylation	  of	  cytosine	  residues	  in	  genomic	  DNA	  is	  an	  important	  epigenetic	  mark	  that	  is	  essential	  for	  normal	  embryonic	  development	  in	  mammals	  (Okano	  et	  al.	  1999)	  ,	  imprinting	  (Li	  et	  al.	  1993),	  X-­‐inactivation	  	  (Goto	  and	  Monk	  1998)	  and	  silencing	  of	  potential	  hazardous	  genetic	  elements	  like	  transposons	  (Walsh	  et	  al.	  1998).	  In	  general,	  DNA	  methylation	  is	  linked	  to	  gene	  silencing,	  but	  its	  capacity	  to	  repress	  gene	  transcription	  depends	  on	  the	  surrounding	  sequence	  context	  and	  in	  particular	  on	  the	  local	  density	  of	  CpGs	  (Weber	  et	  al.	  2007).	  The	  repressor	  function	  of	  CpG	  methylation	  is	  best	  studied	  for	  CpG-­‐dense	  promoter	  regions	  (the	  so	  called	  CpG	  islands)	  that	  are	  frequently	  silenced	  in	  cancer	  as	  a	  consequence	  of	  disease-­‐associated	  aberrant	  CpG	  methylation	  (Plass	  and	  Soloway	  2002;	  Herman	  and	  Baylin	  2003).	  Its	  influence	  on	  gene	  expression	  in	  normal	  physiological	  settings	  is	  less	  well	  understood.	  The	  great	  majority	  of	  CpG	  islands	  is	  protected	  from	  CpG	  methylation	  in	  normal	  cells,	  probably	  due	  to	  the	  presence	  and	  function	  of	  general	  transcription	  factors	  like	  specific	  protein	  (Sp)	  1	  and	  3	  (Brandeis	  et	  al.	  1994).	  There	  is	  substantial	  evidence	  that	  less	  CpG-­‐dense	  promoter	  regions	  are	  more	  frequently	  targeted	  by	  DNA	  methylation	  and	  that	  gene	  expression	  and	  CpG	  methylation	  status	  often	  correlate	  (Schilling	  and	  Rehli	  2007;	  Weber	  et	  al.	  2007).	  Traditionally,	  the	  tissue-­‐	  or	  cell	  type-­‐specific	  DNA	  methylation	  studies	  focused	  on	  proximal	  promoter	  regions.	  However,	  a	  number	  of	  recent	  observations	  suggest	  that	  only	  a	  limited	  number	  of	  promoters	  display	  cell	  type-­‐specific	  CpG	  methylation,	  suggesting	  that	  DNA	  methylation	  might	  have	  a	  minor	  role	  in	  controlling	  cell	  type-­‐	  or	  lineage-­‐specific	  gene	  regulation	  (Meissner	  et	  al.	  2008;	  Mohn	  et	  al.	  2008).	  	  With	  few	  exceptions,	  promoter-­‐distal	  sequences	  have	  received	  little	  attention	  so	  far,	  and	  we	  know	  little	  about	  the	  global	  distribution	  and	  dynamics	  of	  DNA	  methylation	  during	  normal	  developmental	  processes,	  particularly	  in	  lineage-­‐specification	  and	  differentiation	  processes	  in	  the	  adult	  organisms.	  To	  gain	  a	  better	  understanding	  of	  their	  biological	  role,	  CpG	  methylation	  patterns	  have	  to	  be	  studied	  globally	  in	  well	  defined	  model	  systems	  like	  embryonic	  stem	  cells	  or	  the	  hematopoietic	  system.	  The	  latter	  is	  of	  particular	  interest	  for	  epigenetic	  studies	  as	  progenitor	  cells	  as	  well	  as	  various	  differentiated	  cell	  lineages	  can	  be	  isolated	  and	  purified	  for	  a	  comparative	  analysis	  of	  homogenous	  cell	  subpopulations.	  With	  the	  development	  and	  therapeutical	  use	  of	  ‘epigenetic	  drugs’	  like	  DNA	  methyltransferase-­‐	  or	  histone	  deacetylase	  inhibitors,	  it	  is	  of	  growing	  importance	  to	  understand	  the	  underlying	  regulatory	  mechanisms	  and	  potential	  effects	  on	  the	  normal	  hematopoietic	  cell	  system.	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  Natural	  CD4+CD25+	  regulatory	  T	  (Treg)	  cells	  play	  a	  fundamental	  role	  in	  maintaining	  immunological	  self	  tolerance	  and	  immune	  homeostasis	  (Vignali	  et	  al.	  2008)	  .	  They	  develop	  in	  the	  thymus	  as	  an	  independent	  CD4+	  T	  cell	  lineage	  and	  represent	  a	  prime	  example	  for	  epigenetic	  regulation.	  It	  was	  shown	  that	  the	  functional	  program	  of	  Treg	  cells	  is	  at	  least	  partially	  controlled	  by	  miRNA	  pathways	  (Chong	  et	  al.	  2008;	  Liston	  et	  al.	  2008;	  Zhou	  et	  al.	  2008b)	  and	  the	  continuous	  expression	  of	  the	  lineage-­‐directing	  transcription	  factor	  FOXP3	  is	  dependent	  on	  its	  DNA	  methylation	  status	  at	  a	  methylation	  sensitive,	  Treg	  cell-­‐specific	  enhancer	  (Floess	  et	  al.	  2007;	  Kim	  and	  Leonard	  2007;	  Polansky	  et	  al.	  2008).	  Apart	  from	  this	  particular	  region	  at	  the	  FOXP3	  locus,	  we	  know	  little	  about	  the	  regulatory	  role	  of	  DNA	  methylation	  during	  Treg	  lineage	  commitment,	  differentiation	  and	  cell	  type-­‐specific	  gene	  regulation.	  Here	  we	  describe	  a	  comprehensive	  comparative	  analysis	  of	  DNA	  methylation	  patterns	  at	  selected	  gene	  loci	  in	  human	  CD4+CD25-­‐	  conventional	  T	  cells	  (Tconv)	  and	  Treg	  cells.	  In	  line	  with	  recent	  observations	  in	  other	  cell	  systems	  (Meissner	  et	  al.	  2008;	  Song	  et	  al.	  2009),	  we	  found	  that	  the	  majority	  of	  differentially	  methylated	  regions	  (DMR)	  are	  located	  at	  promoter-­‐distal	  sites.	  Many	  of	  these	  areas	  were	  found	  to	  harbor	  DNA	  methylation-­‐dependent	  enhancer	  activity	  in	  reporter	  gene	  assays	  and	  cell	  type-­‐specific	  demethylation	  was	  found	  to	  correlate	  with	  increased	  methylation	  at	  histone	  H3	  lysine	  4	  (H3K4).	  	  	  Thus,	  we	  identified	  a	  number	  of	  cell	  type-­‐specific,	  CpG	  methylation-­‐sensitive	  enhancers	  at	  immunologically	  relevant	  genes	  in	  Treg	  and	  Tconv	  cells.	  In	  a	  more	  general	  point	  of	  view,	  our	  data	  suggest	  that	  the	  restriction	  of	  cell	  type-­‐specific	  enhancers	  is	  a	  key	  function	  of	  DNA	  methylation	  in	  adult	  progenitor	  cells	  and	  that	  differentiation	  and	  lineage	  commitment	  are	  associated	  with	  specific	  methylation	  or	  demethylation	  events	  in	  such	  enhancer	  regions.	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Results	  
	  
Identification	  of	  differentially	  methylated	  regions	  (DMR)	  in	  Treg	  and	  Tconv	  cells	  using	  
Methyl-­‐CpG	  Immunoprecipitation	  (MCIp)	  The	  recent	  development	  of	  fractionation	  techniques	  that	  enrich	  for	  methylated	  DNA	  fragments	  now	  permits	  the	  examination	  of	  CpG	  methylation	  on	  global	  platforms	  such	  as	  oligonucleotide	  tiling	  arrays	  or	  next	  generation	  sequencers.	  Current	  technologies	  are	  particularly	  well	  suited	  to	  address	  CpG	  methylation	  in	  CpG-­‐dense	  regions,	  whereas	  it	  remains	  difficult	  to	  systematically	  analyze	  regions	  of	  lower	  CpG	  content	  that	  comprise	  the	  majority	  of	  mammalian	  genomes.	  	  We	  previously	  developed	  technologies	  for	  the	  fractionation	  of	  genomic	  DNA	  fragments	  depending	  on	  their	  CpG	  density	  (methyl-­‐CpG	  immunoprecipitation,	  MCIp	  (Gebhard	  et	  al.	  2006;	  Schilling	  and	  Rehli	  2007),	  and	  adapted	  this	  approach	  to	  identify	  regions	  that	  are	  differentially	  methylated	  in	  two	  closely	  related	  T	  cell	  populations,	  namely	  Treg	  and	  Tconv	  cells.	  Due	  to	  the	  low	  frequency	  of	  Treg	  cells	  in	  peripheral	  blood	  we	  FACS-­‐purified	  CD45RA+	  naïve	  CD4+CD25high	  T	  cells	  and	  expanded	  those	  cells	  in	  vitro	  (see	  "Material	  &	  Methods").	  We	  previously	  showed	  that	  these	  cells	  homogeneously	  maintain	  all	  phenotypic,	  functional	  and	  epigenetic	  Treg	  cell	  characteristics	  even	  after	  extensive	  in	  vitro	  proliferation	  (Hoffmann	  et	  al.	  2006b;	  Baron	  et	  al.	  2007).	  We	  separated	  gDNA	  from	  both,	  expanded	  Treg	  and	  Tconv	  cells	  (Tregexp	  and	  Tconvexp)	  into	  unmethylated	  (CpG)	  and	  methylated	  pools	  (mCpG)	  using	  MCIp	  and	  compared	  cell	  type-­‐specific	  differences	  in	  DNA	  methylation	  by	  co-­‐hybridization	  of	  the	  two	  umethylated	  or	  the	  two	  methylated	  DNA	  subpopulations	  of	  Treg	  and	  Tconv	  cells,	  respectively,	  to	  locus-­‐wide	  tiling	  arrays.	  As	  enriched	  DNA-­‐fragments	  from	  a	  cell	  type	  in	  the	  methylated	  fraction	  should	  be	  depleted	  in	  the	  unmethylated	  fraction,	  the	  signal	  intensities	  in	  CpG	  pool	  and	  mCpG	  pool	  hybridizations	  should	  complement	  each	  other	  (“Mirror-­‐Image”	  approach,	  see	  Figure	  1A)	  and	  thereby	  allow	  the	  identification	  of	  differentially	  methylated	  regions	  (DMR).	  Because	  we	  expected	  to	  find	  lineage-­‐specific	  methylation	  differences	  with	  greater	  probability	  in	  regions	  associated	  with	  differential	  transcriptional	  activity,	  we	  limited	  our	  analysis	  to	  gene	  loci	  that	  showed	  cell	  type-­‐specific	  gene	  expression	  in	  Treg	  versus	  Tconv	  cells	  (both,	  in	  vitro	  expanded	  or	  freshly	  isolated)	  plus	  several	  control	  regions	  that	  were	  equally	  expressed	  in	  both	  cell	  types.	  Gene	  loci	  were	  selected	  based	  on	  own	  and	  previously	  published	  expression	  studies	  (Pfoertner	  et	  al.	  2006;	  Hill	  et	  al.	  2007)	  to	  mainly	  include	  those	  genes	  that	  are	  differentially	  expressed	  in	  freshly	  isolated	  (unstimulated)	  cells	  but	  also	  in	  ex	  vivo	  cultured	  and	  expanded	  T	  cell	  subsets	  that	  underwent	  several	  cycles	  of	  polyclonal	  TCR	  activation	  (Hoffmann	  et	  al.	  2006b).	  The	  microarray	  used	  in	  this	  study	  covered	  12	  megabases	  of	  the	  human	  genome	  and	  contained	  69	  regions	  (with	  a	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median	  size	  of	  100	  kb)	  and	  128	  proximal	  promoter	  regions	  and	  181	  genes,	  including	  a	  number	  of	  well	  known	  and	  functionally	  relevant	  genes	  like	  CD40LG,	  IFNG,	  FOXP3,	  IL2R,	  CTLA4,	  etc.	  (the	  complete	  list	  of	  selected	  regions	  is	  given	  in	  Supplemental	  Table	  S1).	  	  A	  representative	  scatter	  plot	  of	  comparative	  microarray	  hybridizations	  from	  unmethylated	  (CpG)	  and	  methylated	  pools	  (mCpG)	  is	  shown	  in	  Figure	  1B,	  where	  microarray	  probes	  showing	  the	  expected	  complementary	  behavior	  are	  colored	  in	  red	  (hypomethylated	  in	  Treg)	  and	  blue	  (hypomethylated	  in	  Tconv).	  In	  total,	  we	  identified	  132	  regions	  with	  lineage-­‐specific	  CpG	  methylation	  that	  were	  associated	  with	  53	  genes	  (A	  complete	  list	  of	  DMR	  is	  given	  in	  
Supplemental	  Table	  S2).	  The	  majority	  of	  DMR	  (89%)	  were	  of	  low	  CpG	  content	  (LCRs)	  and	  all	  residual	  sites	  are	  of	  intermediate	  CpG	  content	  using	  the	  classification	  described	  by	  Weber	  et	  al.	  (2007)(Weber	  et	  al.	  2007).	  Only	  seven	  out	  of	  132	  DMR	  overlapped	  with	  known	  proximal	  gene	  promoters,	  64%	  of	  all	  DMR	  were	  located	  within	  gene	  bodies,	  whereas	  36%	  were	  located	  in	  intergenic	  areas.	  As	  shown	  in	  Supplemental	  Figure	  S1,	  DMR	  status	  and	  differential	  mRNA	  expression	  status	  were	  significantly	  correlated	  regardless	  of	  the	  relative	  DMR	  position	  (intergenic/intragenic).	  Next,	  we	  searched	  for	  known	  sequence	  motifs	  enriched	  in	  T	  cell	  subset-­‐specific	  DMR.	  Consensus	  sites	  enriched	  in	  DMR	  as	  compared	  to	  the	  whole	  genome	  included	  cAMP-­‐responsive	  ATF/CREB-­‐sites	  (in	  DMR	  hypomethylated	  in	  Tconv	  cells)	  or	  STAT5-­‐motifs	  (in	  DMR	  hypomethylated	  specifically	  in	  Treg	  cells).	  Lists	  of	  the	  top	  ranking	  motifs	  are	  provided	  in	  
Supplemental	  Table	  S3.	  	  To	  validate	  and	  quantify	  methylation	  differences,	  a	  representative	  set	  of	  DMR	  was	  selected	  for	  MALDI-­‐TOF	  MS	  analysis	  (for	  information	  on	  amplicons	  and	  MALDI-­‐TOF	  MS	  results	  for	  all	  samples	  see	  Supplemental	  Tables	  S4	  and	  S5).	  Mass	  spectrometry	  yields	  quantitative	  methylation	  data	  of	  short	  stretches	  of	  subsequent	  CpGs	  in	  high-­‐throughput	  and	  consequently	  allows	  validation	  of	  large	  sample	  sets.	  An	  example	  of	  microarray	  and	  corresponding	  MS	  results	  is	  shown	  in	  Figure	  1C.	  LRRC32,	  encoding	  the	  Treg	  cell-­‐specific	  surface	  molecule	  GARP	  that	  mediates	  suppressive	  function	  and	  FOXP3	  induction	  (upon	  ectopic	  expression	  in	  naïve	  Tconv	  cells),	  contained	  a	  region	  in	  intron	  1	  that	  showed	  a	  hybridization	  pattern	  indicative	  of	  Treg	  cell-­‐specific	  hypomethylation	  (Figure	  1C,	  left	  bottom	  panel):	  microarray	  signal	  ratios	  of	  Treg-­‐Tconv	  comparisons	  were	  high	  in	  the	  unmethylated	  (CpG)	  and	  low	  in	  the	  methylated	  pools	  (mCpG),	  resulting	  in	  a	  significant	  hypomethylation	  score.	  Mass	  spectrometry	  of	  bisulfite-­‐treated	  DNA	  demonstrated	  that	  the	  center	  region	  was	  indeed	  completely	  methylated	  in	  Tconv	  cells	  and	  only	  weakly	  methylated	  in	  Treg	  cells,	  regardless	  whether	  cells	  were	  freshly	  isolated	  or	  expanded	  (Figure	  1C,	  right	  bottom	  panel).	  In	  total,	  26	  out	  of	  31	  selected	  DMR	  were	  confirmed	  by	  MS.	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Figure	  1:	  
Locus-­‐wide	  identification	  of	  DMR	  using	  the	  MCIp	  ‘mirror	  image’	  approach.	  (A)	  Schematic	  outline	  of	  the	  MCIp	  fragmentation	  and	  hybridization	  strategy.	  The	  fragmented	  genomes	  of	  Tconv	  and	  Treg	  cells	  are	  separated	  into	  unmethylated	  (CpG)	  and	  methylated	  (mCpG)	  pools.	  Each	  pool	  is	  directly	  labeled	  using	  fluorescent	  dyes	  and	  each	  pool	  of	  one	  cell	  type	  is	  compared	  to	  the	  corresponding	  pool	  of	  the	  other	  cell	  type	  on	  a	  locus-­‐wide	  microarray.	  Microarray	  images	  are	  compared	  to	  identify	  regions	  that	  show	  a	  reciprocal	  hybridization	  behavior.	  (B)	  Representative	  scatter	  plots	  of	  CpG-­‐	  and	  mCpG-­‐pool	  hybridizations	  are	  shown.	  Probes	  with	  reciprocal	  signal	  intensity	  ratios	  indicate	  the	  presence	  of	  DMR	  and	  are	  marked	  in	  red	  (Treg	  cells)	  or	  blue	  (Tconv	  cells).	  (C)	  Exemplary	  validation	  of	  microarray	  results	  using	  mass	  spectrometry.	  The	  intron	  1	  region	  of	  LRRC32	  is	  enriched	  in	  the	  unmethylated	  (CpG,	  red	  line)	  and	  depleted	  in	  the	  methylated	  (mCpG,	  black	  line)	  pools	  of	  Treg	  cells.	  A	  large	  hypomethylation	  score	  (defined	  as	  the	  difference	  product	  of	  Log10	  signal	  intensity	  ratios	  of	  both	  hybridizations)	  indicates	  differential	  methylation	  (left	  bottom	  panel).	  The	  same	  region	  was	  analyzed	  by	  MALDI-­‐TOF	  MS	  (Epityper)	  and	  results	  are	  shown	  as	  a	  heatmap	  (the	  scale	  ranges	  from	  pale	  yellow	  (no	  methylation)	  to	  dark	  blue	  (100%	  methylation).	  
Lineage-­‐specific	  DNA	  methylation	  in	  T	  cells	  correlates	  with	  histone	  methylation	  and	  enhancer	  activity	  	  
	   35	  
Methylation	  levels	  at	  DMR	  in	  other	  hematopoietic	  cell	  types	  
	  To	  investigate	  whether	  the	  identified	  DMR	  were	  specific	  for	  T	  cell	  populations,	  we	  also	  obtained	  mass	  spectrometry	  data	  for	  other	  major	  blood	  cell	  types	  including	  CD8+	  T	  cells,	  CD19+	  B	  cells,	  CD56+	  NK	  cells,	  CD14+	  monocytes	  and	  CD34+	  hematopoietic	  progenitor	  cells	  as	  well	  as	  the	  Jurkat	  T	  cell	  line.	  CD34+	  cells	  represent	  a	  mixture	  of	  mainly	  committed	  myeloid,	  but	  also	  common	  hematopoietic	  progenitor	  cells.	  As	  shown	  in	  Supplemental	  Figure	  S2,	  the	  majority	  of	  CpG	  dinucleotides	  located	  in	  DMR	  are	  methylated	  in	  CD34+	  hematopoietic	  progenitor	  cells,	  suggesting	  that	  CpGs	  in	  T	  cell-­‐specific	  DMR	  are	  demethylated	  during	  progenitor	  cell	  differentiation.	  It	  is	  also	  noteworthy	  that	  the	  observed	  CpG	  methylation	  differences	  were	  detected	  both	  in	  freshly	  isolated	  T	  cells	  subsets	  as	  well	  as	  in	  T	  cells	  that	  were	  cultured	  and	  expanded	  in	  vitro.	  Since	  the	  latter	  involved	  a	  polyclonal	  TCR-­‐stimulation	  for	  both	  conventional	  and	  regulatory	  T	  cell	  subsets	  it	  is	  likely	  that	  the	  observed	  differences	  are	  characteristic	  for	  each	  lineage	  and	  are	  not	  affected	  by	  T	  cell	  activation.	  	  	  MS-­‐derived	  hematopoietic	  methylation	  profiles	  are	  shown	  in	  detail	  for	  CTLA4	  (Figure	  2),	  IL2RA	  (Figure	  3)	  and	  FOXP3,	  CD40LG,	  IFNG	  and	  LRRC32	  (Supplemental	  Figures	  S3-­‐S6).	  When	  compared	  with	  other	  blood	  cell	  types,	  only	  few	  regions	  were	  T	  cell	  type-­‐specific,	  including	  two	  upstream	  regions	  of	  CTLA	  (s.	  Figure	  2),	  a	  region	  in	  intron1	  of	  IL2RA	  (s.	  Figure	  3),	  intron	  1	  of	  
FOXP3	  and	  intron	  1	  of	  the	  neighboring	  PPP1R3F	  (see	  Supplemental	  Figure	  S3),	  intron	  4	  of	  CD40LG	  (see	  Supplemental	  Figure	  S4),	  and	  the	  downstream	  DMR	  of	  LRRC32	  (see	  
Supplemental	  Figure	  S6).	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Chromatin	  modification	  and	  CTCF	  binding	  patterns	  across	  the	  CTLA4	  gene	  locus.	  Shown	  are	  the	  following	  tracks	  (from	  top	  to	  bottom):	  mammalian	  Consensus	  (Cons),	  repetitive	  regions	  as	  identified	  by	  the	  RepeatMasker	  program	  (both	  in	  black),	  ChIP-­‐on-­‐Chip	  tracks	  for	  CTCF	  (in	  blue),	  monomethylated	  (pale	  green),	  dimethylated	  (green)	  and	  trimethylated	  (darkgreen)	  lysine	  4	  of	  histone	  H3,	  the	  CpG	  index	  (indicating	  the	  methylation	  density	  300	  bp	  up-­‐	  or	  downstream	  of	  each	  microarray	  probe)	  as	  well	  as	  hypomethylation	  scores	  (in	  red)	  for	  both	  cell	  types.	  Several	  amplicons	  were	  designed	  for	  MALDI-­‐TOF	  MS	  analysis	  of	  bisulfite	  treated	  DNA	  as	  indicated	  below	  the	  tracks.	  Methylation	  levels	  of	  individual	  CpGs	  in	  the	  indicated	  cell	  types	  are	  shown	  color-­‐coded	  as	  described	  in	  the	  Figure	  1	  legend.	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Figure	  3:	  
Chromatin	  modification	  and	  CTCF	  binding	  patterns	  across	  the	  IL2RA	  gene	  locus.	  Tracks	  and	  heat	  maps	  are	  shown	  as	  described	  in	  the	  legend	  of	  Figure	  2.	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Correlation	  between	  DNA	  methylation,	  chromatin	  boundaries	  and	  histone	  methylation.	  The	  majority	  of	  detected	  DMR	  were	  located	  at	  promoter-­‐distal	  sites.	  To	  characterize	  potential	  functions	  of	  these	  regions,	  we	  next	  examined	  binding	  sites	  of	  the	  insulator	  protein	  CTCF.	  Binding	  of	  CTCF	  at	  imprinted	  loci	  restricts	  or	  directs	  enhancer-­‐promotor	  interactions,	  and	  this	  binding	  is	  often	  regulated	  by	  DNA	  methylation	  (Bell	  and	  Felsenfeld	  2000).	  We	  mapped	  CTCF	  binding	  sites	  using	  ChIP-­‐on-­‐Chip	  on	  our	  locus-­‐wide	  tiling	  array.	  The	  binding	  pattern	  of	  CTCF	  was	  almost	  identical	  to	  the	  published	  data	  set	  for	  CD4+	  T	  cells	  (Barski	  et	  al.	  2007)	  and	  showed	  little	  variation	  between	  Treg	  and	  Tconv	  cells.	  In	  addition,	  we	  found	  no	  overlap	  between	  DMR	  and	  CTCF	  binding	  (data	  not	  shown),	  suggesting	  that	  the	  regulation	  of	  CTCF	  controlled	  chromatin	  boundaries	  is	  not	  a	  major	  function	  of	  DMR	  at	  the	  non-­‐imprinted	  loci	  investigated	  in	  this	  study.	  	  	  To	  address	  the	  question	  whether	  DMR	  at	  promoter-­‐distal	  sites	  harbor	  regulatory	  functions,	  we	  examined	  the	  association	  of	  methylation	  patterns	  with	  other	  chromatin	  modifications	  known	  to	  control	  enhancer	  elements.	  Mono-­‐	  and	  dimethylation	  of	  histone	  H3	  lysin	  4	  (H3K4)	  were	  previously	  shown	  to	  mark	  enhancer	  regions	  (Heintzman	  et	  al.	  2007),	  whereas	  H3K4	  trimethylation	  generally	  associates	  with	  transcription	  start	  sites	  (Barski	  et	  al.	  2007).	  Using	  the	  ChIP-­‐on-­‐Chip	  approach	  we	  mapped	  these	  three	  histone	  marks	  in	  expanded	  Treg	  and	  Tconv	  cells.	  In	  general,	  we	  observed	  the	  expected	  continuous	  pattern	  of	  H3K4	  methylation:	  Mono-­‐	  and	  di-­‐methylation	  were	  often	  found	  together	  and	  showed	  a	  similar	  distribution	  if	  no	  tri-­‐methylation	  was	  present.	  If	  tri-­‐methylation	  is	  detected,	  mono-­‐methylation	  tends	  to	  decrease	  (relative	  to	  di-­‐methylation).	  Mono-­‐methylation	  without	  di-­‐methylation	  or	  tri-­‐methylation	  without	  di-­‐methylation	  we	  rarely	  detected.	  Examples	  of	  selected	  gene	  loci	  are	  presented	  in	  Figure	  2	  and	  3,	  as	  well	  as	  in	  Supplemental	  Figures	  S3-­‐S6	  (the	  complete	  set	  of	  microarray	  data	  is	  provided	  as	  UCSC	  Genome	  browser	  track	  files	  in	  the	  Supplemental	  Material).	  	  Since	  the	  three	  possible	  methylation	  states	  of	  H3K4	  are	  not	  independent	  from	  each	  other	  they	  cannot	  be	  correlated	  with	  differential	  CpG	  methylation	  independently.	  However,	  if	  DMR	  correlated	  with	  H3K4	  methylation,	  one	  would	  expect	  to	  observe	  a	  co-­‐enrichment	  of	  cell	  type-­‐specific	  hypomethylation	  and	  H3K4	  methylation	  in	  isolates	  from	  the	  same	  cell	  type.	  The	  diagrams	  in	  Figure	  4	  show	  that	  this	  is	  indeed	  the	  case.	  Di-­‐	  and	  trimethylated	  H3K4	  clearly	  correlated	  with	  the	  differential	  methylation	  status	  at	  sites	  where	  H3K4	  methylation	  was	  observed.	  Due	  to	  the	  interdependence	  of	  H3K4	  methylation	  states	  and	  the	  frequent	  appearance	  of	  di-­‐	  and	  trimethylation	  states,	  monomethylated	  H3K4	  did	  not	  correlate	  with	  the	  differential	  methylation	  status.	  We	  also	  classified	  DMR	  regions	  according	  to	  their	  relative	  H3K4	  methylation	  status.	  Pie	  charts	  in	  Figure	  4D	  illustrate	  the	  distribution	  of	  H3K4	  methylation	  patterns	  at	  cell	  type	  specific	  DMR.	  Regions	  with	  activating	  regulatory	  function	  are	  most	  likely	  in	  those	  classes	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where	  hypomethylation	  in	  one	  cell	  type	  correlates	  with	  an	  increased	  level	  of	  H3K4	  methylation	  in	  the	  same	  cell	  type.	  The	  distribution	  of	  H3K4	  methylation	  patterns	  at	  cell	  type-­‐specific	  DMR	  depending	  on	  their	  relative	  position	  (intergenic/intragenic)	  are	  shown	  in	  Supplemental	  
Figure	  S7.	  In	  line	  with	  previous	  observed	  distribution	  of	  global	  patterns	  (Barski	  et	  al.	  2007;	  Heintzman	  et	  al.	  2007),	  trimethylation	  of	  H3K4	  was	  more	  strongly	  associated	  with	  intragenic	  DMR.	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Figure	  4:	  
Correlation	  of	  DNA	  demethylation	  and	  H3K4	  methylation	  status.	  (A-­‐C)	  Probe	  signal	  ratios	  of	  Tconv	  and	  Treg	  cells	  are	  plotted	  against	  each	  other	  for	  ChIP-­‐on-­‐Chip	  experiments	  of	  monomethylated	  (A),	  dimethylated	  (B)	  and	  trimethylated	  (C)	  lysine	  4	  of	  histone	  H3.	  Probes	  that	  appear	  along	  the	  diagonal	  indicate	  similar	  H3K4	  methylation	  levels,	  whereas	  probes	  above	  or	  below	  the	  diagonal	  indicate	  higher	  methylation	  levels	  in	  Tconv	  or	  Treg	  cells,	  respectively.	  Probes	  in	  DMR	  are	  colored	  (unmethylated	  in	  Tconv:	  blue;	  unmethylated	  in	  Treg:	  red),	  all	  other	  probes	  are	  in	  gray.	  (D)	  The	  two	  pie	  charts	  illustrate	  the	  relationship	  of	  associated	  H3K4	  methylation	  and	  DMR	  hypomethylated	  in	  Tconv	  (left	  chart)	  or	  Treg	  (right	  chart).	  The	  H3K4	  methylation	  status	  was	  classified	  as	  follows:	  DMR	  with	  increased	  H3K4	  tri-­‐methylation	  in	  Treg	  or	  Tconv	  cells	  (Treg	  Tri	  or	  Tconv	  Tri,	  respectively),	  DMR	  with	  increased	  H3K4	  mono-­‐,	  or	  di-­‐,	  but	  no	  tri-­‐methylation	  in	  Treg	  or	  Tconv	  cells	  (Treg	  or	  Tconv	  Mono/Di	  respectively),	  DMR	  with	  H3K4	  methylation	  present	  but	  not	  difference	  between	  T	  cell	  subsets	  (Not	  diff.)	  and	  DMR	  with	  no	  detectable	  H3K4	  methylation	  (No	  H3K4me).	  The	  numbers	  of	  DMR	  in	  each	  sub-­‐class	  are	  shown	  next	  to	  each	  piece	  of	  pie.	  Sub-­‐classes	  where	  hypomethylation	  in	  one	  cell	  type	  correlates	  with	  an	  increased	  level	  of	  H3K4	  methylation	  in	  the	  same	  cell	  type	  are	  marked	  by	  a	  circled	  number.	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Enhancer	  activity	  of	  T	  cell-­‐specific	  DMR	  As	  methylated	  H3K4	  has	  previously	  been	  associated	  with	  enhancer	  activity	  (Heintzman	  et	  al.	  2007)	  and	  co-­‐segregated	  with	  DMR	  in	  our	  experiments,	  we	  next	  asked	  whether	  DMR	  associate	  with	  enhancer	  activity.	  Properties	  of	  generic	  enhancers	  include	  their	  ability	  to	  increase	  transcriptional	  activity	  in	  a	  heterologous	  context,	  which	  can	  be	  studied	  using	  traditional	  reporter	  gene	  assays.	  We	  recently	  developed	  a	  reporter	  vector	  that	  completely	  lacks	  CpG	  dinucleotides	  (Klug	  and	  Rehli	  2006)	  and	  utilized	  this	  system	  to	  test	  for	  heterologous	  enhancer	  activity	  of	  24	  selected	  DMR.	  We	  preferentially	  selected	  DMR	  that	  were	  associated	  with	  genes	  that	  also	  showed	  differential	  gene	  expression	  and	  H3K4	  methylation	  (general	  properties	  of	  the	  selected	  DMR	  are	  listed	  in	  Supplemental	  Table	  S7).	  Transient	  transfections	  were	  performed	  in	  untreated,	  PMA/ionomycin-­‐,	  or	  PHA-­‐treated	  Jurkat	  T	  cells	  using	  unmethylated	  (CpG)	  or	  in	  vitro	  
SssI	  methylated	  (mCpG)	  reporter	  plasmids.	  As	  shown	  in	  Figure	  5,	  twelve	  out	  of	  24	  DMR	  significantly	  enhanced	  the	  activity	  of	  the	  basal	  (CpG-­‐free)	  EF1	  promoter.	  Importantly,	  all	  regions	  lost	  enhancer	  activity	  when	  methylated,	  suggesting	  that	  their	  activity	  is	  critically	  dependent	  on	  their	  CpG	  methylation	  status.	  Functionality	  in	  the	  enhancer	  assay	  did	  not	  correlate	  with	  DMR	  positioning	  (intergenic/intragenic),	  conservation	  status,	  the	  presence	  of	  DNaseI	  hypersensitive	  sites	  in	  CD4+	  T	  cells	  (Boyle	  et	  al.	  2008)	  or	  H3K4	  methylation	  status	  (for	  details	  see	  
Supplemental	  Table	  S7).	  However,	  the	  majority	  of	  regions	  that	  did	  not	  show	  enhancer	  activity	  in	  Jurkat	  cells	  corresponded	  to	  Treg	  cell-­‐specific	  DMR,	  including	  e.g.	  both	  upstream	  CTLA4	  regions,	  and	  an	  upstream	  region	  of	  ZNFN1A2.	  In	  line	  with	  this,	  DMR	  that	  did	  show	  enhancer	  activity	  in	  Jurkat	  cells	  were	  enriched	  for	  Tconv	  cell-­‐associated	  consensus	  binding	  sites	  (cAMP-­‐responsive	  ATF/CREB-­‐sites	  and	  ELK1-­‐sites;	  for	  a	  list	  of	  the	  top	  ranking	  motifs	  see	  
Supplemental	  Table	  S8).	  Since	  Jurkat	  T	  cells	  represent	  a	  leukemic	  counterpart	  of	  conventional	  T	  cells,	  it	  is	  possible	  that	  they	  lack	  Treg	  cell-­‐specific	  transcription	  factors	  that	  are	  necessary	  for	  enhancer	  functions	  of	  these	  regions.	  However,	  some	  Treg	  cell-­‐specific	  DMR	  did	  function	  even	  in	  Jurkat	  cells,	  suggesting	  that	  the	  relevant	  transcription	  factors	  required	  for	  enhancer	  activity	  at	  these	  sites	  were	  available.	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Figure	  5:	  
CpG	  methylation-­‐dependent	  enhancer	  activity	  of	  selected	  DMR.	  Several	  DMR	  were	  cloned	  upstream	  of	  a	  basic	  EF1-­‐promoter	  into	  the	  CpG-­‐free	  luciferase	  vector	  pCpGL-­‐P.	  The	  indicated	  plasmids	  were	  in	  vitro	  SssI-­‐methylated	  (mCpG)	  or	  unmethylated	  (CpG)	  and	  transiently	  transfected	  into	  Jurkat	  T	  cells	  that	  were	  left	  untreated	  (A),	  stimulated	  with	  PMA	  and	  ionomycin	  (B)	  or	  PHA	  (C)	  after	  transfection.	  Luciferase	  activity	  was	  normalized	  against	  the	  activity	  of	  a	  co-­‐transfected	  Renilla	  construct	  and	  mean	  values	  +/-­‐	  SD	  are	  shown	  relative	  to	  the	  unmethylated	  pCpGL-­‐P.	  An	  asterisks	  indicates	  a	  significant	  difference	  between	  methylated	  and	  unmethylated	  plasmids	  (P	  <	  0.05	  paired	  Student’s	  t-­‐test).	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Discussion	  
In	  this	  study	  we	  utilized	  a	  combination	  of	  DNA	  methylation-­‐dependent	  genome	  fractionation	  using	  methyl-­‐CpG	  immunoprecipitation	  (MCIp)	  and	  quantitative	  methylation	  analysis	  on	  a	  mass	  spectrometry	  platform	  (Sequenom	  MassARRAY	  system)	  to	  identify	  differentially	  methylated	  regions	  (DMR)	  in	  two	  closely	  related	  T	  cell	  subtypes	  (Treg	  and	  Tconv	  cells).	  We	  identified	  more	  than	  one	  hundred	  DMR	  in	  69	  selected	  geneloci	  that	  were	  primarily	  located	  at	  promoter-­‐distal	  regions,	  correlated	  with	  differential	  H3K4	  methylation	  patterns	  and	  were	  mostly	  methylated	  in	  CD34+	  hematopoietic	  progenitor	  cells.	  Many	  of	  the	  DMR	  show	  properties	  of	  methylation-­‐sensitive	  enhancers,	  suggesting	  that	  DNA	  methylation	  plays	  a	  role	  in	  establishing	  and	  maintaining	  cell	  type-­‐specific	  gene	  regulation	  by	  restricting	  lineage-­‐specific	  enhancers.	  Previous	  studies	  largely	  focused	  on	  gene	  promoter	  regions	  and,	  although	  there	  is	  ample	  evidence	  for	  cell	  type-­‐specific	  DNA	  methylation	  at	  proximal	  promoters,	  it	  appears	  to	  regulate	  only	  a	  small	  proportion	  of	  genes	  and	  thus	  seems	  to	  play	  only	  a	  minor	  role	  for	  lineage-­‐specific	  gene	  regulation.	  For	  example,	  in	  an	  ES	  cell	  model	  of	  neuronal	  differentiation,	  DNA	  methylation	  was	  shown	  to	  play	  a	  minor	  role	  in	  regulating	  gene	  promoters	  upon	  terminal	  differentiation	  whereas	  it	  appeared	  to	  restrict	  promoters	  of	  pluripotency	  genes	  in	  lineage-­‐committed	  progenitor	  cells	  (Mohn	  et	  al.	  2008).	  In	  this	  study,	  only	  a	  small	  proportion	  (approximately	  5%)	  of	  all	  Treg	  or	  Tconv	  cell-­‐specific	  DMR	  were	  located	  at	  proximal	  promoters,	  indicating	  that	  at	  least	  in	  this	  particular	  model	  system,	  differences	  in	  DNA	  methylation	  occur	  mainly	  at	  promoter-­‐distal	  sites	  and	  were	  thus	  largely	  neglected	  in	  previous	  studies.	  Our	  findings	  in	  CD4+	  T	  cells	  are	  in	  line	  with	  a	  recent	  study	  in	  ES	  cells	  which	  also	  identified	  promoter-­‐distal	  regions	  as	  the	  main	  sites	  of	  dynamic	  changes	  in	  DNA	  methylation	  upon	  differentiation	  (Meissner	  et	  al.	  2008)	  and	  with	  a	  study	  on	  tissue-­‐specific	  CpG	  island	  methylation	  which	  demonstrated	  that	  methylation	  of	  CpG	  islands	  in	  normal	  tissues	  preferentially	  occurs	  at	  promoter-­‐distal	  sites	  (Illingworth	  et	  al.	  2008).	  Most	  DMR	  that	  we	  identified	  were	  of	  low	  CpG	  content	  (LCR),	  suggesting	  that	  promoter-­‐distal	  elements	  may	  differ	  from	  promoter-­‐proximal	  sites,	  where	  cell	  type-­‐specific	  changes	  more	  frequently	  occur	  in	  intermediate	  CpG	  content	  regions	  (Mohn	  et	  al.	  2008).	  Interestingly,	  DMR	  were	  significantly	  enriched	  for	  transcription	  factor	  binding	  motifs	  that	  were	  previously	  shown	  to	  play	  a	  role	  in	  each	  T	  cell	  subset.	  DMR	  hypomethylated	  in	  Tconv	  cells	  were	  enriched	  for	  ATF/CREB	  consensus	  sites	  which	  are	  known	  to	  mediate	  mitogenic	  and	  CD28-­‐dependent	  signals	  (Hsueh	  et	  al.	  1997).	  Regions	  specifically	  demethylated	  in	  Treg	  cells	  were	  enriched	  for	  STAT5	  consensus	  sites.	  Treg	  cell	  survival	  critically	  depends	  on	  the	  presence	  of	  IL-­‐2.	  The	  transcription	  factor	  STAT5	  is	  activated	  through	  the	  IL-­‐2	  receptor	  (Hou	  et	  al.	  1995),	  has	  an	  essential	  role	  in	  CD25+CD4+	  regulatory	  T	  cell	  homeostasis	  (Antov	  et	  al.	  2003)	  and	  is	  known	  to	  regulate	  the	  lineage-­‐specific	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transcription	  factor	  FOXP3	  through	  an	  intronic,	  methylation	  sensitive	  enhancer	  (Zorn	  et	  al.	  2006).	  The	  significant	  enrichment	  of	  consensus	  sites	  does	  not	  necessarily	  imply	  a	  biological	  significance.	  Further	  experiments	  are	  needed	  to	  show	  that	  these	  motifs	  are	  actually	  bound	  by	  transcription	  factors	  in	  vivo.	  However,	  the	  fact	  that	  enriched	  consensus	  motifs	  belong	  to	  transcription	  factors	  with	  known	  importance	  in	  each	  lineage	  may	  point	  to	  a	  functional	  role	  of	  lineage-­‐specific	  DMR.	  	  The	  majority	  of	  DMR	  in	  both	  T	  cell	  subsets	  were	  methylated	  in	  CD34+	  hematopoietic	  progenitor	  cells	  and	  often	  also	  methylated	  in	  other	  mature	  hematopoietic	  lineages.	  CD34+	  cells	  comprise	  a	  relatively	  heterogeneous	  mixture	  of	  committed	  and	  uncommitted	  progenitor	  cells.	  However,	  the	  percentage	  of	  uncommitted	  as	  well	  as	  T	  cell	  lineage-­‐committed	  precursors	  is	  likely	  to	  be	  small.	  Since	  we	  were	  unable	  to	  obtain	  sufficient	  numbers	  of	  primary	  human	  T	  cell	  progenitors,	  it	  is	  unclear	  whether	  individual	  methylation	  patterns	  are	  created	  by	  methylation	  of	  previously	  unmethylated	  CpG	  residues	  or	  by	  demethylation	  of	  previously	  methylated	  sites.	  Because	  CpG	  methylation	  is	  often	  found	  in	  CD34+	  progenitors	  and	  mature	  cells	  of	  both	  myeloid	  and	  lymphoid	  lineages,	  it	  is	  likely	  that,	  in	  many	  cases,	  methylation	  marks	  are	  removed	  during	  lineage	  commitment	  of	  either	  T	  cell	  subtype.	  Previous	  studies	  suggested	  that	  mono-­‐,	  dimethylation	  or	  trimethylation	  at	  lysine	  4	  of	  histone	  H3	  (H3K4)	  at	  promoter-­‐distal	  sites	  is	  often	  associated	  with	  enhancer	  function	  (Barski	  et	  al.	  2007;	  Heintzman	  et	  al.	  2007;	  Wang	  et	  al.	  2008b).	  In	  line	  with	  the	  findings	  of	  a	  recent	  study	  (Meissner	  et	  al.	  2008),	  we	  observed	  an	  enrichment	  of	  H3K4	  methylation	  (both	  di-­‐	  and	  trimethylation)	  at	  many	  DMR	  in	  the	  T	  cell	  type	  that	  was	  hypomethylated,	  which	  suggested	  a	  regulatory	  function	  for	  these	  regions.	  DMR	  will	  be	  most	  likely	  associated	  with	  an	  active	  regulatory	  function	  when	  hypomethylation	  in	  one	  cell	  type	  correlates	  with	  an	  increased	  level	  of	  H3K4	  methylation	  in	  the	  same	  cell	  type.	  However,	  since	  some	  gene	  regulatory	  events	  during	  the	  differentiation	  of	  conventional	  and	  regulatory	  T	  cells	  may	  only	  be	  of	  transient	  nature,	  it	  is	  possible	  that	  DMR	  displaying	  no	  H3K4	  methylation	  in	  our	  analysis	  have	  lost	  this	  dynamic	  histone	  mark	  but	  retained	  the	  more	  stable	  CpG	  methylation	  pattern.	  Converse	  patterns	  (hypomethylation	  in	  one	  cell	  type	  correlates	  with	  an	  increased	  level	  of	  H3K4	  methylation	  in	  the	  other	  cell	  type)	  are	  rarely	  observed	  but	  validated	  in	  at	  least	  one	  case:	  the	  DMR	  located	  upstream	  of	  ID2	  (chr2:8735102-­‐8735444)	  shows	  hypomethylation	  in	  Treg	  cells	  but	  an	  increased	  H3K4	  methylation	  in	  Tconv	  cells.	  The	  biological	  significance	  of	  the	  converse	  patterns	  is	  unclear;	  however,	  it	  is	  possible	  that	  silencing	  elements	  may	  also	  be	  subject	  to	  regulation	  by	  DNA	  methylation.	  Three	  of	  the	  identified	  DMR	  were	  previously	  described	  as	  functional	  enhancer	  elements.	  Both	  upstream	  regions	  at	  the	  IFNG/IL26	  locus	  were	  defined	  as	  conserved,	  activation-­‐induced	  enhancers	  in	  conventional	  murine	  CD4+	  T	  cells	  (Schoenborn	  et	  al.	  2007b).	  In	  Treg	  cells,	  a	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functionally	  important	  intronic	  enhancer	  of	  the	  FOXP3	  gene	  was	  shown	  to	  be	  methylation-­‐sensitive	  (Baron	  et	  al.	  2007;	  Floess	  et	  al.	  2007;	  Kim	  and	  Leonard	  2007).	  Therefore,	  we	  now	  asked	  whether	  other	  DMR	  might	  also	  demonstrate	  enhancer	  properties	  and	  whether	  methylation	  would	  restrict	  enhancer	  activity.	  Half	  of	  the	  twenty-­‐four	  tested	  DMR	  significantly	  enhanced	  the	  activity	  of	  a	  heterologous	  promoter	  in	  transient	  reporter	  gene	  assays	  performed	  in	  a	  T	  cell	  leukemia	  line	  (Jurkat).	  Most	  strikingly,	  all	  regions	  lost	  enhancer	  activity	  upon	  CpG	  methylation.	  Even	  some	  Treg-­‐specific	  DMR	  showed	  enhancer	  activity	  in	  the	  Jurkat	  cells,	  suggesting	  that	  these	  cells	  per	  se	  express	  the	  required	  factors	  for	  enhancer	  function	  and	  that	  CpG	  methylation	  may	  be	  critical	  to	  restrict	  the	  lineage-­‐specific	  enhancer	  function	  of	  these	  DMR	  in	  Tconv	  cells.	  	  In	  some	  cases,	  DMR	  (e.g.	  both	  DMR	  upstream	  of	  CTLA4)	  co-­‐located	  with	  trimethylated	  H3K4	  that	  were	  not	  associated	  with	  detectable	  transcription	  (no	  associated	  ESTs	  or	  CAGE	  tags	  published	  in	  human	  or	  mouse,	  data	  not	  shown).	  Trimethylated	  H3K4	  is	  usually	  associated	  with	  promoters	  and	  its	  occurrence	  at	  enhancers	  is	  debated.	  Whereas	  Heintzmann	  et	  al.	  (2007)	  (Heintzman	  et	  al.	  2007)	  preferentially	  found	  H3K4	  monomethylation	  (and	  little	  or	  no	  H3K4	  trimethylation)	  at	  p300	  associated	  enhancers,	  Barski	  et	  al	  (2007)	  (Barski	  et	  al.	  2007)	  identified	  all	  three	  methylation	  states	  at	  functional	  enhancers.	  It	  is	  therefore	  unclear	  whether	  the	  promoter-­‐distal,	  H3K4	  trimethylated	  sites	  identified	  in	  this	  study	  associate	  with	  so	  far	  uncharacterized	  functional	  transcription	  units,	  or	  whether	  they	  act	  as	  (transcribed)	  enhancer	  regions	  like	  e.g.	  the	  upstream	  enhancer	  of	  the	  myeloid-­‐	  and	  B	  cell	  specific	  SPI1	  gene	  (Hoogenkamp	  et	  al.	  2007).	  Since	  Treg	  cells	  represent	  only	  a	  minor	  fraction	  of	  CD4+	  T	  cells,	  their	  transcriptome	  is	  likely	  under-­‐represented	  in	  public	  cDNA	  sequence	  databases.	  Therefore,	  further	  studies	  aiming	  at	  understanding	  cell	  type-­‐specific	  gene	  regulation	  in	  T	  cell	  subtypes	  will	  require	  a	  more	  comprehensive	  definition	  of	  transcription	  units,	  especially	  in	  Treg	  cells.	  A	  recent	  comprehensive	  study	  of	  the	  regulatory	  potential	  of	  mammalian	  conserved	  non-­‐coding	  sequences	  suggests	  that	  only	  a	  small	  proportion	  of	  these	  regions	  can	  be	  expected	  to	  exhibit	  classical	  cis-­‐regulatory	  activity	  in	  standard	  experimental	  assays	  (Attanasio	  et	  al.	  2008).	  In	  our	  hands,	  only	  a	  minority	  of	  the	  identified	  DMR	  were	  conserved	  during	  evolution.	  For	  example,	  the	  intronic	  DMR	  of	  IL2RA	  was	  not	  conserved	  across	  species	  but	  acted	  as	  the	  strongest	  enhancer	  in	  heterologous	  reporter	  assays.	  Our	  data	  suggest	  that	  conservation-­‐centred	  approaches	  to	  identify	  enhancer	  elements	  may	  miss	  out	  on	  a	  large	  number	  of	  important	  regulatory	  sites.	  In	  addition	  to	  the	  basic	  findings	  on	  cell	  type-­‐specific	  DNA	  methylation	  described	  above,	  our	  study	  identifies	  a	  number	  of	  putative	  regulatory	  elements	  in	  genes	  that	  are	  highly	  important	  for	  T	  cell	  function.	  For	  example,	  we	  found	  a	  methylation-­‐sensitive	  enhancer	  in	  intron	  4	  of	  CD40LG	  in	  Tconv	  cells.	  The	  encoded	  cell	  surface	  receptor	  plays	  an	  important	  role	  in	  regulating	  B	  cell	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function	  through	  its	  interaction	  with	  CD40	  on	  B	  cells	  and	  dendritic	  cells	  (vanKooten	  and	  Banchereau	  1997).	  The	  majority	  of	  interesting	  regions,	  however,	  were	  associated	  with	  genes	  important	  for	  Treg	  cell	  biology.	  It	  was	  previously	  shown	  that	  sustained	  expression	  of	  the	  lineage-­‐determining	  transcription	  factor	  FOXP3	  is	  dependent	  on	  its	  DNA	  methylation	  status	  at	  a	  methylation-­‐sensitive,	  Treg	  cell-­‐specific	  enhancer	  in	  intron	  I	  (Baron	  et	  al.	  2007;	  Floess	  et	  al.	  2007;	  Kim	  and	  Leonard	  2007).	  Our	  locus-­‐wide	  analysis	  identifies	  an	  extensively	  demethylated	  area	  at	  this	  locus	  that	  extends	  into	  the	  neighboring	  protein	  phosphatase	  1,	  regulatory	  (inhibitor)	  subunit	  3F	  (PPP1R3F)	  gene,	  where	  we	  identified	  an	  additional	  methylation-­‐dependent	  enhancer.	  Two	  DMR	  with	  enhancer	  function	  were	  identified	  at	  the	  LRRC32	  locus	  encoding	  a	  recently	  described	  surface	  molecule	  (also	  called	  GARP)	  that	  seems	  to	  contribute	  to	  the	  suppressive	  function	  of	  Treg	  cells	  (Wang	  et	  al.	  2008a).	  A	  novel	  and	  potent	  enhancer	  was	  found	  at	  the	  IL2RA	  gene	  that	  encodes	  the	  alpha	  chain	  of	  the	  IL-­‐2	  receptor	  (CD25).	  This	  methylation-­‐sensitive	  enhancer	  region	  was	  specifically	  demethylated	  in	  both	  freshly	  isolated	  Treg	  cells	  as	  well	  as	  in	  Treg	  cells	  that	  were	  cultured	  and	  expanded	  in	  vitro.	  Since	  cultured	  and	  expanded	  conventional	  T	  cells	  express	  high	  levels	  of	  CD25	  as	  a	  consequence	  of	  TCR	  activation,	  this	  region	  may	  contribute	  to	  regulating	  constitutive	  (rather	  than	  activation-­‐induced)	  CD25	  expression	  in	  Treg	  cells.	  	  Additional	  DMR	  were	  found	  upstream	  of	  ZNFN1A2,	  encoding	  a	  regulator	  of	  lymphocyte	  development	  (Dovat	  et	  al.	  2005),	  and	  CTLA4,	  encoding	  a	  molecule	  that	  is	  constitutively	  expressed	  on	  Treg	  cells	  and	  that	  suppresses	  immune	  responses	  by	  affecting	  the	  activating	  potency	  of	  antigen-­‐presenting	  cells	  (Wing	  et	  al.	  2008).	  Although	  both	  upstream	  CTLA4	  regions	  and	  the	  upstream	  region	  of	  ZNFN1A2	  showed	  no	  enhancer	  activity	  in	  transient	  transfection	  assays,	  the	  exclusive	  DNA	  demethylation	  and	  the	  increased	  H3K4	  methylation	  in	  Treg	  cells	  indicate	  a	  functional	  importance	  of	  these	  regions.	  Their	  activation	  may	  actually	  require	  Treg-­‐specific	  trans-­‐acting	  factors	  that	  are	  not	  present	  in	  Jurkat	  cells	  used	  for	  the	  reporter	  gene	  studies.	  The	  further	  characterization	  of	  the	  identified	  DMR,	  including	  the	  identification	  of	  DNA-­‐binding	  factors	  mediating	  the	  observed	  enhancer	  activities,	  will	  likely	  reveal	  important	  insights	  into	  cell	  type-­‐specific	  gene	  regulation	  in	  T	  cells.	  	  In	  conclusion,	  the	  observed	  distribution	  of	  DMR	  at	  promoter-­‐distal	  regions,	  their	  association	  with	  functional	  chromatin	  marks	  and,	  most	  strikingly,	  their	  methylation-­‐sensitive	  enhancer	  activity	  suggest	  a	  role	  for	  DNA	  methylation	  in	  controlling	  lineage-­‐specific	  gene	  expression	  mainly	  by	  restricting	  promoter-­‐distal	  regulatory	  elements.	  This	  basic	  principle	  is	  likely	  not	  confined	  to	  the	  two	  closely	  related	  T	  cell	  populations	  but	  may	  generally	  apply	  to	  somatic	  cell	  lineages	  in	  adult	  organisms.	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Methods	  
	  
Cell	  purification	  and	  culture	  MNC	  were	  isolated	  from	  leukapheresis	  products	  of	  healthy	  volunteers	  (after	  their	  informed	  consent	  and	  in	  accordance	  with	  protocols	  approved	  by	  the	  local	  authorities)	  by	  density	  gradient	  centrifugation	  over	  Ficoll/Hypaque	  (Biochrom	  AG,	  Berlin,	  Germany).	  CD4+	  cells	  were	  enriched	  using	  magnetically	  labeled	  human	  CD4	  MicroBeads	  (Miltenyi	  Biotec,	  Bergisch	  Gladbach,	  Germany)	  and	  the	  Midi-­‐MACS	  system	  (Miltenyi	  Biotec).	  The	  CD4+	  fraction	  was	  stained	  with	  CD4-­‐FITC	  (SK3),	  CD25-­‐PE	  (2A3)	  and	  CD3-­‐APC	  (UCHT1)	  and	  separated	  into	  CD3+CD4+CD25-­‐	  conventional	  T	  cells	  and	  CD3+CD4+CD25high	  regulatory	  T	  cells	  on	  a	  FACS-­‐Aria	  	  high-­‐speed	  cell	  sorter	  (BD	  Biosciences,	  Heidelberg,	  Germany).	  The	  CD4-­‐	  fraction	  was	  stained	  with	  CD19-­‐FITC	  (4G7),	  CD56-­‐PE	  (B159),	  CD3-­‐PerCP	  (SK7)	  and	  CD8-­‐APC	  (SK1)	  and	  sorted	  into	  CD19+CD3-­‐	  B	  cells,	  CD56+CD3-­‐	  NK	  cells	  and	  CD3+CD8+	  T	  cells.	  Monocytes	  were	  enriched	  from	  MNC	  using	  counter-­‐current	  elutriation	  in	  a	  J6M-­‐E	  Beckman	  centrifuge	  (Beckman,	  Munich,	  Germany)	  with	  a	  large	  chamber	  and	  a	  JE-­‐5	  rotor	  at	  1100g	  at	  a	  flow	  rate	  of	  110	  ml/min	  in	  Hanks'	  balanced	  salt	  solution	  as	  described	  previously.	  Enriched	  cell	  fractions	  were	  stained	  with	  CD14-­‐PE	  (M	  P9)	  and	  CD3-­‐APC	  (UCHT1),	  and	  CD14+CD3-­‐	  monocytes	  were	  further	  purified	  by	  FACS.	  All	  antibodies	  used	  were	  from	  BD	  Biosciences.	  All	  staining	  was	  performed	  in	  PBS	  /	  2%	  FCS.	  Dead	  cells	  were	  excluded	  by	  staining	  with	  propidium	  iodide.	  All	  cell	  populations	  showed	  a	  purity	  of	  >	  95	  %	  upon	  re-­‐analysis.	  T	  cell	  populations	  for	  expansion	  cultures	  were	  isolated	  as	  described	  in	  detail	  before	  (Hoffmann	  et	  al.	  2006b).	  In	  brief,	  PBMC	  were	  stained	  with	  anti-­‐CD25-­‐PE	  and	  CD25+	  cells	  were	  enriched	  by	  the	  use	  of	  anti-­‐PE	  magnetic	  beads	  and	  the	  Midi-­‐MACS	  system	  (Miltenyi	  Biotec).	  CD4+CD25-­‐	  Tconv	  cells	  were	  FACS-­‐purified	  from	  the	  CD25-­‐depleted	  cell	  fraction	  after	  staining	  with	  anti-­‐CD4-­‐FITC,	  CD4+CD25highCD45RA+	  Treg	  cells	  were	  sorted	  from	  the	  CD25-­‐enriched	  population	  after	  staining	  with	  anti-­‐CD4-­‐FITC	  and	  anti-­‐CD45RA-­‐APC.	  Reanalysis	  after	  sorting	  showed	  a	  purity	  of	  >	  98	  %.	  FACS–purified	  Tconv	  and	  Treg	  cell	  populations	  were	  polyclonally	  expanded	  in	  vitro	  for	  11-­‐14	  d	  as	  previously	  described	  (Hoffmann	  et	  al.	  2004).	  Briefly,	  cells	  were	  stimulated	  with	  anti-­‐CD3	  (OKT3;	  kind	  gift	  from	  Janssen-­‐Cilag,	  Neuss,	  Germany)	  and	  anti-­‐CD28	  (CD28.2;	  BD	  Biosciences)	  antibodies	  presented	  by	  CD32-­‐expressing	  L	  929	  cells	  in	  the	  presence	  of	  high-­‐dose	  recombinant	  human	  IL-­‐2	  (rhIL-­‐2,	  300	  U/mL;	  Proleukin,	  Chiron,	  Amsterdam,	  the	  Netherlands).	  To	  exclude	  any	  contamination	  by	  feeder	  cells,	  all	  cultured	  populations	  were	  stained	  with	  CD4-­‐FITC	  and	  PI	  and	  FACS-­‐sorted	  immediately	  prior	  to	  DNA	  isolation.	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Jurkat	  cells	  (humane	  T	  cell	  leukemia)	  were	  grown	  in	  90	  %	  1640	  RPMI	  (PAN	  Biotech	  GmbH)	  plus	  10	  %	  foetal	  bovine	  serum	  (FBS)	  supplemented	  with	  2	  mM	  L-­‐Glutamine	  (Biochrome),	  MEM	  non-­‐essential	  amino	  acids	  (Gibco),	  sodium	  pyruvate	  (Gibco),	  MEM	  vitamines	  (Gibco),	  50	  U/ml	  penicillin/streptomycin	  (Gibco),	  and	  50	  nM	  2-­‐mercaptoethanol	  (Gibco)	  in	  a	  humified	  incubator	  at	  37°C	  and	  5	  %	  CO2.	  	  
RNA	  and	  DNA	  preparation	  Total	  cellular	  RNA	  of	  the	  different	  cell	  types	  was	  isolated	  using	  the	  RNeasy	  Kit	  (Qiagen).	  RNA	  concentration	  was	  measured	  with	  a	  ND-­‐1000	  Spectrophotometer	  (NanoDrop,	  Thermo	  Fisher	  Scientific)	  and	  quality	  was	  controlled	  on	  agarose	  gels	  or	  using	  the	  Bioanalyzer	  (Agilent,	  Boeblingen,	  Germany).	  Genomic	  DNA	  was	  prepared	  using	  the	  Qiagen	  Blood	  &	  Cell	  Culture	  DNA	  Kit	  or	  the	  Qiagen	  DNeasy	  Blood	  &	  Tissue	  Kit	  when	  working	  with	  smaller	  cell	  numbers.	  DNA	  concentration	  was	  determined	  with	  the	  NanoDrop	  spectrophotometer	  and	  quality	  was	  assessed	  by	  agarose	  gel	  electrophoresis.	  	  
T	  cell	  transcriptome	  analysis	  RNA	  preparations	  from	  cultures	  of	  Treg	  and	  Tconv	  cells	  from	  four	  independent	  donors,	  as	  well	  as	  RNA	  preparations	  of	  freshly	  sorted	  Treg	  and	  Tconv	  cells	  from	  three	  independent	  donors	  were	  analyzed	  using	  Whole	  Human	  Genome	  Oligo	  Microarrays	  (Agilent).	  Labeling	  and	  hybridization	  were	  performed	  using	  the	  Agilent	  Gene	  Expression	  system	  according	  to	  the	  manufacturer’s	  instructions.	  In	  brief,	  200	  ng	  to	  1000	  ng	  of	  high-­‐quality	  RNA	  were	  amplified	  and	  Cyanine	  3-­‐CTP	  labeled	  with	  the	  One	  Color	  Low	  RNA	  Input	  Linear	  Amplification	  Kit	  (Agilent).	  Labeling	  efficiency	  was	  controlled	  using	  the	  NanoDrop	  spectrophotometer,	  and	  1.65	  µg	  labeled	  cRNA	  were	  fragmented	  and	  hybridized	  on	  the	  Whole	  Human	  Genome	  Expression	  Array	  (4x44K,	  Agilent).	  Images	  were	  scanned	  immediately	  after	  washing	  using	  a	  DNA	  microarray	  scanner	  (Agilent),	  processed	  using	  Feature	  Extraction	  Software	  9.5.1	  (Agilent)	  and	  further	  analyzed	  using	  GeneSpring	  GX	  software.	  Microarray	  data	  have	  been	  submitted	  and	  are	  available	  from	  the	  NCBI/GEO	  repository	  (accession	  number	  GSE14281).	  Median	  normalized	  expression	  ratios	  for	  genes	  associated	  with	  DMR	  are	  given	  in	  Supplemental	  Table	  S2.	  A	  detailed	  description	  of	  the	  T	  cell	  transcriptome	  analysis	  will	  be	  published	  elsewhere.	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Methyl-­‐CpG	  immunoprecipitation	  (MCIp)	  The	  recombinant	  MBD-­‐Fc	  protein	  was	  produced	  as	  previously	  described	  (Gebhard	  et	  al.	  2006).	  Methyl-­‐CpG	  immunoprecipitation	  was	  performed	  as	  described	  with	  slight	  modifications	  (Schilling	  and	  Rehli	  2007).	  In	  brief,	  genomic	  DNA	  was	  sonicated	  to	  a	  mean	  fragment	  size	  of	  350-­‐400	  bp.	  Four	  µg	  of	  each	  sample	  were	  incubated	  with	  200	  µl	  Protein	  A-­‐Sepharose	  4	  Fast	  Flow	  beads	  (GE	  Healthcare)	  coated	  with	  80	  µg	  purified	  MBD-­‐Fc	  protein	  in	  2	  ml	  Ultrafree-­‐MC	  centrifugal	  filter	  devices	  (Amicon/Millipore)	  for	  3	  h	  at	  4°C	  in	  buffer	  containing	  300	  mM	  NaCl.	  Beads	  were	  centrifuged	  to	  recover	  unbound	  DNA	  fragments	  (300	  mM	  fraction)	  and	  subsequently	  washed	  with	  buffers	  containing	  increasing	  NaCl	  concentrations	  (350,	  400,	  450	  and	  1000	  mM).	  All	  fractions	  were	  desalted	  using	  the	  MinElute	  PCR	  purification	  kit	  (Qiagen).	  The	  distribution	  of	  CpG	  methylation	  densities	  of	  individual	  MCIp	  fractions	  was	  controlled	  by	  qPCR	  using	  primers	  covering	  the	  imprinted	  SNRPN	  and	  a	  genomic	  region	  lacking	  CpGs	  (empty6.2).	  Fractions	  containing	  unmethylated	  DNA	  (300-­‐400	  mM)	  or	  methylated	  DNA	  (≥450	  mM)	  were	  pooled	  before	  subsequent	  labeling.	  	  
Chromatin	  Immunoprecipitation	  (ChIP)	  ChIP	  analysis	  of	  expanded	  and	  sorted	  Treg	  and	  Tconv	  cells	  was	  performed	  essentially	  as	  described	  (Metivier	  et	  al.	  2003).	  Precipitation	  of	  pre-­‐cleared	  chromatin	  from	  2x106	  cells	  was	  done	  overnight	  at	  4	  °C	  using	  2	  µg	  anti-­‐histone	  H3	  lysine	  4	  monomethyl	  (Abcam),	  anti-­‐histone	  H3	  lysine	  4	  dimethyl	  (Upstate),	  anti-­‐histone	  H3	  lysine	  4	  trimethyl	  (Upstate),	  anti-­‐CTCF	  (a	  gift	  from	  V.	  Lobanenkow)	  and	  anti-­‐rabbit	  IgG	  (Upstate).	  After	  reversion	  of	  crosslinks,	  enriched	  DNA	  fragments	  were	  recovered	  using	  the	  Qiaquick	  PCR-­‐purification	  kit	  (Qiagen).	  The	  quality	  of	  each	  ChIP	  was	  controlled	  at	  known	  target	  sites	  by	  qPCR.	  For	  ChIP-­‐on-­‐Chip	  analysis,	  all	  samples	  as	  well	  as	  an	  aliquot	  of	  equally	  treated	  input	  DNA	  were	  amplified	  by	  LM-­‐PCR	  for	  subsequent	  labeling.	  	  
Ligation	  mediated	  PCR	  (LM-­‐PCR)	  ChIP	  and	  input	  DNA	  were	  blunted	  and	  phosphorylated	  for	  30	  minutes	  at	  20	  °C	  in	  50	  µl	  reactions	  containing	  10x	  T4	  DNA	  ligase	  buffer,	  2	  µl	  dNTP	  mix	  (10	  mM	  each),	  3	  U	  T4	  DNA	  polymerase,	  10	  U	  T4	  polynucleotide	  kinase	  and	  1	  U	  Klenow	  DNA	  polymerase.	  Purification	  using	  the	  Qiaquick	  PCR	  purification	  kit	  (Qiagen)	  was	  followed	  by	  the	  addition	  of	  Adenine	  to	  3’-­‐ends	  using	  Klenow	  fragment	  (3’	  to	  5’	  exo	  minus),	  and	  dATP	  (1	  mM)	  for	  30	  minutes	  at	  37	  °C.	  After	  clean-­‐up	  using	  the	  MinElute	  kit	  (Qiagen),	  DNA	  fragments	  were	  ligated	  to	  linker	  DNA	  (60	  µM	  pre-­‐annealed	  JW102s	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5'-­‐GCG	  GTG	  ACC	  CGG	  GAG	  ATC	  TGA	  ATT	  CT-­‐3'	  and	  JW103	  5'-­‐GAA	  TTC	  AGA	  TC-­‐3')	  with	  4	  µl	  DNA	  Quick-­‐Ligase	  (NEB)	  in	  a	  30	  µl	  reaction	  for	  15	  minutes	  at	  RT.	  Samples	  were	  cleaned-­‐up	  (Qiaquick	  PCR	  purification	  kit	  (Qiagen))	  and	  amplified	  using	  Phusion	  Polymerase	  and	  JW102s	  oligonucleotide	  for	  15	  cycles.	  The	  product	  of	  the	  first	  amplification	  was	  diluted	  1/20	  with	  ddH2O	  and	  5	  µl	  of	  the	  dilution	  were	  used	  for	  a	  second	  round	  of	  amplification	  (15	  cycles)	  using	  Phusion	  Polymerase	  HOT	  START	  and	  JW102s	  oligonucleotide.	  The	  amplified	  ChIP	  and	  input	  material	  was	  purified	  using	  Qiaquick	  PCR	  purification	  kit	  (Qiagen).	  	  	  
Design,	  handling	  and	  analysis	  of	  locus-­‐wide	  microarrays	  Fifty-­‐one	  highly	  regulated	  genes	  and	  18	  control	  genes	  were	  selected	  based	  on	  mRNA	  expression	  profiles	  of	  freshly	  sorted	  and	  expanded	  T	  cell	  subsets.	  Custom	  tiling	  arrays	  were	  designed	  for	  the	  69	  selected	  loci	  using	  the	  eArray	  webtool	  (earray.chem.agilent.com/earray/).	  Fluorescently	  labeled	  DNA	  for	  microarray	  hybridization	  of	  DNA	  pools	  from	  MCIp	  or	  LM-­‐PCR	  amplified	  ChIP	  samples	  (1µg	  of	  amplified	  DNA)	  were	  generated	  by	  direct	  labeling	  with	  Alexa	  Fluor	  555–aha–dCTP	  and	  Alexa	  Fluor	  647–aha–dCTP	  using	  the	  BioPrime	  Plus	  Array	  CGH	  Genomic	  Labeling	  System	  (Invitrogen).	  Hybridization	  and	  washing	  was	  performed	  as	  recommended	  by	  the	  manufacturer	  (Agilent).	  Images	  were	  scanned	  immediately	  using	  a	  DNA	  microarray	  scanner	  (Agilent)	  and	  processed	  using	  Feature	  Extraction	  Software	  9.5.1	  (Agilent)	  and	  a	  standard	  CGH	  protocol.	  Processed	  signal	  intensities	  were	  further	  normalized	  using	  GC-­‐dependent	  regression	  and	  imported	  into	  Microsoft	  Office	  Excel	  2007	  for	  further	  analysis.	  Probes	  with	  abnormal	  hybridization	  behavior	  (extremely	  low	  (2507	  probes)	  or	  high	  (5149	  probes)	  signal	  intensities	  in	  both	  channels)	  were	  excluded.	  The	  results	  from	  two	  (CTCF)	  or	  three	  (H3K4	  methylation	  marks)	  independent	  ChIP-­‐on-­‐Chip	  experiments	  were	  averaged	  and	  converted	  into	  UCSC	  Genome	  Browser	  tracks	  (genome.ucsc.edu/)	  for	  visualization.	  To	  detect	  differentially	  methylated	  regions	  (DMR)	  Log10	  ratios	  of	  individual	  probes	  from	  both	  comparative	  genome	  pool	  hybridizations	  were	  subtracted	  to	  obtain	  hypomethylation	  scores	  which	  were	  either	  positive	  (indicating	  hypomethylation	  in	  Treg	  cells)	  or	  negative	  (indicating	  hypomethylation	  in	  Tconv	  cells).	  Hypomethylation	  scores	  of	  two	  independent	  experiments	  were	  averaged	  and	  regions	  were	  counted	  as	  hypomethylated	  if	  the	  average	  hypomethylation	  score	  of	  three	  consecutive	  probes	  was	  above	  a	  threshold	  of	  0.2333	  (at	  least	  above	  the	  97th	  percentile	  of	  all	  scores).	  Averaged	  results	  from	  both	  independent	  experiments	  were	  also	  converted	  into	  UCSC	  Genome	  Browser	  tracks	  (genome.ucsc.edu/)	  and	  all	  track	  files	  are	  provided	  in	  the	  Supplemental	  Material.	  ChIP-­‐	  and	  MCIP-­‐on-­‐Chip	  microarray	  data	  have	  been	  submitted	  and	  are	  available	  from	  the	  NCBI/GEO	  repository	  (accession	  number	  GSE14281).	  Overlaps	  of	  the	  identified	  DMR	  with	  conserved	  sequence	  elements	  predicted	  by	  the	  phastCons	  program	  based	  on	  a	  whole-­‐genome	  alignment	  of	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vertebrates	  and	  with	  DNaseI	  Hypersensitive	  Sites	  (DHS)	  in	  CD4+	  T-­‐cells	  (Boyle	  et	  al.	  2008)	  were	  determined	  using	  the	  Table	  Browser	  at	  the	  UCSC	  Genome	  Browser	  web	  site	  (genome.ucsc.edu/).	  DMR	  were	  classified	  into	  three	  categories	  according	  to	  their	  CpG	  content	  using	  the	  promoter	  definitions	  proposed	  by	  Weber	  et	  al.	  (2005)	  (Weber	  et	  al.	  2007):	  HCRs	  (high-­‐CpG	  regions)	  contain	  a	  CpG	  ratio	  above	  0.75	  and	  GC	  content	  above	  55%	  within	  a	  500	  bp	  DMR-­‐centered	  region;	  LCRs	  (low-­‐CpG	  regions)	  do	  not	  contain	  a	  500-­‐bp	  area	  with	  a	  CpG	  ratio	  above	  0.48;	  and	  ICRs	  (intermediate	  CpG	  regions)	  are	  neither	  HCRs	  nor	  LCRs.	  Enriched	  transcription	  factor	  consensus	  motifs	  in	  DMR	  (500	  bp	  regions)	  were	  identified	  using	  the	  RegionMiner	  tool	  (www.genomatix.de).	  	  
Mass	  spectrometry	  analysis	  of	  bisulfite-­‐converted	  DNA	  We	  chose	  a	  set	  of	  genomic	  regions	  based	  on	  the	  MCIp	  microarray	  results	  and	  designed	  95	  amplicons	  for	  bisulfite	  conversion.	  Genomic	  sequences	  were	  extracted	  from	  the	  UCSC	  genome	  browser	  (www.genome.ucsc.edu/).	  PCR	  primers	  were	  designed	  using	  the	  Epidesigner	  web	  tool	  (www.epidesigner.com/).	  For	  each	  reverse	  primer,	  an	  additional	  T7	  promoter	  tag	  for	  in	  vivo	  transcription	  was	  added,	  as	  well	  as	  a	  10-­‐mer	  tag	  on	  the	  forward	  primer	  to	  adjust	  for	  melting	  temperature	  differences.	  All	  primers	  were	  purchased	  from	  Sigma-­‐Aldrich	  (Munich,	  Germany)	  (for	  sequences	  see	  Supplemental	  Table	  S4).	  Sodium	  bisulfite	  conversion	  was	  performed	  using	  EZ	  DNA	  methylation	  kit	  (Zymo	  Research,	  California,	  USA)	  using	  1	  µg	  of	  genomic	  DNA	  and	  an	  alternative	  conversion	  protocol.	  Amplification	  of	  target	  regions	  was	  followed	  by	  SAP	  treatment,	  reverse	  transcription	  and	  subsequent	  RNA	  base-­‐specific	  cleavage	  (MassCLEAVE,	  Sequenom,	  San	  Diego,	  CA)	  as	  previously	  described	  (Ehrich	  et	  al.	  2005).	  Cleavage	  products	  were	  loaded	  onto	  silicon	  chips	  (spectroCHIP,	  Sequenom,	  San	  Diego,	  CA)	  and	  analysed	  by	  MALDI-­‐TOF	  mass	  spectrometry	  (MassARRAY	  Compact	  MALDI-­‐TOF,	  Sequenom,	  San	  Diego,	  CA).	  Methylation	  was	  quantified	  from	  mass	  spectra	  using	  the	  Epityper	  software	  v1.0	  (Sequenom,	  San	  Diego,	  CA).	  	  	  
Reporter	  assays	  DMR	  regions	  (ranging	  from	  800	  -­‐1200	  bp)	  were	  PCR-­‐amplified	  from	  human	  genomic	  DNA	  and	  cloned	  directly	  into	  the	  CpG-­‐free	  pCpGL-­‐CMV/EF1	  vector	  (Klug	  and	  Rehli	  2006)	  by	  ligation	  or	  using	  the	  In-­‐Fusion	  cloning	  system	  (Clontech,	  Saint-­‐Germain-­‐en-­‐Laye,	  France)	  replacing	  the	  CMV	  enhancer	  with	  the	  DMR	  regions.	  Primer	  sequences	  are	  given	  in	  Supplemental	  Table	  S6.	  All	  inserts	  were	  verified	  by	  sequencing.	  Luciferase	  reporter	  constructs	  were	  either	  mock-­‐treated	  or	  methylated	  in	  vitro	  with	  SssI	  methylase	  for	  4	  hours	  at	  37°C	  and	  purified	  with	  the	  Plasmid	  Quick	  Pure	  Kit	  (Macherey-­‐Nagel,	  Dueren,	  Germany).	  One	  million	  Jurkat	  cells	  were	  transfected	  using	  
Lineage-­‐specific	  DNA	  methylation	  in	  T	  cells	  correlates	  with	  histone	  methylation	  and	  enhancer	  activity	  	  
	   52	  
DEAE-­‐dextran	  and	  1.0	  µg	  of	  each	  reporter	  plasmid,	  and	  0.15	  µg	  Renilla	  control	  vector	  as	  described.	  After	  transfection,	  cells	  were	  either	  left	  untreated,	  stimulated	  with	  20	  ng/ml	  PMA	  and	  1	  µM	  Ionomycin	  or	  with	  PHA	  (1µg/ml)	  alone.	  Triplicate	  transfections	  were	  harvested	  after	  24h.	  Cell	  lysates	  were	  assayed	  for	  firefly	  and	  Renilla	  luciferase	  activities	  using	  the	  Dual-­‐Luciferase	  Reporter	  Assay	  System	  (Promega)	  on	  a	  Lumat	  LB9501	  (Berthold,	  Bad	  Wildbach,	  Germany).	  Firefly	  luciferase	  activity	  of	  individual	  transfections	  was	  normalized	  against	  Renilla	  luciferase	  activity.	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ChIP,	  chromatin	  immunoprecipitation;	  DMR,	  differentially	  methylated	  region;	  ICR,	  intermediate	  CpG	  content	  region;	  LCR,	  low	  CpG	  content	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  MALDI-­‐TOF,	  Matrix	  Assisted	  Laser	  Desorption	  Ionization	  Time-­‐of-­‐flight;	  MCIp,	  methyl-­‐CpG	  immunoprecipitation;	  MS,	  mass	  spectrometry;	  qPCR,	  quantitative	  PCR;	  Tconv	  cell,	  conventional	  T	  cell;	  Treg	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  T	  cells	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  2009	  Jul;19(7):1165-­‐74.	  Epub	  2009	  Jun	  3.	  	  	  	  	   	  
Lineage-­‐specific	  DNA	  methylation	  in	  T	  cells	  correlates	  with	  histone	  methylation	  and	  enhancer	  activity	  	  






Supplemental	  Figure	  S1:	  Comparison	  of	  methylation	  states	  in	  T	  cells	  and	  mRNA	  
expression	  data	  of	  associated	  genes.	  (A)	  The	  box	  plots	  show	  the	  distribution	  of	  of	  mRNA	  expression	  ratios	  (freshly	  sorted	  T	  cells,	  left	  panel;	  in	  vitro	  expanded	  T	  cells,	  right	  panel)	  conditional	  on	  the	  methylation	  status	  of	  the	  associated	  DMR.	  The	  red	  lines	  denote	  medians,	  boxes	  the	  interquartile	  ranges,	  and	  whiskers	  the	  5th	  and	  95th	  percentiles.	  Pair	  wise	  comparisons	  of	  mRNA	  expression	  ratios	  associated	  with	  DMR	  hypermethylated	  in	  Tconv	  or	  Treg	  cells	  are	  significant	  (**	  P<0.001,	  *	  P<0.01	  ,Mann–Whitney	  U	  test,	  two-­‐sided).	  (B)	  Box	  plots	  are	  shown	  as	  in	  (A)	  with	  DMR	  divided	  into	  the	  two	  major	  position	  classes:	  intergenic	  and	  intragenic.	  Differences	  between	  inter-­‐	  and	  intragenic	  pairs	  of	  the	  same	  cell	  type	  and	  the	  same	  DMR	  status	  were	  not	  significant	  (P>0.05,	  Mann–Whitney	  U	  test,	  two-­‐sided).	  
Supplemental	  Figure	  S2:	  Comparison	  of	  methylation	  states	  in	  T	  cells	  and	  CD34+	  
progenitor	  cells.	  The	  methylation	  states	  of	  individual	  CpG	  residues	  obtained	  by	  MALDI-­‐TOF	  MS	  were	  compared	  between	  CD34+	  progenitor	  cells	  and	  the	  highest	  (left	  diagram)	  or	  the	  lowest	  T	  cell	  methylation	  value	  (right	  diagram).	  Differentially	  methylated	  CpG	  residues	  that	  acquire	  methylation	  (compared	  to	  the	  progenitor	  cell)	  should	  be	  found	  in	  the	  upper	  left	  corner	  of	  the	  left	  diagram,	  whereas	  CpG	  residues	  that	  are	  demethylated	  (compared	  to	  the	  progenitor	  cell)	  should	  be	  found	  in	  the	  lower	  right	  corner	  of	  the	  right	  diagram.	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Supplemental	  Figure	  S3:	  Chromatin	  modification	  and	  CTCF	  binding	  patterns	  across	  the	  
FOXP3	  gene	  locus.	  Tracks	  and	  heat	  maps	  are	  shown	  as	  described	  in	  the	  legend	  of	  Figure	  2.	  	  
Supplemental	  Figure	  S4:	  Chromatin	  modification	  and	  CTCF	  binding	  patterns	  across	  the	  
CD40LG	  gene	  locus.	  Tracks	  and	  heat	  maps	  are	  shown	  as	  described	  in	  the	  legend	  of	  Figure	  2.	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Supplemental	  Figure	  S5:	  Chromatin	  modification	  and	  CTCF	  binding	  patterns	  across	  the	  
IFNG	  gene	  locus.	  Tracks	  and	  heat	  maps	  are	  shown	  as	  described	  in	  the	  legend	  of	  Figure	  2.	  
Supplemental	  Figure	  S6:	  Chromatin	  modification	  and	  CTCF	  binding	  patterns	  across	  the	  
LRRC32	  gene	  locus.	  Tracks	  and	  heat	  maps	  are	  shown	  as	  described	  in	  the	  legend	  of	  Figure	  2.	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Supplemental	  Figure	  S7:	  Distribution	  of	  H3K4	  methylation	  patterns	  at	  cell	  type-­‐specific	  
DMR	  depending	  on	  their	  relative	  position	  (intergenic/intragenic).	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Supplemental	  Table	  S1	  
Genomic	  regions	  selected	  for	  Treg/Tconv	  cell	  DMR	  screening	  
	  
Gene	  Symbol	   Location	  (Mar.	  06	  (hg18)	  Assembly)	   Region	  Size	  
ADC	   chr1:33,280,000-­‐33,380,000	   100000	  
ANK3	   chr10:61,350,000-­‐62,200,000	   850000	  
ANXA1	   chr9:74,900,000-­‐75,030,000	   130000	  
CD40LG	   chrX:135,520,000-­‐135,580,000	   60000	  
CHD7	   chr8:61,700,000-­‐62,000,000	   300000	  
CYSLTR1	   chrX:77,300,000-­‐77,600,000	   300000	  
GZMA	   chr5:54,320,000-­‐54,450,000	   130000	  
HOP	   chr4:57,170,000-­‐57,300,000	   130000	  
ID2	   chr2:8,680,000-­‐8,770,000	   90000	  
IFNG	   chr12:66,780,000-­‐66,880,000	   100000	  
IL18RAP	   chr2:102,380,000-­‐102,450,000	   70000	  
MGC33556	   chr1:44,900,000-­‐44,980,000	   80000	  
NELL2	   chr12:43,130,000-­‐43,680,000	   550000	  
TARP/CD3G	   chr7:38,230,000-­‐38,340,000	   110000	  
IL4	   chr5:132,000,000-­‐132,060,000	   60000	  
ADAMTS4	   chr1:159,400,000-­‐159,460,000	   60000	  
ARG1	   chr6:131,860,000-­‐132,000,000	   140000	  
DYX1C1	   chr15:53,430,000-­‐53,610,000	   180000	  
FCRL3	   chr1:155,840,000-­‐155,960,000	   120000	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FOXP3	   chrX:48,970,000-­‐49,030,000	   60000	  
IL1R2/IL1R1	   chr2:101,870,000-­‐102,175,000	   305000	  
LRRC32	   chr11:76,000,000-­‐76,150,000	   150000	  
RTKN2	   chr10:63,580,000-­‐63,780,000	   200000	  
F5/SELP	   chr1:167,730,000-­‐167,900,000	   170000	  
CAMTA1/TNFRSF9/UTS
2	   chr1:7,600,000-­‐7,940,000	   340000	  
WDFY4	   chr10:49,620,000-­‐49,900,000	   280000	  
WNT10A	   chr2:219,443,000-­‐219,490,000	   47000	  
IKZF2	   chr2:213,500,000-­‐213,850,000	   350000	  
NOG	   chr17:51,970,000-­‐52,070,000	   100000	  
IL7R	   chr5:35,850,000-­‐35,940,000	   90000	  
PTPRC	   chr1:196,800,000-­‐197,020,000	   220000	  
TP53INP1	   chr8:96,000,000-­‐96,045,000	   45000	  
IL6R	   chr1:152,590,000-­‐152,720,000	   130000	  
AMOTL2	   chr3:135,500,000-­‐135,630,000	   130000	  
PKD2	   chr4:89,120,000-­‐89,230,000	   110000	  
LGALS3	   chr14:54,605,000-­‐54,685,000	   80000	  
LCAM3	   chr9:132,800,000-­‐132,980,000	   180000	  
PERP	   chr6:138,420,000-­‐138,520,000	   100000	  
S100Z	   chr5:76,165,000-­‐76,270,000	   105000	  
CTLA4	   chr2:204,390,000-­‐204,490,000	   100000	  
IL2RA	   chr10:6,060,000-­‐6,170,000	   110000	  
IL2RB	   chr22:35,835,000-­‐35,905,000	   70000	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ENTPD1	   chr10:97,440,000-­‐97,670,000	   230000	  
NT5E	   chr6:86,170,000-­‐86,270,000	   100000	  
PDE4D	   chr5:58,250,000-­‐59,850,000	   1600000	  
ZEB1	   chr10:31,600,000-­‐31,900,000	   300000	  
FCER1G	   chr1:159,445,000-­‐159,460,000	   15000	  
TRAT1	   chr3:109,990,000-­‐110,090,000	   100000	  
FAIM3	   chr1:205,128,000-­‐205,168,000	   40000	  
MAP3K5	   chr6:136,915,000-­‐137,180,000	   265000	  
GJB6	   chr13:19,665,000-­‐19,765,000	   100000	  
	  
Supplemental	  Table	  S1	  (continued)	  
Genomic	  regions	  selected	  for	  Treg/Tconv	  cell	  DMR	  screening	  
	  
Gene	  Symbol	   Location	  (Mar.	  06	  (hg18)	  Assembly)	   Region	  Size	  
ACTB*	   chr7:5,520,000-­‐5,570,000	   50000	  
B2M	   chr15:42,760,000-­‐42,810,000	   50000	  
LTB	   chr6:31,636,000-­‐31,686,000	   50000	  
SEPT9	   chr17:72,740,000-­‐73,040,000	   300000	  
HPRT1	   chrX:133,390,000-­‐133,490,000	   100000	  
UBC	   chr12:123,950,000-­‐123,980,000	   30000	  
KLF2	   chr19:16,265,000-­‐16,325,000	   60000	  
CD2	   chr1:117,070,000-­‐117,130,000	   60000	  
SPI1	   chr11:47,330,000-­‐47,380,000	   50000	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TLR4	   chr9:119,460,000-­‐119,550,000	   90000	  
TFEC	   chr7:115,350,000-­‐115,500,000	   150000	  
CD14	   chr5:139,980,000-­‐140,000,000	   20000	  
CD19	   chr16:28,840,000-­‐28,870,000	   30000	  
NCAM1	   chr11:112,300,000-­‐112,660,000	   360000	  
GATA1	   chrX:48,515,000-­‐48,547,000	   32000	  
GATA4	   chr8:11,500,000-­‐11,660,000	   160000	  
CSF1R	   chr5:149,400,000-­‐149,490,000	   90000	  
HOXA9	   chr7:27,080,000-­‐27,220,000	   140000	  *	  Control	  loci	  are	  boxed	  in	  green.	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VAMP3 9341 0.01 0.33 A_24_P370887 chr1:7694083-7694556 -59600 intra Treg  LCR   Treg Mono/Di 
    chr1:7696779-7696912 -57074 intra Tconv  LCR   no H3K4me 
    chr1:7742983-7743147 -10855 intra Tconv  LCR   no H3K4me 
PER3 8863 0.12 -0.06 A_24_P291231 chr1:7763681-7763839 -3209 intra Tconv  LCR   Tconv Mono/Di 
    chr1:7780936-7781346a 14172 intra Tconv  LCR yes  no H3K4me 
UTS2 10911 4.66 5.61 A_23_P63343 chr1:7836042-7836108 -393 5-proximal Tconv  LCR   no H3K4me 
TNFRSF9 3604 3.58 4.06 A_23_P51936 chr1:7921606-7922186 1574 intra Treg  LCR   Treg Tri 
    chr1:7923689-7923832 -291 5-proximal Treg yes LCR   Treg Tri 
    chr1:7931900-7932340 -8650 inter Treg  ICR yes DHS Treg Mono/Di 
KIF2C 11004 0.52 -3.02 A_23_P34788 chr1:44978856-44978930 772 intra Treg  LCR  DHS Tconv Tri 
PTPRC 5788 -0.27 0.46 A_23_P125451 chr1:196900673-196900751 25919 intra Treg  LCR  DHS Treg Tri 
    chr1:196941013-196941144 66286 intra Treg  LCR  DHS Not diff. 
FAIM3 9214 -0.44 3.39 A_23_P138125 chr1:205146071-205146415 15666 intra Treg  LCR  DHS Not diff. 
    chr1:205159845-205160036 1968 intra Treg  LCR  DHS Treg Tri 
    chr1:205160872-205161211 867 intra Treg  LCR  DHS Treg Tri 
    chr1:205164864-205165172 -3109 inter Treg  LCR  DHS Treg Mono/Di 
ID2 3398 -2.41 -6.67 A_32_P69368 chr2:8726198-8726662 -13206 inter Treg  LCR   no H3K4me 
    chr2:8735102-8735444 -4363 inter Treg yes LCR yes DHS Tconv Mono/Di 
    chr2:8740559-8740969 1128 intra Treg no ICR yes DHS Tconv Tri 
IL1R2 7850 3.69 4.67 A_23_P79398 chr2:101984548-101985058 2913 intra Treg  LCR   Treg Mono/Di 
    chr2:102045612-102046101 63967 inter Treg  LCR   Not diff. 
CTLA4 1493 2.36 1.96 A_23_P102481 chr2:204408646-204409889 -31484 inter Treg yes LCR yes  Treg Tri 
    chr2:204426657-204428059 -13394 inter Treg yes LCR yes DHS Treg Tri 
    chr2:204443336-204444178 3005 intra Treg yes LCR yes DHS Treg Tri 
    chr2:204446111-204447000 5804 intra Treg yes LCR yes DHS Treg Tri 
    chr2:204460103-204460326 19463 inter Treg  LCR   Treg Mono/Di 
IKZF2 22807 4.49 3.84 A_32_P114284 chr2:213658721-213658870 64554 intra Treg  LCR yes  Treg Mono/Di 
    chr2:213680605-213681119 42488 intra Treg  ICR yes  Treg Tri 
    chr2:213688110-213688358 35116 intra Treg  LCR   Treg Mono/Di 
    chr2:213697294-213697468 25969 intra Treg yes LCR   Treg Tri 
    chr2:213706776-213707454 16235 intra Treg  LCR   Treg Tri 
    chr2:213722578-213724345 -112 5-proximal Treg no LCR yes DHS Treg Tri 
    chr2:213725364-213725750 -2207 inter Treg  ICR yes  Treg Tri 
    chr2:213726946-213727686 -3966 inter Treg yes LCR  DHS Treg Tri 
    chr2:213730460-213730581 -7171 inter Treg  LCR   Treg Mono/Di 
    chr2:213733406-213733693 -10200 inter Treg  LCR   no H3K4me 
SPAG16 79582 0.04 -0.21 A_23_P67785 chr2:213803183-213803316 -54169 inter Treg  ICR   Treg Mono/Di 
    chr2:213809847-213810325 -47333 inter Treg yes LCR yes  Treg Tri 
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    chr2:213813204-213813362 -44136 inter Treg  LCR no no Treg Tri 
    chr2:213814671-213814814 -42676 inter Treg  LCR no no Treg Tri 
HOPX 84525 -0.83 -3.75 A_23_P254507 chr4:57215993-57216190 26128 intra Tconv  ICR no DHS Tconv Tri 
    chr4:57242355-57242622 -269 5-proximal Tconv  LCR yes DHS ND 
PKD2 5311 0.11 1.79 A_24_P106112 chr4:89148733-89149406 1160 intra Treg  LCR yes DHS Treg Tri 
RAB3C 115827 0.91 1.49 A_23_P44794 chr5:58263564-58263732 348985 inter Treg  LCR no no no H3K4me 
    chr5:58265981-58266738 351697 inter Treg  LCR yes DHS ND 
    chr5:58369473-58369731 454939 intra Treg  LCR yes DHS Tconv Tri 
    chr5:58371799-58371934 457204 intra Tconv  LCR no DHS Tconv Tri 
    chr5:58374023-58374163 459430 intra Treg  LCR yes DHS Tconv Mono/Di 
F2RL1 2150 0.61 1.72 A_23_P58835 chr5:76165074-76165598 14707 intra Tconv  LCR yes DHS no H3K4me 
MAP7 9053 -0.40 -0.81 A_24_P98021 chr6:136915800-136915872 -2583 inter Treg  LCR no no no H3K4me 
MAP3K5 4217 1.31 2.40 A_23_P134125 chr6:137124814-137124977 30453 intra Treg  LCR no DHS Treg Tri 
    chr6:137139643-137139811 15622 intra Tconv  LCR no no Treg Mono/Di 
    chr6:137156228-137156491 -1011 inter Treg  LCR no DHS ND 
PERP 64065 1.96 2.35 A_23_P214950 chr6:138458928-138459115 11227 intra Tconv  LCR no no no H3K4me 
    chr6:138468457-138468554 1743 intra Tconv  LCR no no Treg Tri 
HOXA1 3198 0.91 1.04 A_23_P145752 chr7:27103645-27103925 -1645 intra Treg  LCR yes no ND 
HOXA3 3200 0.91 1.49 A_23_P501538 chr7:27146342-27146410 -26 5-proximal Tconv  ICR yes no no H3K4me 
HOXA10 3206 0.91 2.17 A_23_P253368 chr7:27184543-27184956 1449 intra Tconv  LCR yes no no H3K4me 
HOXA13 3209 0.91 1.88 A_23_P31306 chr7:27208821-27209379 -2850 intra Treg  LCR no no no H3K4me 
HOXA13 3209 0.91 1.88 A_23_P31306 chr7:27212390-27212560 -6225 inter Treg  ICR yes no no H3K4me 
GATA4 2626 0.79 1.13 A_24_P932785 chr8:11580580-11581129 -18270 intra Treg  LCR yes no no H3K4me 
    chr8:11583722-11583857 -15335 intra Treg no LCR no no no H3K4me 
    chr8:11601942-11602190 2941 intra Treg  LCR no no no H3K4me 
    chr8:11607397-11607483 8315 intra Treg  LCR no no no H3K4me 
    chr8:11639562-11639728 40520 intra Treg  LCR no no no H3K4me 
CHD7 55636 -1.62 -3.04 A_24_P58381 chr8:61727910-61728135 -25892 inter Treg  LCR no DHS ND 
    chr8:61756004-61756256 2215 intra Tconv  ICR no DHS Tconv Tri 
    chr8:61759841-61760294 6153 intra Treg  LCR no DHS Tconv Mono/Di 
    chr8:61761414-61761574 7579 intra Treg  LCR no no ND 
    chr8:61776071-61776160 22201 intra Tconv  LCR no DHS Tconv Mono/Di 
    chr8:61942900-61943092 189081 inter Tconv  LCR no DHS Tconv Mono/Di 
    chr8:61973666-61973792 219814 inter Tconv  LCR no no no H3K4me 
    chr8:61979393-61979852 225708 inter Tconv  LCR no no Tconv Mono/Di 
    chr8:61982195-61982630 228498 inter Treg  ICR no no ND 
    chr8:61984364-61984705 230620 inter Treg  LCR yes DHS Tconv Tri 
    chr8:61985582-61985644 231698 inter Tconv  ICR yes DHS Tconv Tri 
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    chr8:61987949-61988359 234239 inter Tconv  LCR yes DHS Tconv Mono/Di 
TP53INP1  94241 0.93 1.01 A_23_P168882 chr8:96009841-96010902 -2996 intra Treg yes LCR yes DHS Treg Tri 
    chr8:96028605-96029654 1630 intra Treg  LCR yes DHS Treg Tri 
    chr8:96042041-96042225 -11373 intra Treg  LCR yes DHS ND 
IL15RA 3601 0.70 0.54 A_23_P138680 chr10:6086021-6086185 -26153 inter Tconv  LCR no no Treg Mono/Di 
IL2RA 3559 5.87 0.67 A_23_P127288 chr10:6119192-6119913 24725 intra Treg yes LCR no DHS Treg Tri 
    chr10:6121979-6122460 22058 intra Treg yes LCR no no Treg Tri 
    chr10:6128278-6128419 15929 intra Treg  LCR no DHS Treg Tri 
    chr10:6129214-6129562 14890 intra Treg  LCR no DHS Treg Tri 
    chr10:6134052-6134250 10127 intra Treg  LCR no DHS Treg Tri 
    chr10:6136503-6137025 7514 intra Treg  LCR no no Treg Tri 
    chr10:6137878-6138428 6125 intra Treg  LCR no no Treg Tri 
    chr10:6139024-6140346 4593 intra Treg  LCR yes no Treg Tri 
    chr10:6141939-6142194 2211 intra Treg  LCR no no Treg Tri 
    chr10:6153181-6153487 -9056 inter Treg yes LCR no no Treg Tri 
    chr10:6154347-6154892 -10342 inter Treg yes LCR no DHS Treg Tri 
RBM17 84991 -0.14 -0.54 A_23_P423315 chr10:6164740-6165011 -6148 inter Treg  LCR no no Treg Tri 
    chr10:6168811-6168881 -2178 inter Treg  LCR no DHS Treg Tri 
ZEB1 6935 -0.01 -0.60 A_23_P202013 chr10:31650245-31650763 2357 intra Treg  ICR yes DHS ND 
LRRC18 474354 0.13 -0.29 A_23_P35494 chr10:49833171-49833344 -40975 intra Tconv  LCR yes no no H3K4me 
ANK3 288 -3.25 -3.52 A_23_P301530 chr10:61910645-61910927 -91151 intra Tconv  LCR no no no H3K4me 
RTKN2 219790 4.39 5.47 A_24_P13041 chr10:63631396-63631747 66762 intra Treg  LCR yes no Treg Mono/Di 
    chr10:63669692-63669980 28498 intra Treg  LCR no DHS Treg Tri 
ENTPD1 953   chr10:97638620-97638752 132774 intra Treg  LCR no no no H3K4me 
FANK1 92565 6.32 5.84 A_23_P115785 chr10:127661157-127661287 86070 intra Treg  LCR no no Treg Mono/Di 
    chr10:127674302-127675105 99552 intra Treg  LCR no no Treg Tri 
LRRC32 2615 4.96 5.47 A_24_P389916 chr11:76018362-76018714 40900 inter Treg  LCR yes no Treg Mono/Di 
    chr11:76030870-76031550 28228 inter Treg yes LCR yes no Treg Tri 
    chr11:76056081-76056862 2966 intra Treg yes LCR no no Treg Tri 
    chr11:76058705-76058782 694 intra Treg  LCR yes no Treg Tri 
NCAM1 4684 0.91 1.26 A_23_P1740 chr11:112345302-112345374 7987 intra Treg  LCR no no Tconv Mono/Di 
    chr11:112350888-112350995 13591 intra Treg  LCR yes no no H3K4me 
    chr11:112443435-112443585 106159 intra Treg  LCR yes no no H3K4me 
TTC12 54970 -0.45 1.08 A_23_P24535 chr11:112638456-112638589 -51992 intra Treg  LCR yes no Treg Mono/Di 
NELL2 4753 -4.64 -6.42 A_23_P10025 chr12:43288526-43288688 267807 intra Treg  LCR no no no H3K4me 
IFNG 3458 -1.90 -6.25 A_23_P151294 chr12:66844066-66844304 -4395 inter Tconv yes LCR yes no Tconv Mono/Di 
IL26 55801 -0.06 -5.23 A_23_P128503 chr12:66878821-66878935 26959 inter Tconv yes ICR yes DHS ND 
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GJB2 2706 0.91 -3.44 A_23_P204947 chr13:19666918-19667157 -1961 inter Treg  LCR no DHS Treg Mono/Di 
    chr13:19669218-19669677 -4371 inter Treg no LCR yes DHS Treg Mono/Di 
GJB6 10804 1.79 2.18 A_23_P2745 chr13:19764311-19764922 -99540 inter Treg  ICR no no no H3K4me 
MAPK1IP1L 93487 0.03 0.23 A_24_P107674 chr14:54608917-54609194 20941 inter Treg  LCR no DHS ND 
LGALS3 3958 3.85 2.31 A_23_P128919 chr14:54670099-54670231 4435 intra Tconv  LCR no no Treg Mono/Di 
NOG 9241 -1.08 5.52 A_23_P341938 chr17:52024396-52024835 -1443 inter Tconv no LCR no DHS Treg Mono/Di 
SEPT9 10801 -0.78 0.66 A_24_P147910 chr17:72787432-72787562 -1626 inter Treg  LCR no no no H3K4me 
    chr17:72882994-72883638 -442 5-proximal Tconv yes LCR yes no Tconv Tri 
    chr17:72914128-72914221 1422 intra Treg  LCR no DHS Treg Tri 
EPS15L1 10365 -0.74 -0.74 A_23_P38941 chr19:16323001-16323171 -3971 inter Treg  LCR no DHS Treg Mono/Di 
IL2RB 3560 1.63 0.62 A_24_P203000 chr22:35871285-35872166 4176 intra Treg yes LCR no no Treg Tri 
    chr22:35893803-35894363 -18181 intra Treg yes LCR no no Treg Tri 
CACNA1F 778 -0.27 -0.09 A_23_P148327 chrX:48975534-48975593 1180 intra Treg  LCR no no ND 
FOXP3 7575 3.68 4.60 A_23_P159709 chrX:49002019-49005207 4581 intra Treg yes LCR yes no Treg Tri 
    chrX:49007147-49009512 -136 5-proximal Treg yes ICR yes no Treg Tri 
PPP1R3F 89801 0.21 1.59 A_24_P177604 chrX:49020095-49022146 7093 intra Treg yes LCR yes DHS Treg Tri 
    chrX:49022670-49023240 8927 intra Treg yes LCR no no Treg Tri 
CD40LG 959 -2.48 -4.70 A_23_P62220 chrX:135561484-135561563 3517 intra Tconv  LCR no DHS Tconv Tri 
    chrX:135566710-135566897 8797 intra Tconv yes LCR yes no Tconv Tri 
 
a Coloring indicates larger than 2 fold differences between gene expression levels as determined by microarray analysis. Genes with higher expression in Treg cells are marked in red, those with 
higher expression in Tconv cells in blue. 
b DMR were classified either as intergenic (inter) or intragenic (intra) based on their position relative to known genes. 
c DMR were classified according to their CpG content using the promoter definitions proposed by Weber et al. (2005) as described in the Methods section.  
d Overlap of the identified DMR with conserved sequence elements predicted by the phastCons program based on a whole-genome alignment of vertebrates was done using the Table Browser at 
the UCSC Genome Browser web site (genome.ucsc.edu/). 
e Overlap of the identified DMR with DNaseI hypersensitive sites (DHS) in CD4+ T-cells (Boyle et al, 2008) was determined using the Table Browser at the UCSC Genome Browser web site 
(genome.ucsc.edu/) 
f Histone H3 lysine 4 methylation at DMR regions was classified as follows: Treg or Tconv Tri, increased H3K4 trimethylation in Treg or Tconv cells, respectively; Treg or Tconv Mono/Di, 
increased H3K4 mono-, or di-, but no trimethylation in Treg or Tconv cells, respectively; ND, H3K4 methylation present but not different between T cell subsets. 
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V$ATF.01	   10	   11	   2.35	   1.53	   4.68	   5.32	  
V$CREB.02	   9	   11	   2.42	   1.55	   4.55	   5.2	  
V$CTCF.03	   6	   13	   3.7	   1.92	   3.51	   4.57	  
V$AHRARNT.03	   9	   9	   2.27	   1.51	   3.96	   4.13	  
V$ELK1.02	   8	   10	   2.98	   1.73	   3.36	   3.78	  
V$ATF6.02	   8	   9	   2.52	   1.59	   3.57	   3.77	  
V$AP1.03	   8	   14	   5.21	   2.28	   2.69	   3.63	  
V$NUDR.01	   8	   8	   2.32	   1.52	   3.45	   3.4	  
V$ATF.02	   9	   13	   5.21	   2.28	   2.5	   3.2	  
V$CTCF.04	   4	   9	   3.03	   1.74	   2.97	   3.14	  
V$ZF5.01	   3	   7	   2.08	   1.44	   3.37	   3.07	  























V$NRF1.01	   4	   21	   4.96	   2.23	   4.23	   6.98	  
V$ZF5.01	   9	   24	   6.77	   2.6	   3.55	   6.43	  
V$VMYB.05	   32	   35	   15.56	   3.94	   2.25	   4.8	  
V$STAT5.01	   30	   66	   36.75	   6.06	   1.8	   4.75	  
V$VMYB.03	   30	   33	   15.51	   3.94	   2.13	   4.31	  
V$HMX2.01	   28	   55	   30.92	   5.56	   1.78	   4.24	  
V$ZNF219.01	   17	   36	   18.47	   4.3	   1.95	   3.96	  
V$KKLF.01	   25	   38	   20.2	   4.49	   1.88	   3.85	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V$VMYB.04	   32	   38	   20.78	   4.56	   1.83	   3.67	  
V$MZF1.03	   36	   42	   23.92	   4.89	   1.76	   3.6	  
V$STAT.01	   47	   75	   49.27	   7.02	   1.52	   3.6	  
V$MZF1.01	   37	   43	   24.7	   4.97	   1.74	   3.58	  
V$NFKAPPAB65.01	   28	   36	   20.05	   4.48	   1.8	   3.45	  
V$MAZR.01	   18	   31	   16.84	   4.1	   1.84	   3.33	  
V$OLF1.01	   20	   27	   14.14	   3.76	   1.91	   3.29	  
V$VMYB.02	   26	   30	   16.36	   4.04	   1.83	   3.25	  
V$MZF1.02	   43	   52	   32.93	   5.74	   1.58	   3.24	  
V$HIVEP1.01	   22	   32	   17.93	   4.23	   1.78	   3.21	  
V$FLI.01	   27	   27	   14.47	   3.8	   1.87	   3.16	  
V$ELK1.02	   19	   20	   9.7	   3.11	   2.06	   3.15	  
V$HMX2.02	   30	   68	   46.41	   6.81	   1.47	   3.1	  
V$E2F.01	   36	   45	   28.51	   5.34	   1.58	   3	  
a	   Number	  of	  input	  sequences	  with	  at	  least	  one	  match.	  
b	   Number	  of	  matches	  in	  all	  sequences.	  
c	   Expected	  match	  numbers	  in	  an	  equally	  sized	  sample	  of	  the	  genomic	  background	  and	  the	  standard	  deviation.	  
d	   Overrepresentation	  against	  genomic	  background:	  Fold	  factor	  of	  match	  numbers	  in	  regions	  compared	  to	  an	  equally	  sized	  sample	  of	  the	  background	  (i.e.	  found	  versus	  expected).	  
e	   Z-­‐score	  of	  overrepresentation	  against	  genomic	  background:	  The	  distance	  from	  the	  population	  mean	  in	  units	  of	  the	  population	  standard	  deviation.	  Shown	  are	  only	  highly	  significant	  motifs	  (Z	  score	  >3;	  a	  Z-­‐score	  above	  2	  can	  be	  considered	  statistically	  significant).	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Oligonucleotides for bisulfite amplicon generation 
 
Amplicon Chromosomal Location (hg18) Sense Antisense Dir. 
Epi00197_TNFRSF9.1 chr1:7932138-7932511 aggaagagagGGGTGTAGGTGATAATTGTGATTAAA cagtaatacgactcactatagggagaaggctCTTCCATTATAATAAAAACACAAAAAAACA + 
Epi00003_IL2RA.1 chr10:6118877-6119370 aggaagagagTTGTAGATTGGGATTTGTTAGGGTA cagtaatacgactcactatagggagaaggctCTAAATTCACCCAAAAAACAAAAAA + 
Epi00004_IL2RA.2 chr10:6119558-6119803 aggaagagagAGAGTTTGGGTTATTGGGTAAAGAG cagtaatacgactcactatagggagaaggctCCACAAAAATTTCCTCTAAAAATCA + 
Epi00005_IL2RA.3 chr10:6120520-6121011 aggaagagagATAGTTTAAGGTGGTGGGATAGGAG cagtaatacgactcactatagggagaaggctCAATCCAACATTCTATAACTACAAAATTA + 
Epi00203_IL2RA.1 chr10:6121399-6121972 aggaagagagTTTTTTTTATGATGGATAGGATAGATAGA cagtaatacgactcactatagggagaaggctTTTTACACATTCTCTACCAAAATAACC + 
Epi00006_IL2RA.4 chr10:6122010-6122464 aggaagagagTTATAGGTAGAATGTTTTGTTGAAGTATGA cagtaatacgactcactatagggagaaggctTAAACAAACAACAACCATCAAAAAT + 
Epi00017_IL2RA.15 chr10:6153564-6153844 aggaagagagGTAGTTTTTGGGGGTAATATTGAGG cagtaatacgactcactatagggagaaggctAAACAAAAAATTCATCCAATACCAA + 
Epi00018_IL2RA.16 chr10:6153808-6154224 aggaagagagATATTGGTTTGATTGGTATTGGATG cagtaatacgactcactatagggagaaggctAAAAATCCTACCACCTCAACCTACT + 
Epi00019_IL2RA.17 chr10:6154058-6154547 aggaagagagTATTTTGGGAAGTTAAGGTAGGAGG cagtaatacgactcactatagggagaaggctTTCATTACCCAAAAAATCCCTACTT + 
Epi00020_IL2RA.18 chr10:6154524-6154923 aggaagagagAGTAGGGATTTTTTGGGTAATGAAG cagtaatacgactcactatagggagaaggctAAAAAAACTAAAAATTCATCCCACAC + 
Epi00021_IL2RA.19 chr10:6155117-6155433 aggaagagagTTTTTTTTAGTTATTTTGGGTTTTG cagtaatacgactcactatagggagaaggctAACTCACACTTATAATCCCAACACTTT + 
lrrc32_6534 chr11:76030804-76031729 aggaagagagTTTATAGTTGGTTGGGATGTAGATAATG cagtaatacgactcactatagggagaaggctCACCAAAACTATCAACCTTCAAAAA + 
Epi00205_LRRC32.1 chr11:76055736-76056113 aggaagagagTTTTGAGTTTTAGTTTTTTTATTTGAGG cagtaatacgactcactatagggagaaggctAAATACCTTTTCTCCTACAACATCC + 
Epi00206_LRRC32.2 chr11:76056033-76056454 aggaagagagTTTTAGGTTTTTTATAGTGGGTGTTTT cagtaatacgactcactatagggagaaggctACTAACCAAACAAAACATACTCCCC + 
Epi00207_LRRC32.3 chr11:76056414-76056952 aggaagagagGGTTTTTTAGGTTATTGGGGAGTAT cagtaatacgactcactatagggagaaggctCAAAAAAAACAATCAAAACCCACTA + 
Epi00026_IFNG.1 chr12:66844056-66844260 aggaagagagATGGTTAGAAGGTATAAAAGAAAAGGG cagtaatacgactcactatagggagaaggctAAATCAATATTAAATCCATACCCCC - 
il26_6531 chr12:66878511-66879260 aggaagagagTTTGATTAGGGTTGAGGGAGAAG cagtaatacgactcactatagggagaaggctCCCACAAATACCAATTTAAAAAAAA + 
Epi00208_GJB2.1 chr13:19668983-19669485 aggaagagagTGTTAAAAAGTATATTTTGGTTAGAAATGA cagtaatacgactcactatagggagaaggctTAAAACCACAAACTCCATATCCAAT + 
Epi00209_GJB2.2 chr13:19669465-19670046 aggaagagagGATATGGAGTTTGTGGTTTTAGAATTT cagtaatacgactcactatagggagaaggctCAACACCATTTCACATAAAATAACAA + 
Epi00210_GJB2.3 chr13:19669565-19670072 aggaagagagGAAAGAAGTTTTTTGTGTTTTTTGAT cagtaatacgactcactatagggagaaggctAACCCTACTATCTCTCCTCTTAATAACAA + 
Epi00027_NOG.1 chr17:52016154-52016611 aggaagagagTTTTTTTTGGGTTAGGGTTTGAAAG cagtaatacgactcactatagggagaaggctACTTAAACCTCTTTATCCCTTCCCT + 
Epi00030_NOG.4 chr17:52024346-52024855 aggaagagagTGGAAGATTGGTAAATATTTGAGTT cagtaatacgactcactatagggagaaggctAAAATCTCCAAACCCCCAATATAA + 
Epi00211_SEPT9.1 chr17:72882880-72883313 aggaagagagTTAGGGGTTTTTTTTGTTTTAAATGT cagtaatacgactcactatagggagaaggctCACCAAAATAATCTCAATAAACCCA + 
Epi00212_SEPT9.2 chr17:72883369-72883770 aggaagagagGGTTTTAATTTGTTGGTTTTTTGTG cagtaatacgactcactatagggagaaggctTCCATACTAACTTCTCCCCTACTAACTAA + 
Epi00241_ID2.1 chr2:8726166-8726763 aggaagagagTGGATGGATGTTTTAAAGTTTAGTTATT cagtaatacgactcactatagggagaaggctAAACCACCATCATATTTAACAACATTA + 
Epi00047_ID2.1 chr2:8734408-8734815 aggaagagagTGTGTTTTTTGTTAGGGATTGTAAGT cagtaatacgactcactatagggagaaggctCTTTCACAAAAAATTTTCCTATATCTT + 
Epi00048_ID2.2 chr2:8735298-8735692 aggaagagagATTTGGTTTTAGGGTAAGGGTTTTT cagtaatacgactcactatagggagaaggctAAACCAAAAACTTCCAAATCAACTT + 
Epi00049_ID2.3 chr2:8735719-8736002 aggaagagagTATTAGAAAGGGGATTGGTTTGGTT cagtaatacgactcactatagggagaaggctAACTTTAATCCTAAATTCCTAAAAATACC + 
Epi00050_ID2.4 chr2:8736649-8736919 aggaagagagGGAATGGATATAGTTGTGAGAATAAAA cagtaatacgactcactatagggagaaggctCAACCTAACTCCAAAACTCACTCAC + 
Epi00051_ID2.5 chr2:8738550-8738834 aggaagagagAGTTTTGGAATTTTTTTAGGTGTTG cagtaatacgactcactatagggagaaggctAAATACTTATTACAAACCATACCCAACC + 
Epi00052_ID2.6 chr2:8738655-8739088 aggaagagagGTTTTTTAAGGGTAGTGTATGTAAATG cagtaatacgactcactatagggagaaggctAAAAAAACCACAATTCACTACAACC + 
Epi00053_ID2.7 chr2:8739870-8740348 aggaagagagTGTTATTTTAAGTTTAAGGAGTTGGTGT cagtaatacgactcactatagggagaaggctTTTTTATAATCCACAAACCAACAAA + 
Epi00054_ID2.8 chr2:8740456-8740944 aggaagagagTGATAGTAAAGTATTGTGTGGTTGAA cagtaatacgactcactatagggagaaggctAAAATCCCACATCACAAAATTAAAA + 
Epi00055_ID2.9 chr2:8741022-8741291 aggaagagagTTGTTGTTGGAGATTTAAATAGGAGA cagtaatacgactcactatagggagaaggctCAAAAAATAAAAAAAATCATAAACACCTAC + 
Epi00246_ID2.6 chr2:8748975-8749253 aggaagagagGGTTGTTAATAAAGAAATGATTATTTGAA cagtaatacgactcactatagggagaaggctTTAAACCAATTATCCAAAAATACCC + 
Epi00032_CTLA4.1 chr2:204407956-204408452 aggaagagagGTGTTTATGTGAGTTGAGGGATTAT cagtaatacgactcactatagggagaaggctCAATCCAATTACAAACCATAAAAAATA + 
Epi00033_CTLA4.2 chr2:204408649-204408984 aggaagagagTGTTGTTGTTGGTTGTAAGTATTGTT cagtaatacgactcactatagggagaaggctACCTACCCACTTACTCTAATTCTCA + 
Epi00213_CTLA4.1 chr2:204409089-204409645 aggaagagagTTTTTTGTTGTGATATTGTTTTAGG cagtaatacgactcactatagggagaaggctATCCCTTCTAACCATTCAAATTTCT + 
Epi00034_CTLA4.3 chr2:204409465-204409854 aggaagagagGGTATTGGAGTTATTGAGTTGGTAGA cagtaatacgactcactatagggagaaggctCCCCTACATACAAAAAAAACAACATA + 
Epi00214_CTLA4.2 chr2:204410553-204411141 aggaagagagTGAGTGAAAGAAGTTTATATGAAAAGGT cagtaatacgactcactatagggagaaggctTCATTTCATAACATATAACAATCAATCAA + 
Epi00216_CTLA4.4 chr2:204426356-204426766 aggaagagagTTAAGTTTTAATTGGGTTAGGTTTG cagtaatacgactcactatagggagaaggctTACCCAAACATCTAAAAAACATCAA + 
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Amplicon Chromosomal Location (hg18) Sense Antisense Dir. 
Epi00217_CTLA4.5 chr2:204426643-204427110 aggaagagagTATGGAATTTTTTATGTGAGGTTTGTT cagtaatacgactcactatagggagaaggctAACCAAAACAAAAACTCAATCCTCT + 
Epi00038_CTLA4.7 chr2:204427109-204427432 aggaagagagTTTTTTTGGTTGTTTTGTTTTGATT cagtaatacgactcactatagggagaaggctAAAAAAAATTTCCTCCTTACCTACC + 
Epi00219_CTLA4.7 chr2:204429550-204430103 aggaagagagTTATGATTAAATTTAGTGTGATTAATTGGA cagtaatacgactcactatagggagaaggctAAATAAAACTTTCCTAAAATTCCCAA + 
Epi00220_CTLA4.8 chr2:204430849-204431377 aggaagagagTTTTGTATGTGGTAAGAATTTTATGTGA cagtaatacgactcactatagggagaaggctCCATCACCAACCAAAATCTAAAATA + 
Epi00221_CTLA4.9 chr2:204431356-204431929 aggaagagagTTTAGATTTTGGTTGGTGATGG cagtaatacgactcactatagggagaaggctAAAATAAACCAAACACAAAAAAACAC + 
Epi00222_CTLA4.10 chr2:204432444-204433038 aggaagagagTTTAGGAGTTAGTGTTTGTTATAGATTGTG cagtaatacgactcactatagggagaaggctCCCCACCTAAATAATACATTCAAAA + 
Epi00226_CTLA4.14 chr2:204441638-204442166 aggaagagagAAGGAAAAGGAAAGAAAGAAAGTTATTA cagtaatacgactcactatagggagaaggctTTATAACCCACCCAAATAAACACTC + 
Epi00227_CTLA4.15 chr2:204443006-204443543 aggaagagagTGGGTGATAGAGGTTTAGGGTTAGT cagtaatacgactcactatagggagaaggctAAAACCAAAAAAAACTCAATAAACTCA + 
Epi00233_CTLA4.21 chr2:204445693-204446278 aggaagagagTTTTATAATAGGGGTTTATGTGAAAATG cagtaatacgactcactatagggagaaggctCCTTTAACATCACTAACTAAAACATAACCA + 
Epi00234_CTLA4.22 chr2:204446252-204446789 aggaagagagTTATGTTTTAGTTAGTGATGTTAAAGGTTG cagtaatacgactcactatagggagaaggctTCTTCTATCCATAACATTAACCACATATT + 
Epi00236_IKZF2.2 chr2:213697351-213697584 aggaagagagTGAAATTGTTATTGTGTAGAAGGGG cagtaatacgactcactatagggagaaggctCAAAAAAAATTCATTACATAACATATCCA + 
Epi00040_ZNFN1A2.1 chr2:213723180-213723764 aggaagagagTTTTTTAATTTTTTAAAGAGGAGGTGA cagtaatacgactcactatagggagaaggctTTACCAAAAACCAAAAACAATCCTA + 
Epi00041_ZNFN1A2.2 chr2:213723485-213723925 aggaagagagTTTTTAGGGATGGTTTAGTAGGAAAA cagtaatacgactcactatagggagaaggctTCCAAATAAAAAATAATATCCAAATCC + 
Epi00239_IKZF2.5 chr2:213726239-213726736 aggaagagagAGAGAAATTATTTGGGTTTAGGTTTGTA cagtaatacgactcactatagggagaaggctAACCAAAAACAAAAACTACATCAAC + 
Epi00045_ZNFA1N2.2 chr2:213727375-213727718 aggaagagagAGGGTTTTATTATGTTGGTTAGGGT cagtaatacgactcactatagggagaaggctAACTAAAAAATCTATTTCCTCCCCA + 
Epi00046_ZNFN1A2.1 chr2:213809715-213810256 aggaagagagGGGAAGGTAGTATTATTTTTTGTTTTT cagtaatacgactcactatagggagaaggctAATCTCTCCTAAATTCATTAAAATTCA + 
Epi00240_WNT10A.1 chr2:219476834-219477390 aggaagagagAGTTTTTTAAAGTGTTGGGATTATAGG cagtaatacgactcactatagggagaaggctAAACCCAAATTAATACAAAAATCCA + 
Epi00248_IL2RB.2 chr22:35871983-35872251 aggaagagagTTTTTTATAGGGGATGTTTTTGGAT cagtaatacgactcactatagggagaaggctCAAAAAAAACAAATAAAAACCTACA + 
Epi00251_IL2RB.5 chr22:35893508-35893730 aggaagagagGTTTTATTGTTTTTGGTTGTTTGGT cagtaatacgactcactatagggagaaggctAAACAAATCCTCCCACCTATACC + 
Epi00253_PDE4D.1 chr5:58457591-58458087 aggaagagagGGGGTTTTGATTTTGTGATATATAATTT cagtaatacgactcactatagggagaaggctAATAACTAAAATACAACCTTCTCCTCTTTC + 
Epi00254_PDE4D.2 chr5:58458185-58458681 aggaagagagGGGTTGTTTTTTTAGTATTAGTTTATTTGA cagtaatacgactcactatagggagaaggctATTTCAACTTTCACAAACAACTCCA + 
Epi00067_TNF.1 chr6:31650965-31651237 aggaagagagTTTGGTTTTTAAAAGAAATGGAGGT cagtaatacgactcactatagggagaaggctTCCTTAATAAAAAAACCCATAAACTCA + 
Epi00068_TNF.2 chr6:31651106-31651692 aggaagagagGGGTATTTTTGATGTTTGTGTGTTT cagtaatacgactcactatagggagaaggctAACACTCACCTCTTCCCTCTAAAAA + 
Epi00069_TNF.3 chr6:31651639-31652152 aggaagagagTTTTGTTTGTTGTATTTTGGAGTGA cagtaatacgactcactatagggagaaggctAAACATTCAACAACTCTTTCCCTAA + 
Epi00070_TNF.4 chr6:31651639-31651905 aggaagagagTTTTGTTTGTTGTATTTTGGAGTGA cagtaatacgactcactatagggagaaggctAAACACCTTCCATATACCAAACATC + 
Epi00071_TNF.5 chr6:31652127-31652504 aggaagagagTTTAGGGAAAGAGTTGTTGAATGTT cagtaatacgactcactatagggagaaggctAAAAAAAACTAAAACCCTTAAACTTCC + 
Epi00074_HOXA1.1 chr7:27095653-27096004 aggaagagagGGTTTAGAGTTAGAATTTTTTTTGGAA cagtaatacgactcactatagggagaaggctTTACTAACCACCCACTCAATCAAAT + 
Epi00075_HOXA1.2 chr7:27096226-27096699 aggaagagagGAGATTAGGGATGTGGGTTTTATTTA cagtaatacgactcactatagggagaaggctCTCTTCAAAAATCAAAATTCATATAATCA + 
Epi00077_GATA4.1 chr8:11583609-11584063 aggaagagagTATATTGAGGAGGTGGTTTTGTTTT cagtaatacgactcactatagggagaaggctTTAACCCATAAAAAATTCCAAAAATC + 
Epi00259_TP53INP1.1 chr8:96010388-96010962 aggaagagagTAGAGGAAATTAGTTAGAGTGGATGGT cagtaatacgactcactatagggagaaggctTCCACAAAATAAAAAATCCTCTATCAT + 
Epi00269_FOXP3.1 chrX:48996840-48997010 aggaagagagATTAAAGGATGTAAGAGGTTAAATGGT cagtaatacgactcactatagggagaaggctAATAATTCCAAAAACACCTCCTTTC + 
Epi00270_FOXP3.2 chrX:48997485-48998052 aggaagagagGAGAGGTTGGTGATTTAGAGGTTTA cagtaatacgactcactatagggagaaggctCCAAAAAAATTTAAATAACTTTCCCA + 
Epi00271_FOXP3.3 chrX:48997580-48997983 aggaagagagAGGTTGGAGTGTAGTGGTGTAATTT cagtaatacgactcactatagggagaaggctATAATCCCAACATCAATAACCACAT + 
Epi00272_FOXP3.4 chrX:49001667-49002039 aggaagagagGTTTGTTTTATTTTGGGTTTAGGGT cagtaatacgactcactatagggagaaggctATCCCAACCAATACCTACTTTAACC + 
Epi00081_FOXP3.1 chrX:49003029-49003414 aggaagagagGGGTTTTTTGTTGAGTTTTAGAATTT cagtaatacgactcactatagggagaaggctCTAACAACCACCCCCAAAAAATAAC + 
Epi00082_FOXP3.2 chrX:49003993-49004485 aggaagagagATTTGTTTGGGGGTAGAGGATTTAG cagtaatacgactcactatagggagaaggctACCCCAAAAATCCCAATATCTATAA + 
Epi00083_FOXP3.3 chrX:49004673-49005149 aggaagagagAGGGTTTTTTGTTTATTAGGTTTGG cagtaatacgactcactatagggagaaggctAAAAAAAACCTAAACTACCATTCCC + 
Epi00088_FOXP3.8 chrX:49005022-49005472 aggaagagagTTTTTGTGTGTGTTTTTTTGTTTTT cagtaatacgactcactatagggagaaggctAAACCTCACCTAACCCAACTCTTAT + 
Epi00084_FOXP3.4 chrX:49005180-49005620 aggaagagagGGTTTTTAGTTGGGGAGAGAGTTAG cagtaatacgactcactatagggagaaggctTTTCAAACAACATCAATTAAACCAA + 
Epi00277_FOXP3.9 chrX:49006709-49007185 aggaagagagTTTAGGGTTAGTTTAAGTAGAGGGAGT cagtaatacgactcactatagggagaaggctAACCAAAATCCATATTCAAAAAACA + 
Epi00278_FOXP3.10 chrX:49007665-49008089 aggaagagagTAGAGAGATAGAGAAGGATGAGAGGTATT cagtaatacgactcactatagggagaaggctTTCTATCAATCCACTTCACCAAAAT + 
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V$STAT5.01 8 26 9.22 3.03 2.82 5.36 
V$MYOD.01 7 10 2.59 1.61 3.86 4.29 
V$NFKAPPAB65.01 9 15 5.03 2.24 2.98 4.22 
V$HMX2.02 9 26 11.64 3.41 2.23 4.06 
V$MZF1.02 8 20 8.26 2.87 2.42 3.91 
V$STAT3.02 8 14 5.06 2.25 2.77 3.75 
V$HEN1.02 3 7 1.72 1.31 4.08 3.65 
V$GKLF.01 11 20 9.15 3.02 2.19 3.42 
V$E47.01 8 8 2.34 1.53 3.41 3.37 
V$ZID.01 5 8 2.38 1.54 3.36 3.31 
V$MARE.02 4 8 2.43 1.56 3.29 3.25 
V$NGN_NEUROD.01 7 11 4.24 2.06 2.59 3.04 
















V$CREB2CJUN.01 2 4 0.28 0.53 14.06 6.03 
V$ATF.01 7 10 1.85 1.36 5.4 5.62 
V$ELK1.02 9 11 2.35 1.53 4.68 5.32 
V$CTCF.03 5 12 2.92 1.71 4.11 5.02 
V$HAND2_E12.01 4 11 2.71 1.65 4.06 4.73 
V$ATF6.02 7 9 1.99 1.41 4.53 4.62 
V$CTCF.04 5 10 2.39 1.55 4.18 4.59 
V$CREB1.01 5 7 1.31 1.15 5.32 4.52 
V$CREB.02 5 8 1.91 1.38 4.19 4.05 
V$GABPB1.01 7 10 2.86 1.69 3.5 3.93 
V$CETS1P54.01 9 13 4.42 2.1 2.94 3.85 
V$KLF6.01 7 10 3 1.73 3.34 3.76 
V$MZF1.03 6 15 5.79 2.41 2.59 3.62 
V$STAT5.01 7 20 8.9 2.98 2.25 3.56 
V$MZF1.01 6 15 5.98 2.45 2.51 3.48 
V$E4F.01 7 13 4.89 2.21 2.66 3.44 
V$HIF1.01 6 7 1.87 1.37 3.75 3.39 
V$ETS2.01 11 19 8.71 2.95 2.18 3.32 
V$RB_E2F1_DP1.01 4 8 2.42 1.55 3.31 3.27 
V$USF.04 6 11 3.99 2 2.76 3.26 
V$GKLF.01 11 19 8.83 2.97 2.15 3.25 
V$E2F.02 10 11 4.07 2.02 2.7 3.18 
V$ATF.02 9 11 4.11 2.03 2.68 3.16 
V$OLF1.02 7 10 3.64 1.91 2.75 3.07 
V$ROAZ.01 5 9 3.11 1.76 2.89 3.06 
a Number of input sequences with at least one match. 
b Number of matches in all sequences. 
c Expected match numbers in an equally sized sample of the genomic background and the standard deviation. 
d Overrepresentation against genomic background: Fold factor of match numbers in regions compared to an equally sized 
sample of the background (i.e. found versus expected). 
e Z-score of overrepresentation against genomic background: The distance from the population mean in units of the 
population standard deviation. Shown are only highly significant motifs (Z score >3; a Z-score above 2 can be considered 
statistically significant). 
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Abstract	  
	  CD4+	  T	  cell	  subpopulations	  are	  defined	  through	  their	  lineage-­‐specific	  expression	  of	  transcription	  factors.	  The	  expression	  of	  these	  master	  regulators	  in	  CD4+	  T	  cells	  is	  not	  solely	  controlled	  by	  their	  promotor	   activity,	   but	   also	   by	   epigenetic	  mechanisms.	   It	   has	   recently	   been	   shown	   that	   stable	  expression	   of	   the	   Treg	   lineage-­‐directing	   transcription	   factor	   Foxp3	   is	   dependent	   on	   its	   DNA	  methylation	   status	   at	   a	  methylation	   sensitive,	  Treg	   cell-­‐	   specific	   enhancer,	   called	  Treg-­‐specific	  demethylated	   region	   (TSDR).	  Thus	   far,	   the	   lack	  of	  methods	   for	   the	   isolation	  of	   intact	   genomic	  DNA	  after	   intracellular/intranuclear	   staining	  and	  FACS-­‐sorting	  hampered	  downstream	  genetic	  and	   epigenetic	   analyses	   of	   these	   unique	   T	   cells	   subpopulations.	   Using	   Foxp3-­‐specific	   FACS	  purification	   of	   human	   CD4+CD25+	   T	   cells	   as	   an	   example,	   we	   now	   present	   a	  modified	   phenol-­‐based	   DNA	   isolation	   protocol	   permitting	   further	   downstream	   applications,	   such	   as	   DNA	  methylation	  analyses.	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Introduction	  
	  Several	  cell	  lineages	  and	  T	  cell-­‐subpopulations	  are	  best	  defined	  by	  their	  expression	  of	  a	  specific	  transcription	   factor.	   Yet,	   purification	   of	   such	   cells	   for	   downstream	   genetic	   and	   epigenetic	  analyses	   still	   largely	   relies	   on	   the	   expression	   of	   surrogate	   markers,	   such	   as	   cell	   surface	  molecules,	   that	   often	   do	   not	   discriminate	   accurately	   enough	   to	   obtain	   pure	   populations.	   The	  CD4+	   T	   cell	   compartment	   represents	   a	   prime	   example	   of	   a	   cell	   lineage	   that	   is	   composed	   of	  various	  subpopulations	  and	  differentiation	  states,	  such	  as	  Th1,	  Th2,	  Th17	  and	  natural	  (thymus-­‐derived)	  regulatory	  T	  (Treg)	  cells.	  These	  T	  cell	   subpopulations	  can	  only	  be	  distinguished	   from	  each	  other	  by	  their	  cytokine	  secretion	  profile,	   their	   functional	  characteristics	  or,	  most	  reliably,	  their	   expression	   of	   lineage-­‐defining	   transcription	   factors	   including	   T-­‐bet	   (Szabo	   et	   al.	   2000),	  GATA-­‐3	  (Zheng	  and	  Flavell	  1997),	  RORγT	  (Ivanov	  et	  al.	  2006)	  or	  FOXP3	  (Fontenot	  et	  al.	  2003),	  for	   Th1,	   Th2,	   Th17	   and	   Treg	   cells,	   respectively.	   In	   transgenic	   mouse	   models,	   fluorescent	  reporter	   gene	   products	   permit	   the	   unequivocal	   identification	   and	   isolation	   of	   such	  subpopulations	   for	   downstream	   applications	   by	   fluorescence	   activated	   cell	   sorting	   (FACS)	  (Fontenot	  et	  al.	  2005b).	   In	  humans,	  however,	  CD4+	  T	  cell	  subpopulations	  are	   indistinguishable	  by	   surrogate	   phenotypic	  markers	   and	   identified	   reliably	   only	   after	   intracellular	   staining	  with	  cytokine-­‐	   or	   transcription	   factor-­‐specific	   antibodies.	   Yet,	   formaldehyde	   fixation	   and	  permeabilization,	   required	   for	   the	   intranuclear	   staining	   of	   transcription	   factors,	   induce	  alterations	  (e.g.	  DNA-­‐protein	  cross-­‐links)	  that	  hamper	  the	  extraction	  of	  intact	  genomic	  DNA	  with	  commercially	   available	   isolation	   kits	   (e.g.	   silica	   membrane	   columns;	   data	   not	   shown).	   In	  addition,	  they	  introduce	  polymerase-­‐“blocks”	  complicating	  genetic	  and	  epigenetic	  analyses.	  We	  now	  aimed	  to	  develop	  protocols	  for	  the	  isolation	  of	  intact	  genomic	  DNA	  from	  FACS-­‐purified	  cells	  after	  formaldehyde	  fixation	  and	  intracellular	  staining.	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Results	  and	  Discussion	  
	  It	  has	  previously	  been	  shown	   that	   stable	  expression	  of	   the	  Foxp3	  gene	   in	  mice	   is	   regulated	   in	  parts	  by	  DNA	  methylation.	  Huehn	  and	  colleagues	  described	  a	  Treg-­‐specific	  demethylated	  region	  (TSDR)	  within	  the	  Foxp3	  locus	  that	  is	  completely	  methylated	  in	  conventional	  (Foxp3	  negative)	  T	  cells	  and	  also	  in	  T	  cells	  transiently	  expressing	  Foxp3	  after	  in	  vitro	  stimulation	  in	  the	  presence	  of	  TGF-­‐β	   (so	   called	   "induced	   Treg	   cells")	   (Floess	   et	   al.	   2007;	  Hoffmann	   et	   al.	   2009).	   In	   addition,	  Leonhard	   and	   colleagues	   showed	   that	   this	   TSDR	   contains	   several	   transcription	   factor-­‐binding	  sites,	  acts	  as	  enhancer	  and	  thereby	  stabilizes	  Foxp3	  expression	  (Kim	  and	  Leonard	  2007).	  Using	  high-­‐expression	   of	   CD25	   on	   CD4+	   T	   cells	   as	   a	   surrogate	  marker,	  we	   previously	   confirmed	   the	  specific	  demethylation	  in	  the	  TSDR	  also	  for	  human	  Treg	  cells	  (Baron	  et	  al.	  2007;	  Hoffmann	  et	  al.	  2009;	   Schmidl	   et	   al.	   2009).	   To	   ultimately	   prove	   differential	   DNA	   methylation	   in	   FOXP3-­‐expressing	  Treg	  cells,	  we	  now	  modified	  previously	  described	  methods	  for	  the	  extraction	  of	  DNA	  from	  fixed	  and	  paraffin	  embedded	  histological	  samples	  that	  so	  far	  only	  allowed	  the	  isolation	  of	  fragmented	  (200-­‐400bp)	  DNA,	  that	  was	  unsuited	  for	  reliable	  epigenetic	  analyses	  (Jackson	  et	  al.	  1990).	  For	  the	   isolation	  of	   intact	  genomic	  DNA	  from	  FOXP3-­‐sorted	  Treg	  cells,	  we	  now	  isolated	  human	   CD4+	   T	   cells	   from	  MNCs	   and	   stained	   the	   cells	   for	   CD4,	   CD25	   and	   intranuclear	   FOXP3	  using	   standard	   protocols	   (s.	   Methods	   section).	   Afterwards,	   the	   cells	   were	   FACS-­‐sorted	   into	  CD4+CD25+FOXP3+,	   CD4+CD25+FOXP3-­‐	   and	   CD4+CD25-­‐FOXP3-­‐	   subpopulations	   and	   re-­‐analyzed	  by	   flow	  cytometry	   to	   confirm	   their	  purity	   (Fig.	  1a).	   Intact	  genomic	  DNA	   from	   the	  FACS-­‐sorted	  subpopulations	  was	  then	  isolated	  using	  a	  modified	  phenol-­‐based	  DNA	  extraction	  protocol,	   first	  described	  in	  1956	  (Kirby	  1956).	  The	  implemented	  modifications	  included	  the	  supplementation	  of	   sufficient	   RNAse	   and	   protease	   activity	   for	   the	   liberation	   of	   DNA	   and	   the	   provision	   of	  substantial	   kinetic	   and	   thermal	   energy,	   which	   was	   decisive	   to	   reverse	   fomaldehyde-­‐induced	  conformational	   changes	   and	  non-­‐covalent	   as	  well	   as	   covalent	   cross-­‐links	   (Fowler	   et	   al.	   2008).	  Incubation	  of	   the	  cells	   in	  an	  appropriate	   lysis	  buffer	   (see	  Methods)	  at	  60°C	  on	  a	   temperature-­‐controlled	   shaker	   for	   approximately	   24h	   turned	   out	   to	   be	   the	   crucial	   step	   for	   the	   isolation	   of	  intact	  and	  pure	  genomic	  DNA.	  We	  obtained	  12.7±2.4	  µg	  high	  molecular	  DNA	  from	  2x106	  cells	  (n	  =	   9	   independent	   isolations),	   which	   is	   well	   in	   line	   with	   standard	   extraction	   procedures	   from	  unfixed	   cells.	   The	   DNA	   was	   of	   high	   purity	   as	   revealed	   by	   UV	   spectrometry	   with	   a	   mean	  absorption	  ratio	  at	  A260/A280	  of	  1.93	  and	  a	  mean	  absorption	  ratio	  at	  A260/A230	  of	  2.23	  (Fig.	  1b,	  for	  details	  on	  individual	  extractions	  see	  Supplementary	  Fig.	  1	  and	  Supplementary	  Tab.	  1).	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  Genomic	   DNA	   isolated	   by	   this	   method	   was	   perfectly	   suited	   for	   downstream	   applications,	   as	  exemplarily	  shown	  in	  a	  MALDI-­‐TOF	  mass-­‐spectrometry-­‐based	  DNA	  methylation	  analysis	  of	  the	  human	  FOXP3	   gene.	  As	   shown	   in	  Figure	  2	   (and	  Supplementary	  Table	  2),	   the	  DNA	  methylation	  status	   of	   the	   FOXP3	   locus	   was	   profoundly	   different	   in	   the	   three	   T	   cell	   subpopulations:	   As	  expected,	   CD4+CD25+FOXP3+	   cells	   showed	   complete	   demethylation	   over	   a	   large	   genomic	  interval,	   including	   the	   methylation	   sensitive,	   Treg	   cell	   specific	   enhancer	   TSDR	   (Floess	   et	   al.	  2007;	  Kim	  and	  Leonard	  2007).	  In	  contrast,	  CD4+CD25+FOXP3-­‐	  T	  cells	  were	  demethylated	  only	  at	  the	   proximal	   promoter	   CpGs,	   whereas	   the	   majority	   of	   CpGs	   (including	   the	   TSDR)	   were	  methylated	  to	  the	  same	  extent	  as	  in	  CD4+CD25-­‐	  conventional	  T	  cells.	  The	  partial	  demethylation	  of	   the	  Foxp3	  promoter	   in	  CD4+CD25+FOXP3-­‐	  T	   cells	   indicates	   the	  proven	  ability	  of	   activated	  T	  cells	   to	   transiently	   express	   FOXP3	   without	   demethylation	   of	   the	   TSDR	   region	   (Huehn	   et	   al.	  2009).	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Figure	  1:	  	  
DNA	  isolation	  from	  CD4+	  T	  cells	  stained	  and	  FACS-­‐sorted	  for	  differential	  expression	  of	  
the	  transcription	  factor	  FOXP3	  (a)	  Sort	  gates	  for	  the	  FACS	  purification	  and	  re-­‐analysis	  of	  FOXP3-­‐stained	  CD4+	  T	  cells.	  One	  representative	  out	  of	  three	  independent	  experiments	  is	  shown.	  (b)	  Isolation	  of	  highly	  pure	  genomic	  DNA	  as	  indicated	  by	  fragment	  length	  and	  absorbance	  ratios	  (A260	  nm/A280	  nm,	  A260	  nm/A230	  nm)	  detected	  by	  UV	  spectrometry.	  Displayed	  is	  one	  representative	  out	  of	  three	  independent	  experiments.	  1:	  CD4+CD25-­‐	  T	  cells;	  2:	  CD4+CD25+FOXP3+	  Treg	  cells;	  3:	  CD4+CD25+FOXP3-­‐	  T	  cells;	  M:	  λ	  Hind	  III-­‐marker;	  bp:	  basepairs.	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  In	  summary,	  we	  present	  a	  new	  and	  reliable	  method	  for	  the	  isolation	  of	  high	  molecular	  DNA	  from	  FACS-­‐sorted	  cells	  that	  are	  fixed,	  permeabilized	  and	  stained	  for	  intranuclear	  transcription	  factors.	  Genomic	  DNA	  from	  such	  cells	  is	  of	  high	  purity	  and	  suited	  for	  sensitive	  downstream	  applications	  such	  as	  MALDI-­‐TOF	  MS	  based	  DNA	  methylation	  analysis,	  that	  includes	  bisulphite	  conversion	  and	  PCR	  amplification	  of	   the	  extracted	  DNA.	  As	  a	  proof	  of	  principle,	  we	  examined	   the	  methylation	  status	  of	   the	  TSDR	  in	  FACS-­‐sorted	  human	  FOXP3+	  Treg	  cells,	  which	  was	  shown	  to	  have	  crucial	  enhancer	   activity	   and	   to	   be	   critically	   involved	   in	   the	   maintenance	   of	   natural	   Treg	   lineage	  stability	   (Baron	   et	   al.	   2007;	   Floess	   et	   al.	   2007;	   Kim	   and	   Leonard	   2007;	   Polansky	   et	   al.	   2008;	  Hoffmann	  et	  al.	  2009;	  Huehn	  et	  al.	  2009;	  Schmidl	  et	  al.	  2009).	  Overall,	   this	  method	  offers	  new	  prospects	   for	  the	  analysis	  of	  molecularly	  defined	  cell	  populations,	  such	  as	  natural	  and	   induced	  Treg	  cells,	  and	  will	  also	  be	  valuable	  for	  a	  broad	  range	  of	  other	  cellular	  systems.	  	   	  
Figure	  2:	  	  
Methylation	  analysis	  of	  the	  FOXP3	  locus.	  The	  DNA	  methylation	  status	  of	  the	  FOXP3	  locus	  was	  analyzed	  by	  MALDI-­‐TOF	  MS.	  Results	  are	  shown	  as	  heatmap	  (the	  scale	  ranges	  from	  white	  (no	  methylation)	  to	  dark	  blue	  (100%	  methylation));	  CpGs	  not	  detectable	  by	  MS	  are	  marked	  in	  gray.	  A,	  B	  and	  C	  mark	  isolates	  from	  three	  separate	  experiments.	  In	  CD4+CD25+FOXP3+	  T	  cells	  the	  DNA	  of	  the	  FOXP3	  locus	  is	  completely	  demethylated,	  while	  CpGs	  of	  CD4+CD25-­‐	  T	  cells	  are	  completely	  methylated.	  CD4+CD25+FOXP3-­‐	  T	  cells	  resemble	  CD4+CD25-­‐	  T	  cells	  except	  for	  the	  
FOXP3	  promoter	  region,	  which	  is	  partially	  demethylated.	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Isolation,	   FOXP3-­‐staining	   and	   FACS-­‐sorting	   of	   human	   CD4+	   T	   cells.	   Human	   PBMC	   were	  isolated	  by	  Ficoll	  (Biocoll;	  Biochrom	  AG,	  Berlin,	  Germany)	  density	  gradient	  centrifugation	  from	  leukapheresis	   products	   of	   healthy	   volunteers	   (after	   their	   informed	   consent	   and	   in	   accordance	  with	   protocols	   approved	   by	   the	   local	   authorities).	   CD4+	   cells	   were	   enriched	   with	   CD4	  MicroBeads	   (Miltenyi	   Biotec,	   Bergisch	   Gladbach,	   Germany)	   using	   the	   Midi-­‐MACS®	   system	  (Miltenyi	  Biotec).	  CD4-­‐enriched	  cells	  were	  stained	  with	  anti-­‐CD4-­‐FITC	  and	  anti-­‐CD25-­‐APC	  (both	  BD	   Biosciences,	   NJ,	   USA)	   and	   anti-­‐FOXP3-­‐PE	   (eBioscience,	   San	   Diego,	   CA).	   For	   intracellular	  FOXP3	   staining,	   the	   FOXP3	   Staining	   Buffer	   Set	   (eBioscience)	   was	   used	   according	   to	   the	  manufacturer’s	   instructions,	   with	   the	   following	  modifications:	   1x108	   CD4-­‐enriched	   cells	   were	  resuspended	   in	   20	   ml	   fixation/permeabilization	   buffer	   for	   30	   min	   at	   4°C;	   for	   intracellular	  staining,	   1x108	   cells	   were	   resuspended	   in	   2	  ml	   permeabilization	   buffer	   and	   40	   µl	   normal	   rat	  serum	  (eBioscience)	  were	  added.	  After	  incubation	  for	  15	  min	  at	  4°C	  in	  the	  dark,	  450	  µl	  of	  anti-­‐human	  FOXP3-­‐PE	  antibody	  were	  added	  followed	  by	  incubation	  for	  another	  30	  min	  at	  4°C	  in	  the	  dark.	  Finally,	  cells	  were	  resuspended	  in	  PBS	  and	  sorted	  into	  CD4+CD25-­‐,	  CD4+CD25+FOXP3+	  and	  CD4+CD25+FOXP3-­‐	  T	   cells	  using	  a	  FACS-­‐Aria®	  high-­‐speed	   cell	   sorter	   (BD	  Biosciences).	   Sorting	  gates	  were	  defined	  as	  shown	   in	  Figure	  1a	  and	  sorted	  cell	  populations	  routinely	  showed	  >96%	  purity	   (range:	   96%-­‐98%)	   upon	   re-­‐analysis.	   All	   buffers	   for	   staining	   and	   fixation	   were	   free	   of	  DNase-­‐activity.	  
	  
DNA	  isolation	  from	  FOXP3-­‐sorted	  cells.	  The	  DNA	  extraction	  procedure	  is	  a	  modified	  phenol-­‐based	  protocol	  (Kirby	  1956).	  Up	  to	  2.5	  x	  106	  FACS-­‐sorted	  cells	  were	  resuspended	  in	  300	  µl	  lysis-­‐buffer	  containing	  100	  mM	  NaCl	  (C.	  Roth	  GmbH,	  Karlsruhe,	  Germany),	  10	  mM	  Tris	  HCl	  (Roth),	  50	  mM	  EDTA	  (Merck	  KGaA,	  Darmstadt,	  Germany),	  0.5%	  SDS	  (Roth),	  0.1	  mg/ml	  proteinase	  K	  (Roche	  Diagnostics	  GmbH,	  Mannheim,	  Germany),	  20	  µg/ml	  RNase	  A	  (Qiagen	  GmbH,	  Hilden,	  Germany)	  and	  the	  pH	  was	  adjusted	  to	  8.0	  with	  NaOH	  (Roth).	  The	  lysate	  was	  incubated	  on	  a	  thermoshaker	  at	   60°C	   for	   approximately	   24	   h.	   Then,	   300	   µl	   phenol	   were	   added	   and	   mixed	   rapidly.	   After	  centrifugation	  at	  3.400	  x	  g	   for	  5	  min	  at	  4°C,	   the	  aqueous	  (upper)	  phase	  was	  transferred	   into	  a	  new	  tube	  and	  900	  µl	  of	  95%	  ethanol	  (Mallinckrodt	  Baker,	  Deventer,	  The	  Netherlands),	  0.12	  M	  sodium	   acetate	   (Merck)	   were	   added.	   After	   vigorous	   mixing,	   DNA	   precipitated	   and	   became	  visible.	  After	  incubation	  for	  at	  least	  20	  min	  at	  -­‐20°C,	  DNA	  was	  pelleted	  for	  15	  min	  at	  13,700	  x	  g	  at	  4°C	   and	  washed	  with	   600	   µl	   70%	  Ethanol	   for	   5	  min	   at	   RT.	   After	   centrifugation	   for	   15	  min	   at	  13.700	  x	  g	  at	  4°C	  the	  supernatant	  was	  completely	  removed	  and	  DNA	  was	  dried	  for	  10	  min	  at	  RT	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or	  at	  60°C	  to	  remove	  residual	  ethanol.	  Finally,	  DNA	  was	  dissolved	  in	  100	  µl	  TE-­‐buffer	  (Qiagen)	  for	   approximately	  24	  h	  on	   a	   shaker	   at	  60°C	   and	  another	  24	  h	   at	  4°C.	  DNA	  content	   and	  purity	  were	  measured	  using	  the	  NanoDrop	  1000	  spectrometer	  (NanoDrop	  Technologies,	  Wilmington,	  USA).	   Fragment	   length	   of	   the	   obtained	   DNA	   was	   determined	   by	   0.5	   %	   Agarose	   gel-­‐electrophoresis	   and	   ethidium-­‐bromide	   stained	   gels	   were	   scanned	   on	   a	   Typhoon	   9200	   (GE	  Healthcare,	  Piscataway,	  NJ)	  (Fig.	  1b	  and	  Supplementary	  Fig.	  1).	  	  	  
Mass	  spectrometry	  analysis	  of	  bisulfite-­‐converted	  DNA.	  We	  previously	  designed	  a	  set	  of	  11	  partially	   overlapping	   amplicons	   covering	   regions	   of	   the	   human	   FOXP3	   gene	   to	   detect	  differentially	   methylated	   regions	   (DMR)	   in	   CD4+CD25+	   and	   CD4+CD25-­‐	   T	   cells	   (Schmidl	   et	   al.	  2009).	   The	   same	   regions	   were	   analyzed	   in	   CD4+CD25-­‐,	   CD4+CD25+FOXP3+	   and	  CD4+CD25+FOXP3-­‐	  T	  cells	  and	  0%,	  50%	  and	  100%	  methylated	  control	  templates	  were	  generated	  as	  previously	  described	  (Schmidl	  et	  al.	  2009).	  Sodium	  bisulfite	  conversion	  was	  performed	  using	  the	   EZ	  DNA	  methylation	   kit	   (Zymo	  Research,	   Orange,	   CA)	   using	   1	   µg	   of	   genomic	  DNA	   and	   an	  alternative	  conversion	  protocol.	  The	  incubation	  parameters	  where	  changed	  as	  follows:	  95°C	  for	  30	   sec,	   50°C	   for	   15	   min	   (repeated	   for	   20	   cycles).	   PCR	   amplification	   of	   target	   regions	   was	  followed	   by	   SAP	   treatment,	   reverse	   transcription	   and	   subsequent	   RNA	   base-­‐specific	   cleavage	  (MassCLEAVE,	  Sequenom,	  San	  Diego,	  CA)	  as	  previously	  described	  (Ehrich	  et	  al.	  2005).	  Cleavage	  products	   were	   loaded	   onto	   spectroCHIPs	   (Sequenom)	   and	   analysed	   by	   MALDI-­‐TOF	   mass	  spectrometry	   (MassARRAY	   Compact	   MALDI-­‐TOF,	   Sequenom).	   Methylation	   ratios	   were	  determined	  from	  mass	  spectra	  using	  the	  Epityper	  software	  v1.0	  (Sequenom).	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Materials	  and	  Methods	  
	  
Isolation,	  FOXP3-­‐staining	  and	  FACS-­‐sorting	  of	  human	  CD4+	  T	  cells.	  Human	  PBMC	  were	  isolated	  by	  Ficoll	  (Biocoll;	  Biochrom	  AG,	  Berlin,	  Germany)	  density	  gradient	  centrifugation	  from	  leukapheresis	  products	  of	  healthy	  volunteers	  (after	  their	  informed	  consent	  and	  in	  accordance	  with	  protocols	  approved	  by	  the	  local	  authorities).	  CD4+	  cells	  were	  enriched	  with	  CD4	  MicroBeads	  (Miltenyi	  Biotec,	  Bergisch	  Gladbach,	  Germany)	  using	  the	  Midi-­‐MACS®	  system	  (Miltenyi	  Biotec).	  CD4-­‐enriched	  cells	  were	  stained	  with	  anti-­‐CD4-­‐FITC	  and	  anti-­‐	  CD25-­‐APC	  (both	  BD	  Biosciences,	  NJ,	  USA)	  and	  anti-­‐FOXP3-­‐PE	  (eBioscience,	  San	  Diego,	  CA).	  For	  intracellular	  FOXP3	  staining,	  the	  FOXP3	  Staining	  Buffer	  Set	  (eBioscience)	  was	  used	  according	  to	  the	  manufacturer’s	  instructions,	  with	  the	  following	  modifications:	  1x108	  CD4-­‐enriched	  cells	  were	  resuspended	  in	  20	  ml	  fixation/permeabilization	  buffer	  for	  30	  min	  at	  4°C;	  for	  intracellular	  staining,	  1x108	  cells	  were	  resuspended	  in	  2	  ml	  permeabilization	  buffer	  and	  40	  μl	  normal	  rat	  serum	  (eBioscience)	  were	  added.	  After	  incubation	  for	  15	  min	  at	  4°C	  in	  the	  dark,	  450	  μl	  anti-­‐human	  FOXP3-­‐PE	  antibody	  was	  added	  followed	  by	  incubation	  for	  another	  30	  min	  at	  4°C	  in	  the	  dark.	  Finally,	  cells	  were	  resuspended	  in	  PBS	  and	  sorted	  into	  CD4+CD25-­‐,	  CD4+CD25+FOXP3+	  and	  CD4+CD25+FOXP3-­‐	  T	  cells	  using	  a	  FACS-­‐Aria®	  highspeed	  cell	  sorter	  (BD	  Biosciences).	  Sorting	  gates	  are	  shown	  in	  Figure	  1A	  and	  sorted	  cell	  populations	  routinely	  showed	  >96%	  purity	  (range:	  96%-­‐98%)	  upon	  re-­‐analysis.	  All	  buffers	  for	  staining	  and	  fixation	  were	  free	  of	  DNase-­‐activity.	  	  
DNA	  isolation	  from	  FOXP3-­‐sorted	  cells.	  The	  DNA	  extraction	  procedure	  is	  a	  modified	  phenol-­‐based	  protocol	  (Kirby	  1956).	  Up	  to	  2.5	  x	  106	  FACS-­‐sorted	  cells	  were	  resuspended	  in	  300	  μl	  lysis-­‐buffer	  containing	  100	  mM	  NaCl	  (C.	  Roth	  GmbH,	  Karlsruhe,	  Germany),	  10	  mM	  Tris	  HCl	  (Roth),	  50	  mM	  EDTA	  (Merck	  KGaA,	  Darmstadt,	  Germany),	  0.5%	  SDS	  (Roth),	  0.1	  mg/ml	  proteinase	  K	  (Roche	  Diagnostics	  GmbH,	  Mannheim,	  Germany),	  20	  μg/ml	  RNase	  A	  (Qiagen	  GmbH,	  Hilden,	  Germany)	  and	  the	  pH	  was	  adjusted	  to	  8.0	  with	  NaOH	  (Roth).	  The	  lysate	  was	  incubated	  on	  a	  thermoshaker	  at	  60°C	  for	  approximately	  24	  h.	  Then,	  300	  μl	  phenol	  were	  added	  and	  mixed	  rapidly.	  After	  centrifugation	  at	  3.400	  x	  g	  for	  5	  min	  at	  4°C,	  the	  aqueous	  (upper)	  phase	  was	  transferred	  into	  a	  new	  tube	  and	  900	  μl	  of	  95%	  ethanol	  (Mallinckrodt	  Baker,	  Deventer,	  The	  Netherlands),	  0.12	  M	  sodium	  acetate	  (Merck)	  were	  added.	  After	  vigorous	  mixing,	  DNA	  precipitated	  and	  became	  visible.	  After	  incubation	  for	  at	  least	  20	  min	  at	  -­‐20°C,	  DNA	  was	  pelleted	  for	  15	  min	  at	  13,700	  x	  g	  at	  4°C	  and	  washed	  with	  600	  μl	  70%	  Ethanol	  for	  5	  min	  at	  RT.	  After	  centrifugation	  for	  15	  min	  at	  13.700	  x	  g	  at	  4°C	  the	  supernatant	  was	  completely	  removed	  and	  DNA	  was	  dried	  for	  10	  min	  at	  RT	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or	  at	  60°C	  to	  remove	  residual	  ethanol.	  Finally,	  DNA	  was	  dissolved	  in	  100	  μl	  TE-­‐buffer	  (Qiagen)	  for	  approximately	  24	  h	  on	  a	  shaker	  at	  60°C	  and	  another	  24	  h	  at	  4°C.	  DNA	  content	  and	  purity	  were	  measured	  using	  the	  NanoDrop	  1000	  spectrometer	  (NanoDrop	  Technologies,	  Wilmington,	  USA).	  Fragment	  length	  of	  the	  obtained	  DNA	  was	  determined	  by	  0.5	  %	  Agarose	  gel-­‐electrophoresis	  and	  ethidiumbromide	  stained	  gels	  were	  scanned	  on	  a	  Typhoon	  9200	  (GE	  Healthcare,	  Piscataway,	  NJ)	  (Fig.	  1B	  and	  Supplementary	  Fig.	  1).	  Mass	  spectrometry	  analysis	  of	  bisulfite-­‐converted	  DNA.	  We	  previously	  designed	  a	  set	  of	  11	  partially	  overlapping	  amplicons	  covering	  regions	  of	  the	  human	  FOXP3	  gene	  to	  detect	  differentially	  methylated	  regions	  (DMR)	  in	  CD4+CD25+	  and	  CD4+CD25-­‐	  T	  cells	  (Schmidl	  et	  al.	  2009).	  The	  same	  regions	  were	  analyzed	  in	  CD4+CD25-­‐,	  CD4+CD25+FOXP3+	  and	  CD4+CD25+FOXP3-­‐	  T	  cells	  and	  0%,	  50%	  and	  100%	  methylated	  control	  templates	  were	  generated	  as	  previously	  described	  (Schmidl	  et	  al.	  2009).	  Sodium	  bisulfite	  conversion	  was	  performed	  using	  the	  EZ	  DNA	  methylation	  kit	  (Zymo	  Research,	  Orange,	  CA)	  using	  1	  μg	  of	  genomic	  DNA	  and	  an	  alternative	  conversion	  protocol.	  The	  incubation	  parameters	  where	  changed	  as	  follows:	  95°C	  for	  30	  sec,	  50°C	  for	  15	  min	  (repeated	  for	  20	  cycles).	  PCR	  amplification	  of	  target	  regions	  was	  followed	  by	  SAP	  treatment,	  reverse	  transcription	  and	  subsequent	  RNA	  base-­‐specific	  cleavage	  (MassCLEAVE,	  Sequenom,	  San	  Diego,	  CA)	  as	  previously	  described	  (Ehrich	  et	  al.	  2005).	  Cleavage	  products	  were	  loaded	  onto	  spectroCHIPs	  (Sequenom)	  and	  analysed	  by	  MALDI-­‐TOF	  mass	  spectrometry	  (MassARRAY	  Compact	  MALDI-­‐TOF,	  Sequenom).	  Methylation	  ratios	  were	  determined	  from	  mass	  spectra	  using	  the	  Epityper	  software	  v1.0	  (Sequenom).	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3.3 	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SUMMARY	  	  
	  
The	   adoptive	   transfer	   of	   in	  vitro	   expanded	   regulatory	   T	   (Treg)	   cells	   is	   a	   promising	   treatment	  option	   for	   autoimmune	   as	   well	   as	   alloantigen-­‐induced	   diseases.	   Yet,	   concerns	   about	   the	  phenotypic	   and	   functional	   stability	   of	   Treg	   cells	   upon	   in	   vitro	   culture	   command	   both,	   careful	  selection	   of	   the	   starting	   population	   and	   thorough	   characterization	   of	   the	   final	   cell	   product.	  Recently,	   a	   high	   degree	   of	   developmental	   plasticity	   has	   been	   described	   for	   murine	   Treg	   and	  Th17	   cells.	   Similarly,	   IL-­‐17-­‐producing	   FOXP3+	   cells	   have	   been	   detected	   among	   the	   CD45RA-­‐	  memory-­‐type	   subpopulation	   of	   human	   Treg	   cells	   ex	  vivo.	   This	   prompted	   us	   to	   investigate	   the	  predisposition	   of	   human	   naïve	   and	   memory	   Treg	   cells	   to	   develop	   into	   Th17	   cells	   during	  polyclonal	   in	   vitro	   expansion.	   Here,	   we	   show	   that	   stimulation-­‐induced	   DNA	   demethylation	   of	  
RORC,	  which	  encodes	  the	  lineage-­‐defining	  transcription	  factor	  for	  Th17	  cells,	  occurs	  selectively	  in	   CD45RA-­‐	  memory-­‐type	   Treg	   cells,	   irrespective	   of	   their	   FOXP3	   expression	   level.	   In	   contrast,	  naïve	   CD45RA+	   Treg	   cells	   retain	   stable	   CpG	   methylation	   across	   the	   RORC	   locus	   even	   upon	  prolonged	   ex	   vivo	   expansion	   and	   in	   consequence	   show	   only	   a	   marginal	   tendency	   to	   express	  
RORC	   and	   develop	   into	   IL-­‐17-­‐producing	   cells.	   These	   findings	   are	   highly	   relevant	   for	   the	  generation	  of	  therapeutic	  Treg	  cell	  products.	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INTRODUCTION	  	  
Natural	  CD4+CD25highFOXP3+	  Treg	  cells	  play	  a	  central	  role	   in	  maintaining	  immune	  homeostasis	  and	  preventing	  destructive	  auto-­‐	  or	  allo-­‐immune	  responses,	  as	  demonstrated	  	  in	  several	  murine	  disease	  models	   (Asano	   et	   al.	   1996;	   Salomon	   et	   al.	   2000;	   Hoffmann	   et	   al.	   2002a;	   Taylor	   et	   al.	  2002;	  Edinger	  et	  al.	  2003;	  Mottet	  et	  al.	  2003).	  Due	  to	  their	  scarcity	  in	  peripheral	  blood,	  potential	  therapeutic	  Treg	  cell	  applications	   in	  humans	  will	   require	   their	  ex	  vivo	   expansion.	  Yet,	   the	  now	  well-­‐documented	   heterogeneity	   and	   developmental	   plasticity	   of	   Treg	   cells	   in	  vitro	   and	   in	  vivo	  (Hoffmann	  et	  al.	  2009;	  Miyara	  et	  al.	  2009;	  Zhou	  et	  al.	  2009b;	  Zhou	  et	  al.	  2009c)	  raises	  concerns	  that	   ex	   vivo	   culture	   may	   alter	   the	   molecular	   and	   functional	   characteristics	   of	   the	   cells.	   We	  previously	  showed	   that	  FOXP3,	   the	   transcription	   factor	  determining	  Treg	   lineage	  commitment	  and	   required	   for	   their	   suppressive	   function,	   is	   progressively	   down-­‐regulated	   upon	   in	   vitro	  expansion	   of	   memory-­‐type	   CD45RA-­‐	   Treg	   cells	   (RA-­‐	   Treg),	   a	   process	   that	   correlates	   with	  increased	   DNA	   methylation	   at	   several	   regions	   within	   the	   FOXP3	   locus,	   reduced	   suppressive	  activity	   and	   increased	   expression	   of	   IL-­‐2	   and	   IFNg	   in	   these	   converting	   cells	   (Hoffmann	   et	   al.	  2006b;	  Hoffmann	  et	  al.	  2009).	   Interestingly,	  naïve	  CD45RA+	  Treg	  cells	   (RA+	  Treg),	  despite	   the	  acquisition	  of	  a	  memory	  phenotype	  in	  many	  other	  aspects	  ((Hoffmann	  et	  al.	  2006b;	  Hoffmann	  et	  al.	  2009)	  and	  own	  unpublished	  data),	   retain	  stable	  FOXP3	  expression	  and	  suppressive	  activity	  and	  show	  no	  tendency	  to	  up-­‐regulate	  those	  proinflammatory	  cytokines,	  even	  after	  prolonged	  in	  
vitro	   expansion.	   Several	   reports,	   however,	   have	   now	   demonstrated	   a	   particularly	   close	  relationship	   between	   Treg	   and	   Th17	   cells	   in	   the	   murine	   system	   and	   a	   high	   degree	   of	  developmental	  plasticity,	  including	  the	  occurrence	  of	  FOXP3+	  T	  cells	  co-­‐expressing	  IL-­‐17	  and/or	  the	  retinoic	  acid	  receptor-­‐related	  orphan	  receptor	  gt	  (RORgt),	  the	  lineage-­‐defining	  transcription	  factor	   for	  Th17	   cells	   	   (Ivanov	   et	   al.	   2006;	   Lochner	   et	   al.	   2008;	   Yang	   et	   al.	   2008b;	   Zhang	   et	   al.	  2008;	   Tartar	   et	   al.	   2010).	   Similarly,	   Voo	   et	   al.	   recently	   detected	   FOXP3/RORC	  double-­‐positive	  cells	  in	  peripheral	  blood	  as	  well	  as	  in	  lymphoid	  organs	  of	  healthy	  human	  volunteers	  (Voo	  et	  al.	  2009).	   Furthermore,	   the	   groups	   led	   by	   Sakaguchi	   and	   Valmori	   both	   showed	   that	   peripheral	  blood	   derived	   memory-­‐type,	   but	   not	   naïve	   human	   CD4+CD25highFOXP3+	   T	   cells	   express	   high	  levels	  of	  RORC	  ex	  vivo	  and	  that	  a	  minor	  fraction	  of	  these	  cells	  indeed	  produce	  IL-­‐17	  after	  in	  vitro	  stimulation	   	  (Ayyoub	  et	  al.	  2009;	  Miyara	  et	  al.	  2009).	  In	  addition,	   in	  vitro	  conversion	  of	  human	  Treg	  cells,	  especially	  of	  those	  with	  memory	  phenotype,	  into	  IL-­‐17-­‐producing	  effector	  T	  cells	  has	  been	  reported,	  provided	  cells	  were	  kept	  under	  Th17-­‐polarizing	  culture	  conditions	  	  (Deknuydt	  et	  al.	  2009).	  Since	  the	  long	  predicted	  precursor–progeny	  relationship	  between	  CD45RA+	  naïve	  and	  CD45RA-­‐	   memory	   Treg	   cells	   has	   now	   been	   confirmed	   in	   vivo	   (Miyara	   et	   al.	   2009),	   we	  investigated	   the	   predisposition	   of	   human	   naïve	   and	   memory-­‐type	   Treg	   cells	   to	   develop	   into	  
Epigenetic	  reprogramming	  oft	  the	  RORC	  locus	  in	  in	  vitro	  expanded	  regulatory	  T	  cells	  	  
	   88	  
potentially	  pathogenic	  Th17	  cells	  when	  stimulated	  under	  the	  non-­‐polarizing	  culture	  conditions	  designed	  for	  clinical	  Treg	  cell	  products.	  We	  now	  show	  that	  under	  such	  conditions	  an	  epigenetic	  reprogramming	   of	   the	  RORC	   locus	   and	   emergence	   of	   IL-­‐17	   secreting	   cells	   occur	   selectively	   in	  memory-­‐type,	  but	  not	  in	  naïve	  Treg	  cells.	  Interestingly,	  by	  further	  subdividing	  the	  memory	  Treg	  cell	  pool,	  we	  reveal	  that	  DNA	  demethylation	  of	  the	  RORC	   locus	  is	  even	  more	  pronounced	  in	  the	  subset	  with	   preserved	   FOXP3	   expression	   as	   compared	   to	   those	   cells	   that	   have	   already	   down-­‐regulated	  FOXP3	  expression	  after	  repeated	  in	  vitro	  stimulation.	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RESULTS	  AND	  DISCUSSION	  
	  
DNA	  demethylation	  at	  the	  RORC	  locus	  occurs	  in	  human	  memory	  but	  not	  in	  naïve	  Treg	  cells	  upon	  in	  vitro	  expansion	  	  Recently,	   the	   paradigm	   of	   stable	   lineage	   commitment	   of	   CD4+	   T	   cells	   had	   to	   be	   revised	  considerably.	  Differentiation	  of	  naïve,	  Foxp3-­‐	  conventional	  T	  cells	  (Tconv)	  into	  Foxp3+	  Treg	  cells	  in	   the	   periphery	   is	   now	   well	   accepted	   	   (Chen	   et	   al.	   2003;	   Klunker	   et	   al.	   2009).	   Likewise,	  conversion	  of	  Treg	  cells	  into	  pro-­‐inflammatory	  effector	  T	  cells	  that	  no	  longer	  express	  Foxp3	  has	  been	   shown	   by	   us	   and	   others	   both	   in	   the	  murine	   and	   in	   the	   human	   system	   (Hoffmann	   et	   al.	  2006b;	  Hoffmann	  et	  al.	  2009;	  Zhou	  et	  al.	  2009c).	  With	  the	  identification	  of	  FOXP3+IL-­‐17+	  T	  cells	  in	   the	  peripheral	  blood	  of	  healthy	  human	  subjects	  another	   level	  of	  complexity	   in	   this	   field	  has	  been	  unravelled	  (Ayyoub	  et	  al.	  2009;	  Miyara	  et	  al.	  2009).	  Whereas	  the	  physiological	  role	  of	  such	  cells	   is	   still	   under	   debate	   (Lochner	   et	   al.	   2008;	   Yang	   et	   al.	   2008b;	   Tartar	   et	   al.	   2010),	   recent	  reports	   about	   the	   emergence	   of	   IL-­‐17	   producing	   cells	   in	   human	   Treg	   cultures	   (Koenen	   et	   al.	  2008;	   Ayyoub	   et	   al.	   2009;	   Beriou	   et	   al.	   2009)	   have	   revived	   the	   question	   of	   phenotypic	   and	  functional	  stability	  of	  Treg	  cells	  during	  in	  vitro	  expansion	  and	  the	  safety	  of	  such	  cell	  products	  for	  clinical	   application.	   We	   therefore	   determined	   the	   predisposition	   of	   highly	   purified	   naïve	   and	  memory	   Treg	   cells	   to	   convert	   into	   FOXP3+IL-­‐17+	   T	   cells	   and	   consequently	   into	   potentially	  hazardous	   Th17	   cells	   during	   in	   vitro	   expansion	   under	   the	   non-­‐polarizing	   culture	   conditions	  intended	  for	  clinical	  trials.	  	  The	   regulation	   of	   key	   developmental	   as	   well	   as	   functionally	   important	   genes	   is	   in	   part	  orchestrated	   by	   epigenetic	   mechanisms	   such	   as	   histone	   modification	   and	   DNA	   (CpG)	  methylation.	  The	  importance	  of	  such	  epigenetic	  regulation	  for	  stable	  expression	  or	  repression	  of	  
FOXP3	   (and	   that	   of	   several	   other	   Treg	   signature	   genes)	   has	   recently	   been	   shown	   by	   us	   and	  others	  for	  murine	  as	  well	  as	  human	  Treg	  cells	  (Baron	  et	  al.	  2007;	  Hoffmann	  et	  al.	  2009;	  Huehn	  et	  al.	  2009;	  Lal	  and	  Bromberg	  2009;	  Lal	  et	  al.	  2009;	  Schmidl	  et	  al.	  2009).	  Since	  expression	  of	   the	  transcription	   factor	   RORC	   is	   central	   for	   the	   development	   of	   Th17	   cells,	   we	   focused	   our	  investigation	  on	  cell-­‐specific	  changes	  in	  the	  DNA	  methylation	  patterns	  at	  this	  gene	  locus.	  	  We	  first	  isolated	  CD45RA+	  naïve	  and	  CD45RA-­‐	  memory-­‐type	  CD4+CD25high	  T	  cells	  (RA+	  and	  RA-­‐	  Treg,	   respectively)	   by	   FACS	   from	   the	   peripheral	   blood	   of	   healthy	   volunteers	   (Fig.	   1A),	  determined	   their	   DNA	  methylation	   status	   at	   several	   conserved	   non-­‐coding	   regions	   across	   the	  
RORC	   locus	  and	  compared	   it	   to	   that	   found	   in	   in	  vitro	   generated,	  FACS-­‐purified	  Th17	  cells	   (Fig.	  1B).	   Clear	   differences	   between	   the	   DNA	   methylation	   patterns	   of	   Th17	   cells	   and	   both	   Treg	  populations	   could	   be	   observed	   that	   were	   particularly	   noticeable	   in	   the	   proximal	   promoter	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region	   (covered	   by	   amplicons	   R4/R5	   in	   Fig.	   1B	   and	   shown	   in	   more	   detail	   for	   the	   promoter	  region	   around	   the	   transcription	   start	   site	   (TSS;	   amplicon	   R5)	   in	   Fig.	   1C).	   RA-­‐	   Treg	   showed	  significantly	  less	  DNA	  methylation	  at	  the	  promoter	  region	  ex	  vivo	  as	  compared	  to	  RA+	  Treg	  (P	  <	  0.001;	   n	   =3-­‐5;	   Student's	   t-­‐test),	   which	   is	   in	   line	   with	   recent	   reports	   detecting	   RORC	   mRNA	  expression	  in	  freshly	  isolated	  human	  memory-­‐type	  but	  not	  naïve	  Treg	  cells	  (Ayyoub	  et	  al.	  2009).	  We	   then	   expanded	   both	   Treg	   populations	   (RA+	   and	   RA-­‐	   Treg)	   under	   non-­‐polarizing	   culture	  conditions	   and,	   given	   the	   dissociation	   of	   RA-­‐	   Treg	   into	   a	   FOXP3-­‐maintaining	   and	   a	   FOXP3-­‐downregulating	   subpopulation	   after	   two	   to	   three	   rounds	   of	   re-­‐stimulation	   (Hoffmann	   et	   al.	  2006b),	  we	  FACS-­‐sorted	  the	  two	  populations	  and	  analyzed	  their	  DNA	  methylation	  status	  at	  the	  
RORC	   locus	   individually.	   Isolation	  of	   intact	  genomic	  DNA	  from	  fixed	  and	   intracellularly	  stained	  cells	   was	   achieved	   with	   our	   recently	   described	   protocol	   (Hansmann	   et	   al.	   2010).	   Direct	  comparison	  of	  freshly	  isolated	  and	  expanded	  cells	  revealed	  a	  further	  loss	  of	  CpG	  methylation	  in	  RA-­‐	  Treg	  cells	  during	  expansion	  at	  several	  regions	  within	  the	  RORC	  locus,	  including	  the	  proximal	  promoter	  (Fig.	  1B	  and	  1C),	  which	  was	  most	  pronounced	   in	   the	  subpopulation	   that	  maintained	  FOXP3	  expression	  during	  culture.	  In	  fact,	  this	  subpopulation	  of	  RA-­‐	  Treg	  cells	  developed	  a	  CpG	  methylation	   pattern	   almost	   identical	   to	   that	   of	   Th17	   cells	   (Fig.	   1B).	   Since	   the	   cells	  were	   kept	  under	   non-­‐polarizing	   conditions	   during	   in	   vitro	   expansion,	   these	   changes	   might	   be	   due	   to	  triggering	   signals	   received	   already	   in	   vivo	   that	   primed	   RA-­‐	   Treg	   cells	   for	   a	   stimulation-­‐dependent	   epigenetic	   reprogramming.	   In	   support	   of	   this	   view,	   Lochner	   et	   al.	   (Lochner	   et	   al.	  2008)	   as	   well	   as	   Tartar	   et	   al.	   (Tartar	   et	   al.	   2010)	   reported	   on	   Foxp3+RORgt+	   T	  cells	   in	  immunocompetent	  mice	  that	  showed	  the	  potential	  to	  develop	  into	  either	  Foxp3+RORgt-­‐	  Treg	  or	  Foxp3-­‐RORgt+IL-­‐17+	   Th17	   cells	   in	   response	   to	   respective	   lineage-­‐driving	   stimuli.	   In	   vivo,	   such	  developmentally	   flexible	   precursor	   cells	   might	   thus	   provide	   the	   basis	   for	   an	   efficient,	   yet	  regulated	   immune	   response.	   In	   contrast,	   in	   vitro	   expansion	   had	   no	   detectable	   impact	   on	   the	  methylation	  status	  of	  RORC	  in	  RA+	  Treg	  cells,	  irrespective	  of	  the	  number	  of	  restimulation	  cycles	  or	   FOXP3	   expression	   levels,	   suggesting	   that	   polyclonal	   TCR	   triggering	   and	   co-­‐stimulation	   via	  CD28	   in	  vitro	   is	   insufficient	   to	   induce	  DNA	  demethylation	   of	   the	  RORC	   locus	   and	   thus	   a	   Th17	  developmental	   program	   in	   naïve	   Treg	   cells.	   In	   support	   of	   these	   results,	  RORC	  mRNA	   levels	   in	  freshly	  isolated	  (d0)	  as	  well	  as	  in	  in	  vitro	  expanded	  RA+	  Treg	  were	  found	  to	  be	  almost	  100-­‐fold	  lower	   than	   in	   RA-­‐	   Treg,	   even	   after	   prolonged	   in	   vitro	   culture	   (>	   36d)	   (Fig.	   1D).	   Similar	  differences	  were	  observed	  in	  freshly	  isolated	  and	  14d	  expanded	  RA+	  and	  RA-­‐	  Tconv	  cells	  (Suppl.	  Fig.	  S2A).	  Interestingly,	  even	  when	  in	  vitro	  expanded	  RA+	  Treg	  cells	  were	  cultured	  under	  Th17-­‐polarizing	   conditions	   for	   an	   additional	   6	   days,	   their	   RORC	   locus	   remained	   methylated	   and	  neither	  RORC	  mRNA	  levels	  nor	   the	  number	  of	   IL-­‐17-­‐producing	  cells	   increased	   in	  such	  cultures	  (see	   Fig.	   1B	   and	   Suppl.	   Fig.	   S2B	   and	   S2C).	   Importantly,	   this	   pronounced	  maintenance	   of	   DNA	  methylation	   in	   RA+	   Treg	   cells	   during	   expansion	   was	   not	   due	   to	   a	   general	   inability	   to	  demethylate	   DNA,	   since	   the	   Tconv	   cell-­‐specific	   differentially	   methylated	   region	   (DMR)	   at	   the	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CD40LG	  locus	  (Schmidl	  et	  al.	  2009)	  gradually	  lost	  DNA	  methylation	  in	  the	  few	  FOXP3-­‐	  Treg	  cells	  that	  appeared	  during	  extensive	  in	  vitro	  culture	  (data	  not	  shown).	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Figure	  1:	  
DNA	  methylation	  status	  of	  the	  human	  RORC	  locus	  of	  Treg	  subpopulations.	  (A)	  Schematic	  presentation	  of	  analyzed	  cell	  types.	  For	  the	  generation	  of	  Th17	  cells	  FACS-­‐purified	  CD4+CD25intCD45RA-­‐	  Tconv	  cells	  were	  polyclonally	  expanded,	  restimulated	  with	  PMA/ionomycin,	  intracellularly	  stained	  for	  IL-­‐17	  and	  the	  cytokine-­‐positive	  fraction	  was	  isolated	  by	  FACS.	  Memory	  CD4+CD25highCD45RA-­‐	  (RA-­‐)	  and	  naïve	  CD4+CD25highCD45RA+	  (RA+)	  Treg	  cells	  from	  healthy	  donors	  were	  in	  vitro	  expanded	  as	  detailed	  in	  the	  'Material	  and	  Methods'	  section	  before	  intracellular	  staining	  and	  FACS-­‐based	  fractionation	  into	  FOXP3+	  and	  FOXP3-­‐	  cells.	  Intact	  genomic	  DNA	  isolated	  from	  these	  cell	  populations	  was	  used	  for	  methylation	  analysis.	  (B)	  Schematic	  map	  of	  the	  human	  RORC	  locus	  (from	  the	  UCSC	  browser,	  http://genome.ucsc.edu/)	  with	  the	  following	  features	  from	  top	  to	  bottom:	  scale,	  conservation	  over	  17	  mammalian	  species,	  repeats,	  RORC	  gene	  structure	  and	  isoforms,	  regions	  cloned	  for	  enhancer	  reporter	  assays	  shown	  in	  (F)	  (blue	  boxes)	  and	  amplicons	  generated	  for	  methylation	  analysis	  by	  MALDI-­‐TOF	  MS	  (black	  boxes).	  The	  methylation	  status	  of	  individual	  CpGs	  is	  shown	  in	  a	  heat	  map	  for	  the	  indicated	  cell	  types.	  In	  addition	  to	  the	  subpopulations	  detailed	  in	  (A),	  CD45RA+	  Treg	  were	  also	  analyzed	  after	  an	  in	  vitro	  expansion	  for	  11d	  under	  non-­‐polarizing	  culture	  conditions	  followed	  by	  an	  additional	  6d	  culture	  period	  either	  under	  identical,	  non-­‐polarizing	  conditions	  (RA+	  Treg	  NP)	  or	  under	  Th17-­‐polarizing	  conditions	  (RA+	  Treg	  Th17).	  	  Each	  CpG	  is	  represented	  by	  a	  small	  square	  with	  methylation	  levels	  ranging	  from	  0%	  (white)	  to	  100%	  (dark	  blue)	  or	  not	  analyzed	  (grey).	  Data	  represent	  means	  of	  at	  least	  three	  independent	  experiments.	  (C)	  Overall	  CpG	  methylation	  status	  of	  the	  promoter	  region	  at	  the	  transcription	  start	  site	  (TSS)	  (R4	  in	  Fig.	  1B)	  of	  individual	  samples.	  Each	  box	  represents	  one	  donor	  and	  the	  black	  line	  displays	  the	  respective	  average.	  Significant	  differences	  exist	  between	  the	  following	  T	  cell	  populations:	  RA+	  and	  RA-­‐	  Treg/d0	  (P<0.001),	  RA-­‐	  Treg/d0	  and	  FOXP3+	  RA-­‐	  Treg/d21-­‐23	  (P<0.001),	  FOXP3+	  and	  FOXP3-­‐	  RA-­‐	  Treg/d21-­‐23	  (P<0.001),	  Th17	  cells	  and	  all	  other	  populations	  except	  FOXP3+	  RA-­‐	  Treg/d21-­‐23	  (all	  P<0.005;	  n=3-­‐7;	  Student's	  t-­‐test).	  (D)	  RORC	  mRNA	  expression	  of	  RA+	  and	  RA-­‐	  Treg	  directly	  after	  isolation	  (d0)	  and	  after	  in	  vitro	  expansion	  for	  the	  indicated	  time	  periods..	  mRNA	  expression	  was	  measured	  by	  qRT-­‐PCR	  and	  normalized	  to	  18S	  rRNA	  expression.	  Data	  represent	  means	  +	  SD	  from	  n=4	  (d0),	  n=8	  (d14)	  and	  n=3	  (d36+)	  independent	  cultures	  set	  up	  with	  cells	  from	  up	  to	  8	  different	  donors.	  Asterisks	  indicate	  significant	  differences	  between	  subpopulations	  (*p<0.05,	  **p<0.01,	  paired	  two-­‐tailed	  Student’s	  t-­‐test).	  (E)	  RORC	  expression	  of	  CD4+CD25-­‐CD45RA+	  T	  cells	  polyclonally	  activated	  for	  5d	  in	  the	  presence	  of	  0,	  1,	  5,	  10	  or	  20	  µM	  5-­‐Aza-­‐2’deoxy-­‐cytidine.	  RORC	  expression	  was	  measured	  via	  qRT-­‐PCR	  and	  normalized	  to	  18S	  RNA	  expression.	  Asterisks	  indicate	  significant	  differences	  between	  treatment	  groups	  (n=3;	  p<0.05,	  Student’s	  t-­‐test).	  (F)	  Several	  conserved	  regions	  of	  RORC	  (blue	  boxes	  in	  B)	  were	  cloned	  upstream	  of	  a	  basic	  EF1-­‐promoter	  into	  the	  CpG-­‐free	  luciferase	  vector	  pCpGL.	  The	  indicated	  plasmids	  were	  in	  vitro	  SssI	  methylated	  or	  left	  unmethylated	  and	  subsequently	  transfected	  transiently	  into	  Jurkat	  T	  cells	  which	  were	  stimulated	  with	  TGFβ	  after	  transfection.	  Luciferase	  activity	  was	  normalized	  to	  a	  cotransfected	  Renilla	  construct	  and	  to	  the	  unmethylated	  “empty”	  control	  vector	  which	  harbors	  only	  the	  EF1-­‐promoter	  (pCpGL-­‐P).	  Asterisks	  indicate	  significant	  differences	  between	  methylated	  and	  unmethylated	  plasmids	  (P	  <	  0.05,	  Student’s	  t-­‐test).	  
Epigenetic	  reprogramming	  oft	  the	  RORC	  locus	  in	  in	  vitro	  expanded	  regulatory	  T	  cells	  	  
	   94	  
Several	  DMR	  in	  the	  RORC	  locus	  harbour	  newly	  identified	  methylation-­‐dependent	  enhancer	  activity	  To	   investigate	  whether	   the	   differential	   DNA	  methylation	   patterns	   found	   at	   the	  RORC	   locus	   of	  expanded	   RA+	   and	   RA-­‐	   Treg	   cells	   are	   functionally	   relevant,	   we	   initially	   treated	   CD4+CD25-­‐CD45RA+	   naïve	   Tconv	   cells	   with	   5-­‐aza-­‐2’deoxycytidine,	   a	   potent	   DNA	   methyl-­‐transferase	  inhibitor.	   Treatment	   with	   the	   demethylating	   agent	   for	   five	   days	   led	   to	   a	   dose-­‐dependent	  induction	  of	  RORC	  mRNA	  expression	   (Fig.	  1E),	   indicating	   that	  RORC	  expression	   is	   regulated	   at	  least	   in	   part	   by	   DNA	   methylation.	   Next,	   we	   designed	   reporter	   constructs	   to	   test	   the	   DNA	  methylation-­‐dependent	   ability	   of	   promoter-­‐distal	   conserved	   regions	   (RORC1-­‐5,	   positions	   are	  indicated	  in	  Fig.	  1B	  as	  light	  blue	  boxes)	  to	  enhance	  the	  activity	  of	  a	  heterologous	  promoter	  and	  performed	   luciferase	   reporter	   assays	   in	   Jurkat	   T	   cells.	   As	   shown	   in	   Fig.	  1F,	   three	   out	   of	   five	  promoter-­‐distal	  regions	  significantly	  enhanced	  the	  activity	  of	  the	  basal	  (CpG-­‐free)	  EF1	  promoter	  (Klug	  and	  Rehli	  2006).	  All	  regions	  lost	  enhancer	  activity	  when	  DNA	  was	  methylated,	  suggesting	  that	  their	  activity	  is	  critically	  dependent	  on	  their	  CpG	  methylation	  status,	  as	  previously	  observed	  for	  Treg	  and	  Tconv	  specific	  DMR	  at	  FOXP3	  and	  other	  loci	  (Schmidl	  et	  al.	  2009).	  	  
IL-­‐17	   producers	   emerge	   predominantly	   among	   the	   subpopulation	   of	   RA-­‐	   Treg	   cells	   with	   stable	  
FOXP3	  expression	  The	  observed	  DNA	  methylation	  patterns	  suggested	  increased	  transcription	  of	  RORC	  especially	  in	  
in	  vitro	  expanded	  FOXP3+	  memory-­‐type	  RA-­‐	  Treg	  cells.	  Since	  it	  is	  difficult	  to	  obtain	  intact	  mRNA	  from	  intracellularly	  stained	  and	  sorted	  cells,	  we	  analyzed	  the	  impact	  of	  ex	  vivo	  expansion	  on	  the	  capacity	   of	   the	   various	  Treg	   populations	   to	   secrete	   IL-­‐17,	   an	   important	   consequence	   of	   RORC	  expression	  and	  key	  characteristic	  of	  Th17	  cells	  (Fig.	  2).	  Fig.	  2A	  provides	  a	  particularly	  distinctive	  example	   and	   Fig.	   2C	   combined	   data	   regarding	   the	   proportion	   of	   IL-­‐17	   producers	   among	   the	  respective	  Treg	  cell	  populations	  as	  determined	  by	  simultaneous	  intracellular	  staining	  for	  FOXP3	  and	   IL-­‐17	   after	   5h	   PMA/ionomycin	   stimulation.	   The	   results	   demonstrate	   that	   the	   ability	   to	  produce	  IL-­‐17	  was	  most	  pronounced	  in	  the	  FOXP3+	  subpopulation	  of	  in	  vitro	  expanded	  RA-­‐	  Treg	  cells	  (Fig.	  2A	  &	  C),	  which	  correlates	  with	  the	  extensive	  DNA	  demethylation	  seen	  at	  the	  promoter	  region	  as	  well	   as	   in	   several	  other	  DMRs	  across	   the	  RORC	   locus	   in	   these	   cells.	   In	   contrast,	  RA+	  Treg	   cells	  maintained	   FOXP3	   expression	   to	   a	   large	   extent	   (Fig.	   2B)	   and	   showed	   no	   or	   only	   a	  marginal	   tendency	   to	   secrete	   IL-­‐17,	   even	   after	   repetitive	   in	  vitro	   stimulation	   (Fig.	   2C).	   Similar	  differences	   were	   observed	   between	   freshly	   isolated	   as	   well	   as	   in	   vitro	   expanded	   naive	   and	  memory-­‐type	  Tconv	  cells	  (Suppl.	  Fig.	  S2D).	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Figure	  2:	  	  
Emergence	   of	   FOXP3+	   and	   FOXP3-­‐	   IL17-­‐producers	   in	   naïve	   and	   memory	   Treg	   cell	  
cultures.	   CD45RA+	   (naïve)	   and	   CD45RA-­‐	   (memory)	   Treg	   cells	   were	   sorted	   from	   PBMC	   and	  cultured	  as	  detailed	  in	  the	  'Material	  and	  Methods'	  section.	  Freshly	  sorted	  or	  in	  vitro	  expanded	  cells	   were	   stimulated	   with	   PMA/ionomycin	   for	   5h	   followed	   by	   simultaneous	   intracellular	  staining	   for	   FOXP3	   and	   IL-­‐17.	   A	   particularly	   distinctive	   example	   (A)	   and	   combined	   data	   of	  FOXP3	  expression	  (B)	  and	  proportion	  of	  FOXP3+IL-­‐17+	  and	  FOXP3-­‐IL-­‐17+	  cells	  (C)	  in	  4	  different	  naïve	  (RA+)	  or	  memory	  (RA-­‐)	  Treg	  cultures	  from	  4	  different	  donors.	  RA+	  Treg	  cells	  had	  to	  be	  kept	  in	  culture	  for	  at	  least	  36d	  and	  restimulated	  at	  least	  5	  times	  before	  downregulating	  FOXP3.	  RA-­‐	  Treg	  were	  kept	  for	  a	  maximum	  of	  16	  d.	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CONCLUDING	  REMARKS	  
In	  conclusion,	  we	  show	  that	  ex	  vivo	  expansion	  of	  natural	  CD45RA-­‐	  memory-­‐type	  Treg	  cells	  even	  under	  neutral,	  non-­‐Th17-­‐polarizing	  culture	  conditions	  results	  in	  the	  epigenetic	  reprogramming	  of	  their	  RORC	  locus	  and	  the	  development	  of	  Th17-­‐like	  cells.	  In	  sharp	  contrast,	  naïve	  Treg	  cells	  do	  not	  show	  this	  tendency	  during	  in	  vitro	  culture.	  It	  is	  unknown	  to	  date	  to	  which	  extent	  conversion	  of	   Treg	   cells	   can	   occur	   after	   adoptive	   transfer	   in	   patients,	   especially	   under	   inflammatory	  conditions.	   However,	   their	  well-­‐documented	  molecular	   and	   functional	   stability	   during	   in	  vitro	  culture	  clearly	  favours	  the	  use	  of	  CD45RA+	  naïve	  Treg	  cells	  for	  future	  clinical	  applications.	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MATERIALS	  AND	  METHODS	  
Cell	  purification	  and	  culture	  PBMCs	  were	  isolated	  from	  leukapheresis	  products	  of	  healthy	  volunteers	  (approved	  by	  the	  local	  Ethics	   committee	   and	   with	   their	   informed	   consent)	   by	   density	   gradient	   centrifugation.	  CD4+CD25highCD45RA+	  naïve	  Treg	  cells,	  CD4+CD25highCD45RA-­‐	  memory	  Treg	  cells	  and	  CD4+CD25-­‐	  Tconv	   cells	   were	   isolated	   by	   FACS	   (BD	   FACSAria,	   BD	   Biosciences,	   Heidelberg,	   Germany)	   and	  expanded	   in	   vitro	   as	   described	   previously	   (Hoffmann	   et	   al.	   2004;	   Hoffmann	   et	   al.	   2006b).	   In	  brief,	  T	  cells	  were	  cultured	  on	   irradiated,	  huCD32-­‐expressing	  L929	  cells	  with	  anti-­‐CD3	  (OKT3;	  Orthoclone,	   Ortho	   Biotech	   (Neuss,	   Germany))	   and	   anti-­‐CD28	   antibodies	   (CD28.2,	   BD	  Biosciences;	  100	  ng/mL	  each)	  in	  the	  presence	  of	  high-­‐dose	  IL-­‐2	  (Proleukin,	  Chiron,	  Amsterdam,	  Netherlands;	   300	   U/mL)	   and	   restimulated	   weekly.	   Cultures	   were	   continued	   until	   a	   FOXP3-­‐	  subpopulation	   became	   detectable,	   rested	   for	   4d	   in	  medium	  with	   IL-­‐2,	   stained	   for	   FOXP3	   and	  sorted	  into	  FOXP3+	  and	  FOXP3-­‐	  cells	  by	  FACS.	  A	  representative	  example	  of	  the	  gating	  strategy	  for	  sorting	   is	  provided	   in	  Supplementary	  Fig.	   S1.	  For	   the	  generation	  of	  highly	  purified	  Th17	  cells,	  FACS-­‐purified	   CD4+CD25intCD45RA-­‐	   (FOXP3-­‐)	   T	   cells	  were	   cultured	   for	   11d	   as	   detailed	   above,	  rested	   for	  2d	  and	  re-­‐stimulated	   for	  5h	  with	  20	  ng/ml	  PMA/1	  µM	  ionomycin	   in	   the	  presence	  of	  GolgiStop	   (BD	   Biosciences).	   Cells	   were	   intracellularly	   stained	   with	   AF488-­‐conjugated	   anti-­‐human-­‐IL-­‐17A	  (64DEC17;	  eBioscience)	  and	  IL-­‐17A+	  cells	  were	  purified	  by	  FACS.	  	  
Th17	  polarization	  of	  in	  vitro	  expanded	  T	  cells	  Th17	   polarization	   was	   carried	   out	   according	   to	   Manel	   et	   al.	   (Manel	   et	   al.	   2008)	   with	   minor	  modifications.	   T	  cell	   populations	   were	   harvested	   on	   d11	   of	   in	   vitro	   expansion	   under	   non-­‐polarizing	   conditions	   and	   further	   cultured	   for	   additional	   6	   days	   either	   under	   the	   same	  conditions	   (as	   described	   above)	   or	   in	   the	   presence	   of	   recombinant	   human	   IL-­‐1β	   (10	   ng/ml),	  recombinant	   human	   IL-­‐23	   (10	   ng/ml;	   both	   R&D	   Systems,	  Wiesbaden-­‐Nordenstadt,	   Germany),	  anti-­‐human	   IL-­‐4	   antibodies	   (functional	   grade	   purified,	   1	   µg/ml),	   anti-­‐human	   IFN-­‐γ	   antibodies	  (functional	   grade	   purified,	   1	   µg/ml;	   both	   eBioscience)	   and	   recombinant	   human	   TGF-­‐β1	   (10	  ng/ml;	  PeproTech,	  Hamburg,	  Germany)	  for	  Th17	  polarization.	  	  	  
Simultaneous	  FOXP3	  and	  cytokine	  detection	  Treg	   cells	   were	   harvested	   from	   cultures	   and	   rested	   for	   4d	   in	  medium	  with	   IL-­‐2	   (300	   U/mL)	  before	  stimulation	  with	  PMA/ionomycin	   in	   the	  presence	  of	  GolgiStop	   for	  5h	  as	  detailed	  above.	  
Epigenetic	  reprogramming	  oft	  the	  RORC	  locus	  in	  in	  vitro	  expanded	  regulatory	  T	  cells	  	  
	   98	  
Simultaneous	   intracellular	   staining	   for	   FOXP3	   and	   IL-­‐17	   was	   performed	   according	   to	   the	  manufacturers’	  instructions	  using	  the	  FOXP3	  staining	  buffer	  set	  (eBioscience,	  San	  Diego,	  CA),	  PE-­‐,	   APC-­‐	   or	   Pacific	   Blue-­‐labelled	   anti-­‐human-­‐FOXP3	   (PCH101)	   and	  AF488-­‐	   or	   APC-­‐labelled	   anti-­‐human-­‐IL-­‐17A	  (eBio64DEC17)	  (all	  from	  eBioscience).	  	  	  
DNA	  demethylation	  with	  5-­‐Aza-­‐2’deoxycytidine	  Sorted	  CD4+CD25-­‐CD45RA+	  T	   cells	  were	   stimulated	  with	   anti	  CD3/CD28-­‐coated	  beads	   (T	   cell	  expander	   Dynabeads®,	   Invitrogen,	   Darmstadt,	   Germany)	   for	   5d	   in	   the	   presence	   of	   varying	  concentrations	  of	  5-­‐Aza-­‐2’deoxycytidin	  (Sigma	  Aldrich,	  Munich,	  Germany).	  	  	  
Preparation	  of	  RNA	  and	  DNA	  and	  quantitative	  RT-­‐PCR	  	  Genomic	  DNA	  for	  DNA	  methylation	  analysis	  from	  fixed	  and	  FACS™-­‐purified	  cells	  was	  extracted	  and	   quality-­‐controlled	   as	   described	   recently	   (Hansmann	   et	   al.	   2010)	   and	   outlined	   in	   the	  Supplementary	  Material.	  Genomic	  DNA	  from	  unfixed	  cells	  was	  isolated	  using	  the	  DNeasy	  blood	  and	  tissue	  kit	  (Qiagen,	  Hilden,	  Germany).	  Total	  cellular	  RNA	  was	   isolated	  using	  the	  RNeasy	  Kit	  (Qiagen)	   including	   DNase	   digestion	   and	   qRT-­‐PCR	   for	   RORC	   expression	   was	   performed	   using	  primer	  sequences	  listed	  in	  Supplementary	  Table	  S1.	  	  
Mass	  spectrometry	  analysis	  of	  bisulfite-­‐converted	  DNA	  MALDI-­‐TOF	   MS	   analysis	   and	   sodium	   bisulfite	   conversion	   were	   performed	   as	   previously	  published	  (Ehrich	  et	  al.	  2005;	  Schmidl	  et	  al.	  2009)	  (for	  details	  see	  the	  Supplementary	  Material).	  Methylation	   ratios	   were	   determined	   from	   mass	   spectra	   using	   the	   Epityper	   software	   v1.0	  (Sequenom®).	   Methylation	   values	   indicated	   in	   the	   heatmap	   in	   this	   manuscript	   are	   average	  values	   of	   at	   least	   three	   independent	   experiments.	   PCR	   primers	   were	   designed	   using	   the	  Methprimer	  (Li	  and	  Dahiya	  2002)	  web	  tool	  (http://www.urogene.org/methprimer/).	  	  	  
Reporter	  assays.	  Putative	  enhancer	  regions	  were	  cloned	  directly	  into	  the	  CpG-­‐free	  pCpGL-­‐CMV/EF1	  vector	  (Klug	  and	  Rehli	  2006)	  replacing	  the	  CMV	  enhancer	  with	  the	  PCR-­‐amplified	  region	  (Primer	  sequences	  see	   Supplementary	   Table	   S1),	   SssI	   methylated	   in	   vitro	   or	   left	   unmethylated,	   and	   DEAE-­‐transfected	  in	  Jurkat	  cells	  as	  previously	  described	  (Schmidl	  et	  al.	  2009).	  Following	  transfection,	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cells	  were	  either	  left	  untreated	  or	  stimulated	  with	  TGFβ	  (PeproTech	  EC,	  London,	  10	  ng/ml	  over	  night	   plus	   10	   ng/ml	   added	   the	   next	  morning	   for	   additional	   5h).	   Cell	   lysates	  were	   assayed	   for	  firefly	   and	   Renilla	   luciferase	   activities	   using	   the	   Dual-­‐Luciferase	   Reporter	   Assay	   System	  (Promega,	   Mannheim,	   Germany)	   on	   a	   Lumat	   LB9501	   (Berthold	   Detection	   Systems	   GmbH,	  Pforzheim,	   Germany).	   Firefly	   luciferase	   activity	   of	   individual	   transfections	   was	   normalized	  against	  Renilla	  luciferase	  activity.	  	  	  
Statistical	  analysis	  Differences	  in	  DNA	  methylation	  and	  mRNA	  expression	  between	  the	  various	  T	  cell	  populations	  as	  well	   as	   in	   the	   number	   of	   IL-­‐17	   producing	   cells	   per	   culture	   or	   subpopulation	   and	   in	   enhancer	  activity	   of	   selected	   putative	   enhancer	   regions	  were	   analyzed	   using	   the	   two-­‐tailed	   Student's	   t-­‐test.	  Where	  applicable,	  a	  paired	  two-­‐tailed	  Student's	  t-­‐test	  was	  performed.	  	  P-­‐values	  of	  less	  than	  0.05	  were	  considered	  significant.	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Preparation	  of	  RNA	  and	  DNA	  and	  quantitative	  RT-­‐PCR	  	  Genomic	  DNA	  for	  DNA	  methylation	  analysis	  from	  fixed	  and	  FACS™-­‐purified	  cells	  was	  extracted	  and	   quality-­‐controlled	   as	   described	   recently	   (Hansmann	   et	   al.	   2010).	   In	   brief	   up	   to	   2.5	   x	   106	  FACS-­‐sorted	   cells	   were	   resuspended	   in	   300	   μl	   lysis-­‐buffer	   containing	   100	   mM	   NaCl	   (C.	   Roth	  GmbH,	   Karlsruhe,	   Germany),	   10	  mM	   Tris	   HCl	   (Roth),	   50	  mM	   EDTA	   (Merck	   KGaA,	   Darmstadt,	  Germany),	   0.5%	   SDS	   (Roth),	   0.1	   mg/ml	   proteinase	   K	   (Roche	   Diagnostics	   GmbH,	   Mannheim,	  Germany),	  20	  μg/ml	  RNase	  A	  (Qiagen	  GmbH,	  Hilden,	  Germany)	  and	  the	  pH	  was	  adjusted	  to	  8.0	  with	  NaOH	  (Roth).	  The	  lysate	  was	  incubated	  on	  a	  thermoshaker	  at	  60°C	  for	  approximately	  24	  h.	  Then,	  300	  μl	  phenol	  were	  added	  and	  mixed	  rapidly.	  After	  centrifugation	  at	  3,400	  x	  g	  for	  5	  min	  at	  4°C,	   the	   aqueous	   (upper)	   phase	  was	   transferred	   into	   a	   new	   tube	   and	   900	   μl	   of	   95%	   ethanol	  (Mallinckrodt	  Baker,	  Deventer,	  The	  Netherlands),	  0.12	  M	  sodium	  acetate	   (Merck)	  were	  added.	  After	  vigorous	  mixing,	  DNA	  precipitated	  and	  became	  visible.	  After	  incubation	  for	  at	  least	  20	  min	  at	  -­‐20°C,	  DNA	  was	  pelleted	  for	  15	  min	  at	  13,700	  x	  g	  at	  4°C	  and	  washed	  with	  600	  μl	  70%	  Ethanol	  for	   5	   min	   at	   RT.	   After	   centrifugation	   for	   15	   min	   at	   13,700	   x	   g	   at	   4°C	   the	   supernatant	   was	  completely	  removed	  and	  DNA	  was	  dried	  for	  10	  min	  at	  RT	  or	  at	  60°C	  to	  remove	  residual	  ethanol.	  Finally,	  DNA	  was	  dissolved	  in	  100	  μl	  TE-­‐buffer	  (Qiagen)	  for	  approximately	  24	  h	  on	  a	  shaker	  at	  60°C	  and	  another	  24	  h	  at	  4°C.	  DNA	  content	  and	  purity	  were	  measured	  using	  the	  NanoDrop	  1000	  spectrometer	  (NanoDrop	  Technologies,	  Wilmington,	  USA).	  Fragment	  length	  of	  the	  obtained	  DNA	  was	  determined	  by	  0.5	  %	  Agarose	  gel-­‐electrophoresis	  and	  ethidiumbromide	  stained	  gels	  were	  scanned	  on	  a	  Typhoon	  9200.	  	  	  
Mass	  spectrometry	  analysis	  of	  bisulfite-­‐converted	  DNA	  MALDI-­‐TOF	   MS	   analysis	   and	   sodium	   bisulfite	   conversion	   were	   performed	   as	   previously	  published	  (Ehrich	  et	  al.	  2005;	  Schmidl	  et	  al.	  2009).	  Sodium	  bisulfite	  conversion	  was	  performed	  using	  the	  EZ	  DNA	  methylation	  kit	  (Zymo	  Research,	  Orange,	  CA)	  using	  1	  μg	  of	  genomic	  DNA	  and	  an	  alternative	  conversion	  protocol.	  The	  incubation	  parameters	  where	  changed	  as	  follows:	  95°C	  for	   30	   sec,	   50°C	   for	   15	  min	   (repeated	   for	   20	   cycles).	   PCR	   amplification	   of	   target	   regions	  was	  followed	   by	   SAP	   treatment,	   reverse	   transcription	   and	   subsequent	   RNA	   base-­‐specific	   cleavage	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(MassCLEAVE™,	   Sequenom®,	   San	   Diego,	   CA)	   as	   previously	   described.	   Cleavage	   products	  were	  loaded	   onto	   spectroCHIPs	   (Sequenom®)	   and	   analysed	   by	   MALDI-­‐TOF	   mass	   spectrometry	  (MassARRAY™	   Compact	   MALDI-­‐TOF,	   Sequenom®).	   Methylation	   ratios	   were	   determined	   from	  mass	  spectra	  using	  the	  Epityper	  software	  v1.0	  (Sequenom®).	  Methylation	  values	  indicated	  in	  the	  heatmap	  in	  this	  manuscript	  are	  average	  values	  of	  at	   least	  three	   independent	  experiments.	  PCR	  primers	   were	   designed	   using	   the	   Methprimer	   (Li	   and	   Dahiya	   2002)	   web	   tool	  (http://www.urogene.org/methprimer/).	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Supplementary	  Figures	  
	  
	  	   	  
Supplementary	  Figure	  S1	  Representative	  example	  of	  the	  gating	  strategy	  used	  to	  sort	  in	  vitro	  expanded	  RA-­‐	  Treg	  cells	  into	  a	  FOXP3+	  and	  a	  FOXP3-­‐	  cell	  fraction	  before	  isolation	  of	  genomic	  DNA	  for	  methylation	  analysis.	  Purity	  of	  the	  sorted	  cells	  was	  reproducibly	  >95%	  
Epigenetic	  reprogramming	  oft	  the	  RORC	  locus	  in	  in	  vitro	  expanded	  regulatory	  T	  cells	  	  




Supplementary	   Figure	   S2:	   RA+	   Treg	   do	   not	   convert	   into	   Th17	   cells	   under	   Th17-­‐
polarizing	   culture	   conditions.	   (A)	   CD45RA+	   (naïve)	   and	   CD45RA-­‐	   (memory)	   CD4+CD25-­‐	  Tconv	  cells	  were	  sorted	   from	  PBMC	  and	  cultured	   for	  14d	  under	  non-­‐polarizing	  conditions	  as	  detailed	  in	  the	  'Material	  and	  Methods'	  section.	  RORC	  mRNA	  expression	  of	  freshly	  sorted	  (d0)	  or	  
in	   vitro	   expanded	   and	   rested	   cells	   (d14)	   was	   analyzed	   by	   qRT-­‐PCR	   and	   normalized	   to	   18S	  rRNA	   expression.	   Data	   represent	  means	   +	   SD	   of	   n=4	   independent	   cultures	   set	   up	  with	   cells	  from	   4	   different	   donors.	   Asterisks	   indicate	   significant	   differences	   between	   subpopulations	  (*p<0.05,	  **p<0.01,	  paired	  two-­‐tailed	  Student's	  t-­‐test).	  (B)	  RORC	  mRNA	  expression	  in	  CD45RA+	  and	   CD45RA-­‐	   Treg	   after	   in	   vitro	   expansion	   for	   11d	   under	   non-­‐polarizing	   culture	   conditions	  followed	  by	  an	  additional	  6d	  culture	  period	  either	  under	   identical,	  non-­‐polarizing	  conditions	  (NP)	  or	  under	  Th17-­‐polarizing	  conditions	  (Th17).	   	  RORC	  mRNA	  expression	  was	  measured	  by	  qRT-­‐PCR	  and	  normalized	  to	  18S	  rRNA	  expression.	  (C)	  IL-­‐17-­‐producing	  cells	  among	  CD45RA+	  and	   CD45RA-­‐	   Treg	   cultured	   as	   detailed	   in	   (B)	   and	   stimulated	   with	   PMA/ionomycin	   in	   the	  presence	   of	   GolgiStop	   for	   an	   additional	   5	   h.	   IL-­‐17-­‐producing	   cells	   were	   determined	   by	  intracellular	  staining.	  CD4+CD25-­‐CD45RA-­‐	  Tconv	  cells	  (RA-­‐	  Tconv)	  were	  cultured	  in	  parallel	  as	  internal	   control.	   Data	   in	   (B)	   and	   (C)	   represent	   means	   +	   SD	   of	   n=4	   independent	   cultures	  established	   with	   cells	   from	   4	   different	   donors.	   Asterisks	   indicate	   significant	   differences	  between	  treatment	  groups	  (*	  p<0,05;	  **p<0.01;	  paired	  two-­‐sided	  Student's	  t-­‐test).	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3.4 	  Dominant	  Th2	  differentiation	  of	  human	  
regulatory	  T	  cells	  upon	  loss	  of	  FOXP3	  
expression	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ABSTRACT	  
	  
CD4+CD25+FOXP3+	   regulatory	   T	   cells	   (Treg)	   are	   pivotal	   for	   peripheral	   self-­‐tolerance.	   They	  prevent	   immune	   responses	   to	   auto-­‐	   and	   alloantigens	   and	   are	   thus	   under	   close	   scrutiny	   as	  cellular	  therapeutics	  for	  autoimmune	  diseases	  and	  the	  prevention	  or	  treatment	  of	  alloresponses	  after	   organ	   or	   stem	   cell	   transplantation.	  We	   previously	   showed	   that	   human	   Treg	   cells	  with	   a	  memory	  cell	  phenotype,	  but	  not	  those	  with	  a	  naïve	  phenotype,	  rapidly	  down-­‐regulate	  expression	  of	   the	   lineage-­‐defining	   transcription	   factor	   forkhead	  box	  P3	   (FOXP3)	  upon	   in	   vitro	   expansion.	  We	   now	   compared	   the	   transcriptomes	   of	   stable	   FOXP3+	   Treg	   and	   converted	   FOXP3-­‐	   'ex-­‐Treg'	  cells	  by	  applying	  a	  newly	  developed	  intranuclear	  staining	  protocol	  that	  permits	  the	  isolation	  of	  intact	   mRNA	   from	   fixed,	   permeabilized	   and	   FACS-­‐purified	   cell	   populations.	   Whole	   genome	  microarray	  analysis	  revealed	  strong	  and	  selective	  upregulation	  of	  Th2	  signature	  genes,	  including	  GATA-­‐3,	   IL-­‐4,	   IL-­‐5	  and	  IL-­‐13,	  upon	  downregulation	  of	  FOXP3.	  Th2	  differentiation	  of	  converted,	  FOXP3-­‐	  ex-­‐Treg	  cells	  occurred	  even	  under	  non-­‐polarizing	  conditions	  and	  could	  not	  be	  prevented	  by	   IL-­‐4	   signaling	   blockade.	   Thus,	   our	   studies	   identify	   Th2	   differentiation	   as	   the	   default	  developmental	  program	  of	  human	  Treg	  cells	  after	  downregulation	  of	  FOXP3.	  	  	  	   	  
Dominant	  Th2	  differentiation	  of	  human	  regulatory	  T	  cells	  upon	  loss	  of	  FOXP3	  expression	  	  
	   109	  
INTRODUCTION	  
	  
Natural	   regulatory	   T	   cells	   (Treg)	   are	   indispensable	   for	   the	   maintenance	   of	   dominant	   self-­‐tolerance	  and	  can	  suppress	  the	  activation,	  proliferation	  and	  effector	  function	  of	  a	  wide	  range	  of	  immune	  cells,	  including	  CD4+	  and	  CD8+	  T	  cells,	  natural	  killer	  and	  natural	  killer	  T	  cells,	  B	  cells	  and	  antigen	  presenting	  cells.	  They	  are	  thymus-­‐derived	  and	  characterized	  by	  the	  expression	  of	  CD4,	  CD25	  and	   the	   transcription	   factor	   forkhead	  box	  P3	   (FOXP3)	   (Sakaguchi	   et	   al.	   2008).	   FOXP3	   is	  pivotal	  for	  the	  development	  and	  function	  of	  Treg	  and	  loss	  of	  function	  mutations	  of	  FOXP3	  cause	  lethal	   autoimmune	   syndromes	   in	   mice	   and	   man	   (Brunkow	   et	   al.	   2001;	   Wildin	   et	   al.	   2001).	  During	  Treg	  development	  and	  in	  mature	  peripheral	  Treg,	  FOXP3	  represses	  many	  inflammation-­‐associated	   genes	   but	   also	   positively	   induces	   a	   gene	   expression	   profile	   that	   supports	   Treg	  function	  (Hill	  et	  al.	  2007;	  Zheng	  et	  al.	  2007).	  This	  Treg	  profile	  seems	  to	  depend	  on	  the	  strength	  and	  stability	  of	  FOXP3	  expression,	  as	  Treg	  function	  is	  partially	  lost	  in	  genetically	  modified	  mice	  that	  express	  only	  low	  Foxp3	  levels	  (Wan	  and	  Flavell	  2007).	  The	  stability	  of	  FOXP3	  expression	  is	  in	   parts	   regulated	   by	   epigenetic	   mechanisms,	   as	   shown	   by	   the	   differential	   DNA	   methylation	  pattern	  of	  the	  FOXP3	  locus	  and	  differential	  histone	  modifications	  in	  Treg	  and	  conventional	  CD4+	  T	  cells	  (Baron	  et	  al.	  2007;	  Kim	  and	  Leonard	  2007;	  Miyara	  et	  al.	  2009;	  Schmidl	  et	  al.	  2009;	  Wei	  et	  al.	  2009).	  Recent	  studies	  employing	  conditional	  Foxp3	  knock-­‐out	  mice	  revealed	  that	  peripherally	  induced	   suppressor	   cell	   populations	   do	  not	   compensate	   for	   the	   lack	   of	   Treg	   (Kim	  et	   al.	   2007;	  Kim	   et	   al.	   2009).	   Thus,	   thymus-­‐derived	   Treg	   are	   crucial	   for	   the	   preservation	   of	   peripheral	  tolerance	  and	  their	  adoptive	  transfer	  is	  a	  promising	  strategy	  for	  the	  treatment	  of	  inflammatory	  bowel	  disease	   (Mottet	  et	  al.	  2003),	  autoimmunity	   (Brusko	  et	  al.	  2008;	  Miyara	  et	  al.	  2009)	  and	  the	  prevention	  of	  alloresponses	  after	  solid	  organ	  (Nadig	  et	  al.	  2010)	  or	  stem	  cell	  transplantation	  (Hoffmann	   et	   al.	   2002a;	   Edinger	   et	   al.	   2003;	   Di	   Ianni	   et	   al.	   2011b).	   For	   such	   applications,	  we	  previously	   described	   culture	  methods	   that	   permit	   the	   100-­‐	   to	   1000-­‐fold	   expansion	   of	   human	  Treg	   in	  vitro	  within	  two	  to	  three	  weeks	  (Hoffmann	  et	  al.	  2004;	  Hoffmann	  et	  al.	  2006b).	  Yet,	  we	  and	   others	   reported	   that	   Treg	   selected	   on	   the	   basis	   of	   a	   CD4+CD25highCD127low/neg	   phenotype	  were	  heterogeneous	  with	  respect	  to	  the	  frequency	  of	  FOXP3+	  cells	  after	   in	  vitro	  expansion	  and	  we	  confirmed	  the	  down-­‐regulation	  of	  FOXP3	  in	  Treg	  clones	  (Hoffmann	  et	  al.	  2009).	  The	  loss	  of	  FOXP3	  was	   almost	   exclusively	   confined	   to	   CD45RA-­‐	  memory-­‐type	   Treg,	  while	   CD45RA+	   naive	  Treg	  homogeneously	  maintained	  FOXP3	  expression	  even	  after	  three	  weeks	  in	  culture	  (Hoffmann	  et	  al.	  2006b;	  Miyara	  et	  al.	  2009).	  Based	  on	  these	  findings,	  we	  suggested	  selecting	  CD45RA+	  Treg	  for	  the	  generation	  of	  Treg	  products	  for	  clinical	  trials,	  while	  the	  fate	  of	  CD45RA-­‐	  Treg	  after	  in	  vitro	  stimulation	   required	   further	   clarification.	   For	   this	   purpose,	   we	   now	   developed	   new	  methods	  that	   permit	   the	   isolation	   of	   intact	  mRNA	   from	   fixed,	   permeabilized	   and	   FOXP3-­‐stained,	   FACS-­‐
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sorted	   cells	   to	   compare	   the	   differential	   gene	   expression	   profiles	   in	   converted	   vs.	   stable	   Treg	  using	   whole	   genome	   microarrays.	   We	   found	   that	   Treg	   rapidly	   and	   strongly	   upregulate	   Th2	  genes	   upon	   loss	   of	   FOXP3	   expression.	   These	   findings	   were	   confirmed	   on	   protein	   level	   as	  converted	   Treg	   secrete	   high	   amounts	   of	   IL-­‐4,	   IL-­‐5	   and	   IL-­‐13,	   but	   hardly	   any	   Th1	   or	   Th17	  cytokines.	   Thus,	   using	   new	   technologies	   that	   permit	   the	   examination	   of	   human	  Treg	  with	   the	  same	   accuracy	   as	   in	   murine	   Foxp3-­‐reporter	   models,	   we	   now	   demonstrate	   the	   dominant	  conversion	   of	   human	   Treg	   into	   Th2	   cells	   upon	   in	   vitro	   stimulation.	   These	   findings	   are	   highly	  relevant	  for	  researchers	  planning	  adoptive	  cell	  therapies	  with	  in	  vitro	  expanded	  Treg.	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MATERIAL	  AND	  METHODS	  
	  
Isolation	  and	  cultivation	  of	  human	  Treg	  PBMC	  were	  isolated	  from	  leukapheresis	  products	  of	  healthy	  volunteers	  (approved	  by	  the	  Ethics	  committee	   and	   after	   their	   informed	   consent)	   by	   density	   gradient	   centrifugation.	  CD4+CD25highCD45RA+	  “naïve”	  and	  CD4+CD25highCD45RA-­‐	  “memory”	  Treg	  were	  purified	  by	  FACS	  (BD	   FACSAria,	   BD	   Biosciences,	   Heidelberg,	   Germany)	   from	   MACS	   (Miltenyi	   Biotec,	   Bergisch	  Gladbach,	  Germany)	  pre-­‐enriched	  CD25+	   cells.	  Treg	  were	   cultured	   for	  11d	  on	  huFcgR+	  murine	  feeder	   cells	   (L929	   cells)	  with	   anti-­‐CD3	   and	   anti-­‐CD28	   antibodies	   in	   the	   presence	   of	   IL-­‐2	   (300	  U/ml)	  and	  rested	  for	  additional	  3-­‐4	  d	  in	  medium	  with	  IL-­‐2,	  as	  described	  before	  (Hoffmann	  et	  al.	  2006b;	   Hoffmann	   et	   al.	   2011).	   For	   inhibition	   of	   IL-­‐4	   signaling,	   anti-­‐IL-­‐4-­‐	   (clone	  MP4-­‐25D2,	   1	  µg/ml;	   eBioscience,	   San	   Diego,	   CA;),	   anti	   IL-­‐4R-­‐	   (clone	   25463,	   500	   ng/ml;	   R&D	   Systems,	  Minneapolis,	  MN)	  or	  both	  antibodies	  were	  added	  during	  expansion	  and	  resting.	  	  	  
Intranuclear	  FOXP3	  staining	  for	  subsequent	  RNA	  extraction	  (‘ethanol/tryptone	  method’)	  Surface	  staining	  of	  CD4	  (FITC-­‐conjugate;	  BD	  Biosciences)	  was	  carried	  out	   in	  PBS/2	  %	  FCS.	  For	  FOXP3	   staining	   and	   subsequent	   RNA	   extraction,	   PBS	   with	   2	  %	   tryptone	   (Roth,	   Karlsruhe,	  Germany)	  and	  0.1	  %	  DEPC	  (Roth)	  was	  used.	  The	  buffer	  was	  autoclaved,	  cooled	  to	  4°C	  and	  used	  for	   all	   washing	   and	   incubation	   steps	   throughout	   the	   procedure	   except	   otherwise	   stated.	  Following	   surface	   staining,	   cells	  were	  washed	  once,	   resuspended	  on	  a	  vortex	   in	   ice-­‐cold	  70	  %	  ethanol	   (up	   to	   7	   x	   107	   cells	   in	   2	   ml)	   and	   fixed	   for	   15	   min	   at	   -­‐20°C,	   then	   washed	   twice	   and	  resuspended	  in	  1	  ml	  tryptone/DEPC	  buffer	  containing	  20	  µl	  rat	  serum	  (eBioscience)	  and	  20	  µl	  recombinant	  RNasin®	  ribonuclease	  inhibitor	  (20-­‐40	  U/µl;	  Promega,	  Madison,	  WI,	  USA).	  After	  5	  min	   incubation	   at	   4°C,	   50	   µl	   anti-­‐human	   FOXP3	   (APC-­‐conjugate,	   clone	   PCH101,	   eBioscience)	  were	  added	  and	  cells	  were	  incubated	  for	  another	  25	  min	  at	  4°C	  in	  the	  dark.	  Cells	  were	  washed,	  resuspended	  at	  1	  x	  107	  cells/ml	  and	  FACS-­‐sorted	  into	  tryptone/DEPC	  buffer.	  RNA	  was	  extracted	  immediately	   and	   its	   integrity	   checked	  with	   the	  RNA	  6000	  Nano	  Kit	   on	   an	  Agilent	  Bioanlayzer	  (Agilent,	  Böblingen,	  Germany).	  	  
Transcription	  factor	  and	  intracellular	  cytokine	  staining	  Cells	   were	   stimulated	   for	   5h	   with	   PMA	   (20	  ng/ml)/ionomycin	   (1	  µM)	   in	   the	   presence	   of	  GolgiStop	   (BD	   Biosciences)	   and	   stained	   using	   the	   FOXP3	   staining	   buffer	   set	   (eBioscience,	  Frankfurt,	  Germany)	  and	  the	  following	  anti-­‐human	  antibodies:	  FOXP3	  (PE-­‐,	  eFluor450-­‐	  or	  APC-­‐conjugated,	  clone	  PCH101),	  IL-­‐4	  (APC-­‐	  or	  AF488-­‐conjugated,	  clone	  8D4-­‐8),	  IL-­‐5	  (PE-­‐conjugated,	  clone	  TRFK5),	  IL-­‐13	  (FITC-­‐conjugated,	  clone	  PVM13-­‐1),	  IL-­‐17A	  (FITC-­‐	  or	  APC-­‐conjugated,	  clone	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eBio64DEC17),	   all	   from	   eBioscience,	   IFN-­‐γ	   (FITC-­‐,	   PE-­‐	   or	   APC-­‐conjugated,	   clone	   B27,	   BD	  Biosciences),	  IL-­‐10	  (AF488-­‐	  or	  APC-­‐conjugated,	  clone	  JES3-­‐9D7,	  eBioscience	  or	  clone	  JES3-­‐19F1,	  BD	   Biosciences),	   anti-­‐mouse/human	   GATA-­‐3	   (PE-­‐conjugated,	   clone	   TWAJ)	   and	   anti-­‐mouse/human	   T-­‐bet	   (AF647-­‐conjugated,	   clone	   eBio4B10),	   both	   from	   eBioscience.	   Data	   were	  acquired	   on	   a	   BD	   LSRII	   or	   FACSCalibur	   (BD	   Biosciences)	   and	   analyzed	  with	   FlowJo	   software	  (Treestar	  Inc,	  Ashland,	  OR,	  USA).	  	  
RNA	  extraction	  RNA	  was	  isolated	  from	  FACS	  sorted	  cells	  using	  the	  RNeasy	  Micro	  Kit	  (Qiagen,	  Hilden,	  Germany)	  or	  TRizol®	  Reagent	  (Invitrogen,	  Darmstadt,	  Germany).	  When	  RNA	  was	  extracted	  from	  less	  than	  1	  x	   106	   cells,	   glycogen	   (Roche	   GmbH,	   Mannheim,	   Germany)	   was	   added	   during	   the	   TRizol®	  procedure.	  	  
Microarray	  analysis	  of	  gene	  expression	  	  RNA	   preparations	   from	   FOXP3-­‐sorted	   CD4+CD25highCD45RA-­‐	   	   Treg	   from	   five	   donors	   were	  analyzed	  using	  Whole	  Human	  Genome	  Oligo	  Microarrays	   (Agilent).	  Labeling	  and	  hybridization	  were	   performed	   using	   the	   Agilent	   Gene	   Expression	   system	   according	   to	   the	   manufacturer’s	  instructions.	   In	   brief,	   50	   to	   200	   ng	   of	   high-­‐quality	   RNA	   were	   amplified	   and	   Cyanine	   3-­‐CTP	  labeled	  with	  the	  One	  Color	  Low	  Input	  Quick	  Amp	  Labeling	  Kit	  (Agilent).	  	  Sixhundred	  ng	  labeled	  cRNA	  were	  fragmented	  and	  hybridized	  on	  the	  Whole	  Human	  Genome	  Expression	  Array	  G4851A	  (8x60K,	   Agilent).	   Images	   were	   scanned	   using	   a	   DNA	   microarray	   scanner,	   processed	   using	  Feature	   Extraction	   Software	   and	   further	   analyzed	   using	   GeneSpring	   GX	   (all	   from	   Agilent).	  Fluorescence	   signals	   were	   normalized	   to	   the	   75th	   percentile	   and	   baseline	   transformed	   to	   the	  median	  of	  all	  samples.	  Features	  were	  discarded	  which	  did	  not	  have	  a	  minimum	  raw	  expression-­‐value	  of	  40	  in	  at	  least	  3	  out	  of	  10	  samples.	  Different	  microarray	  probes	  covering	  the	  same	  gene	  were	  combined	  using	  the	  gene-­‐level	  technology	  of	  the	  GeneSpring	  GX	  software.	  Expression	  data	  for	   the	   donor-­‐matched	   comparisons	   of	   variance	   (Supplemental	   Fig.	   2)	   were	   percentile	  normalized	   as	   above,	   but	   not	   baseline	   transformed.	   Microarray	   data	   are	   available	   from	   the	  NCBI/GEO	  repository	  (GSE26190;	  	  http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=zfsphaacqwosqds&acc=GSE26190).	  	  
Quantitative	  RT-­‐PCR	  RNA	   was	   transcribed	   into	   cDNA	   with	   Reverse	   Transcriptase	   (Promega)	   and	   analyzed	   on	   an	  Eppendorf	   Realplex4	   S	   Cycler.	   Messenger	   RNA	   expression	   levels	   were	   normalized	   to	   Beta-­‐2-­‐
Microglobulin	  (B2M)	  or	  18S	  RNA.	  Primer	  sequences	  are	  listed	  in	  Supplemental	  Table	  1.	  	  
Western	  blot	  analysis	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For	  preparation	  of	  whole	  cell	  extracts	  1-­‐5	  x	  106	  cells	  were	  washed	  with	  PBS,	  pelleted,	  dissolved	  in	  100	  μl	  of	  2x	  SDS	  sample	  buffer	  with	  complete	  protease-­‐	  and	  phosphatase	  inhibitors	  (Roche)	  per	   5	   x	   106	   cells	   ,	   heated	   at	   95°C	   for	   10	   min	   and	   vortexed	   for	   1	  min.	   For	   western	   blots,	  equivalents	   of	   0.5-­‐0.75	   x	   106	   cells	   were	   separated	   by	   SDS-­‐PAGE	   and	   blotted	   on	   PVDF	  membranes,	   followed	  by	  blocking	  (1	  h	  at	  RT	  withTris-­‐buffered	  saline/5	  %	  milk	  powder/0.1	  %	  Tween	   20)	   and	   probing	   with	   polyclonal	   rabbit	   anti-­‐human	   STAT6	   (#9362;	   Cell	   Signaling	  Technology,	   Frankfurt,	   Germany)	   or	   anti-­‐human	   phospho-­‐STAT6	   antibodies	   (Tyr641,	   #9361,	  Cell	   Signaling	   Technology)	   at	   4°C	   overnight.	   Blots	   were	   washed	   and	   incubated	   with	   alkaline	  phosphatase-­‐conjugated	   goat	   anti-­‐rabbit	   antibody	   (Dako	   Cytomation,	   Hamburg,	   Germany).	  Bands	   were	   visualized	   with	   ECL	   solution	   on	   Hyperfilm,	   scanned	   using	   a	   Molecular	   Dynamics	  personal	  densitometer	  SI	  and	  quantified	  with	  ImageQuant	  5.2	  (all	  from	  GE	  Healthcare).	  	  
Cytokine	  detection	  in	  culture	  supernatants	  Supernatants	  were	  collected	  on	  d	  11	  of	  Treg	  cultures.	  Concentrations	  of	  IL-­‐4,	  IL-­‐5,	  IL-­‐13,	  IL-­‐10,	  IL-­‐17	   and	   IFN-­‐γ	   were	   determined	   using	   Cytokine	   Bead	   Array	   Flex-­‐Sets	   (BD	   Bioscience)	  according	  to	  the	  manufacturer’s	  instructions.	  	  
Statistical	  analysis	  Statistical	   significance	   was	   determined	   by	   paired	   or	   unpaired	   two-­‐tailed	   Student’s	   t-­‐test,	   as	  indicated	  in	  figure	  legends.	  A	  p-­‐value	  ≤	  0.05	  was	  considered	  significant.	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RESULTS	  	  
Isolation	  of	  intact	  RNA	  from	  FACS-­‐sorted	  cells	  after	  intranuclear	  FOXP3	  staining	  There	   is	   increasing	   evidence	   for	   plasticity	  within	   the	   Treg	   lineage,	  which	   includes	   the	   loss	   of	  FOXP3	  and	  the	  conversion	  of	  Treg	  into	  potentially	  pro-­‐inflammatory	  T	  helper	  cell	  subsets	  (Xu	  et	  al.	   2007;	   Komatsu	   et	   al.	   2009;	   Zhou	   et	   al.	   2009c;	   Schmidl	   et	   al.	   2011).	   The	   study	   of	   gene	  expression	  patterns	  in	  FOXP3-­‐losing	  Treg	  could	  extend	  our	  understanding	  of	  this	  plasticity	  and	  reveal	   the	   underlying	  molecular	  mechanisms.	  However,	   paraformaldehyde	   (PFA)	   contained	   in	  commercially	  available	  FOXP3	  staining	  kits	  induces	  conformational	  changes	  and	  covalent	  as	  well	  as	   non-­‐covalent	   cross-­‐links	   in	   nucleic	   acids	   and	   proteins	   and	   thus	   impedes	   the	   subsequent	  extraction	  of	  intact	  RNA.	  We	  therefore	  established	  an	  alternative	  FOXP3	  staining	  method	  using	  70	  %	  ethanol	   for	   fixation	  and	  permeabilization	   that	  does	  not	   induce	  such	  cross-­‐links	  and	   thus	  allows	   the	   extraction	   of	   intact	   high-­‐quality	   RNA.	   Staining	   for	   FOXP3	   and	   subsequent	   flow	  cytometric	   sorting	   was	   carried	   out	   in	   tryptone-­‐	   and	   RNase	   inhibitor-­‐containing	   PBS.	   Both	  additives	   were	   essential	   for	   maintaining	   RNA	   integrity	   during	   the	   staining	   and	   sorting	  procedure.	   The	   frequencies	   of	   FOXP3+	   cells	   among	   in	   vitro	   expanded	   CD45RA-­‐	   Treg	   detected	  with	   this	   protocol	   were	   comparable	   to	   those	   obtained	  with	   a	   commercial	   FOXP3	   staining	   kit	  (Fig.	  1A;	   divergence	   ranged	   from	   -­‐10.6	   %	   to	   +	   5.7	   %;	   n=4).	   FACS-­‐separated	   populations	  routinely	  showed	  >	  95	  %	  purity	  upon	  re-­‐analysis	  (96.9	  ±	  1.2	  %	  for	  FOXP3+	  and	  98.1	  ±	  0.9	  %	  for	  FOXP3-­‐	   cells,	   respectively,	   n=5;	   see	   also	   Supplemental	   Fig.	  1).	  RNA	  extracted	   from	  sorted	   cells	  displayed	   little	   or	   no	   signs	   of	   degradation	   (Fig.	  1B)	   and	   mean	   RNA	   integrity	   numbers	   (RIN)	  (Schroeder	  et	  al.	  2006)	  were	  7.9	  (range:	  7.3-­‐9.0;	  n=14)	  in	  fixed	  samples	  and	  9.4	  (range:9.2-­‐9.5;	  n=5)	  in	  unfixed	  controls.	  RNA	  yield	  and	  quality	  depended	  on	  the	  time	  span	  between	  fixation	  and	  cell	  lysis	  for	  RNA	  extraction:	  best	  results	  were	  obtained	  by	  keeping	  preparation	  times	  short	  and	  samples	   cold	   and	   RNase-­‐free.	   Thus,	   this	   PFA-­‐free	   FOXP3	   staining	   protocol	   (referred	   to	   as	  “ethanol/tryptone	   method”)	   allowed	   the	   reliable	   extraction	   of	   largely	   intact	   RNA	   from	  intranuclearly	  stained	  and	  FACS-­‐sorted	  cells.	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In	  vitro	  expanded	  CD45RA-­‐	  Treg	  show	  a	  Th2	  gene	  expression	  signature	  upon	  loss	  of	  FOXP3	  
expression	  We	  previously	  showed	  that	  FOXP3	  expression	  is	  primarily	  lost	  in	  CD45RA-­‐	  “memory”	  Treg	  after	  
in	  vitro	  stimulation	  (Hoffmann	  et	  al.	  2006b;	  Hoffmann	  et	  al.	  2009).	  To	  analyze	  the	  fate	  of	  FOXP3-­‐losing	  memory	   Treg	   on	   the	   level	   of	   gene	   expression,	   FACS-­‐sorted	   CD4+CD25highCD45RA-­‐	   Treg	  were	   in	  vitro	  expanded	  and	  subsequently	  sorted	  into	  FOXP3+	  and	  FOXP3-­‐	  populations	  applying	  the	  ethanol/tryptone	  method.	  RNA	  was	  extracted	  and	  analyzed	  using	  whole	  genome	  expression	  microarrays.	  Combined	  results	  of	  five	  independent	  experiments	  are	  presented	  as	  heatmaps	  for	  selected	  gene	  classes	  in	  Fig.	  2A.	  Detailed	  mRNA	  expression	  levels	  of	  individual	  cell	  cultures	  can	  be	  found	  in	  Supplemental	  Fig.	  2.	  	  






















Isolation	  of	  intact	  RNA	  from	  human	  T	  cells	  after	  intranuclear	  staining	  for	  FOXP3	  
(A)	   In	   vitro	   expanded	   CD45RA-­‐	   Treg	   were	   stained	   for	   FOXP3	   using	   either	   a	   commercially	  available	   FOXP3	   staining	   kit	   (left)	   or	   the	   ethanol-­‐tryptone	   method	   (right).	   Plots	   are	  representative	   of	   n=4	   independent	   experiments.	   Numbers	   indicate	   percentages	   of	   cells.	   (B)	  Electropherograms	  of	  RNA	  extracted	   from	  expanded	  human	  CD45RA-­‐	  Treg.	  Cells	  were	  either	  stained	   for	   FOXP3	   using	   the	   ethanol/tryptone	  method	   and	   separated	   by	   FACS	   (left;	   FOXP3-­‐	  population;	   representative	   of	   n=14	   independent	   RNA	   preparations)	   or	   remained	   unfixed	  before	   RNA	   extraction	   (right;	   representative	   of	   n=5	   independent	   preparations).	   RIN:	   RNA	  Integrity	  Number.	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As	  expected,	  we	  observed	  significantly	  higher	  mRNA	  levels	  of	  Treg	  signature	  genes	  (e.g.	  FOXP3,	  
CTLA4,	   IL2RA)	   in	   the	   FOXP3+	   as	   compared	   to	   the	   corresponding	   FOXP3-­‐population.	   Yet	  surprisingly,	  a	  dramatic	  increase	  of	  Th2	  cytokine	  mRNA	  (IL4,	  IL5,	  IL13)	  was	  detected	  in	  FOXP3-­‐	  cells,	  but	  no	  significant	  difference	  between	  the	  two	  subpopulations	  with	  respect	  to	  other	  Th	  cell	  lineage-­‐	  and	  inflammation-­‐associated	  cytokine	  genes	  (IFNG,	  IL6,	  IL9,	  IL10,	  IL12,	  IL17,	  IL21,	  IL23,	  
IL24).	   Likewise,	   key	   transcription	   factors	   for	   Th2	   differentiation,	   namely	   GATA3	   and	   GFI1,	  showed	  a	   significantly	  higher	  expression	   in	  FOXP3-­‐	   cells,	  whereas	   the	  genes	  RORC	   and	  STAT1,	  responsible	  for	  Th17	  and	  Th1	  lineage	  commitment,	  respectively,	  were	  suppressed.	   In	  addition,	  FOXP3-­‐	  cells	  highly	  expressed	  GPR44,	  also	  known	  as	  CRTH2,	  which	  encodes	  the	  Th2	  cell-­‐specific	  G	   protein-­‐coupled	   receptor	   CD294	   (Cosmi	   et	   al.	   2000)	   (Fig.	   2A).	   Thus,	   the	   FOXP3-­‐	   population	  showed	   a	   gene	   signature	   dominated	   by	   Th2	   lineage-­‐associated	   genes	   including	   cytokines,	  transcription	  factors,	  signaling	  molecules	  and	  cell	  surface	  receptors.	  Since	  STAT6	  is	  critically	  involved	  in	  IL-­‐4-­‐induced	  Th2	  development	  (Kaplan	  et	  al.	  1996),	  we	  also	  asked	  whether	  the	  expression	  of	  typical	  STAT6	  target	  genes	  (including	  LTB,	  SOCS1,	  IRF8)	  would	  be	  altered	  during	  Treg	   conversion.	   Interestingly,	   their	   expression	   levels	  were	  not	   significantly	  different	  between	  FOXP3+	  and	  FOXP3-­‐	  populations,	  neither	  was	   that	  of	  MAF	   encoding	  a	   trans-­‐activator	  of	  the	  IL-­‐4	  gene	  (Lin	  et	  al.	  2010a).	  Microarray	   data	  were	   validated	   at	   the	   single	   gene	   level	   using	   qRT-­‐PCR	   (Fig.	   2B).	   As	   controls,	  RNA	   isolated	   from	  in	  vitro	  expanded,	  FOXP3-­‐stained	  and	  sorted	  CD45RA+	  Treg	  as	  well	  as	   from	  expanded	   bulk	   CD45RA-­‐	   Treg	   without	   prior	   fixation	   were	   analyzed	   (Fig.	   2B).	   As	   expected,	  FOXP3+	  cells	  from	  cultures	  of	  CD45RA-­‐	  and	  CD45RA+	  Treg	  showed	  comparably	  high	  FOXP3	  and	  low	   GATA3	   mRNA	   expression.	   When	   total	   CD45RA-­‐	   unfixed	   cells	   were	   compared	   to	  ethanol/tryptone-­‐fixed	   subpopulations,	   they	   mainly	   showed	   intermediate	   mRNA	   expression,	  confirming	  the	  reliability	  of	  the	  RNA	  preparation	  procedure	  (Fig.	  2B).	  Taken	  together,	  the	  gene	  expression	  profile	  of	  FOXP3-­‐	  cells	  developing	  from	  initially	  FOXP3+	  CD45RA-­‐	  Treg	  upon	   in	  vitro	  stimulation	  indicated	  Th2	  differentiation.	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Figure	  2:	  Transcriptome	  analysis	  of	  human	  FOXP3-­‐sorted	  CD45RA-­‐	  Treg	  (A)	  Relative	  gene	  expression	   levels	  of	  selected	  gene	  classes	  of	  FOXP3-­‐sorted	  CD45RA-­‐	  Treg	  of	   five	   independent	  donors	  (microarray	  data	  normalized	  to	  the	  median	  of	  all	  samples)	  are	  presented	  in	  heatmaps	  by	  a	  pseudo-­‐color	   scale	  as	   indicated.	  Data	  were	   filtered	  as	  described	   in	   the	  methods	  section.	  Genes	   that	   showed	   significant	   expression	   differences	   between	   FOXP3+	   and	   FOXP3-­‐	  subpopulations	  (paired	  Student’s	  t-­‐test,	  asymptotic	  p-­‐value	  computation,	  cut-­‐off	  p≤0.05)	  with	  a	  fold-­‐change	  of	  ≥2	  are	  marked	  by	  an	  asterisk.	  For	  detailed	  gene	  expression	  levels	  of	  selected	  genes	   in	   individual	   Treg	   cultures	   see	   Supplemental	   Fig.	   2.	   (B)	   Microarray	   results	   were	  validated	  by	  qRT-­‐PCR	   for	   the	   indicated	  genes	   in	  FOXP3+	   (blue	  bars)	  and	  FOXP3-­‐	   cells	   (green	  bars)	  derived	  from	  CD45RA-­‐	  Treg	  cultures.	  FOXP3+	  cells	  sorted	  from	  expanded	  CD45RA+	  Treg	  (red	  bars)	  and	  unsorted	  CD45RA-­‐	  Treg	  (gray	  bars)	  served	  as	  controls.	  Values	  represent	  means	  +SD	  (n≥3).	  Significant	  differences	  in	  gene	  expression	  between	  FOXP3+	  and	  FOXP3-­‐	  cells	  derived	  from	   the	  CD45RA-­‐	  Treg	   population	   are	   indicated	   above	  bars	   (*p≤0.05,	   **p≤0.01,	   ***p≤0.001,	  paired	  two-­‐tailed	  Student’s	  t-­‐test).	  ND:	  not	  detected.	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Figure	   3:	   CD45RA-­‐	   Treg	   predominantly	   produce	   Th2	   cytokines	   upon	   loss	   of	   FOXP3	  
expression.	   CD45RA-­‐	   Treg,	   either	   ex	   vivo	   (d	   0)	   or	   after	   in	   vitro	   expansion	   (d	   15),	   were	  stimulated	   for	   5h	   with	   PMA/ionomycin	   and	   stained	   for	   FOXP3	   and	   various	   cytokines.	   (A)	  Percentages	  of	  CD45RA-­‐	  Treg	  producing	   the	   indicated	  cytokines.	   IL-­‐5	  was	  not	  determined	  ex	  
vivo.	   Horizontal	   bars	   represent	   means	   of	   n=3-­‐17	   independent	   analyses	   with	   cells	   from	  different	   donors.	   ***	   p≤0.001	   as	   compared	   to	   the	   number	   of	   IL-­‐4	   producers;	   two-­‐tailed	  unpaired	  Student's	  t-­‐test.	  (B)	  Proportion	  of	  FOXP3-­‐expressing	  cells	  among	  indicated	  cytokine	  producers	   after	   in	   vitro	   expansion.	   Horizontal	   bars	   represent	  means	   of	   n=9-­‐17	   independent	  analyses.	   *	   p≤0.05,	   ***	   p≤0.001	   as	   compared	   to	   the	   number	   of	   FOXP3+	   cells	   among	   IL-­‐4	  producers;	  two-­‐tailed	  unpaired	  Student's	  t-­‐test.	  	  (C)	  Representative	  example	  of	  IL-­‐4-­‐	  and	  IL13-­‐producing	  cells	  among	  CD45RA-­‐	  Treg	  ex	  vivo	  (d	  0)	  and	  after	  in	  vitro	  expansion	  (d	  15).	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FOXP3-­‐	  cells	  from	  CD45RA-­‐	  Treg	  cultures	  predominantly	  produce	  Th2	  cytokines	  To	  correlate	  the	  mRNA	  expression	  data	  with	  cytokine	  production,	  freshly	  isolated	  as	  well	  as	   in	  
vitro	  expanded	  CD45RA-­‐	  and	  CD45RA+	  Treg	  were	  stained	  for	  FOXP3	  and	  Th	  cell	  lineage-­‐defining	  cytokines	   (Fig.	   3).	   In	   freshly	   isolated	   cells	   the	   expression	   frequency	   for	   one	   or	   more	   Th	   cell	  lineage	   signature	   cytokines	   (IL-­‐4,	   IL-­‐10,	   IL-­‐13,	   IFN-­‐γ,	   IL-­‐17)	   never	   exceeded	   5	  %.	   In	   contrast,	  after	  in	  vitro	  expansion	  approximately	  30	  %	  of	  the	  cells	  within	  CD45RA-­‐	  Treg	  cultures	  started	  to	  produce	   one	   or	   more	   of	   the	   Th2	   cytokines	   IL-­‐4,	   IL-­‐5	   and	   IL-­‐13	   (Fig.	   3A).	   Although	   we	   also	  detected	  IFN-­‐γ+	  and/or	  IL-­‐17+	  cells	   in	  these	  cultures	  (as	  previously	  described	  by	  us	  and	  others	  (Ayyoub	  et	  al.	  2009;	  Hoffmann	  et	  al.	  2009;	  McClymont	  et	  al.	  2011;	  Schmidl	  et	  al.	  2011)),	   their	  frequencies	  were	   significantly	   lower	   than	   those	   of	   the	   Th2	   cytokine	   producers	   (Fig.	   3A).	   Th2	  cytokine	  production	  was	  largely	  confined	  to	  the	  FOXP3-­‐	  subpopulation,	  whereas	  IFN-­‐γ,	  IL-­‐10	  and	  IL-­‐17	   producers	  were	   almost	   equally	   distributed	   between	   FOXP3+	   and	   FOXP3-­‐	   cells	   (Fig.	   3B).	  Confirming	   our	   previous	   findings,	   CD45RA+	   Treg	   remained	   uniformly	   FOXP3+	   and	   comprised	  hardly	  any	  cytokine	  producing	  cells	  before	  and	  after	  in	  vitro	  expansion	  ((Hoffmann	  et	  al.	  2006b;	  Hoffmann	  et	  al.	  2009)	  and	  data	  not	  shown).	  	  
	  
	  
Th2	  cytokine	  production	  in	  expanded	  CD45RA-­‐	  Treg	  is	  associated	  with	  high	  GATA-­‐3	  expression	  
GATA3,	  the	  lineage-­‐defining	  transcription	  factor	  for	  Th2	  cells,	  was	  highly	  expressed	  in	  CD45RA-­‐	  Treg	   that	   had	   downregulated	   FOXP3	   upon	   in	   vitro	   stimulation	   (Fig.	   2).	   To	   analyze	   whether	  
GATA3	   expression	  was	   restricted	   to	   Th2	   cytokine	   producers,	   in	  vitro	   expanded	   CD45RA-­‐	   Treg	  were	   simultaneously	   stained	   for	   cytokine	   production	   and	   the	   presence	   of	   GATA-­‐3.	   GATA-­‐3	  














































Th2	   cytokine	   production	   in	   in	   vitro	   expanded	   CD45RA-­‐	   Treg	   is	   associated	   with	   high	  
GATA-­‐3	   expression.	   In	   vitro	   expanded	   CD45RA-­‐	   Treg	   were	   stimulated	   for	   5h	   with	  PMA/ionomycin,	   then	   stained	   for	   GATA-­‐3	   and	   indicated	   cytokines.	   The	   histogram	   shows	  GATA-­‐3	   expression	   of	   IL-­‐4+,	   IL-­‐17+	   or	   IFN-­‐γ+	   cells,	   respectively.	   MFI	   for	   GATA-­‐3	   was	  significantly	   different	   between	   IL-­‐4+	   and	   IFN-­‐γ+	   cells	   (p=0.046;	   n=6;	   two-­‐tailed	   unpaired	  Student's	  t-­‐test)	  as	  well	  as	  IL-­‐4+	  and	  IL-­‐17+	  cells	  (p=0.009;	  n=5;	  two-­‐tailed	  unpaired	  Student's	  
t-­‐test).	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expression	  was	  significantly	  higher	   in	   IL-­‐4	  producing	  cells	  when	  compared	   to	   IL-­‐17	  and	   IFN-­‐γ	  producers	  (Fig.	  4).	  	  
Inhibition	  of	  IL-­‐4	  signaling	  does	  not	  block	  Th2	  differentiation	  in	  CD45RA-­‐	  Treg	  	  Th2	  differentiation	  from	  naive	  conventional	  T	  cells	  is	  mainly	  driven	  by	  IL-­‐4	  (Kaplan	  et	  al.	  1996).	  Since	   CD45RA-­‐	   Treg	   secreted	   IL-­‐4	   and	   other	   Th2	   cytokines	   under	   the	   non-­‐polarizing	   culture	  conditions	  applied	  in	  this	  study,	  we	  next	  asked	  to	  which	  extent	  endogenous	  IL-­‐4	  supported	  the	  conversion	  of	  initially	  FOXP3+	  Treg	  into	  cells	  of	  the	  Th2	  lineage.	  To	  block	  IL-­‐4	  signaling,	  CD45RA-­‐	  Treg	  were	  cultured	  in	  the	  presence	  of	  anti-­‐IL-­‐4-­‐antibodies,	  anti-­‐IL-­‐4R-­‐antibodies	  or	  both	  during	  the	   entire	   expansion	   period.	   The	   treatment	   effectively	   prevented	   phosphorylation	   of	   the	  transcription	  factor	  signal	  transducer	  and	  activator	  of	  transcription	  6	  (STAT6),	  a	  crucial	  step	  in	  IL-­‐4	  signaling	  and	  Th2	  induction	  (Fig.	  5A	  &	  B).	  However,	  despite	  profound	  inhibition	  of	  STAT6	  activation,	   the	   frequencies	   of	   cytokine	   secreting	   cells	   in	   CD45RA-­‐	   Treg	   cultures	   were	   only	  marginally	   altered,	   with	   a	   slight	   but	   not	   statistically	   significant	   reduction	   of	   Th2	   cytokine	  producers	  and	  a	  minor,	  statistically	  insignificant	  increase	  in	  IFN-­‐γ-­‐	  or	  IL-­‐17-­‐secreting	  cells	  (Fig.	  5C	   &	   D).	   In	   line	   with	   these	   findings,	   cytokine	   concentrations	   in	   supernatants	   of	   blocked	   and	  unblocked	   cultures	   showed	   no	   significant	   differences,	   except	   for	   IL-­‐4,	   because	   IL-­‐4	  neutralization	  by	  anti-­‐IL-­‐4-­‐antibodies	  expectedly	  reduced	  IL-­‐4	   levels,	  while	  blockade	  of	   the	   IL-­‐4R	   increased	   IL-­‐4	   concentrations,	   proving	   that	   IL-­‐4	   is	   consumed	   in	   such	   cultures	   (Fig.	   5E).	  Overall,	   these	   data	   indicate	   that	   Th2	   differentiation	   of	   CD45RA-­‐	   Treg	   cells	   does	   not	   require	  endogenous	  IL-­‐4	  but	  seems	  to	  represent	  the	  default	  developmental	  pathway	  upon	  loss	  of	  FOXP3.	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Figure	  5	  
Inhibition	  of	  IL-­‐4	  signaling	  does	  not	  block	  Th2	  differentiation	  of	  CD45RA-­‐	  Treg	  during	  
in	   vitro	   expansion.	   CD45RA-­‐	  Treg	  were	   expanded	   in	   the	  presence	  or	   absence	  of	   anti-­‐IL-­‐4,	  anti-­‐IL-­‐4R	  or	  both	  antibodies.	  (A)	  Phosphorylated	  STAT6	  (pSTAT6)	  in	  whole	  cell	  extracts	  was	  analyzed	   by	   western	   blot.	   Total	   STAT6	   was	   analyzed	   as	   a	   loading	   control.	   Shown	   is	   one	  representative	   immunostaining	   (n=3).	   (B)	   Western	   blot	   band	   intensities	   were	   quantified	  with	   a	   densitometer.	   Phospho-­‐STAT6	   band	   intensities	   of	   unblocked	   cultures	   were	   set	   to	  100%.	  Values	  represent	  means	  +	  SD	  (***	  p≤0.001;	  n=3;	  two-­‐tailed	  unpaired	  Student's	  t-­‐test	  performed	   with	   absolute	   values).	   (C)	   and	   (D)	   Cells	   were	   stimulated	   for	   5	   h	   with	  PMA/ionomycin,	  then	  stained	  for	  FOXP3	  and	  indicated	  cytokines.	  Dot	  plots	   in	  (C)	  show	  one	  representative	   experiment.	   Bars	   in	   (D)	   represent	   mean	   percentages	   +	   SD	   of	   cytokine	  producers	   among	   expanded	   CD45RA-­‐	   Treg.	   For	   better	   comparison	   of	   n=5-­‐9	   individual	  cultures,	  the	  numbers	  of	  cytokine-­‐producing	  cells	  in	  unblocked	  cultures	  were	  scaled	  to	  100%.	  Unblocked	   cultures	   contained	   on	   average	   29.1%,	   15.5%	   and	   26.4%	   IL-­‐4,	   IL-­‐5	   and	   IL-­‐13	  producers,	   respectively,	   and	   	   9.3%,	   9.9%	   and	   7.1%	   IL-­‐10,	   IFN-­‐γ	   and	   IL-­‐17	   producers,	  respectively.	   (E)	   Supernatants	   from	   treated	   or	   untreated	   CD45RA-­‐	   Treg	   cultures	   were	  analyzed	  for	  cytokine	  content	  on	  d11	  of	  in	  vitro	  expansion.	  Bars	  represent	  means	  +	  SD	  of	  n=5-­‐9	   independent	   cultures.	   *	   p≤0.05,	   **	  p≤0.01	   as	   compared	   to	   unblocked	   cultures;	   two-­‐tailed	  unpaired	  Student's	  t-­‐test	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DISCUSSION	  
There	   is	   increasing	  evidence	   that	  Treg	   lineage	   commitment	  may	  not	  be	   irreversible,	   as	  down-­‐regulation	  of	  FOXP3	  and	  consecutive	  expression	  of	  Th1	  and	  Th2	  cytokines	  by	  Treg	  cells	  has	  been	  observed	  by	  several	  groups.	  (Ayyoub	  et	  al.	  2009;	  Beriou	  et	  al.	  2009;	  Zhou	  et	  al.	  2009a;	  Zhou	  et	  al.	  2009c;	  Zhu	  and	  Paul	  2010;	  Schmidl	  et	  al.	  2011).	  We	  showed	  that	  in	  particular	  human	  CD45RA-­‐	  memory-­‐type	  Treg	  lose	  FOXP3	  expression	  upon	  in	  vitro	  stimulation,	  while	  CD45RA+	  naïve	  Treg	  maintain	   high	   FOXP3	   levels	   even	   after	   extended	   culture	   periods.	   Importantly,	   both	   FACS-­‐purified	   starting	   populations	   contained	   equivalent	   frequencies	   of	   FOXP3+	   cells	   before	   in	   vitro	  stimulation	  (>93%)	  and	  both	  showed	  equally	  homogeneous	  demethylation	  at	  the	  Treg-­‐specific	  demethylated	   region	   (TSDR),	   a	   sensitive	   epigenetic	   mark	   for	   the	   identification	   of	   Treg	   and	  currently	  the	  most	  reliable	  marker	  for	  the	  exclusion	  of	  contaminations	  by	  induced-­‐	  or	  non-­‐Treg	  (Baron	   et	   al.	   2007;	   Schmidl	   et	   al.	   2009;	   Hansmann	   et	   al.	   2010).	   Furthermore,	   we	   ultimately	  proved	  loss	  of	  FOXP3	  expression	  by	  the	  serial	  examination	  of	  human	  Treg	  clones	  in	  our	  previous	  studies	  (Hoffmann	  et	  al.	  2009).	  Since	  Treg	  instability	  may	  be	  detrimental	  for	  future	  adoptive	  cell	  therapies	   (or	   those	   already	   underway	   at	   some	   centers	   (Brunstein	   et	   al.	   2011a;	   Di	   Ianni	   et	   al.	  2011b)),	  we	  now	  examined	  the	  fate	  of	  Treg	  that	   lose	  FOXP3	  upon	   in	  vitro	  stimulation.	  For	  this	  purpose,	  we	  developed	  a	  cell	  fixation	  and	  permeabilization	  protocol	  that	  allowed	  the	  isolation	  of	  intact	   mRNA	   from	   FOXP3-­‐stained	   and	   FACS-­‐sorted	   cells.	   In	   contrast	   to	   previously	   described	  methods	  (Boniface	  et	  al.	  2010),	  the	  isolated	  RNA	  was	  not	  degraded	  but	  of	  high	  quality	  and	  suited	  for	   sensitive	   downstream	   assays,	   such	   as	   qRT-­‐PCR	   and	   microarray	   based	   whole	   genome	  expression	  analyses.	  The	  use	  of	  ethanol	  for	  fixation	  prevented	  the	  cross-­‐linking	  of	  nucleic	  acids	  and	  proteins	   (Fowler	  et	  al.	  2008)	   that	   is	  caused	  by	  PFA	  contained	   in	  commercial	   staining	  kits.	  Furthermore,	  our	  method	  improves	  previously	  described	  RNA	  isolation	  protocols	  developed	  by	  Esser	   and	   colleagues	   (Esser	   et	   al.	   1995),	   because	   it	   permits	   the	   simultaneous	   detection	   of	  fluorescently	   labelled	   surface	  markers.	   Since	   this	   technology	   is	   applicable	   to	   a	  wide	  variety	  of	  transcription	  factors	  and	  cell	  types,	  it	  may	  advance	  many	  areas	  in	  cellular	  biology.	  	  Classical	  differentiation	  of	  naive	  CD4+	  T	  cells	  into	  Th1	  or	  Th2	  cells	  is	  mainly	  induced	  by	  the	  local	  cytokine	   milieu	   as	   well	   as	   the	   type	   of	   antigen	   and	   antigen	   presenting	   cell.	   IFN-­‐γ	   and	   IL-­‐12	  polarize	   toward	   Th1	   differentiation	   via	   the	   transcription	   factors	   STAT4,	   STAT1	   and	   T-­‐bet	  (Lighvani	   et	   al.	   2001;	   Thieu	   et	   al.	   2008).	   Th2	   cells	   are	   induced	   by	   IL-­‐4	   that	   induces	   GATA-­‐3,	  usually	  in	  a	  STAT6-­‐dependent	  fashion	  and	  the	  hallmark	  of	  Th2	  cells	  is	  their	  secretion	  of	  IL-­‐4,	  IL-­‐5	  and	  IL-­‐13	  (Shimoda	  et	  al.	  1996;	  Takeda	  et	  al.	  1996;	  Zheng	  and	  Flavell	  1997;	  Zhu	  et	  al.	  2004).	  T-­‐bet	  and	  GATA-­‐3	  reciprocally	  repress	  each	  other	  (Szabo	  et	  al.	  1997;	  Kurata	  et	  al.	  1999;	  Djuretic	  et	  al.	  2007b)	  and	  FOXP3	  in	  Treg	  is	  supposed	  to	  prohibit	  expression	  of	  both	  these	  lineage	  defining	  transcription	  factors	  (Zheng	  and	  Rudensky	  2007).	  Nevertheless,	  co-­‐expression	  of	  Foxp3	  and	  T-­‐bet	  has	  been	  observed	   in	  activated	  murine	  Treg	  under	   type	  1	   inflammatory	   conditions,	  which	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permits	  their	  migration	  to	  inflammatory	  sites,	  but	  does	  not	  induce	  Th1	  cytokine	  secretion	  (Koch	  et	   al.	   2009).	   Our	   comparative	   analysis	   of	   human	   CD45RA-­‐	  memory	   Treg-­‐derived	   FOXP3+	   and	  FOXP3-­‐	   subpopulations	  now	   revealed	   that	   typical	  marker	   genes	  of	  Treg,	   such	   as	  CTLA4,	  LAG3,	  
IL2RA,	  LGALS3	  and	  LRRC32	  are	  down-­‐regulated	  upon	  loss	  of	  FOXP3	  expression,	  while	  IL7R	  and	  
CD40LG,	  usually	  not	  expressed	  by	  Treg,	  are	  up-­‐regulated.	  More	  strikingly,	  the	  cells	  losing	  FOXP3	  upon	   in	  vitro	  stimulation	  under	  non-­‐polarizing	  conditions	  converted	  into	  Th2-­‐like	  cells	  as	  they	  started	  to	  overexpress	  a	  number	  of	  Th2-­‐specific	  genes,	  such	  as	  the	  signature	  cytokines	  IL4,	  IL5	  and	  IL13,	  the	  transcription	  factors	  GATA3	  and	  GFI1	  and	  the	  surface	  receptor	  GPR44.	  In	  contrast,	  expression	  of	  Th1	  or	  Th17	  signature	  genes,	  such	  as	  TBX21	  and	  RORC,	  was	  even	  lower	  in	  FOXP3-­‐	  as	  compared	  to	  FOXP3+	  cells	   isolated	  from	  the	  same	  cultures	  (Fig.	  2).	  The	  conversion	  into	  Th2	  cells	   upon	   loss	   of	   FOXP3	   expression	   dramatically	   exceeded	   the	   previously	   described	  differentiation	  into	  Th1	  or	  Th17	  cells	  (Ayyoub	  et	  al.	  2009;	  Hoffmann	  et	  al.	  2009;	  McClymont	  et	  al.	  2011;	  Schmidl	  et	  al.	  2011).	  Both,	  the	  high	  frequency	  of	  Th2	  cytokine	  producers	  among	  FOXP3-­‐	  CD45RA-­‐	   Treg	   and	   the	   substantial	   concentrations	   of	   Th2	   cytokines	   in	   CD45RA-­‐	   Treg	   culture	  supernatants	   corroborated	   these	   results.	   In	  murine	   studies,	   induction	  of	   cytokine	   secretion	   in	  'former'	  Treg	  cells	  has	  also	  been	  observed,	  either	  upon	  foxp3	  deletion	  (Williams	  and	  Rudensky	  2007),	  or	  upon	  expression	  of	  a	  non-­‐functional	  Foxp3	  protein	  (Lin	  et	  al.	  2007).	  While	  Rudensky	  and	   coworkers	   found	  only	  Th1	   cytokines	   in	  C57BL/6	  animals	   (Williams	  and	  Rudensky	  2007),	  Chatila's	  group	  also	  observed	  a	  dramatic	  increase	  in	  IL-­‐4	  secretion	  after	  Foxp3	  downregulation	  in	  BALB/c	  mice	  (Lin	  et	  al.	  2007).	  Thus,	  a	  genetic	  predisposition	  may	  influence	  the	  conversion	  of	  Treg.	   Interestingly,	   however,	   artificial	   attenuation	   of	   Foxp3	   expression	   has	   been	   described	   to	  induce	  predominantly	  a	  Th2	  phenotype	  in	  Foxp3low-­‐expressing	  cells	  even	  in	  C57BL/6	  mice	  (Wan	  and	   Flavell	   2007)	   and	   this	   conversion	   seems	   to	   be	   an	   intrinsic	   developmental	   program	   that	  occurs	  independently	  of	  IL4/STAT6	  signaling,	  yet	  still	  requires	  GATA-­‐3	  expression	  (Wang	  et	  al.	  2010).	   In	  Th2	  differentiation	  of	  naive	  conventional	  T	  cells,	   IL-­‐4	  causes	  STAT6	  phosphorylation	  by	  JAK1	  and	  JAK3	  kinases	  leading	  to	  STAT6	  dimerization	  and	  nuclear	  translocation	  that	  in	  turn	  supports	  IL4	  and	  IL4R	  as	  well	  as	  GATA3	  transcription	  (Kaplan	  et	  al.	  1996).	  Blocking	  IL-­‐4/STAT6	  signaling	   in	   human	  Treg	   by	   the	   addition	   of	   anti-­‐IL-­‐4	   antibodies,	   anti-­‐IL-­‐4R	   antibodies	   or	   both	  during	  culture	  resulted	  in	  a	  dramatic	  reduction	  of	  STAT6	  phosphorylation,	  as	  expected.	  Yet,	  the	  frequencies	   of	   IL-­‐4,	   IL-­‐5	   and	   IL-­‐13	   producing	   cells	   and	   the	   amount	   of	   secreted	   Th2	   cytokines	  were	  only	  marginally	  diminished,	  suggesting	  that	  auto-­‐	  or	  paracrine	  IL-­‐4/STAT6	  signaling	  is	  not	  the	   main	   cause	   of	   Th2	   conversion.	   To	   which	   extent	   IL-­‐4	   independent	   signaling	   cascades	   are	  involved	  in	  Th2	  conversion	  of	  human	  Treg	  requires	  further	  clarification.	  For	  murine	  T	  cells	  it	  has	  previously	   been	   shown	   that	   IL-­‐2	   combined	   with	   CD28	   co-­‐stimulation	   can	   induce	   Th2	  differentiation	   in	  an	   IL-­‐4/STAT6-­‐independent,	  but	  STAT5-­‐dependent	  manner	   (Zhu	  et	  al.	  2003;	  Cote-­‐Sierra	  et	  al.	  2004).	  Since	  our	  stimulation	  conditions	  provide	  all	  required	  components	  (CD3,	  CD28	   and	   high-­‐dose	   IL-­‐2	   stimulation),	   this	   pathway	   may	   be	   involved	   in	   Treg	   conversion.	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However,	  we	   rather	   reason	   that	  Th2	   conversion	  of	  CD45RA-­‐	  Treg	   represents	   a	  developmental	  program	  that	  is	  imprinted	  on	  the	  cells	  by	  repeated	  contact	  to	  (self-­‐)	  antigen	  in	  vivo,	  as	  CD45RA+	  naïve	  Tregs	  do	  not	  convert	  although	  exposed	  to	  the	  same	   in	  vitro	  conditions.	  In	  support	  of	  this	  hypothesis,	   an	   increased	  GATA-­‐3	   expression	   in	   CD45RA-­‐	   Treg	   (as	   compared	   to	   CD45RA+	  Treg	  and	  Tconv	  cells)	  was	  detectable	  already	  before	  in	  vitro	  expansion	  (Supplemental	  	  Fig.	  3).	  In	  mice,	  Th2	   conversion	   of	   wild-­‐type	   Tregs	   in	   vivo	   has	   been	   described	   (Wang	   et	   al.	   2010)	   as	   well	   as	  conversion	  into	  IL-­‐4	  secreting	  follicular	  B	  helper	  T	  cells	  (Tsuji	  et	  al.	  2009)	  and	  it	  remains	  to	  be	  determined	   whether	   this	   is	   also	   a	   frequent	   event	   in	   humans,	   where	   diminished	   FOXP3	  expression	  of	  Treg	  has	  been	  observed	  in	  patients	  with	  atopic	  diseases	  (Provoost	  et	  al.	  2009).	  In	   summary,	   by	   performing	   the	   first	   comparative	   transcriptome	   analyses	   of	   human	   Treg	   and	  their	  converted	  progeny	  identified	  and	  separated	  on	  the	  basis	  of	   their	  FOXP3	  expression	   level,	  we	   show	   that	   differentiation	   towards	   a	   Th2	   phenotype	   represents	   the	   dominant	   pathway	   of	  human	  Treg	  upon	  loss	  of	  FOXP3	  expression.	  These	  findings	  further	  elucidate	  the	  developmental	  plasticity	  of	  Treg	   in	  humans	   (Zhou	  et	   al.	  2009b)	  and	  are	   thus	  of	  high	   relevance	   for	   current	  as	  well	  as	  future	  adoptive	  Treg	  therapies.	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Supplemental	  Figure	  1	  
The	   ‘ethanol/tryptone	   method’	   allows	   high	   purity	   sorting	   of	   FOXP3+	   and	   FOXP3-­‐	  
populations	   from	   expanded	   CD45RA-­‐	   Treg.	   CD45RA-­‐	   Treg	   were	   in	   vitro	   expanded	   and	  stained	   for	  CD4	  and	  FOXP3	  using	   the	   ‘ethanol/tryptone	  method’.	  Numbers	  within	   the	  gates	  indicate	  percentages	  of	  gated	  cells.	  Plots	  are	  representative	  of	  n=5	  independent	  experiments.	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Supplemental	  Figure	  2	  
Reproducibility	   of	   microarray	   results.	   Bar	   charts	   present	   normalized	   microarray	   probe	  intensities	   for	   genes	   from	  Fig.	   2A	   showing	   significant	   expression	  differences	   for	  FOXP3+	   and	  FOXP3-­‐	   CD45RA-­‐	   Treg	   cell	   populations	   after	   expansion	   of	   n=5	   different	   donors.	   Expression	  values	  for	  FOXP3+	  samples	  (light	  gray	  bars)	  and	  matched	  FOXP3-­‐	  samples	  (dark	  gray	  bars)	  are	  shown	  in	  ascending	  intensity	  value	  order	  of	  FOXP3+	  samples.	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Supplemental	  Figure	  3	  
Increased	   GATA-­‐3	   expression	   in	   freshly	   isolated	   CD45RA-­‐	   Treg	   cells.	   GATA-­‐3	   mRNA	  expression	   levels	  were	  analyzed	   in	   freshly	   isolated	  and	  FACS-­‐sorted	  CD4+CD25-­‐CD45RA+	  and	  CD4+CD25-­‐CD45RA-­‐	   Tconv	   and	   CD4+CD25highCD45RA+	   and	   CD4+CD25highCD45RA-­‐	   Treg	   cells.	  Data	  are	  shown	  normalized	  to	  18S	  RNA.	  *p≤0.05	  as	  compared	  to	  CD45RA-­‐	  Treg;	  n=4;	  unpaired	  two-­‐tailed	  Student’s	  t-­‐test.	  
Dominant	  Th2	  differentiation	  of	  human	  regulatory	  T	  cells	  upon	  loss	  of	  FOXP3	  expression	  	  
	   130	  
Supplemental	  Table	  1:	  Primer	  Sequences	  used	  in	  real-­‐time	  qPCR	  5’-­‐3’	  
	  
FOXP3_S	   GAAACAGCACATTCCCAGAGTTC	  
FOXP3_AS	   ATGGCCCAGCGGATGAG	  
RORC_S	   GCAGCGCTCCAACATCTTCTC	  
RORC_AS	   GCACACCGTTCCCACATCTC	  
CTLA4_S	   CACGGGACTCTACATCTGCAAGG	  
CTLA4_AS	   GAAGTCAGAATCTGGGCACGG	  
TNFRSF9_S	   GTTGCTTTGGGACATTTAACGATCAG	  
TNFRSF9_AS	   TTCACAAGCACAGACTTTCCATCC	  
GATA3_S	   GACCCTGTCTGCAATGCCTG	  
GATA3_AS	   TCTGGATGCCTTCCTTCTTCATAGTC	  
KLRB1_S	   CTGTGCTGGGATTATTCTCCTTGTC	  
KLRB1_AS	   TTCCTGCTCTGTTGAATGTCCAC	  
IL4_S	   CACAGCAGTTCCACAGGCAC	  
IL4_AS	   CGTACTCTGGTTGGCTTCCTTCAC	  
CD40L_S	   CATGTCATAAGTGAGGCCAGCAG	  
CD40L_AS	   TTTCCAGGGTTACCAAGTTGTTGCTC	  
B2M_S	   TGAGTATGCCTGCCGTGTGA	  
B2M_AS	   TGATGCTGCTTACATGTCTCGAT	  
18S_S	   ACCGATTGGATGGTTTAGTGAG	  
18S_AS	   CCTACGGAAACCTTGTTACGAC	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Abstract	  
CD4+CD25+FOXP3+	  human	  regulatory	  T	  cells	  (Treg)	  are	  essential	  for	  self-­‐tolerance	  and	  immune	  homeostasis.	  Here,	  we	  describe	  the	  promoterome	  of	  CD4+CD25highCD45RA+	  naïve	  and	  CD4+CD25highCD45RA–	  memory	  Treg	  and	  their	  CD25–	  conventional	  T	  cell	  (Tconv)	  counterparts	  both	  before	  and	  after	  in	  vitro	  expansion	  by	  cap	  analysis	  of	  gene	  expression	  adapted	  to	  single	  molecule	  sequencing	  (HeliscopeCAGE).	  We	  performed	  comprehensive	  comparative	  digital	  gene	  expression	  analyses	  and	  revealed	  new	  orphan	  transcription	  start	  sites,	  of	  which	  several	  were	  validated	  as	  alternative	  promoters	  of	  known	  genes	  including	  FOXP3	  and	  CTLA4.	  For	  all	  in	  vitro	  expanded	  subsets,	  we	  additionally	  generated	  genome-­‐wide	  maps	  of	  poised	  and	  active	  enhancer	  elements	  marked	  by	  histone	  H3	  lysine	  4	  monomethylation	  and	  histone	  H3	  lysine	  27	  acetylation.	  Analysis	  of	  cell	  type-­‐specific	  regulatory	  elements	  revealed	  a	  specific	  enrichment	  of	  several	  transcription	  factor	  binding	  motifs.	  We	  validated	  promising	  candidates	  by	  chromatin	  immunoprecipitation	  coupled	  to	  next	  generation	  sequencing	  and	  identified	  STAT5	  and	  FOXP3	  as	  well	  as	  RUNX1	  and	  ETS1	  as	  global	  regulators	  of	  Treg-­‐	  and	  Tconv-­‐specific	  enhancers,	  respectively.	  In	  summary	  we	  provide	  a	  highly	  detailed	  and	  easily	  accessible	  resource	  of	  gene	  expression	  and	  -­‐regulation	  in	  Treg	  and	  Tconv	  subpopulations.	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Introduction	  
Naturally	  occurring	  thymus	  derived	  CD4+CD25+	  regulatory	  T	  cells	  (Treg)	  in	  humans	  are	  crucial	  to	  control	  self-­‐tolerance	  and	  immune	  homeostasis	  by	  suppressing	  a	  wide	  variety	  of	  immune	  responses	  (Sakaguchi	  2004).	  They	  express	  the	  transcription	  factor	  FOXP3,	  which	  is	  indispensable	  for	  Treg	  function	  as	  FOXP3	  mutations	  cause	  lethal	  autoimmune	  diseases	  in	  mice	  and	  humans	  (Bennett	  et	  al.	  2001;	  Brunkow	  et	  al.	  2001).	  Their	  suppressive	  abilities	  make	  Tregs	  interesting	  for	  clinical	  applications	  as	  their	  adoptive	  transfer	  can	  avert	  unwanted	  immune	  reactions	  in	  allogeneic	  hematopoietic	  stem	  cell	  transplantation	  as	  well	  as	  autoimmune	  diseases	  or	  organ	  transplantation	  (Hoffmann	  et	  al.	  2002a;	  Edinger	  et	  al.	  2003;	  Brusko	  et	  al.	  2008;	  Nadig	  et	  al.	  2010;	  Edinger	  and	  Hoffmann	  2011a).	  	  In	  perspective	  of	  their	  therapeutic	  application	  we	  developed	  expansion	  protocols	  for	  human	  Treg	  cells	  (Hoffmann	  et	  al.	  2004)	  and	  demonstrated	  that	  CD45RA+	  naïve	  Treg	  cells	  stably	  express	  FOXP3	  during	  in	  vitro	  culture	  in	  contrast	  to	  the	  CD45RA-­‐	  memory	  population	  (Hoffmann	  et	  al.	  2006b).	  CD45RA-­‐	  Treg	  showed	  not	  only	  a	  heterogeneous	  FOXP3	  expression	  profile	  but	  also	  diminished	  suppressive	  function	  and	  the	  potential	  to	  differentiate	  into	  proinflammatory	  T	  helper	  phenotypes	  after	  in	  vitro	  expansion	  (Hoffmann	  et	  al.	  2006b;	  Schmidl	  et	  al.	  2011;	  Hansmann	  et	  al.	  2012).	  This	  data	  raises	  questions	  about	  Treg	  cell	  stability,	  plasticity	  and	  inherited	  subset	  properties	  and	  –	  in	  view	  of	  clinical	  applications	  –	  demand	  an	  in-­‐depth	  molecular	  characterization.	  Recent	  technical	  advances	  in	  high	  throughput	  sequencing	  technologies	  such	  as	  the	  adaption	  of	  cap	  analysis	  of	  gene	  expression	  (CAGE)	  to	  Heliscope	  single	  molecule	  sequencing	  (Heliscope	  CAGE)	  increase	  the	  accuracy	  and	  information	  content	  of	  gene	  expression	  analysis	  (Kanamori-­‐Katayama	  et	  al.	  2011).	  Heliscope	  CAGE	  quantifies	  full-­‐length	  5’-­‐capped	  transcripts	  and	  maps	  genuine	  transcription	  start	  sites	  (TSS)	  at	  base	  pair	  resolution,	  which	  allows	  studying	  the	  proximal	  regulatory	  inputs	  driving	  gene	  expression	  and	  uncovering	  novel	  promoters.	  FANTOM	  (functional	  annotation	  of	  the	  mammalian	  genome)	  is	  an	  international	  consortium	  that	  determined	  and	  quantified	  the	  TSS	  in	  several	  hundred	  cell	  types	  and	  tissues	  to	  create	  a	  reference	  database	  of	  gene	  expression	  and	  the	  location	  of	  promoters	  in	  mice	  and	  humans	  (the	  FANTOM5	  consortium,	  unpublished	  observations).	  Here,	  as	  part	  of	  the	  5th	  phase	  of	  the	  FANTOM	  project	  (FANTOM5)	  we	  applied	  Heliscope	  CAGE	  to	  CD4+CD25highCD45RA+	  naïve	  and	  CD4+CD25highCD45RA–	  memory	  Treg	  and	  their	  CD25–	  conventional	  T	  cell	  (Tconv)	  counterparts	  both	  before	  and	  after	  in	  vitro	  expansion	  for	  a	  detailed	  delineation	  of	  subset-­‐specific	  TSS	  locations,	  gene	  expression	  profiles	  and	  potentially	  novel	  promoters.	  In	  addition	  to	  gene	  promoters,	  the	  genome	  comprises	  numerous	  noncoding	  elements	  such	  as	  enhancers,	  silencers	  and	  boundary	  elements	  to	  regulate	  gene	  expression	  (Ong	  and	  Corces	  2011).	  Compelling	  evidence	  from	  global	  studies	  identified	  the	  enrichment	  of	  histone	  3	  lysine	  4	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monomethylation	  (H3K4me1)	  and	  histone	  3	  lysine	  27	  acetylation	  (H3K27ac)	  at	  “poised”	  and	  “active”	  enhancers,	  respectively	  (Heintzman	  et	  al.	  2007;	  Creyghton	  et	  al.	  2010;	  Rada-­‐Iglesias	  et	  al.	  2011).	  Enhancers	  are	  distributed	  throughout	  the	  genome	  in	  a	  cell	  type-­‐specific	  manner	  (Heintzman	  et	  al.	  2009)	  and	  are	  also	  characterized	  by	  local	  DNA	  hypomethylation	  (Schmidl	  et	  al.	  2009;	  Sérandour	  et	  al.	  2011;	  Stadler	  et	  al.	  2011)	  and	  the	  binding	  of	  general	  as	  well	  as	  cell	  type-­‐specific	  transcription	  factors	  (TFs)	  that	  translate	  environmental	  and	  inherited	  cues	  in	  cooperation	  with	  the	  chromatin	  environment	  into	  distinct	  gene	  expression	  programs	  (Lupien	  et	  al.	  2008;	  Heinz	  et	  al.	  2010;	  Ernst	  et	  al.	  2011;	  Sérandour	  et	  al.	  2011;	  Pham	  et	  al.	  2012).	  In	  Treg,	  the	  stable	  expression	  of	  FOXP3	  itself	  is	  controlled	  by	  both	  DNA	  methylation	  and	  chromatin	  state,	  which	  both	  influence	  the	  binding	  of	  various	  TFs	  to	  its	  intronic	  enhancer	  (Huehn	  et	  al.	  2009;	  Lal	  and	  Bromberg	  2009).	  We	  previously	  extended	  those	  initial	  observations	  by	  describing	  more	  than	  130	  differentially	  methylated	  regions	  (DMR)	  between	  Treg	  and	  Tconv	  cells	  (Schmidl	  et	  al.	  2009).	  Interestingly,	  many	  DMRs	  were	  located	  at	  key	  Treg	  and	  Tconv	  gene	  loci,	  overlapped	  with	  an	  active	  chromatin	  environment	  and	  showed	  methylation	  sensitive	  enhancer	  function	  (Schmidl	  et	  al.	  2009).	  First	  next	  generation	  sequencing	  studies	  on	  human	  Treg	  and	  Tconv	  described	  differential	  FOXP3	  binding	  in	  activated	  Treg	  and	  Tconv	  cells	  and	  its	  impact	  on	  gene	  expression	  (Birzele	  et	  al.	  2011).	  However,	  most	  of	  the	  analyses	  of	  TFs	  regulating	  Treg	  function	  were	  only	  performed	  in	  rodents	  or	  restricted	  to	  single	  loci	  in	  human	  cells.	  To	  better	  understand	  the	  global	  regulatory	  networks	  in	  human	  CD4+	  T	  cell	  subpopulations	  we	  herein	  describe	  the	  promoterome	  of	  freshly	  isolated	  as	  well	  as	  in	  vitro	  expanded	  naïve	  (CD45RA+)	  and	  memory	  (CD45RA-­‐)	  Treg	  and	  Tconv	  by	  Heliscope	  CAGE.	  In	  in	  vitro	  expanded	  cells	  we	  extended	  the	  promoter	  data	  by	  the	  mapping	  of	  poised	  and	  active	  enhancers	  throughout	  the	  genome.	  Enhancers	  show	  cell	  type-­‐specific	  enrichment	  of	  TF	  binding	  motifs	  and	  we	  highlight	  the	  global	  role	  of	  FOXP3,	  RUNX1,	  ETS1	  and	  STAT5	  in	  cell	  type-­‐specific	  enhancer	  architecture	  and	  gene	  regulation	  by	  chromatin	  immunopreciptiation	  followed	  by	  next	  generation	  sequencing	  (ChIP-­‐seq).	  The	  integrated	  analysis	  of	  promoters	  and	  enhancers	  identifies	  subset-­‐specific	  properties	  of	  gene	  regulation	  and	  yields	  a	  valuable	  resource	  on	  gene	  expression	  and	  regulation	  in	  Treg	  and	  Tconv	  subsets	  for	  the	  scientific	  community.	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Methods	  
Cells–CD4+CD25–CD45RA+,	  CD4+CD25–CD45RA–,	  CD4+CD25highCD45RA+	  and	  CD4+CD25highCD45RA–	  T	  cells	  were	  isolated	  as	  described	  elsewhere	  (Hoffmann	  et	  al.	  2006b).	  	  All	  T	  cell	  populations	  were	  in	  vitro	  expanded	  as	  previously	  described	  (Hoffmann	  et	  al.	  2004).	  Jurkat	  cells	  (human	  T	  cell	  leukemia)	  where	  cultured	  as	  previously	  described	  (Schmidl	  et	  al.	  2009).	  
RNA	  preparation–RNA	  for	  CAGE	  sequencing	  and	  RACE-­‐PCR	  was	  isolated	  using	  the	  miRNeasy	  RNA	  isolation	  kit	  (Qiagen,	  Hilden,	  Germany).	  
HeliscopeCAGE-­‐sequencing	  and	  data	  analysis–Heliscope	  CAGE	  sequencing	  and	  sequence	  alignment	  was	  performed	  as	  part	  of	  the	  FANTOM5	  project	  (the	  FANTOM	  consortium,	  unpublished	  information).	  Normalization	  of	  individual	  tag	  libraries	  was	  done	  using	  the	  common	  power-­‐law	  distribution	  approach	  (Balwierz	  et	  al.	  2009).	  Expression	  data	  for	  annotated	  coding	  or	  noncoding	  genes	  (according	  to	  Gencode	  release	  10	  data)	  was	  extracted	  by	  collecting	  normalized	  tag	  counts	  in	  regions	  -­‐500	  to	  +200	  relative	  to	  all	  annotated	  transcription	  start	  sites	  associated	  with	  a	  single	  geneID.	  Digital	  gene	  expression	  analysis	  of	  normalized	  data	  was	  performed	  using	  edgeR	  (Robinson	  et	  al.	  2010).	  
3’	  and	  5’RACE-­‐PCR–CDNA	  from	  RNA	  of	  T	  cell	  subpopulations	  was	  generated	  with	  the	  SMARTer™	  RACEcDNA	  Amplification	  Kit	  (Clontech,	  Saint-­‐Germain-­‐en-­‐Laye,	  France)	  according	  to	  the	  manufacturers’	  instructions.	  	  Rapid	  Amplification	  of	  cDNA	  Ends	  (RACE)	  was	  performed	  with	  the	  Advantage	  2	  Polymerase	  System	  (Clontech)	  and	  a	  gene	  specific	  primer	  (gsp).	  When	  no	  distinct	  fragment	  sizes	  were	  observed,	  the	  PCR	  product	  was	  diluted	  and	  amplified	  with	  a	  nested	  gene	  specific	  primer	  (ngsp).	  Single	  bands	  were	  gel	  purified	  with	  the	  Qiagen	  gel	  extraction	  kit	  (Qiagen),	  cloned	  with	  the	  StrataClone	  PCR	  Cloning	  Kit	  (Agilent)	  according	  to	  the	  manufacturers’	  instructions	  and	  sequenced	  (Life	  Technologies,	  Regensburg,	  Germany).	  Primer	  sequences	  are	  listed	  in	  Supplemental	  Table	  S1.	  
ChIP-­‐sequencing	  and	  data	  analysis–ChIP	  of	  two	  healthy	  donors	  and	  library	  construction	  were	  done	  essentially	  as	  described	  (Pham	  et	  al.	  2012)	  using	  antibodies	  against	  H3K4me1	  (Abcam),	  H3K27ac	  (Abcam),	  STAT5	  (Santa	  Cruz	  Biotechnology),	  ETS1	  (Santa	  Cruz	  Biotechnology),	  RUNX1	  (Abcam)	  and	  FOXP3	  (Novus	  Biologicals).	  Sequence	  tags	  were	  mapped	  to	  the	  current	  human	  reference	  genome	  (GRCh37/hg19)	  using	  Bowtie	  (Langmead	  2010).	  Downstream	  analysis	  of	  uniquely	  mapped	  tags	  including	  quality	  control,	  peak	  calling,	  and	  motif	  analysis	  were	  done	  as	  described	  using	  HOMER	  (Heinz	  et	  al.	  2010).	  A	  UCSC	  Genome	  Browser	  track	  hub	  of	  the	  entire	  data	  set	  is	  found	  at	  http://www.ag-­‐rehli.de.	  
De	  novo	  motif	  analyses–Enriched	  sequence	  motifs	  were	  de	  novo	  extracted	  from	  regions	  surrounding	  differentially	  expressed	  CAGE	  clusters	  determined	  by	  edgeR	  (P≤0.01	  for	  pairwise	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comparisons;	  -­‐300	  to	  +50	  bp	  from	  cluster	  center)	  using	  HOMER.	  For	  ChIP-­‐seq	  data	  sets,	  enhancers	  (distal	  H3K4me1	  and	  H3K27ac	  regions,	  defined	  as	  being	  located	  at	  least	  1000	  bp	  away	  from	  GencodeV10	  annotated	  TSS)	  were	  extracted	  using	  a	  fixed	  region	  size	  of	  1kb	  for	  replicate	  samples	  (and	  with	  a	  tag	  enrichment	  in	  one	  sample	  in	  comparison	  with	  the	  other	  in	  case	  of	  cell	  type-­‐specific	  enhancers).	  Motifs	  were	  extracted	  from	  1kb	  regions	  using	  HOMER.	  
Reporter	  plasmid	  construction	  and	  purification–The	  native	  as	  well	  as	  new	  CTLA4	  and	  FOXP3	  TSS	  were	  amplified	  from	  genomic	  DNA	  using	  PCR	  primers	  listed	  in	  Supplemental	  Table	  S1.	  The	  PCR	  fragments	  were	  cloned	  in	  the	  pGL4.10	  vector	  (Promega)	  and	  sequenced	  for	  validation.	  For	  transient	  transfections,	  plasmids	  were	  isolated	  and	  purified	  using	  the	  EndoFree	  Plasmid	  Kit	  (Qiagen).	  
Transient	  DNA	  transfection–Jurkat	  cells	  were	  stimulated	  and	  transfected	  using	  DEAE-­‐dextran	  essentially	  as	  described	  (Schmidl	  et	  al.	  2009).	  The	  transfected	  cells	  were	  cultivated	  for	  48	  h,	  harvested,	  and	  cell	  lysates	  were	  assayed	  for	  firefly	  and	  renilla	  luciferase	  activity	  in	  duplicates	  using	  the	  Dual	  Luciferase	  Reporter	  Assay	  System	  (Promega)	  on	  a	  Lumat	  LB9501	  (Berthold,	  Bad	  Wildbach,	  Germany)	  in	  three	  independent	  experiments.	  Firefly	  luciferase	  activity	  was	  normalized	  against	  Renilla	  luciferase	  activity	  and	  an	  empty	  vector	  control.	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Results	  To	  analyze	  gene	  expression	  as	  well	  as	  the	  exact	  promoter	  locations	  of	  T	  cell	  subpopulations,	  we	  subjected	  three	  biological	  replicates	  of	  highly	  purified	  primary	  (labeled	  with	  prefixed	  “p”)	  CD4+CD25highCD45RA+	  naïve	  Treg	  (pRA+Treg),	  CD4+CD25highCD45RA–	  memory	  Treg	  (pRA-­‐Treg),	  CD4+CD25–CD45RA+	  naïve	  Tconv	  (pRA+Tconv)	  and	  CD4+CD25–CD45RA–	  memory	  Tconv	  (pRA-­‐Tconv)	  to	  HeliscopeCAGE.	  Additionally,	  we	  in	  vitro	  expanded	  all	  subpopulations	  as	  previously	  described	  (Hoffmann	  et	  al.	  2006b)	  and	  subjected	  them	  to	  HeliscopeCAGE	  sequencing	  as	  well	  (labeled	  with	  prefixed	  “e”).	  The	  sorting	  strategy	  with	  representative	  FACS	  plots	  is	  charted	  in	  Figure	  1.	  	  
	  
	  To	  quantify	  gene	  expression	  we	  collected	  normalized	  digital	  CAGE	  tag	  counts	  for	  gene	  promoters	  associated	  with	  known	  genes	  (according	  to	  GencodeV10	  annotation).	  Overall	  11022	  
Figure	  1:	  
T	  cell	  isolation	  and	  expansion.	  (A.)	  Sorting	  strategy	  for	  CD4+CD25highCD45RA+	  (pRA+Treg),	  CD4+CD25highCD45RA–	  (pRA-­‐Treg),	  CD4+CD25–CD45RA+	  (pRA+Tconv)	  and	  CD4+CD25–CD45RA–	  (pRA-­‐Tconv)	  from	  human	  PBMCs	  as	  described	  in	  Methods.	  (B.)	  Cells	  were	  reanalyzed	  after	  sorting	  on	  a	  separate	  cytometer	  (FACSCalibur).	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protein-­‐coding	  and	  1168	  non-­‐coding	  genes	  were	  expressed	  with	  at	  least	  1	  TPM	  (tags	  per	  million)	  in	  one	  subpopulation.	  We	  next	  performed	  digital	  gene	  expression	  (DGE)	  analysis	  of	  protein-­‐coding	  genes	  using	  the	  edgeR	  software	  package	  (Robinson	  et	  al.	  2010)	  for	  pairwise	  comparisons	  between	  subpopulations.	  A	  multidimensional	  scaling	  plot	  (MDS)	  clustered	  replicates	  together	  and	  clearly	  separated	  Treg	  from	  Tconv	  in	  one	  dimension	  and	  in	  vitro	  expanded	  from	  primary	  cells	  in	  the	  other	  dimension	  (Figure	  2A).	  Figure	  2B	  shows	  a	  representative	  DGE	  analysis	  with	  the	  top	  50	  differentially	  expressed	  protein-­‐coding	  genes	  (ranked	  by	  q-­‐value)	  between	  pRA+Treg	  and	  pRA+Tconv.	  As	  expected,	  well-­‐characterized	  signature	  genes	  appeared	  in	  the	  top	  ranked	  list,	  for	  example	  FOXP3,	  IL2RA,	  CTLA4,	  IKZF2	  and	  
CD40LG.	  Plots	  of	  top	  50	  differentially	  regulated	  genes	  of	  additional	  pairwise	  comparisons	  are	  displayed	  in	  Supplementary	  Figure	  S1.	  We	  next	  defined	  a	  “core”	  pTreg	  gene	  signature	  by	  identifying	  a	  set	  of	  genes	  that	  was	  differentially	  expressed	  in	  both	  pRA+Treg	  vs.	  pRA+Tconv	  as	  well	  as	  in	  pRA-­‐Treg	  vs.	  pRA-­‐Tconv	  comparisons.	  In	  addition,	  we	  compared	  the	  expression	  levels	  of	  these	  61	  “core”	  genes	  in	  pTreg	  to	  those	  in	  eTreg	  (Figure	  2C).	  This	  Treg	  core	  signature	  comprises	  intensively	  studied	  Treg	  marker	  and,	  additionally,	  only	  recently	  discovered	  genes	  found	  to	  be	  essential	  to	  foster	  or	  restrict	  Treg	  function	  such	  as	  THEMIS	  and	  SATB1	  (Beyer	  et	  al.	  2011;	  Chabod	  et	  al.	  2012).	  However,	  we	  could	  also	  include	  several	  genes	  less	  well	  described	  in	  the	  Treg	  context	  such	  as	  LAIR2,	  METTL7A,	  and	  RTKN2	  as	  being	  upregulated	  as	  well	  as	  TCF7	  (TCF-­‐1),	  ANK3,	  NELL2	  and	  ANXA1	  as	  being	  downregulated	  in	  pTreg	  and	  eTreg.	  Interestingly,	  a	  transcript	  isoform	  of	  RTKN2,	  a	  gene	  that	  was	  previously	  reported	  to	  be	  expressed	  in	  lymphocytes	  (Collier	  et	  al.	  2004),	  showed	  exclusive	  expression	  in	  Treg	  when	  compared	  to	  the	  roughly	  3000	  samples	  sequenced	  in	  the	  FANTOM5	  project	  (the	  FANTON5	  consortium,	  unpublished	  observations).	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HeliscopeCAGE-­‐based	  digital	  expression	  analysis.	  For	  digital	  gene	  expression	  analysis,	  tag	  counts	  were	  collected	  within	  -­‐500	  to	  +200	  bp	  of	  GencodeV10	  annotated	  coding	  gene	  promoters	  as	  outlined	  in	  the	  Methods	  section.	  (A.)	  A	  multidimensional	  scaling	  (MDS)	  plot	  for	  replicate	  HeliscopeCAGE-­‐based	  digital	  expression	  data	  shows	  distance	  of	  samples	  based	  on	  tag	  distribution	  in	  expressed	  genes.	  (B.)	  Digital	  gene	  expression	  data	  for	  the	  top	  50	  differentially	  expressed	  genes	  in	  a	  pairwise	  comparison	  of	  pRA+Treg	  vs.	  pRA+Tconv.	  (C.)	  A	  Treg	  “core”	  signature	  displaying	  unsupervised	  hierarchical	  clustering	  of	  genes	  differing	  highly	  significant	  in	  expression	  between	  pTreg	  vs.	  pTconv	  in	  both	  CD45RA+	  naïve	  and	  CD45RA-­‐	  memory	  subpopulations.	  eTreg	  were	  included	  in	  the	  clustering	  to	  visualize	  expression	  changes	  of	  core	  Treg	  genes	  after	  in	  vitro	  expansion.	  Values	  were	  log2	  transformed	  and	  normalized	  to	  the	  geometric	  mean	  of	  tag	  counts	  in	  pTreg	  and	  pTconv	  subpopulations	  for	  every	  gene.	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Since	  Treg	  are	  intensively	  studied	  for	  future	  clinical	  applications,	  we	  were	  particularly	  interested	  in	  the	  differential	  expression	  of	  Treg-­‐specific	  effector	  molecules	  in	  the	  Treg	  subsets.	  The	  genes	  CTLA4,	  IL2RA	  (CD25),	  TGFB1,	  TIGIT	  and	  TNFRSF10B	  were	  highly	  expressed	  in	  all	  Treg	  populations	  (Figure	  3A).	  In	  contrast,	  several	  genes	  were	  not	  expressed	  in	  pRA+Treg	  but	  upregulated	  in	  pRA-­‐Treg,	  namely	  TNFRSF18	  (GITR),	  LAG3,	  GZMA,	  IL-­‐10,	  FGL2	  and	  ENTPD1	  (CD39).	  Interestingly,	  eRA+Treg	  resembled	  pRA+Treg	  with	  respect	  to	  their	  effector	  molecule	  repertoire	  with	  the	  exceptions	  that	  they	  express	  higher	  amounts	  of	  GITR,	  LGAS1	  and	  IL2RA	  than	  their	  primary	  counterparts.	  Only	  few	  molecules	  were	  expressed	  exclusively	  in	  eRA-­‐Treg,	  namely	  TNFSF11,	  NRP1,	  EBI3	  (IL-­‐35	  subunit)	  and	  GZMB.	  However,	  since	  this	  population	  shows	  heterogeneity	  (Schmidl	  et	  al.	  2011;	  Hansmann	  et	  al.	  2012),	  unequivocal	  identification	  of	  the	  cells	  expressing	  these	  effector	  genes	  is	  excluded.	  Another	  crucial	  factor	  in	  adoptive	  T	  cell	  therapy	  is	  the	  potential	  ability	  of	  the	  cells	  to	  home	  to	  specific	  locations	  in	  the	  host	  (Campbell	  and	  Koch	  2011).	  The	  homing	  receptors	  that	  mediate	  migration	  to	  inflamed	  tissues	  CCR2,	  CCR5	  and	  CCR8	  as	  well	  as	  the	  skin/mucosa-­‐,	  liver-­‐	  and	  intestine	  homing	  receptors	  CCR10,	  CXCR6	  and	  CCR9	  were	  not	  expressed	  in	  pRA+Treg,	  but	  were	  present	  in	  pRA-­‐Treg	  (Figure	  3B).	  Notably,	  eRA+Treg	  resembled	  pRA-­‐Treg	  cells	  more	  than	  pRA+Treg	  with	  regard	  to	  their	  CCR	  expression	  with	  the	  exception	  of	  CCR6,	  CCR9	  as	  well	  as	  CCR10.	  Interestingly,	  in	  contrast	  to	  pTreg	  populations,	  eTreg	  do	  not	  express	  CXCR5,	  a	  receptor	  described	  for	  homing	  to	  B	  cell	  follicles	  and	  germinal	  centers.	  Recent	  publications	  suggest	  that	  Treg	  express	  other	  lineage	  specific	  transcription	  factors	  that	  drive	  specialized	  gene	  expression	  programs	  in	  order	  to	  suppress	  the	  corresponding	  T	  helper	  cell-­‐associated	  inflammation	  (Chaudhry	  et	  al.	  2009;	  Koch	  et	  al.	  2009;	  Zheng	  et	  al.	  2009).	  We	  therefore	  investigated	  if	  TFs	  of	  other	  lineages	  are	  already	  expressed	  in	  our	  pTreg	  and	  if	  the	  expression	  pattern	  changes	  upon	  in	  vitro	  expansion,	  as	  this	  could	  influence	  their	  suppressive	  properties.	  pRA-­‐Treg	  –in	  contrast	  to	  pRA+Treg-­‐	  expressed	  an	  array	  of	  TFs	  (albeit	  at	  low	  levels)	  of	  other	  T	  cell	  lineages	  as	  shown	  in	  Figure	  3C	  exemplarily	  for	  MAF,TBX21	  and	  RORC.	  The	  Th2	  transcription	  factors	  AHR,	  PRDM1	  and	  GATA3	  were	  expressed	  in	  both	  Treg	  populations	  but	  to	  a	  higher	  degree	  in	  pRA-­‐Treg.	  Of	  note,	  upon	  in	  vitro	  expansion,	  eRA+Treg	  upregulate	  the	  Th1	  and	  Th2	  transcription	  factors	  TBX21	  and	  MAF,	  respectively.	  However,	  the	  highest	  expression	  of	  Th2-­‐associated	  TFs	  was	  observed	  in	  eRA-­‐Treg.	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  Finally,	  DGE	  was	  also	  performed	  for	  noncoding	  genes.	  Among	  the	  most	  significant	  transcripts	  upregulated	  in	  RA+Treg	  compared	  to	  RA+Tconv	  populations	  is	  CTC-­‐231011.1,	  the	  host	  transcript	  for	  mir146a,	  a	  miRNA	  that	  is	  involved	  in	  Treg-­‐mediated	  control	  of	  Th1	  responses	  in	  the	  murine	  system	  (Lu	  et	  al.	  2010a)	  (Suppplementary	  Figure	  S2).	  In	  addition,	  we	  identified	  several	  uncharacterized	  noncoding	  genes	  that	  are	  differentially	  expressed	  between	  subsets	  and	  might	  be	  involved	  in	  subset-­‐specific	  function.	  Taken	  together,	  our	  detailed	  DGE	  analysis	  of	  coding	  and	  noncoding	  genes	  in	  T	  cell	  subpopulations	  highlights	  cell	  type-­‐specific	  properties	  and	  
Figure	  3	  
Effector	  molecule-­‐,	  homing	  receptor-­‐,	  and	  transcription	  factor	  expression	  in	  T	  cell	  
subpopulations.	  Absolute	  tag	  counts	  (log2	  transformed)	  of	  (A.)	  Treg	  effector	  molecules,	  (B.)	  genes	  involved	  in	  homing	  and	  (C.)	  transcription	  factors.	  Data	  are	  presented	  as	  a	  heatmap	  with	  yellow,	  blue	  and	  red	  representing	  low,	  intermediate	  and	  high	  expression,	  respectively.	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presents	  a	  foundation	  to	  investigate	  previously	  uncharacterized	  but	  potentially	  important	  molecules	  for	  the	  function	  of	  Treg	  and	  Tconv	  subsets.	  CAGE	  clusters	  not	  annotated	  to	  a	  known	  promoter	  could	  represent	  promoters	  of	  new	  genes,	  alternative	  promoters	  of	  known	  genes	  or	  TSS	  of	  enhancer	  RNAs	  (Kanamori-­‐Katayama	  et	  al.	  2011;	  Djebali	  et	  al.	  2012).	  As	  expected,	  we	  found	  that	  CAGE	  clusters	  in	  close	  vicinity	  to	  known	  T	  cell-­‐expressed	  promoters	  are	  surrounded	  by	  high	  levels	  of	  H3K27ac	  and	  intermediate	  levels	  of	  H3K4me1	  (Figure	  4A),	  two	  histone	  modifications	  that	  demarcate	  open	  chromatin	  around	  promoters	  and	  enhancers.	  Interestingly,	  “non-­‐annotated”	  clusters	  (distal	  to	  GencodeV10	  promoter)	  displayed	  a	  similar	  epigenetic	  signature	  (albeit	  at	  a	  lower	  level),	  which	  strongly	  indicates	  functionality	  for	  a	  large	  fraction	  of	  genomic	  elements	  associated	  with	  such	  CAGE	  peaks	  (Figure	  4A).	  To	  highlight	  the	  potency	  of	  Heliscope	  CAGE	  to	  detect	  novel	  promoters	  in	  T	  cells,	  we	  performed	  5’RACE	  PCR	  for	  several	  examples	  where	  annotated	  promoter	  and	  CAGE	  TSS	  differed.	  At	  several	  selected	  loci,	  transcripts	  of	  known	  genes	  emerging	  from	  CAGE	  TSS	  were	  identified	  (Figure	  4B,	  Supplementary	  Figure	  S3A).	  In	  addition	  to	  the	  Treg-­‐specific	  TSS	  for	  RTKN2	  mentioned	  above,	  a	  second	  Treg-­‐exclusive	  non-­‐annotated	  upstream	  TSS	  was	  found	  that	  produced	  a	  spliced	  RNA	  (Supplementary	  Figure	  S3B).	  Interestingly,	  novel	  CAGE	  TSS	  were	  also	  found	  at	  the	  well-­‐studied	  Treg	  signature	  genes	  CTLA4	  and	  FOXP3	  (Figure	  4C).	  The	  Treg-­‐specific	  TSS	  upstream	  of	  CTLA4	  yielded	  inter	  alia	  transcripts	  that	  extended	  into	  the	  annotated	  CTLA4	  gene	  and	  potentially	  encode	  for	  a	  novel	  CTLA4	  isoform.	  All	  sequenced	  clones	  derived	  from	  3’-­‐	  and	  5’-­‐RACE	  PCR	  of	  the	  CTLA4	  upstream	  TSS	  are	  displayed	  in	  Supplementary	  Figure	  S3C.	  At	  the	  
FOXP3	  locus,	  a	  conserved	  cluster	  of	  additional	  Treg-­‐specific	  TSS	  was	  found	  approximately	  1kb	  upstream	  of	  the	  annotated	  FOXP3	  promoter.	  5’-­‐RACE	  from	  the	  native	  promoter/5’-­‐untranslated	  region	  confirmed	  spliced	  transcripts	  extending	  to	  this	  novel	  upstream	  TSS	  cluster.	  Reporter	  assays	  using	  upstream	  sequences	  of	  the	  alternative	  FOXP3	  TSS	  but	  not	  the	  novel	  CTLA4	  TSS	  showed	  high	  luciferase	  activity	  when	  transfected	  in	  Jurkat	  cells,	  suggesting	  general	  activity	  of	  the	  newly	  discovered	  FOXP3	  TSS	  with	  the	  capacity	  to	  increase	  transcription	  after	  stimulation	  (Figure	  4D).	  In	  summary,	  these	  results	  demonstrate	  that	  non-­‐annotated	  CAGE	  clusters	  in	  T	  cells	  can	  indeed	  represent	  functional	  promoters.	  Intriguingly,	  we	  also	  identified	  TSS	  with	  Treg-­‐exclusive	  expression	  as	  well	  as	  new	  TSS	  in	  proximity	  of	  well-­‐studied	  key	  Treg	  genes.	  The	  biological	  significance	  of	  these	  novel	  transcripts	  will	  be	  subject	  of	  further	  research.	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Figure	  4:	  Novel	  CAGE	  clusters.	  (A.)	  Histogram	  of	  histone	  modifications	  in	  the	  vicinity	  of	  CAGE	  clusters.	  Expressed	  clusters	  (expression	  >1	  tag	  per	  million)	  of	  all	  in	  vitro	  expanded	  subpopulations	  were	  merged	  and	  then	  separated	  in	  annotated	  and	  non-­‐annotated	  to	  a	  GencodeV10	  promoter.	  H3K4me1	  and	  H3K27ac	  ChIP-­‐seq	  tag	  counts	  of	  in	  vitro	  expanded	  subpopulations	  were	  combined	  and	  then	  annotated	  to	  expressed	  gene	  promoter-­‐associated	  or	  non-­‐annotated	  CAGE	  clusters.	  (B.)-­‐(C.)	  5’-­‐RACE	  confirms	  the	  presence	  of	  spliced	  transcripts	  from	  novel	  CAGE	  TSS.	  UCSC	  browser	  graphics	  are	  shown	  for	  the	  indicated	  genomic	  positions	  including	  H3K27ac	  signal	  of	  expanded	  populations,	  GencodeV10	  gene	  annotation,	  CAGE	  signals	  for	  all	  eight	  T	  cell	  subpopulations	  and	  aligned	  results	  from	  5’-­‐RACE-­‐PCR.	  Numbers	  of	  sequenced	  clones	  are	  indicated	  in	  brackets.	  (D.)	  Relative	  luciferase	  activity	  of	  the	  new	  FOXP3	  and	  CTLA4	  TSS.	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Recent	  studies	  demonstrated	  the	  possibility	  to	  identify	  key	  regulators	  in	  transcriptional	  regulation	  by	  epigenetic	  “fingerprinting”	  of	  cell	  type-­‐specific	  enhancers	  (Pham	  et	  al.	  2012).	  Hence,	  we	  initially	  analyzed	  active	  enhancers	  characterized	  by	  promoter-­‐distal	  enrichment	  of	  H3K27ac	  in	  eRA+Treg	  and	  expanded	  CD4+CD25-­‐	  Tconv	  (“eTconv”;	  not	  separated	  by	  CD45RA).	  This	  identified	  6822	  and	  7112	  putative	  enhancer	  regions,	  respectively.	  De	  novo	  motif	  analysis	  of	  enhancers	  yielded	  a	  broad	  panel	  of	  highly	  enriched	  DNA	  sequences	  with	  frequent	  similarities	  to	  known	  TF	  consensus	  motifs	  (Supplementary	  Figure	  S4).	  In	  addition	  to	  analyzing	  complete	  enhancer	  sets	  we	  also	  determined	  motif	  fingerprints	  in	  eRA+Treg	  and	  eTconv-­‐specific	  enhancers	  (three-­‐fold	  difference	  in	  H3K27ac	  signal).	  eTconv	  enhancers	  (a	  total	  of	  2387	  regions)	  were	  clearly	  dominated	  by	  an	  ETS,	  RUNX	  and	  IRF	  motif-­‐signature	  whereas	  eRA+Treg	  enhancers	  (1963	  regions)	  lacked	  a	  significant	  RUNX	  motif	  but	  showed	  a	  JUN/AP1,	  KLF,	  STAT5	  and	  Forkhead	  signature	  (Figure	  5A).	  Many	  TFs	  corresponding	  to	  the	  extracted	  de	  novo	  motifs	  were	  shown	  to	  play	  crucial	  roles	  in	  Treg	  development	  and	  function,	  but	  the	  global	  impact	  of	  these	  factors	  on	  enhancer	  architecture	  in	  human	  Treg	  has	  not	  been	  shown	  before.	  To	  confirm	  the	  in	  
silico-­‐derived	  motif	  signatures	  we	  generated	  TF-­‐binding	  data	  using	  ChIP-­‐seq	  for	  the	  possible	  regulators	  ETS1,	  RUNX1,	  STAT5	  and	  FOXP3	  in	  eRA+Treg	  and	  eTconv.	  We	  then	  evaluated	  the	  ChIP-­‐seq	  signal	  strengths	  of	  the	  corresponding	  TF	  in	  the	  cell	  type-­‐specific	  enhancers.	  First,	  we	  merged	  both	  eRA+Treg-­‐	  as	  well	  as	  eTconv-­‐derived	  peaks	  of	  the	  corresponding	  TF	  and	  overlapped	  the	  merged	  set	  with	  the	  respective	  cell	  type-­‐specific	  enhancer	  regions.	  We	  then	  counted	  the	  transcription	  factor	  ChIP-­‐seq	  signals	  in	  the	  overlapping	  regions.	  In	  line	  with	  the	  observed	  overrepresentation	  of	  motifs	  in	  specific	  enhancers,	  we	  indeed	  observed	  an	  enrichment	  of	  STAT5	  ChIP-­‐seq	  signal	  in	  eRA+Treg-­‐specific	  enhancers	  (Figure	  5B).	  In	  contrast,	  ETS1	  and	  RUNX1	  ChIP-­‐seq	  tags	  were	  both	  highly	  enriched	  in	  eTconv	  enhancers,	  which	  parallels	  their	  motif	  distribution.	  Interestingly,	  FOXP3	  ChIP-­‐seq	  signals	  were	  equally	  enriched	  in	  FOXP3	  binding	  sites	  overlapping	  with	  eRA+Treg-­‐	  as	  well	  as	  with	  eTconv-­‐specific	  enhancers.	  Taken	  together,	  we	  identified	  enhancers	  in	  eRA+Treg	  and	  eTconv	  and	  could	  identify	  the	  participation	  of	  the	  key	  regulators	  ETS1,	  STAT5,	  RUNX1	  and	  FOXP3	  in	  cell	  type-­‐specific	  enhancer	  architecture	  based	  on	  their	  de	  novo	  motif	  signatures.	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Cell	  type-­‐specific	  enhancers.	  (A.)	  Motif	  composition	  of	  cell	  type-­‐specific	  active	  enhancers	  in	  eRA+Treg	  compared	  to	  eTconv.	  Shown	  are	  extracted	  de	  novo	  motifs,	  their	  hypergeometric	  P-­‐value	  and	  the	  best	  matching	  known	  motif	  families	  (with	  the	  similarity	  score	  to	  the	  best	  matching	  known	  motif	  in	  brackets).	  (B.)	  ChIP-­‐seq	  signal	  strength	  and	  corresponding	  motif	  enrichment	  of	  STAT5,	  FOXP3,	  ETS1	  and	  RUNX1	  in	  eRA+Treg-­‐	  and	  eTconv-­‐specific	  active	  enhancers.	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  Next,	  we	  extended	  the	  histone	  profiling	  to	  characterize	  enhancer	  elements	  in	  all	  subpopulations.	  We	  generated	  additional	  maps	  of	  H3K4me1	  and	  H3K27ac	  for	  eRA+Treg,	  eRA-­‐Treg,	  eRA+Tconv	  and	  eRA-­‐Tconv	  from	  two	  independent	  donors	  that	  were	  also	  used	  for	  CAGE	  profiling.	  We	  then	  isolated	  distal	  cell	  type-­‐specific	  regions	  for	  H3K4me1	  and	  H3K27ac	  in	  pairwise	  comparisons	  (two-­‐fold	  difference	  in	  enrichment	  between	  the	  two	  populations	  to	  be	  compared).	  Enhancers	  can	  act	  over	  large	  distances,	  which	  makes	  it	  difficult	  to	  assign	  distal	  regulatory	  regions	  to	  the	  actual	  target	  genes.	  With	  the	  matching	  CAGE	  expression	  data	  now	  available	  for	  every	  subset	  we	  collected	  all	  CAGE	  clusters	  surrounding	  specific	  enhancer	  regions	  as	  well	  as	  their	  expression	  level	  (represented	  by	  CAGE	  tag	  counts).	  As	  shown	  in	  the	  bubble	  plot	  representations	  in	  Figure	  6A,	  subset-­‐specific	  enhancers	  defined	  by	  H3K4me1	  or	  H3K27ac	  were	  significantly	  associated	  with	  higher	  tag	  counts	  in	  neighboring	  CAGE	  clusters	  of	  the	  same	  cell	  type	  (p<0.001,	  Wilcoxon	  signed	  rank	  test),	  suggesting	  that	  these	  regions	  indeed	  represent	  subset-­‐specific	  enhancers.	  Even	  in	  highly	  similar	  populations	  (e.g.	  eRA+Treg	  vs.	  eRA-­‐Treg)	  many	  enhancers	  specific	  for	  either	  subpopulation	  could	  be	  identified	  that	  were	  positively	  associated	  with	  neighboring	  CAGE	  cluster	  expression	  in	  the	  same	  cell	  type	  (p<0.001,	  Wilcoxon	  signed	  rank	  test	  for	  all	  comparisons)	  (Supplementary	  Figure	  S5).	  In	  summary,	  we	  provide	  the	  so	  far	  most	  comprehensive	  enhancer	  maps	  of	  human	  T	  cell	  subpopulations	  and	  confirmed	  their	  positive	  correlation	  to	  gene	  expression.	  Having	  determined	  subset-­‐specific	  cis-­‐regulatory	  regions	  from	  CAGE	  clusters	  as	  well	  as	  from	  H3K4me1/H3K27ac	  enhancers	  we	  systematically	  determined	  their	  motif	  composition	  to	  deduce	  possible	  regulators.	  Different	  classes	  of	  cis-­‐regulatory	  elements	  (promoters,	  poised	  enhancers,	  active	  enhancers)	  varied	  in	  their	  motif	  composition	  (Supplementary	  Figure	  S6).	  We	  then	  created	  a	  non-­‐redundant	  combined	  atlas	  of	  enriched	  motifs	  of	  cis-­‐regulatory	  regions	  for	  eRA+Treg	  versus	  eRA+Tconv	  subpopulations	  and	  analyzed	  which	  TFs	  are	  differentially	  expressed	  (adjusted	  p-­‐value<0.05,	  Figure	  6B).	  We	  observed	  cell	  type-­‐specific	  overrepresentation	  of	  JUN,	  PAX,	  NFE,	  KLF	  and	  forkhead	  motifs	  in	  eTregRA+	  and	  E2F,	  CREB,	  TCF,	  GTF	  and	  Helix-­‐loop-­‐Helix	  motifs	  in	  eRA+Tconv.	  Notably,	  many	  specific	  signature	  motifs	  had	  a	  corresponding	  regulated	  TF	  candidate-­‐	  JUNB/FOSL2	  (JUN	  motif),	  BATF	  (PAX	  motif),	  BACH1	  (NFE	  motif),	  KLF2/3/7/19	  (KLF	  motif),	  MAF	  (MAF	  motif),	  FOXP3	  (FOX	  and	  FOXP	  motif)	  in	  the	  eRA+Treg	  set	  and	  E2F1/7/8	  (E2F	  motif),	  CREB2L	  (CREB	  motif),	  TCF7/19	  (TCF	  motif)	  and	  ARNTL/AHR/MXD3/ID2	  (potentially	  binding	  bHLH	  motif)	  for	  the	  eRA+Tconv	  set	  of	  motifs.	  Still,	  we	  are	  aware	  that	  not	  all	  motifs	  can	  be	  explained	  by	  differential	  expression	  of	  a	  TF	  as	  expression	  and	  activity	  of	  some	  TF	  classes	  is	  regulated	  by	  mRNA	  stability,	  protein	  degradation	  or	  posttranslational	  modifications	  like	  acetylation	  or	  phosphorylation.	  However,	  with	  respect	  to	  ChIP-­‐seq	  confirmation	  of	  motif	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signatures	  described	  before,	  these	  results	  provide	  a	  new	  and	  comprehensive	  framework	  to	  systematically	  identify	  key	  regulators	  of	  gene	  expression	  in	  human	  T	  cell	  subpopulations.	  
	  
Figure	  6	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Discussion	  
By	  using	  powerful	  genome-­‐wide	  approaches	  we	  were	  able	  to	  analyze	  the	  gene-­‐regulatory	  landscape	  of	  human	  T	  cell	  subpopulations	  in	  an	  unprecedented	  depth.	  Recently,	  human	  CD4+CD25high	  Treg	  were	  described	  as	  heterogeneous,	  with	  CD45RA–	  memory	  Treg	  expressing	  TFs	  and	  cytokines	  of	  other	  proinflammatory	  lineages	  in	  contrast	  to	  CD45RA+	  naïve	  Treg	  (Hoffmann	  et	  al.	  2006b;	  Ayyoub	  et	  al.	  2009;	  Miyara	  et	  al.	  2009;	  Schmidl	  et	  al.	  2011;	  Hansmann	  et	  al.	  2012).	  In	  addition,	  several	  murine	  ex	  vivo	  Treg	  populations	  showed	  specific	  gene	  expression	  characteristics	  in	  dependence	  of	  their	  tissue	  origin	  and	  homing	  receptor	  repertoire	  (Feuerer	  et	  al.	  2010;	  Duhen	  et	  al.	  2012).	  In	  line	  with	  these	  observations,	  we	  delineated	  differences	  in	  the	  expression	  of	  effector	  molecules,	  homing	  receptors	  and	  transcription	  factors	  of	  other	  T	  cell	  lineages	  between	  naïve	  and	  memory	  Treg	  subpopulations.	  Interestingly,	  upon	  in	  vitro	  expansion,	  eRA+Treg	  do	  not	  dramatically	  change	  their	  Treg-­‐specific	  effector	  molecule	  repertoire	  but	  alter	  the	  expression	  of	  several	  homing	  receptors	  despite	  the	  observation	  that	  this	  population	  retains	  a	  stable	  Treg	  phenotype	  even	  after	  extensive	  in	  vitro	  expansion	  (Hoffmann	  et	  al.	  2006b).	  These	  observations	  should	  be	  carefully	  considered	  upon	  adoptive	  transfer	  of	  T	  cells	  and	  are	  valuable	  for	  future	  analysis	  of	  cell	  fate,	  plasticity	  as	  well	  as	  migratory	  potential	  of	  eTreg	  in	  clinical	  applications.	  Apart	  from	  differences	  we	  also	  defined	  shared	  expression	  patterns	  in	  pRA+Treg	  and	  pRA-­‐Treg.	  In	  addition	  to	  well-­‐known	  key	  Treg	  genes	  we	  also	  identified	  unanticipated	  candidate	  genes	  that	  share	  the	  unique	  Treg-­‐signature	  expression	  pattern.	  Among	  these	  genes	  were	  transcription	  factors,	  enzymes	  and	  surface	  proteins,	  but	  further	  work	  is	  required	  to	  determine	  their	  role	  in	  Treg	  biology.	  Using	  modern	  molecular	  methods	  becomes	  indispensable	  to	  understand	  the	  complexity	  of	  our	  genome.	  Recently,	  intensive	  CAGE	  and	  RNA	  sequencing	  studies	  in	  human	  cells	  revealed	  tens	  of	  thousands	  undiscovered	  TSSs	  that	  represent	  promoters	  of	  functional	  protein	  coding	  and	  
Figure	  6:Correlation	  of	  cell	  type-­‐specific	  enhancers	  to	  gene	  expression	  and	  their	  
potential	  regulators.	  (A.)	  Bubble	  plot	  representation	  of	  CAGE-­‐TSS	  activity	  around	  eRA+Treg	  vs	  eRA+Tconv	  enhancer	  candidate	  regions	  showing	  at	  least	  two-­‐fold	  different	  H3K27ac	  or	  H3K4me1	  signals.	  The	  bubble	  plots	  encode	  three	  quantitative	  parameters	  per	  CAGE	  cluster:	  distance	  from	  the	  putative	  enhancer,	  log10	  of	  fold	  change	  in	  CAGE	  cluster	  tag	  count	  between	  eRA+Treg	  and	  eRA+Tconv	  (Y-­‐axis)	  and	  the	  absolute	  CAGE	  cluster	  tag	  count	  of	  the	  T	  cell	  subset	  with	  the	  highest	  expression	  level	  (bubble	  diameter).	  There	  is	  a	  clear	  bias	  for	  the	  putative	  enhancer	  elements	  to	  associate	  with	  CAGE	  clusters	  upregulated	  in	  the	  corresponding	  cell	  type	  (P<0.001,	  Wilcoxon	  signed	  rank	  test).	  (B.)	  A	  non-­‐redundant	  combined	  set	  of	  de	  novo	  motifs	  from	  CAGE	  clusters	  and	  enhancers	  in	  eRA+Treg	  vs.	  eRA+Tconv.	  Shown	  are	  motifs	  with	  a	  highly	  similar	  match	  to	  a	  known	  TF	  motif.	  Absolute	  tag	  counts	  (log2	  transformed)	  of	  differentially	  expressed	  TFs	  matching	  a	  de	  novo	  motif	  are	  presented	  as	  colored	  boxes	  with	  yellow,	  blue	  and	  red	  representing	  low,	  intermediate	  and	  high	  expression,	  respectively.	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noncoding	  transcripts	  (FANTOM5	  main	  paper(Djebali	  et	  al.	  2012).	  Strikingly,	  most	  gene	  loci	  produce	  several	  transcript	  isoforms	  simultaneously.	  Isoform	  transcription	  can	  be	  driven	  by	  different	  regulatory	  inputs	  and	  potentially	  be	  translated	  into	  alternative	  peptides,	  which	  can	  have	  significant	  impact	  on	  the	  phenotype	  of	  a	  cell.	  Here,	  we	  validated	  so	  far	  undescribed	  TSSs	  as	  new	  alternative	  promoters	  of	  known	  genes	  and	  could	  even	  identify	  new	  transcripts	  at	  the	  intensively	  studied	  CTLA4	  and	  FOXP3	  loci.	  Although	  their	  biological	  significance	  has	  to	  be	  evaluated,	  the	  CTLA4	  and	  FOXP3	  TSS	  were	  Treg-­‐specific,	  and	  the	  FOXP3	  TSS	  region	  showed	  general	  activity	  in	  transient	  transfections.	  So	  how	  is	  cell	  type-­‐specific	  expression	  of	  these	  TSS	  achieved?	  Despite	  the	  lack	  of	  STAT5,	  ETS1,	  RUNX1	  or	  FOXP3	  binding	  in	  the	  vicinity	  of	  the	  new	  CTLA4	  or	  FOXP3	  TSSs,	  de	  novo	  motif	  signatures	  suggest	  auxiliary	  TFs	  of	  the	  IRF,	  NFE,	  JUN,	  KLF,	  MAF,	  PAX	  and	  NFkB	  family	  that	  could	  drive	  TSS	  expression.	  Interestingly,	  previous	  comparative	  DNA	  methylation	  studies	  in	  Treg	  and	  Tconv	  cells	  demonstrated	  hypermethylation	  of	  these	  two	  TSS-­‐regions	  in	  all	  analyzed	  hematopoietic	  cells	  except	  Treg	  (Schmidl	  et	  al.	  2009).	  This	  suggests	  epigenetic	  silencing	  of	  these	  elements	  in	  other	  cell	  types	  but	  their	  activation	  in	  Treg	  upon	  DNA	  demethylation.	  	  	  Enhancers	  display	  an	  even	  greater	  diversity	  than	  promoters.	  They	  are	  distributed	  in	  a	  cell	  type-­‐specific	  manner	  throughout	  the	  genome	  and	  designated	  by	  the	  deposition	  of	  H3K4me1	  and	  H3K27ac	  (Heintzman	  et	  al.	  2009;	  Creyghton	  et	  al.	  2010;	  Rada-­‐Iglesias	  et	  al.	  2011).	  By	  comparative	  analysis	  of	  H3K27ac	  and	  H3K4me1	  patterns,	  we	  were	  able	  to	  identify	  several	  thousand	  specific	  enhancers	  in	  eTreg	  and	  eTconv.	  Computational	  analysis	  of	  enhancers	  allowed	  us	  to	  extract	  sequences	  that	  matched	  consensus-­‐binding	  motifs	  of	  TFs	  known	  to	  be	  essential	  for	  Treg	  and	  Tconv	  function.	  In	  comparisons	  between	  eRA+Treg	  and	  eTconv	  these	  included	  forkhead,	  ETS,	  STAT,	  IRF,	  JUN/AP1,	  KLF	  as	  well	  as	  RUNX	  motifs.	  STAT5	  was	  shown	  to	  bind	  and	  directly	  regulate	  expression	  of	  the	  Foxp3	  gene	  in	  mice,	  a	  finding	  that	  was	  also	  suggested	  for	  human	  Treg	  by	  indirect	  evidence	  (Zorn	  et	  al.	  2006;	  Yao	  et	  al.	  2007).	  In	  addition,	  ETS1	  and	  RUNX	  proteins	  were	  also	  described	  to	  regulate	  Treg	  gene	  expression	  in	  mice	  and	  humans	  (Bruno	  et	  al.	  2009;	  Kitoh	  et	  al.	  2009;	  Mouly	  et	  al.	  2010;	  Polansky	  et	  al.	  2010).	  We	  therefore	  generated	  the	  first	  genome-­‐wide	  maps	  of	  ETS1-­‐,	  RUNX1-­‐	  and	  STAT5-­‐binding	  in	  human	  eRA+Treg	  and	  eTconv	  and	  confirmed	  increased	  binding	  of	  the	  particular	  TF	  to	  whether	  eRA+Treg	  or	  eTconv	  specific	  enhancers	  in	  correspondence	  to	  their	  motif	  distribution.	  At	  least	  for	  in	  vitro	  expanded	  cells,	  this	  brings	  forth	  the	  observation	  that	  RUNX1	  and	  ETS1	  were	  more	  associated	  with	  eTconv	  enhancers	  than	  eRA+Treg	  enhancers	  on	  a	  global	  scale	  in	  contrast	  to	  their	  established	  significance	  in	  Treg	  development	  and	  function.	  Further,	  by	  combining	  H3K27ac	  and	  FOXP3	  ChIP-­‐seq,	  we	  observed	  FOXP3	  occupancy	  at	  eTregRA+-­‐specific	  enhancers,	  but	  also	  at	  sites	  that	  are	  potential	  enhancers	  in	  eTconv.	  This	  raises	  the	  possibility	  that	  FOXP3	  controls	  the	  expression	  of	  Tconv-­‐associated	  genes	  by	  the	  occupation	  of	  their	  distal	  enhancers.	  In	  summary,	  we	  generated	  the	  so	  far	  most	  
The	  enhancer	  and	  promoter	  landscape	  of	  human	  regulatory	  and	  conventional	  T	  cell	  subpopulations	  	  
	   153	  
comprehensive	  dataset	  on	  TSS	  location,	  gene	  expression,	  TF	  binding,	  and	  enhancer	  profiling	  in	  human	  T	  cell	  subpopulations.	  Moreover,	  we	  could	  show	  that	  it	  is	  possible	  to	  extract	  key	  regulators	  based	  on	  their	  motif	  “fingerprints”	  in	  enhancers	  as	  described	  recently	  for	  a	  monocyte	  differentiation	  model	  (Pham	  et	  al.	  2012).	  	  Finally,	  we	  hope	  that	  our	  dataset	  ameliorates	  the	  clinical	  application	  of	  human	  Treg.	  In	  addition	  to	  gene	  expression	  studies,	  genome-­‐wide	  TF	  binding	  and	  histone	  modification	  data	  will	  be	  useful	  to	  evaluate	  mechanisms	  as	  well	  as	  effects	  of	  drugs	  that	  modulate	  signaling	  pathways	  or	  the	  epigenetic	  status	  of	  T	  cells.	  As	  an	  example,	  different	  classes	  of	  HDAC	  inhibitors	  (HDACi)	  were	  described	  to	  have	  varying	  effects	  on	  immune	  cells	  including	  Treg	  as	  well	  as	  Tconv	  (Akimova	  et	  al.	  2012).	  Histone	  deacetylase	  (HDAC)	  complexes	  modify	  gene	  expression	  by	  controlling	  the	  acetylation	  of	  histones	  or	  other	  regulatory	  proteins	  including	  STAT5	  or	  FOXP3.	  Hence,	  with	  global	  maps	  of	  histone	  acetylation	  as	  presented	  here,	  the	  impact	  of	  different	  HDACis	  on	  the	  acetylation	  status	  of	  immunologically	  relevant	  genes	  in	  Treg	  and	  Tconv	  could	  be	  studied.	  This	  could	  help	  to	  improve	  in	  vitro	  expansion	  strategies	  and,	  hence,	  to	  improve	  the	  potential	  of	  therapeutic	  cell	  products.	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Supplementary	  Figure	  S1:	  Heliscope	  CAGE-­‐based	  digital	  expression	  analysis	  of	  T	  cell	  
populations.	  For	  digital	  gene	  expression	  analysis,	  tag	  counts	  were	  collected	  within	  -­‐500	  to	  +200	  bp	  of	  GencodeV10	  annotated	  coding	  gene	  promoters	  as	  outlined	  in	  Methods.	  Digital	  gene	  expression	  data	  for	  the	  top	  50	  differentially	  expressed	  genes	  of	  the	  indicated	  pairwise	  comparisons	  are	  shown	  (log2	  transformed	  tag	  counts).	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Supplementary	  Figure	  S2:	  Gene	  expression	  analysis	  of	  noncoding	  genes.	  For	  digital	  gene	  expression	  analysis,	  CAGE	  tag	  counts	  were	  collected	  within	  -­‐500	  to	  +200	  bp	  of	  GencodeV10	  annotated	  noncoding	  gene	  promoters	  as	  outlined	  in	  Methods.	  Digital	  gene	  expression	  data	  for	  the	  top	  20	  differentially	  expressed	  genes	  of	  the	  indicated	  pairwise	  comparisons	  are	  shown	  (log2	  transformed	  tag	  counts).	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Supplementary	  Figure	  S3:	  RACE-­‐PCR	  of	  novel	  CAGE	  TSS.	  (A.)-­‐(C.)	  5’RACE-­‐PCR	  confirms	  spliced	  transcript	  from	  novel	  CAGE	  TSS.	  UCSC	  browser	  graphics	  are	  shown	  for	  the	  indicated	  genomic	  positions	  including	  H3K27ac	  signal	  of	  expanded	  populations,	  GencodeV10	  gene	  annotation,	  CAGE	  signals	  for	  all	  eight	  T	  cell	  subpopulations	  and	  aligned	  results	  from	  5’-­‐RACE-­‐PCR.	  Numbers	  of	  sequenced	  clones	  are	  indicated	  in	  brackets.	  (C.)	  Additional	  3’-­‐RACE	  PCR	  was	  performed	  to	  determine	  3’-­‐ends	  of	  the	  transcript	  emerging	  from	  the	  new	  CTLA4	  upstream	  TSS.	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Supplementary	  Figure	  S4:	  Enhancer	  motif	  signatures	  of	  H3K27ac	  enhancers.	  Motif	  composition	  of	  all	  active	  enhancers	  in	  eRA+Treg	  and	  eRA+Tconv	  defined	  by	  H3K27ac.	  Shown	  are	  extracted	  de	  novo	  motifs,	  their	  hypergeometric	  P-­‐value	  and	  the	  best	  matching	  known	  motif	  families	  (with	  the	  similarity	  score	  to	  the	  best	  matching	  known	  motif	  in	  brackets).	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Supplementary	  Figure	  S5:	  Correlation	  of	  cell	  type-­‐specific	  enhancers	  to	  cell	  type-­‐specific	  
gene	  expression.	  Bubble	  plot	  representation	  of	  CAGE-­‐TSS	  activity	  around	  enhancer	  candidate	  regions	  showing	  at	  least	  two-­‐fold	  different	  H3K27ac	  or	  H3K4me1	  signals.	  The	  bubble	  plots	  encode	  three	  quantitative	  parameters	  per	  CAGE	  cluster:	  distance	  from	  the	  putative	  enhancer,	  log10	  of	  fold	  change	  in	  CAGE	  cluster	  tag	  count	  between	  pairwise	  compared	  cell	  types	  (Y-­‐axis)	  and	  the	  absolute	  CAGE	  cluster	  tag	  count	  of	  the	  T	  cell	  subset	  with	  the	  highest	  expression	  level	  (bubble	  diameter).	  There	  is	  a	  clear	  bias	  for	  the	  putative	  enhancer	  elements	  to	  associate	  with	  CAGE	  clusters	  upregulated	  in	  the	  corresponding	  cell	  type	  (P<0.001,	  Wilcoxon	  signed	  rank	  test).	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Supplementary	  Figure	  S6:	  Motif	  signatures	  in	  different	  classes	  of	  cis-­‐regulatory	  
elements.	  Motif	  composition	  of	  cis-­‐regulatory	  elements	  in	  (A.)	  eRA+Treg	  (vs.	  eRA+Tconv)	  and	  (B.)	  eRA+Tconv(vs.	  eRA+Treg).	  Motifs	  were	  de	  novo	  extracted	  from	  CAGE	  clusters,	  H3K4me1	  and	  H3K27ac	  enhancers.	  Shown	  are	  extracted	  de	  novo	  motifs,	  their	  hypergeometric	  P-­‐value	  and	  the	  best	  matching	  known	  motif	  families	  (with	  the	  similarity	  score	  to	  the	  best	  matching	  known	  motif	  in	  brackets).	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Supplemental	  Table	  S1	  
Experiment/Primer name Sequence 5'-3' 
  5'RACE-PCR 












  3'RACE-PCR 




  cloning of TSS regions 









newTSS_Ctla4_BglII ACGTCAagatctCGATGTGAAATGCACTGAATCC 	  	   	  
The	  enhancer	  and	  promoter	  landscape	  of	  human	  regulatory	  and	  conventional	  T	  cell	  subpopulations	  	  
	   164	  
	  	  
Discussion	  	  
	   165	  
4 Discussion	  
As	  outlined	  in	  the	  introduction,	  gene	  regulation	  is	  controlled	  by	  the	  interaction	  of	  transcription	  factors	  with	  cis-­‐regulatory	  modules	  encoded	  in	  the	  DNA	  sequence.	  These	  interactions	  are	  governed	  by	  epigenetic	  mechanisms	  that	  help	  to	  establish	  and	  maintain	  gene	  expression	  programs.	  Basic	  mechanisms	  of	  gene	  regulation	  are	  best	  studied	  in	  model	  systems	  that	  comprise	  cells	  emerging	  from	  a	  common	  progenitor	  and	  developing	  into	  different	  functional	  entities.	  Ideally,	  the	  model	  system	  closely	  resembles	  the	  in	  vivo	  situation	  to	  reduce	  artifacts	  resulting	  from	  experimental	  conditions	  or	  artificial	  cell	  systems.	  	  Hematopoietic	  cells	  emerge	  from	  a	  common	  progenitor,	  differentiate	  into	  a	  wide	  array	  of	  specialized	  cell	  types	  and	  can	  often	  be	  obtained	  easily	  from	  volunteers	  by	  leukapheresis	  and	  FACS.	  This	  makes	  them	  a	  suitable	  system	  to	  analyze	  differential	  development	  and	  gene	  expression	  as	  well	  the	  contribution	  of	  epigenetic	  mechanisms	  to	  these	  processes.	  With	  the	  possibility	  to	  obtain	  highly	  pure	  human	  regulatory	  and	  conventional	  T	  cells	  (Treg	  and	  Tconv,	  respectively)	  and	  the	  technologies	  to	  expand	  them	  in	  vitro	  (Hoffmann	  et	  al.	  2004;	  Hoffmann	  et	  al.	  2006b),	  we	  used	  Treg	  and	  Tconv	  to	  obtain	  insights	  into	  basic	  mechanisms	  of	  differential	  gene	  expression	  (chapters	  3.1;	  3.2;	  3.3;	  3.4;	  3.5).	  This	  included	  the	  application	  of	  high-­‐throughput	  analysis	  of	  DNA	  methylation,	  genome-­‐wide	  in	  vivo	  DNA-­‐protein	  interactions	  and	  gene	  expression.	  Our	  findings	  shed	  light	  into	  the	  role	  of	  DNA	  methylation	  at	  distal	  regulatory	  regions	  and	  helped	  to	  identify	  molecular	  characteristics,	  plasticity,	  stability	  as	  well	  as	  heterogeneity	  of	  T	  cell	  populations	  (chapters	  3.1;	  3.3;	  3.4;	  3.5).	  Moreover,	  integrated	  analysis	  of	  regulatory	  features	  allowed	  the	  prediction	  of	  key	  factors	  involved	  in	  global	  regulation	  of	  gene	  expression	  in	  Treg	  and	  Tconv	  (chapter	  3.5).	  These	  insights	  are	  of	  immediate	  interest	  to	  understand	  Treg	  biology	  in	  the	  perspective	  of	  regulatory	  T	  cells’	  non-­‐redundant	  role	  in	  maintaining	  the	  integrity	  of	  the	  immune	  system	  and	  their	  prospective	  application	  in	  clinical	  settings.	  
4.1 General	  insights	  into	  cell	  type-­‐specific	  gene	  regulation	  in	  
Treg	  and	  Tconv	  
4.1.1 Distribution	  of	  differential	  DNA	  methylation	  in	  regulatory	  and	  conventional	  
T	  cells	  At	  the	  beginning	  of	  this	  thesis,	  most	  studies	  on	  DNA	  methylation	  investigated	  the	  methylation	  status	  of	  CpG	  islands	  (CGIs)	  in	  malignant	  cells	  (Singal	  and	  Ginder	  1999;	  Issa	  2004).	  Aberrant	  DNA	  methylation	  in	  cancer	  can	  occur	  tumor-­‐specific	  at	  many	  CGIs	  and	  is	  involved	  in	  silencing	  of	  tumor	  suppressor	  genes	  (Singal	  and	  Ginder	  1999;	  Toyota	  et	  al.	  2001).	  Hence,	  analysis	  of	  DNA	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methylation	  in	  cancerous	  cells	  is	  intensively	  studied	  to	  classify	  cancer	  types,	  develop	  markers	  for	  early	  diagnosis,	  predict	  cancer	  progression	  and	  analyze	  the	  molecular	  mechanisms	  of	  the	  disease	  (Singal	  and	  Ginder	  1999;	  Issa	  2004;	  Stumpel	  et	  al.	  2009;	  Yan	  et	  al.	  2012).	  Until	  few	  years	  ago	  technical	  issues	  restricted	  DNA	  methylation	  analyses	  to	  CpG-­‐rich	  regions,	  as	  CpG-­‐content	  independent	  genome-­‐wide	  DNA	  methylation	  analysis	  techniques	  were	  only	  recently	  established	  and	  affinity	  based	  methods	  captured	  only	  CpG-­‐dense	  regions	  effectively	  (Suzuki	  and	  Bird	  2008).	  	  Because	  of	  the	  very	  limited	  knowledge	  about	  the	  role	  of	  DNA	  methylation	  patterns	  at	  non-­‐promoter	  regions	  in	  normal	  cell	  development,	  we	  investigated	  locus-­‐wide	  DNA	  methylation	  differences	  between	  Treg	  and	  Tconv	  (chapter	  3.1).	  To	  this	  end,	  we	  adapted	  our	  methyl-­‐CpG-­‐immunoprecipitation	  (MCIp)	  assay	  to	  recover	  both	  the	  methylated	  (mCpG)	  and	  unmethylated	  (CpG)	  DNA	  fractions	  from	  Treg	  and	  Tconv	  (Gebhard	  et	  al.	  2006;	  Schilling	  and	  Rehli	  2007;	  Schilling	  et	  al.	  2009).	  Comparative	  hybridization	  of	  the	  precipitated	  DNA	  pools	  from	  these	  two	  cell	  types	  on	  custom	  microarrays	  allowed	  the	  identification	  of	  more	  than	  130	  differentially	  methylated	  regions	  (DMRs)	  at	  69	  loci	  representing	  regions	  of	  differentially	  expressed	  genes	  between	  Treg	  and	  Tconv	  (chapter	  3.1).	  We	  then	  validated	  target	  regions	  with	  mass	  spectrometry	  based	  DNA	  methylation	  analysis	  (MassARRAY)	  and	  also	  evaluated	  the	  methylation	  status	  of	  the	  identified	  DMRs	  in	  various	  hematopoietic	  cells	  including	  CD8+	  T	  cells,	  CD56+	  natural	  killer	  cells,	  CD14+	  monocytes,	  CD19+	  B	  cells	  and	  CD34+	  hematopoietic	  progenitor	  cells.	  The	  DMRs	  we	  discovered	  were	  mostly	  well	  defined	  and	  covered	  several	  hundreds	  of	  base	  pairs.	  However,	  in	  case	  of	  the	  FOXP3	  locus	  hypomethylation	  in	  Treg	  stretched	  over	  the	  whole	  locus,	  which	  might	  reflect	  the	  exclusive	  expression	  of	  this	  transcription	  factor	  in	  Treg	  (chapter	  3.1).	  Interestingly,	  most	  DMRs	  were	  not	  highly	  conserved,	  did	  not	  overlap	  with	  an	  annotated	  promoter	  and	  had	  a	  low	  to	  intermediate	  CpG	  content.	  These	  observations	  suggest	  that	  most	  promoter	  and	  CpG	  island-­‐centered	  experiments	  miss	  the	  majority	  of	  sites	  that	  are	  differentially	  methylated.	  In	  fact,	  in	  vitro	  models	  of	  neural	  progenitors	  differentiating	  into	  neurons	  showed	  that	  DNA	  methylation	  changes	  at	  promoters	  are	  rare	  events	  in	  late	  differentiation	  steps	  and	  might	  not	  be	  the	  prevalent	  mechanisms	  to	  control	  gene	  expression	  (Mohn	  et	  al.	  2008).	  In	  line	  with	  this,	  recent	  genome-­‐wide	  DNA	  methylation	  studies	  support	  the	  finding	  that	  DNA	  methylation	  is	  most	  dynamic	  at	  promoter-­‐distal	  sites	  of	  lower	  CpG-­‐content	  (Meissner	  et	  al.	  2008;	  Stadler	  et	  al.	  2011).	  	  
4.1.2 DMRs	  are	  associated	  with	  histone	  marks,	  novel	  promoters	  and	  enhancer	  
function	  Histone	  modification	  profiling	  can	  be	  used	  to	  classify	  the	  function	  of	  DNA	  elements	  (Ernst	  et	  al.	  2011).	  Histone	  3	  Lysine	  4	  trimethylation	  (H3K4me3)	  marks	  actively	  transcribed	  regions	  and	  virtually	  all	  CGIs,	  whereas	  enhancers	  are	  characterized	  by	  the	  presence	  of	  Histone	  3	  Lysine	  4	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monomethylation,	  Histone	  3	  Lysine	  4	  dimethylation	  and	  Histone	  3	  Lysine	  27	  acetylation	  (H3K4me1,	  H3K4me2	  and	  H3K27ac,	  respectively)	  (Barski	  et	  al.	  2007;	  Heintzman	  et	  al.	  2007;	  Lupien	  et	  al.	  2008;	  Heintzman	  et	  al.	  2009;	  Ernst	  et	  al.	  2011;	  Rada-­‐Iglesias	  et	  al.	  2011).	  We	  performed	  chromatin	  immunopreciptiation	  (ChIP)	  coupled	  to	  microarray	  hybridization	  (ChIP-­‐on-­‐chip)	  to	  identify	  H3K4me1,	  -­‐me2,	  and	  -­‐me3	  at	  the	  same	  loci	  we	  investigated	  for	  differential	  DNA	  methylation	  in	  Treg	  and	  Tconv.	  Interestingly,	  we	  found	  a	  significant	  overlap	  of	  “active”	  H3K4	  methylation	  at	  DMRs,	  suggesting	  the	  presence	  of	  regulatory	  elements	  at	  DMRs.	  When	  tested	  in	  luciferase	  reporter	  assays,	  many	  DMRs	  showed	  enhancer	  function	  that	  was	  abrogated	  by	  in	  vitro	  methylation	  of	  the	  reporter	  construct	  (chapter	  3.1).	  	  The	  observed	  dynamics	  in	  DNA	  methylation	  at	  distal	  regions,	  the	  associated	  “active”	  chromatin	  marks	  and	  methylation-­‐sensitive	  enhancer	  function	  suggest	  a	  close	  association	  of	  DMRs	  and	  lineage-­‐specific	  gene	  regulation.	  In	  fact,	  our	  results	  illustrated	  for	  the	  first	  time	  such	  a	  close	  relation	  of	  differential	  DNA	  methylation	  and	  enhancer	  function	  in	  non-­‐malignant	  cells.	  In	  support	  of	  these	  findings,	  Sérandour	  and	  colleagues	  reported	  that	  upon	  FOXA1	  activation	  and	  its	  cell	  type-­‐specific	  recruitment	  to	  enhancers	  in	  MCF7	  or	  LNCaP	  cells	  these	  enhancers	  were	  associated	  with	  an	  increase	  of	  H3K4	  methylation	  and	  a	  decrease	  of	  DNA	  methylation	  (Sérandour	  et	  al.	  2011).	  Similar	  reports	  described	  cell	  type-­‐specific	  DMRs	  as	  active	  regulatory	  regions	  in	  in	  
vitro	  differentiation	  models	  of	  neuronal	  progenitors	  (Stadler	  et	  al.	  2011)	  and	  glucocorticoid-­‐responsive	  cell	  lines	  (Wiench	  et	  al.	  2011).	  On	  a	  genome-­‐wide	  level,	  DNA	  methylation	  is	  inversely	  correlated	  with	  the	  binding	  of	  transcription	  factors,	  further	  supporting	  the	  view	  that	  DMRs	  often	  represent	  regulatory	  regions	  (Lister	  et	  al.	  2009;	  Stadler	  et	  al.	  2011).	  It	  is	  still	  not	  completely	  understood	  how	  and	  to	  what	  extent	  DNA	  methylation	  controls	  regulatory	  regions	  and	  how	  differential	  DNA	  methylation	  patterns	  are	  established.	  However,	  in	  silico	  analysis	  of	  Treg	  DMRs	  revealed	  an	  overrepresentation	  of	  specific	  transcription	  factor	  (TF)	  consensus	  sites	  including	  CREB/ATF	  and	  STAT5	  (chapter	  3.1).	  These	  factors	  are	  essential	  for	  FOXP3	  expression	  in	  Treg	  and	  might	  contribute	  to	  the	  establishment	  of	  DMRs	  (Fontenot	  et	  al.	  2005a;	  Kim	  and	  Leonard	  2007).	  DNA	  hypomethylation	  at	  enhancers	  could	  result	  from	  the	  blocking	  of	  DNA	  methyltransferases	  (DNMTs)	  by	  bound	  transcription	  factors	  (TFs),	  leading	  to	  passive	  demethylation	  during	  DNA	  replication.	  In	  fact,	  many	  TFs	  do	  not	  have	  a	  CpG	  in	  their	  consensus	  site	  and	  might	  even	  bind	  to	  their	  recognition	  sequence	  in	  the	  close	  vicinity	  of	  methylated	  DNA,	  which	  could	  promote	  passive	  demethylation.	  In	  contrast	  to	  this	  consideration,	  the	  discovery	  of	  5-­‐hydroxymethylcytosine	  as	  an	  intermediate	  in	  active	  DNA	  demethylation	  linked	  this	  mark	  to	  
cis-­‐regulatory	  regions	  (Stroud	  et	  al.	  2011;	  Szulwach	  et	  al.	  2011;	  Sérandour	  et	  al.	  2012).	  This	  implies	  active	  removal	  of	  DNA	  methylation	  at	  enhancers.	  Moreover,	  DNA	  demethylation	  at	  distal	  regions	  was	  observed	  in	  proliferation-­‐free	  differentiation	  systems,	  which	  supports	  active	  DMR	  establishment	  (Klug	  et	  al.	  2010).	  In	  case	  of	  the	  differentially	  methylated	  Foxp3	  enhancer	  (also	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known	  as	  conserved	  noncoding	  sequence	  2	  [CNS2]	  or	  Treg-­‐specific	  demethylated	  region	  [TSDR]),	  DNA	  methylation	  blocks	  the	  binding	  of	  Runx,	  ETS-­‐1	  and	  CREB/ATF	  proteins	  in	  vitro	  (Floess	  et	  al.	  2007;	  Kim	  and	  Leonard	  2007;	  Polansky	  et	  al.	  2010;	  Zheng	  et	  al.	  2010).	  It	  is	  unknown	  if	  another	  DNA	  methylation-­‐insensitive	  TF	  is	  needed	  to	  “open”	  the	  enhancer,	  or	  if	  the	  
in	  vivo	  situation	  allows	  binding	  of	  these	  TFs	  alone	  or	  in	  cooperation	  with	  other	  TFs	  as	  discussed	  in	  the	  introduction.	  Consistent	  with	  our	  in	  silico	  analysis	  is	  the	  notion	  that	  DNA	  elements	  can	  autonomously	  determine	  their	  DNA	  methylation	  status	  depending	  on	  the	  binding	  of	  transcription	  factors	  (Lienert	  et	  al.	  2011).	  The	  establishment	  of	  DNA	  hypomethylation	  was	  not	  a	  function	  of	  CpG	  density,	  but	  was	  based	  on	  the	  presence	  of	  TF	  consensus	  motifs	  (Lienert	  et	  al.	  2011).	  More	  mechanistic	  studies	  and	  temporal	  investigations	  of	  changes	  in	  DNA	  methylation	  will	  be	  needed	  to	  resolve	  these	  complex	  processes	  that	  establish	  DNA	  methylation	  patterns.	  It	  would	  be	  of	  great	  interest	  if	  differential	  DNA	  methylation	  was	  a	  general	  hallmark	  of	  important	  cell	  type-­‐specific	  enhancers.	  Genome-­‐wide	  DNA	  methylation	  profiles	  could	  then	  be	  used	  to	  identify	  specific	  regulatory	  regions	  in	  any	  cell	  type.	  DNA	  methylation	  as	  a	  tool	  for	  enhancer	  detection	  would	  be	  advantageous	  compared	  to	  histone	  modification	  analysis,	  because	  DNA	  is	  more	  stable	  and,	  in	  addition,	  easier	  to	  isolate	  than	  chromatin	  for	  histone	  ChIPs.	  DNA	  for	  sensitive	  downstream	  applications	  such	  as	  mass	  spectrometry-­‐based	  DNA	  methylation	  analysis	  can	  even	  be	  obtained	  from	  fixed	  cells	  as	  we	  demonstrated	  for	  FOXP3-­‐stained	  cells	  (chapter	  3.3).	  	  Obviously	  the	  custom	  microarray	  for	  DMR	  analysis	  was	  designed	  to	  include	  differentially	  expressed	  genes	  between	  Treg	  and	  Tconv	  and	  is	  therefore	  biased	  towards	  functionally	  important	  regions.	  Still,	  it	  is	  noteworthy	  that	  we	  found	  several	  DMRs	  at	  virtually	  all	  Treg	  signature	  genes	  including	  FOXP3,	  IL2RA,	  CTLA4,	  IKZF2	  and	  LGAS3	  and	  several	  Tconv-­‐specific	  genes	  including	  IFNG	  and	  CD40LG.	  Some	  of	  the	  DMRs	  covered	  known	  enhancers	  at	  the	  IFNG	  and	  
FOXP3	  locus	  (Floess	  et	  al.	  2007;	  Schoenborn	  et	  al.	  2007a).	  In	  addition,	  by	  using	  transient	  reporter	  gene	  assays,	  we	  confirmed	  new	  potential	  enhancers	  at	  the	  IL2RA,	  LRRC32,	  LGALS3,	  
TP53INP1,	  PPP1R3F	  (the	  gene	  upstream	  of	  FOXP3),	  CD40LG,	  IL-­‐26,	  ID2	  and	  SEPT9	  genes.	  Some	  DMR-­‐enhancer	  assays	  were	  inactive	  when	  transfected	  into	  Jurkat	  cells.	  This	  may	  be	  caused	  by	  the	  absence	  of	  factors	  in	  Jurkat	  cells	  that	  would	  be	  required	  for	  Treg-­‐specific	  regulatory	  regions	  to	  be	  active.	  Thus,	  transfection	  of	  primary	  cells	  would	  be	  a	  promising	  strategy	  to	  clarify	  whether	  these	  regions	  are	  potential	  enhancers	  or	  not.	  Another	  challenge	  is	  to	  link	  an	  enhancer	  to	  its	  target	  promoter,	  since	  enhancers	  can	  act	  over	  long	  distances	  and	  do	  not	  necessarily	  interact	  with	  the	  closest	  promoter	  (Lettice	  et	  al.	  2003;	  Spilianakis	  and	  Flavell	  2004;	  Lomvardas	  et	  al.	  2006).	  This	  is	  certainly	  of	  interest	  for	  the	  putative	  enhancer	  located	  upstream	  of	  the	  FOXP3	  gene	  in	  the	  PPP1R3F	  locus.	  PPP1R3F	  is	  not	  differentially	  expressed	  between	  Treg	  and	  Tconv	  (chapter	  3.1).	  We	  could	  demonstrate	  that	  in	  Treg	  the	  PPP1R3F	  enhancer	  shows	  H3K27ac,	  H3K4me1	  and	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the	  binding	  of	  STAT5	  in	  a	  Treg-­‐specific	  manner	  (chapter	  3.5).	  This	  suggests	  that	  this	  enhancer	  contributes	  to	  the	  regulation	  of	  another	  gene	  than	  PPP1R3F,	  e.g.	  FOXP3.	  This	  hypothesis	  could	  be	  tested	  with	  the	  3C	  technique	  to	  confirm	  the	  physical	  interaction	  of	  the	  FOXP3	  promoter	  with	  this	  upstream	  DMR	  (Dekker	  et	  al.	  2002).	  However,	  preliminary	  3C	  experiments	  on	  primary	  cell	  populations	  are	  technically	  challenging	  and	  did	  not	  yield	  evaluable	  results	  (data	  not	  shown).	  	  We	  also	  noted	  an	  association	  of	  DMRs	  with	  H3K4me3	  at	  several	  loci	  including	  CTLA4	  and	  
RTKN2.	  This	  histone	  modification	  is	  normally	  associated	  with	  active	  transcription	  or	  CGIs,	  but	  was	  rarely	  connected	  with	  enhancers	  so	  far	  (Heintzman	  et	  al.	  2007;	  Deaton	  and	  Bird	  2011;	  Pekowska	  et	  al.	  2011).	  Although	  few	  DMRs	  cover	  an	  annotated	  promoter,	  there	  is	  still	  the	  possibility	  that	  some	  harbor	  transcription	  start	  sites	  (TSSs)	  of	  previously	  unrecognized	  cell	  type-­‐specific	  transcripts	  because	  especially	  Treg	  were	  underrepresented	  in	  expressed	  sequence	  tag/mRNA	  sequencing	  and	  annotation	  projects	  due	  to	  their	  scarcity	  in	  blood.	  As	  part	  of	  the	  FANTOM5	  project	  we	  could	  generate	  global	  single	  base	  pair	  resolution	  maps	  of	  TSSs	  in	  Treg	  and	  Tconv	  by	  the	  application	  of	  cap	  analysis	  of	  gene	  expression	  (CAGE)	  adapted	  to	  single	  molecule	  sequencing	  (Kanamori-­‐Katayama	  et	  al.	  2011)	  (chapter	  3.5).	  This	  detected	  in	  fact	  TSSs	  signals	  at	  one	  CTLA4-­‐	  and	  one	  RTKN2-­‐	  located	  DMRs	  in	  Treg	  populations	  (chapter	  3.5).	  5’-­‐RACE	  experiments	  confirmed	  inter	  alia	  spliced	  transcripts	  emerging	  from	  the	  TSS	  located	  upstream	  of	  the	  native	  CTLA4	  promoter	  into	  the	  annotated	  CTLA4	  gene.	  In	  case	  of	  RTKN2,	  5’-­‐RACE	  PCR	  confirmed	  a	  spliced	  transcript	  emerging	  from	  the	  intergenic	  DMR	  into	  the	  downstream	  exon.	  Of	  note,	  when	  compared	  to	  more	  than	  1900	  FANTOM	  samples,	  these	  TSSs	  are	  very	  specific	  for	  Treg	  cells	  (the	  FANTOM	  consortium,	  unpublished	  observations).	  Epigenetic	  features	  mirror	  the	  Treg-­‐specific	  expression	  of	  the	  CTLA4	  upstream	  TSS:	  MassARRAY	  analysis	  revealed	  exclusive	  demethylation	  in	  regulatory	  T	  cells	  and	  was	  not	  observed	  in	  the	  panel	  of	  other	  hematopoietic	  lineages	  (chapter	  3.1).	  Noteworthy,	  MassARRAY	  analysis	  highlighted	  striking	  similarities	  in	  the	  DNA	  methylation	  profiles	  at	  enhancers	  between	  in	  vitro	  expanded	  and	  primary	  T	  cell	  populations,	  which	  supports	  earlier	  experimental	  evidence	  that	  ascribed	  phenotypic	  stability	  to	  
in	  vitro	  expanded	  CD45RA+	  naïve	  Treg	  that	  were	  used	  in	  these	  experiments	  (Hoffmann	  et	  al.	  2004;	  Hoffmann	  et	  al.	  2006b).	  	  Taken	  together,	  we	  identified	  more	  than	  130	  DMRs	  at	  immunologically	  relevant	  genes	  in	  Treg	  and	  Tconv.	  In	  line	  with	  recent	  publications,	  we	  could	  show	  that	  the	  majority	  of	  DMRs	  were	  located	  inter-­‐	  or	  intragenic	  and	  had	  a	  low	  CpG	  content	  (chapter	  3.1).	  Of	  capital	  importance	  was	  the	  finding	  that	  DMRs	  were	  associated	  with	  active	  chromatin	  marks	  and	  showed	  DNA	  methylation-­‐sensitive	  enhancer	  activity.	  In	  two	  confirmed	  cases	  DMRs	  harbored	  previously	  unrecognized	  cell	  type-­‐specific	  TSSs.	  MassARRAY	  generated	  DNA	  methylation	  profiles	  demonstrated	  similarities	  between	  expanded	  and	  primary	  Treg	  and	  further	  showed	  that	  DMRs	  demethylated	  in	  Treg	  or	  Tconv	  were	  normally	  hypermethylated	  in	  progenitor	  cells	  and	  other	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hematopoietic	  lineages.	  Our	  results	  suggest	  that	  differential	  DNA	  methylation	  marks	  enhancers	  and	  regulates	  lineage-­‐specific	  gene	  expression.	  Moreover,	  we	  established	  a	  methylation	  “fingerprint”	  that	  identifies	  regulatory	  T	  cells	  on	  a	  molecular	  basis.	  
4.1.3 Enhancer	  profiling	  identifies	  key	  regulators	  in	  T	  cell	  subpopulations	  With	  their	  rapid	  improvement	  and	  decreasing	  costs,	  next	  generation	  sequencing	  technologies	  became	  the	  method	  of	  choice	  for	  systematic	  analysis	  of	  gene	  regulation.	  Global	  analysis	  of	  chromatin	  states,	  transcription	  start	  sites	  and	  transcription	  factor	  binding	  have	  increased	  our	  understanding	  of	  the	  organization	  and	  regulation	  of	  our	  genome	  and	  is	  crucial	  to	  understand	  basic	  principles	  of	  biology	  and	  disease	  (Bernstein	  et	  al.	  2012).	  As	  outlined	  in	  the	  introduction,	  enhancers	  contribute	  substantially	  to	  gene	  regulation	  in	  complex	  multicellular	  organisms.	  They	  are	  more	  diverse	  than	  promoters,	  activated	  in	  a	  cell	  type-­‐specific	  manner	  and	  can	  be	  dissected	  by	  biochemical	  properties	  including	  DNase	  hypersensitivity	  as	  well	  as	  the	  deposition	  of	  certain	  histone	  modifications	  (Heintzman	  et	  al.	  2009;	  Bernstein	  et	  al.	  2010;	  Bernstein	  et	  al.	  2012;	  Thurman	  et	  al.	  2012).	  “Poised”	  enhancers	  are	  associated	  with	  the	  distal	  deposition	  of	  H3K4me1,	  whereas	  “active”	  enhancers	  were	  described	  to	  be	  associated	  with	  H3K27ac	  among	  other	  histone	  modifications	  (Barski	  et	  al.	  2007;	  Heintzman	  et	  al.	  2007;	  Creyghton	  et	  al.	  2010;	  Rada-­‐Iglesias	  et	  al.	  2011).	  To	  extend	  our	  restricted	  ChIP-­‐on-­‐chip	  based	  approach	  to	  profile	  histone	  modifications	  in	  Treg	  and	  Tconv,	  we	  generated	  genome-­‐wide	  maps	  of	  H3K4me1	  and	  H3K27ac	  in	  in	  vitro	  expanded	  CD4+CD25highCD45RA+	  naïve	  Treg	  (eRA+Treg),	  CD4+CD25highCD45RA–	  memory	  Treg	  (eRA-­‐Treg),	  CD4+CD25–CD45RA+	  naïve	  Tconv	  (eRA+Tconv)	  and	  CD4+CD25–CD45RA–	  memory	  Tconv	  (eRA-­‐Tconv)	  (chapter	  3.5).	  Thereby	  we	  were	  able	  to	  identify	  thousands	  of	  putative	  enhancers	  in	  every	  cell	  type.	  By	  pairwise	  comparisons	  we	  could	  also	  identify	  several	  thousand	  putative	  enhancers	  that	  were	  cell	  type-­‐specific	  for	  even	  closely	  related	  subpopulations	  (e.g.	  eRA+Treg	  and	  eRA-­‐Treg).	  A	  recent	  report	  also	  described	  H3K4me1	  in	  Treg	  and	  Tconv,	  and	  claimed	  to	  find	  many	  specific	  putative	  regulatory	  regions	  (Tian	  et	  al.	  2011).	  However,	  uncertainty	  about	  experimental	  conditions	  in	  cell	  purification	  and	  ChIP	  experiments	  prevented	  us	  from	  integrating	  these	  available	  datasets	  in	  our	  analysis.	  With	  enhancers	  binding	  general-­‐	  and	  cell	  type-­‐specific	  transcription	  factors,	  they	  are	  characterized	  by	  an	  overrepresentation	  of	  TF	  consensus	  binding	  sequences	  (Lupien	  et	  al.	  2008;	  Heinz	  et	  al.	  2010;	  Hardison	  and	  Taylor	  2012b;	  Neph	  et	  al.	  2012).	  Hence,	  by	  analyzing	  the	  sequence	  composition	  in	  in	  vitro	  expanded	  Treg-­‐	  and	  Tconv-­‐specific	  enhancers	  we	  identified	  the	  enrichment	  of	  motifs	  that	  matched	  known	  TF	  consensus	  sites	  including	  STAT,	  ETS,	  RUNX,	  forkhead,	  KLF	  and	  IRF	  motifs	  (chapter	  3.5).	  Factors	  of	  these	  families	  were	  already	  described	  to	  be	  essential	  for	  Treg	  development	  including	  STAT5,	  ETS1,	  RUNX1	  and	  FOXP3.	  However,	  with	  the	  exception	  of	  FOXP3,	  the	  contribution	  of	  these	  factors	  to	  global	  gene	  regulation	  was	  only	  explored	  in	  the	  murine	  system	  or	  on	  a	  very	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limited	  basis	  in	  humans	  (chapter	  3.5).	  Hence,	  we	  identified	  the	  binding	  of	  STAT5,	  ETS1,	  RUNX1	  and	  FOXP3	  by	  chromatin	  immunoprecipitation	  coupled	  to	  next	  generation	  sequencing	  (ChIP-­‐seq)	  in	  in	  vitro	  expanded	  Treg	  and	  Tconv.	  The	  binding	  of	  the	  corresponding	  TF	  followed	  their	  motif	  distribution	  in	  cell	  type-­‐specific	  enhancers.	  This	  demonstrated,	  in	  line	  with	  a	  recent	  report,	  that	  de	  novo	  motif	  analyses	  of	  regulatory	  regions	  can	  identify	  key	  regulators	  of	  cellular	  states	  (Pham	  et	  al.	  2012).	  These	  analyses	  revealed	  also	  that	  RUNX1	  and	  ETS1	  mainly	  contributed	  to	  eTconv-­‐specific	  enhancer	  architecture	  in	  contrast	  to	  their	  established	  function	  in	  Treg	  development	  and	  function	  (chapter	  3.5;	  (Kitoh	  et	  al.	  2009;	  Mouly	  et	  al.	  2010),	  which	  highlights	  the	  importance	  of	  global	  analysis	  to	  understand	  the	  contribution	  to	  gene	  regulation	  of	  a	  certain	  TF.	  In	  summary	  we	  provide	  the	  so	  far	  most	  comprehensive	  resource	  concerning	  TF	  binding	  and	  histone	  profiling	  on	  human	  T	  cell	  populations.	  This	  data	  will	  improve	  studies	  on	  gene	  regulation	  of	  single	  genes	  and	  allows	  comparative	  epigenomic	  analyses	  in	  the	  context	  of	  a	  growing	  pool	  of	  datasets.	  
4.2 Plasticity,	  stability	  and	  heterogeneity	  of	  human	  T	  cell	  
populations	  
4.2.1 Methodology	  advancements	  In	  contrast	  to	  the	  murine	  system	  where	  genetically	  engineered	  mice	  allow	  the	  easy	  purification	  of	  viable	  fluorescence-­‐labeled	  Foxp3+	  cells	  (Fontenot	  et	  al.	  2005b),	  FOXP3	  staining	  of	  human	  cells	  requires	  cell	  permeabilization	  and	  fixation	  with	  paraformaldehyde.	  So	  far,	  this	  procedure	  hindered	  any	  purification	  of	  nucleic	  acids	  for	  downstream	  analysis	  and	  prohibited	  functional	  cellular	  essays	  (Hoffmann	  et	  al.	  2006a).	  For	  such	  purposes,	  human	  Treg	  cells	  can	  be	  FACS-­‐purified	  only	  by	  the	  use	  of	  surrogate	  markers,	  namely	  by	  high	  expression	  of	  CD4	  and	  CD25	  as	  well	  as	  low	  or	  absent	  expression	  of	  CD127	  (Hoffmann	  et	  al.	  2006a;	  Liu	  et	  al.	  2006;	  Seddiki	  et	  al.	  2006).	  However,	  CD4+CD25+CD127lo	  cells	  are	  not	  a	  homogeneous	  cell	  population	  but	  contain,	  for	  example,	  CD45RA-­‐	  “memory”	  and	  CD45RA+	  “naive”	  subpopulations	  (Hoffmann	  et	  al.	  2006b).	  Interestingly,	  fractions	  of	  human	  CD45RA-­‐	  memory	  Treg	  can	  produce	  proinflammatory	  cytokines	  and	  express	  the	  T	  helper	  (Th)17	  determining	  transcription	  factor	  RORC	  (Koenen	  et	  al.	  2008;	  Ayyoub	  et	  al.	  2009;	  Beriou	  et	  al.	  2009;	  Miyara	  et	  al.	  2009;	  Voo	  et	  al.	  2009).	  Also,	  in	  the	  murine	  system,	  instability	  or	  loss	  of	  Foxp3	  expression	  led	  to	  increased	  proinflammatory	  cytokine	  production	  in	  “ex-­‐Treg”	  (Xu	  et	  al.	  2007;	  Duarte	  et	  al.	  2009;	  Komatsu	  et	  al.	  2009;	  Zhou	  et	  al.	  2009c).	  After	  in	  vitro	  expansion	  of	  human	  Treg,	  CD45RA-­‐	  cells	  partially	  lost	  FOXP3	  expression	  in	  contrast	  to	  their	  CD45RA+	  naïve	  counterparts	  that	  maintained	  a	  stable	  Treg	  ph
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(Hoffmann	  et	  al.	  2006b;	  Hoffmann	  et	  al.	  2009).	  These	  observations	  challenge	  the	  paradigm	  of	  a	  stable	  Treg	  lineage	  and	  raise	  questions	  about	  the	  stability	  and	  proinflammatory	  potential	  of	  Treg	  subpopulations,	  especially	  in	  view	  of	  planned	  and	  ongoing	  clinical	  trials	  using	  Treg	  cell	  products	  for	  the	  treatment	  of	  patients	  with	  autoimmune	  diseases	  or	  for	  the	  induction	  of	  tolerance	  after	  stem	  cell	  or	  organ	  transplantation.	  Molecular	  markers	  prove	  to	  be	  useful	  to	  distinguish	  stable	  from	  unstable	  Foxp3+	  cells.	  As	  an	  example,	  only	  the	  complete	  demethylation	  of	  the	  Foxp3	  TSDR	  enhancer	  is	  associated	  with	  stable	  Foxp3	  expression	  (Floess	  et	  al.	  2007;	  Polansky	  et	  al.	  2008;	  Hoffmann	  et	  al.	  2009;	  Miyao	  et	  al.	  2012),	  and	  therefore	  we	  established	  DNA	  methylation	  “fingerprints”	  that	  permit	  conclusions	  about	  the	  stability	  and	  identity	  of	  T	  cell	  populations	  (chapters	  3.2;	  3.3).	  To	  analyze	  molecular	  characteristics	  of	  human	  expanded	  T	  cell	  subpopulations	  we	  first	  improved	  molecular	  methods	  to	  isolate	  DNA	  and	  RNA	  from	  human	  FOXP3-­‐stained	  FACS-­‐sorted	  cells	  (chapters	  3.2;	  3.4).	  To	  revert	  paraformaldehyde-­‐introduced	  crosslinks	  of	  nucleic	  acids	  resulting	  from	  commercial	  FOXP3	  staining	  protocols,	  the	  sorted	  cells	  were	  incubated	  at	  60°C	  in	  the	  presence	  of	  sodium	  dodecyl	  sulfate	  and	  salt	  following	  the	  “reverse-­‐crosslinking”	  procedures	  in	  ChIP	  protocols	  (Kuo	  and	  Allis	  1999).	  Subsequent	  phenol-­‐based	  DNA	  purification	  yielded	  DNA	  of	  high	  quality	  and	  molecular	  weight	  that	  was	  suitable	  for	  sensitive	  downstream	  applications	  such	  as	  DNA	  methylation	  analysis	  with	  the	  MassARRAY	  (chapter	  3.2).	  For	  RNA	  isolation	  of	  FOXP3-­‐sorted	  cells	  the	  staining	  procedure	  had	  to	  be	  adapted.	  Paraformaldehyde	  was	  substituted	  by	  ethanol	  for	  fixation	  of	  the	  cells,	  which	  permitted	  similar	  cell	  purities	  after	  FACS-­‐sorting	  as	  established	  commercial	  staining	  protocols,	  but	  allowed	  the	  purification	  of	  RNA	  suitable	  for	  qPCR	  as	  well	  as	  microarray	  hybridizations	  (chapter	  3.4).	  We	  then	  used	  these	  technologies	  to	  analyze	  DNA	  methylation	  in	  FOXP3-­‐maintaining	  and	  FOXP3-­‐losing	  expanded	  CD4+CD25+CD45RA+	  and	  CD4+CD25+CD45RA-­‐	  expansion	  cultures	  (chapter	  3.3)	  as	  well	  as	  gene	  expression	  in	  CD4+CD25+CD45RA-­‐FOXP3+	  and	  CD4+CD25+CD45RA-­‐FOXP3-­‐	  subpopulations	  (chapter	  3.4).	  	  
4.2.2 DNA	  methylation	  analysis	  and	  gene	  expression	  profiling	  of	  T	  cell	  
subpopulations	  We	  found	  that	  DNA	  demethylation	  at	  the	  RORC	  locus	  occurred	  mainly	  in	  CD45RA-­‐	  memory	  but	  not	  CD45RA+	  naïve	  Treg	  after	  in	  vitro	  expansion	  (chapter	  3.3).	  Demethylation	  was	  most	  prominent	  at	  the	  RORC	  promoter,	  but	  occurred	  also	  at	  distal	  sites.	  In	  support	  of	  our	  previous	  findings	  (chapter	  3.1),	  some	  distal	  DMRs	  harbored	  methylation	  sensitive	  enhancers.	  Interestingly,	  DNA	  hypomethylation	  was	  most	  pronounced	  in	  CD45RA-­‐	  memory	  Treg	  that	  retained	  FOXP3	  expression.	  In	  line	  with	  this,	  most	  Interleukin	  (IL)-­‐17-­‐producing	  cells	  emerged	  from	  this	  population	  and	  showed	  a	  DNA	  methylation	  pattern	  almost	  identical	  to	  that	  of	  in	  vitro	  generated	  IL-­‐17-­‐producing	  cells	  (chapter	  3.3).	  Microarray-­‐based	  gene	  expression	  analysis	  of	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expanded	  memory	  Treg	  subpopulations	  revealed	  that	  mainly	  the	  CD4+CD25+CD45RA-­‐FOXP3-­‐	  fraction	  transcribed	  large	  amounts	  of	  the	  Th2	  cytokines	  IL-­‐4,	  IL-­‐5	  and	  IL-­‐13,	  but	  few	  Th1	  and	  Th17	  cytokines	  (chapter	  3.4).	  We	  confirmed	  these	  findings	  also	  on	  protein	  levels.	  Expression	  of	  Th2-­‐associated	  genes	  including	  GATA3,	  MAF,	  GFI1	  and	  GPR44	  as	  well	  as	  the	  Tconv	  markers	  CD127	  and	  CD40LG	  were	  upregulated	  in	  FOXP3-­‐	  memory	  Treg	  whereas	  the	  FOXP3+	  fraction	  expressed	  much	  higher	  amounts	  of	  Treg	  signature	  genes	  as	  well	  as	  RORC.	  	  Taken	  together,	  CD45RA+	  Treg	  retain	  a	  stable	  Treg	  phenotype	  even	  after	  3-­‐4	  weeks	  of	  in	  vitro	  culture.	  In	  contrast,	  some	  CD45RA-­‐	  memory	  Treg	  cells	  can	  develop	  into	  potentially	  harmful	  Th-­‐like	  subsets.	  Moreover,	  in	  our	  culture	  conditions,	  the	  default	  pathway	  of	  Treg	  development	  is	  a	  Th2	  phenotype	  upon	  loss	  of	  FOXP3	  expression.	  Experiments	  in	  mice	  with	  unstable	  Foxp3	  expression	  or	  Foxp3	  deletion	  in	  Treg	  show	  increased	  Th2	  cytokine	  production,	  which	  parallels	  our	  findings	  in	  the	  human	  system	  (Lin	  et	  al.	  2007;	  Wan	  and	  Flavell	  2007).	  This	  conversion	  was	  dependent	  on	  Gata3	  (Wang	  et	  al.	  2010),	  although	  we	  excluded	  the	  contribution	  of	  IL-­‐4/STAT6	  (a	  pathway	  for	  Gata3	  activation	  (Kaplan	  et	  al.	  1996;	  Takeda	  et	  al.	  1996;	  Zheng	  and	  Flavell	  1997))	  to	  Th2	  development	  in	  our	  system	  (chapter	  3.4).	  Nevertheless,	  GATA3	  can	  be	  activated	  through	  alternative	  signaling	  pathways	  mediated	  by	  notch	  (Amsen	  et	  al.	  2007).	  Another	  possibility	  is	  the	  promotion	  of	  Th2	  conversion	  by	  our	  culture	  conditions.	  Treg	  expansion	  cultures	  receive	  repetitive	  TCR	  stimulation	  and	  high	  doses	  of	  IL-­‐2,	  which	  activate	  STAT5	  signaling	  that	  plays	  a	  critical	  role	  in	  Th2	  differentiation	  (Kagami	  et	  al.	  2001;	  Zhu	  et	  al.	  2003;	  Cote-­‐Sierra	  et	  al.	  2004).	  The	  observed	  prevalence	  of	  IL-­‐17	  production	  and	  RORC	  hypomethylation	  in	  expanded	  FOXP3+	  memory	  Treg	  is	  in	  line	  with	  recent	  publications.	  Several	  research	  groups	  ascribed	  RORC/IL-­‐17	  expression	  to	  FOXP3+	  memory	  cells	  in	  vitro	  and	  in	  vivo	  (Ayyoub	  et	  al.	  2009;	  Beriou	  et	  al.	  2009;	  Miyara	  et	  al.	  2009;	  Voo	  et	  al.	  2009).	  In	  contrast,	  even	  after	  extended	  in	  vitro	  expansion,	  CD45RA+	  Treg	  did	  not	  show	  increased	  RORC	  expression	  or	  IL-­‐17	  production	  (chapter	  3.3).	  Importantly,	  no	  demethylation	  of	  the	  RORC	  locus	  was	  observed	  in	  CD45RA+	  Treg,	  arguing	  for	  continuous	  RORC	  silencing	  in	  these	  cells	  and	  for	  a	  development	  of	  IL-­‐17	  producing	  cells	  preferentially	  from	  memory	  Treg	  (chapter	  3.3).	  Yet,	  a	  recent	  publication	  that	  suggests	  the	  emergence	  of	  RORC+	  cells	  from	  CD45RA+	  naïve	  FOXP3+	  Treg	  (Valmori	  et	  al.	  2010).	  These	  discrepancies	  may	  be	  due	  to	  differences	  in	  cell	  isolation	  strategies	  or	  caused	  by	  varying	  extracellular	  stimuli	  in	  the	  respective	  experimental	  setups.	  However,	  the	  high	  cell	  purity	  in	  our	  experiments	  and	  the	  observed	  epigenetic	  stability	  of	  the	  RORC	  locus	  in	  CD45RA+	  cells	  strongly	  argues	  against	  their	  differentiation	  into	  IL-­‐17	  producing	  cells.	  Yet,	  the	  ex	  vivo	  situation	  does	  not	  resemble	  the	  actual	  situation	  in	  humans,	  and	  it	  will	  be	  a	  challenge	  to	  address	  the	  fate	  of	  Treg	  subpopulations	  in	  vivo.	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4.2.3 Cap	  analysis	  of	  gene	  expression	  extends	  the	  information	  content	  of	  gene	  
expression	  analysis	  In	  addition	  to	  microarray-­‐based	  gene	  expression	  analysis,	  participation	  in	  the	  FANTOM	  (functional	  annotation	  of	  the	  mammalian	  genome;	  http://fantom.gsc.riken.jp)	  project	  enabled	  us	  to	  use	  the	  HeliscopeCAGE	  technology.	  Heliscope	  CAGE	  (cap	  analysis	  of	  gene	  expression	  adapted	  to	  single	  molecule	  sequencing)	  maps	  genuine	  transcription	  start	  sites	  (TSSs)	  at	  base	  pair	  resolution	  and	  measures	  gene	  expression	  in	  a	  PCR	  unbiased	  manner	  (Kanamori-­‐Katayama	  et	  al.	  2011).	  Hence,	  we	  subjected	  three	  biological	  replicates	  of	  highly	  purified	  primary	  (labeled	  with	  prefixed	  “p”)	  CD4+CD25highCD45RA+	  naïve	  Treg	  (pRA+Treg),	  CD4+CD25highCD45RA–	  memory	  Treg	  (pRA-­‐Treg),	  CD4+CD25–CD45RA+	  naïve	  Tconv	  (pRA+Tconv)	  and	  CD4+CD25–CD45RA–	  memory	  Tconv	  (pRA-­‐Tconv)	  as	  well	  as	  in	  vitro	  expansion	  cultures	  of	  every	  subpopulation	  to	  HeliscopeCAGE	  sequencing	  (chapter	  3.5).	  In	  addition	  to	  known	  promoters	  we	  found	  many	  additional	  TSSs	  that	  were	  not	  annotated	  to	  a	  transcript.	  These	  TSSs	  could	  represent	  alternative	  promoters,	  promoters	  of	  undiscovered	  genes,	  TSSs	  of	  enhancer	  RNAs	  or	  re-­‐capping	  events	  (Kim	  et	  al.	  2010;	  Kanamori-­‐Katayama	  et	  al.	  2011;	  Melgar	  et	  al.	  2011;	  Djebali	  et	  al.	  2012).	  As	  already	  addressed	  above,	  we	  could	  validate	  several	  new	  TSSs	  as	  alternative	  promoters	  of	  known	  genes	  by	  5’-­‐PCR	  (chapter	  3.5).	  Of	  great	  interest	  was	  the	  discovery	  of	  new	  TSSs	  at	  immunologically	  important	  genes.	  In	  addition	  to	  the	  new	  CTLA4	  TSS,	  we	  were	  even	  able	  to	  identify	  novel	  TSSs	  at	  a	  conserved	  region	  upstream	  of	  the	  intensively	  studied	  FOXP3	  locus.	  This	  TSS	  produced	  a	  spliced	  transcript	  that	  extends	  into	  the	  native	  FOXP3	  mRNA.	  In	  addition,	  reporter	  gene	  assays	  demonstrated	  strong	  general	  activity	  of	  this	  TSS	  cluster	  in	  Jurkat	  T	  cells,	  which	  was	  further	  increased	  after	  stimulation.	  The	  biological	  significance	  of	  these	  finding	  is	  still	  unclear	  and	  demands	  further	  research.	  However,	  DNA	  at	  this	  new	  FOXP3	  TSS	  cluster	  was	  demethylated	  in	  Treg	  but	  hypermethylated	  in	  all	  other	  tested	  hematopoietic	  cells	  (chapter	  3.1),	  which	  implies	  epigenetic	  regulation	  and	  can	  explain	  Treg-­‐exclusive	  expression	  of	  this	  element.	  In	  addition,	  epigenetic	  profiles	  around	  these	  new	  TSSs	  were	  similar	  to	  the	  profiles	  at	  promoters	  of	  known	  genes	  expressed	  in	  the	  analyzed	  T	  cell	  populations.	  Hence,	  these	  results	  imply	  that	  a	  significant	  fraction	  of	  the	  newly	  discovered	  TSSs	  is	  indeed	  functional.	  This	  is	  in	  line	  with	  growing	  evidence	  that	  the	  transcriptional	  landscape	  in	  mammals	  is	  much	  more	  complex	  than	  anticipated,	  and	  that	  a	  large	  fraction	  of	  non-­‐annotated	  transcripts	  is	  not	  “noise”	  or	  “junk”,	  but	  highly	  regulated	  and	  functionally	  important	  output	  (Djebali	  et	  al.	  2012).	  It	  will	  be	  essential	  to	  explore	  to	  what	  extend	  alternative	  promoters	  produce	  alternative	  proteins	  that	  might	  have	  a	  completely	  different	  function	  or	  cellular	  localization	  due	  to	  additional	  or	  lacking	  domains.	  In	  addition	  to	  uncovering	  new	  TSSs,	  CAGE	  also	  represents	  a	  measure	  of	  gene	  expression	  in	  general.	  We	  therefore	  could	  retrieve	  differences	  and	  similarities	  in	  the	  expression	  of	  Treg	  effector	  molecules,	  homing	  receptors	  as	  well	  as	  TFs	  in	  primary	  and	  in	  vitro	  expanded	  T	  cell	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subpopulations	  (chapter	  3.5).	  In	  line	  with	  work	  of	  Myara	  and	  colleagues	  we	  find	  that	  pRA-­‐Treg	  show	  more	  Treg-­‐specific	  effector	  molecules	  including	  GZMA	  and	  LAG3	  as	  compared	  to	  pRA+Treg	  (Miyara	  et	  al.	  2009).	  This	  observation	  supports	  the	  suggestion	  that	  pRA-­‐Treg	  contain	  Treg	  that	  are	  in	  “active	  suppression	  mode”.	  In	  vitro	  expanded	  eRA+Treg	  show	  similar	  expression	  of	  effector	  molecules	  as	  pRA+Treg.	  Interestingly,	  in	  vitro	  expansion	  clearly	  changes	  the	  expression	  of	  the	  homing	  receptor	  repertoire	  of	  eRA+Treg	  that	  resemble	  more	  pRA-­‐Treg	  in	  this	  aspect	  (chapter	  3.5).	  	  The	  coexpression	  of	  homing	  receptors	  and	  TFs	  of	  other	  T	  helper	  cell	  lineages	  is	  thought	  to	  drive	  gene	  expression	  programs	  that	  allows	  specialized	  Treg	  to	  localize	  and	  suppress	  immune	  responses	  of	  a	  certain	  type	  (Campbell	  and	  Koch	  2011).	  As	  an	  example,	  the	  Th1-­‐associated	  transcription	  factor	  T-­‐bet	  was	  shown	  to	  be	  essential	  for	  Treg-­‐mediated	  suppression	  of	  Th1	  inflammation	  in	  mice	  (Koch	  et	  al.	  2009).	  	  Expression	  of	  T-­‐bet	  in	  Treg	  also	  induced	  the	  expression	  of	  the	  chemokine	  receptor	  Cxcr3	  that	  enabled	  T-­‐bet+	  Treg	  to	  migrate	  to	  sites	  of	  Th1	  infections.	  These	  specialized	  Th-­‐like	  Treg	  subpopulations	  can	  be	  distinguished	  by	  homing	  receptor	  expression	  and,	  although	  still	  suppressive	  in	  vitro,	  by	  the	  expression	  of	  TFs	  and	  cytokines	  similar	  to	  their	  Th-­‐counterparts	  (Duhen	  et	  al.	  2012).	  We	  observed	  the	  expression	  of	  many	  Th-­‐associated	  homing	  receptors	  in	  pRA-­‐Treg	  including	  CXCR3,	  CCR4,	  CCR6,	  CCR8	  as	  well	  as	  CCR10,	  which	  are	  likely	  expressed	  only	  on	  different	  fractions	  of	  the	  pRA-­‐Treg	  pool	  and	  represent	  in	  parts	  the	  aforementioned	  specialized	  pRA-­‐Treg	  subpopulations.	  In	  line	  with	  chapter	  3.3,	  we	  observed	  higher	  expression	  of	  the	  Th17-­‐determining	  transcription	  factor	  RORC	  in	  memory	  T	  cell	  populations.	  Moreover,	  we	  also	  detected	  the	  Treg-­‐Th2	  differentiation	  phenotype	  (characterized	  by	  the	  expression	  profile	  of	  Th2-­‐related	  TFs	  and	  cytokines	  including	  GATA3,	  MAF,	  IL-­‐4,	  IL-­‐5	  and	  IL-­‐13)	  ascribed	  to	  FOXP3-­‐	  eRA-­‐	  “ex”Treg	  in	  the	  TSSs	  expression	  of	  the	  complete	  eRA-­‐Treg	  population	  (not	  separated	  in	  FOXP3+	  and	  FOXP3-­‐	  cells),	  which	  supports	  our	  earlier	  observations	  (chapter	  3.4).	  
4.3 Treg	  in	  the	  clinic	  and	  future	  perspectives	  In	  summary,	  our	  findings	  strongly	  support	  the	  use	  of	  pRA+Treg	  cells	  to	  generate	  cell	  products	  for	  clinical	  applications.	  Primary	  RA+Treg	  can	  be	  expanded	  in	  vitro	  to	  sufficient	  numbers	  and	  maintain	  stable	  FOXP3	  expression	  and	  suppressive	  function	  in	  contrast	  to	  pRA-­‐Treg	  that	  have	  proinflammatory	  potential	  (chapters	  3.3;	  3.4;	  3.5).	  The	  adoptive	  transfer	  of	  Treg	  to	  cure	  autoimmune	  diseases	  or	  to	  prevent	  transplantation-­‐related	  diseases	  such	  as	  graft	  versus	  host	  disease	  (GvHD)	  is	  well	  established	  in	  model	  systems	  (Cohen	  et	  al.	  2002;	  Hoffmann	  et	  al.	  2002a;	  Mottet	  et	  al.	  2003;	  Nguyen	  et	  al.	  2007)	  and	  is	  explored	  in	  first	  clinical	  trials.	  Ambitious	  pioneer	  experiments	  demonstrated	  longevity	  of	  administered	  in	  vitro	  expanded	  Treg	  in	  recipients,	  and	  no	  Treg	  product-­‐related	  toxicities	  were	  observed	  (Brunstein	  et	  al.	  2011a;	  Edinger	  and	  Hoffmann	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2011a).	  In	  another	  study,	  administered	  Treg	  were	  used	  to	  prevent	  GvHD	  in	  the	  absence	  of	  pharmacologic	  GvHD	  prophylaxis,	  encouraging	  further	  clinical	  trials	  (Di	  Ianni	  et	  al.	  2011b).	  However,	  many	  of	  the	  transplanted	  T	  cell	  pools	  contained	  high	  percentages	  of	  FOXP3-­‐	  cells.	  Our	  results	  suggest	  that	  these	  cells	  could	  result	  from	  CD45RA-­‐	  populations	  that	  might	  not	  be	  suppressive	  anymore	  when	  transplanted	  and	  can	  cause	  harm	  to	  the	  recipient	  by	  conversion	  to	  a	  proinflammatory	  Th-­‐like	  phenotype.	  Hence,	  we	  suggest	  using	  CD45RA+	  Treg	  as	  a	  starting	  population	  for	  in	  vitro	  expansion.	  Another	  strategy	  to	  obtain	  pure	  Treg	  products	  is	  the	  expansion	  of	  Treg	  with	  mTOR	  (mammalian	  target	  of	  rapamycin)	  inhibitors,	  which	  favors	  the	  expansion	  of	  Treg	  while	  inhibiting	  Tconv	  function	  and	  proliferation	  (Tresoldi	  et	  al.	  2011).	  However,	  mTOR	  inhibitors	  also	  induce	  FOXP3	  in	  Tconv	  and	  a	  contamination	  of	  proinflammatory	  Th	  cells	  in	  theses	  expansion	  cultures	  cannot	  be	  excluded	  (Edinger	  and	  Hoffmann	  2011a).	  Nevertheless,	  one	  has	  to	  take	  into	  account	  that	  RA+Treg	  significantly	  change	  the	  expression	  of	  many	  homing	  receptors	  upon	  in	  vitro	  expansion,	  which	  alters	  their	  migratory	  potential	  after	  transplantation	  and	  may	  influence	  therapy	  outcomes	  (chapter	  3.5).	  In	  future	  perspectives,	  our	  established	  DNA	  methylation	  markers	  at	  key	  Treg	  genes	  could	  be	  used	  to	  characterize	  the	  purity	  and	  proinflammatory	  potential	  of	  Treg	  products	  before	  administering	  them	  to	  patients.	  The	  requirements	  for	  this	  analysis	  are	  solely	  low	  amounts	  of	  high	  quality	  genomic	  DNA	  that	  can	  be	  obtained	  easily	  from	  the	  product	  (chapter	  3.2).	  DNA	  methylation	  fingerprints	  at	  lineage-­‐specific	  TFs	  as	  demonstrated	  for	  the	  RORC	  locus	  (chapter	  3.3)	  might	  be	  suitable	  to	  estimate	  the	  risk	  of	  converion	  to	  another	  phenotype.	  Of	  course,	  even	  small	  populations	  of	  Th	  cells	  could	  expand	  to	  large	  numbers	  in	  vivo,	  which	  may	  not	  be	  predictable	  with	  the	  actual	  level	  of	  knowledge.	  Nonetheless,	  possibilities	  and	  limitations	  of	  molecular	  fingerprinting	  in	  predicting	  cell	  identity	  and	  stability	  should	  be	  further	  elucidated.	  The	  newly	  developed	  methods	  to	  extract	  DNA	  and	  RNA	  from	  sorted	  human	  cells	  could	  shed	  more	  light	  into	  the	  important	  topic	  of	  cell	  stability,	  plasticity	  and	  heterogeneity	  (chapters	  3.2;	  3.4).	  For	  example,	  the	  TF	  Helios	  was	  suggested	  to	  be	  only	  expressed	  in	  thymus	  derived	  but	  not	  in	  induced	  Treg	  (Thornton	  et	  al.	  2010).	  By	  separating	  Helios+	  and	  Helios-­‐	  human	  Treg,	  one	  could	  analyze	  epigenetic	  fingerprint	  and	  gene	  expression	  to	  specify	  the	  differential	  molecular	  properties	  of	  these	  two	  populations.	  In	  addition,	  these	  techniques	  could	  be	  applied	  to	  Treg	  subpopulations	  that	  express	  transcription	  factors	  of	  other	  lineages	  to	  explore	  their	  molecular	  properties.	  Our	  mapping	  of	  DNA	  methylation,	  genome-­‐wide	  transcription	  factor	  binding	  as	  well	  as	  histone	  modifications	  (chapter	  3.5)	  open	  the	  possibility	  to	  explore	  the	  effect	  of	  drugs	  that	  alter	  signaling	  pathways	  or	  the	  epigenetic	  status	  of	  a	  cell.	  As	  an	  example,	  IL-­‐2	  pathway	  inhibitors	  that	  ultimately	  reduce	  or	  abrogate	  STAT5	  binding	  to	  its	  target	  genes	  were	  used	  in	  clinical	  settings	  to	  dampen	  effector	  T	  cell	  responses	  while	  retaining	  Treg	  function	  (Sewgobind	  et	  al.	  2010).	  With	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STAT5	  binding	  sites	  known	  in	  eTreg	  and	  eTconv	  (chapter	  3.5)	  it	  is	  possible	  to	  address	  changes	  in	  STAT5	  binding	  patterns	  upon	  IL-­‐2	  pathway	  blockade	  and	  explore	  for	  example	  the	  differences	  in	  sensitivity	  of	  Treg	  and	  Tconv	  to	  the	  respective	  treatments.	  Furthermore,	  histone	  deacetylase	  inhibitors	  (HDACi)	  inhibit	  the	  action	  of	  histone	  deacetylases	  (HDAC).	  The	  latter	  control	  the	  acetylation	  status	  of	  histone	  and	  non-­‐histone	  proteins	  including	  several	  transcription	  factors,	  which	  has	  impact	  on	  chromatin	  accessibility	  or	  protein	  stability,	  dimerization	  as	  well	  as	  DNA	  binding,	  respectively	  (Akimova	  et	  al.	  2012).	  Pan-­‐HDACi	  can	  inhibit	  a	  broad	  range	  of	  HDACs,	  but	  there	  are	  also	  substances	  that	  allow	  the	  targeted	  inhibition	  of	  specific	  HDACs.	  The	  use	  of	  HDACi	  has	  varying	  effects	  on	  different	  immune	  cells	  including	  Treg.	  In	  mice,	  trichostatin	  A	  (TSA)	  increased	  the	  number	  as	  well	  as	  suppressive	  abilities	  of	  Treg	  in	  vivo	  and,	  in	  conjunction	  with	  a	  short	  course	  of	  low-­‐dose	  rapamycin,	  induced	  permanent,	  Treg-­‐dependent	  cardiac	  and	  islet	  allograft	  survival	  and	  donor-­‐specific	  allograft	  tolerance	  (Tao	  et	  al.	  2007).	  Different	  classes	  of	  HDACi	  also	  increased	  the	  suppressive	  potency	  of	  primary	  and	  in	  vitro	  expanded	  human	  Treg	  (Akimova	  et	  al.	  2010).	  It	  is	  suggested	  that	  administration	  of	  the	  epigenetic	  drugs	  stabilizes	  Treg	  transcription	  factors	  including	  FOXP3	  as	  well	  as	  STAT5	  and	  induces	  the	  heat-­‐shock	  response	  to	  boost	  Treg	  function	  or	  survival,	  respectively	  (van	  Loosdregt	  et	  al.	  2010;	  Beier	  et	  al.	  2011).	  In	  addition,	  the	  expression	  of	  key	  Treg-­‐factors	  are,	  at	  least	  in	  part,	  correlated	  to	  the	  gene’s	  acetylation	  status	  as	  demonstrated	  for	  the	  FOXP3	  promoter	  (Mantel	  et	  al.	  2006).	  However,	  the	  molecular	  effects	  of	  HDACi	  application	  on	  immunologically	  important	  genes	  were	  not	  elucidated	  yet.	  With	  the	  genome-­‐wide	  distribution	  of	  H3K27ac	  available	  now	  (chapter	  3.5),	  one	  could	  study	  global	  and	  local	  changes	  in	  acetylation	  patterns	  caused	  by	  different	  HDACi	  to	  understand	  molecular	  mechanisms	  that	  underlie	  phenotypic	  changes	  in	  treated	  cell	  populations.	  Taken	  together,	  the	  molecular	  characterization	  of	  Treg	  and	  Tconv	  subpopulations	  presented	  here	  provides	  insights	  into	  basic	  principles	  of	  gene	  regulation	  and	  elucidates	  the	  impact	  of	  DNA	  methylation,	  histone	  modifications	  and	  transcription	  factor	  binding	  on	  cell	  type-­‐specific	  gen	  expression.	  Moreover,	  technical	  refinements	  of	  standard	  methodologies	  allowed	  the	  detailed	  analysis	  of	  the	  stability,	  heterogeneity	  as	  well	  as	  plasticity	  of	  T	  cell	  subsets	  and	  will	  be	  valuable	  to	  improve	  the	  therapeutic	  potential	  of	  T	  cell	  products	  for	  clinical	  applications.	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